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ABSTRACT 
 
XXX Pharmacy is an independently-owned retail pharmacy in Johannesburg.  Good 
Pharmacy Practice standards make it mandatory for pharmacists to provide 
“pharmaceutical care”, a highly patient-centred approach to providing pharmaceutical 
services.  Since XXX Pharmacy has a high patient load, a shortage of dispensary 
staff and a strategic focus on operational efficiency, the question arose whether 
pharmacists comply fully with Good Pharmacy Practice standards for the provision of 
pharmaceutical care.  Non-compliance poses operational risks that could undermine 
the business’s financial performance.  The research statement was thus that the 
current performance management system undermines compliance with Good 
Pharmacy Practice standards for the provision of pharmaceutical care to patients.   
 
A triangulation approach was used.  The quantitative research method, in which 200 
patients completed a questionnaire, investigated two research objectives: (i) whether 
the pharmacy complies with Good Pharmacy Practice standards for pharmaceutical 
care; and (ii) whether there is a relationship between patients’ race or gender and 
their responses.  The qualitative research method involved conducting individual 
semi-structured interviews with all four dispensary employees to achieve another two 
research objectives: (i) to determine whether the provision of pharmaceutical care is 
viewed as a key performance area by pharmacists; and (ii) to investigate what 
aspects of the implementation of the performance management system are viewed 
as enabling or undermining the provision of pharmaceutical care.   
 
At least 50% of patients perceive only two out of ten pharmaceutical care services as 
always being provided.  These two services relate to patient counselling.  The 
remaining pharmaceutical care services that are not always provided, according to 
patients, relate primarily to analysing the appropriateness of pharmacotherapy, 
including efficacy and side effects, assessing patient compliance and generic 
substitution.  Interview results support patient counselling being given preference 
over other pharmaceutical care services.  Although the racial group responding most 
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favourably to whether pharmaceutical care services are provided is African, and the 
gender responding most favourably is male, this cannot be conclusively confirmed.  
All pharmacists agree that the provision of pharmaceutical care is a key performance 
area and there are several commendable aspects of the performance management 
system, but there are ten key weaknesses in this which have the potential to 
undermine compliance with Good Pharmacy Practice standards.  These weaknesses 
extend from inadequacies relating to the pharmacy’s vision and mission statement; 
to poor awareness of Good Pharmacy Practice standards; to the absence of 
fundamental documentation, such as job descriptions, and performance appraisals; 
confusion regarding performance objectives; inadequate training and development; 
misunderstandings regarding rewards; problems with management style and the 
organisational culture; to a shortage of dispensary staff.  Prominent findings are that 
time pressures contribute to it being difficult to provide pharmaceutical care, and that 
a key performance target is to serve customers as quickly and efficiently as possible.   
 
In addressing the above weaknesses in the performance management system, five 
recommendations are made: (i) conducting a training session, at which dispensary 
employees can learn about Good Pharmacy Practice standards and important 
pharmacy-related information, and provide input into aspects of the performance 
management system; (ii) the owner-manager using this feedback to develop key 
documents that are either absent or weakly developed, in alignment with Good 
Pharmacy Practice standards, and the use of these as performance management 
tools; (iii) the introduction and implementation of a performance appraisal process 
and linking this to a training and development programme and rewards system; (iv) 
developing an open communication culture that promotes the enactment of the 
values of pharmaceutical care; and (v) employing two pharmacist interns over a 
period of two years.  For the first four recommendations, a comprehensive 
implementation plan is proposed, detailing desired outcomes, key activities, 
responsible stakeholders and expected costs and timelines, to allow for weaknesses 
in the performance management system to be addressed within 11 weeks, and for 
key activities to be initiated that can then be performed at specified intervals.  These 
recommendations could potentially enhance XXX Pharmacy’s compliance with Good 
Pharmacy Practice standards for the provision of pharmaceutical care to patients.   
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CHAPTER ONE: INTRODUCTION AND BACKGROUND TO THE PROBLEM 
 
1.1 Problem in context 
 
XXX Pharmacy is an independently-owned retail pharmacy1 located in a residential 
area in Johannesburg, South Africa.  The pharmacy is situated in a medical centre, 
opposite a private hospital.  Due to its location, the pharmacy has long trading hours 
and is very busy.  The high patient load, as well as a shortage of pharmacists and 
pharmacist’s assistants, has contributed to the owner-manager2, who has owned the 
pharmacy for five years and worked in it for eleven years, adopting a strategy of 
increasing operational efficiency.   
 
The current performance management system (PMS) reflects this focus on 
efficiency, with minimal time afforded to individual pharmacist-patient3 interactions 
and an emphasis on the use of financial, quantitative key performance indicators 
(KPIs), such as sales figures and the number of prescriptions dispensed.  During 
busy times, pharmacists often have no direct interaction with patients, as front-shop 
assistants serve as intermediaries, bringing prescriptions to the dispensary and 
transporting the processed medication to patients.  Pharmacists thus have little, if 
any, time to communicate directly with patients and provide pharmaceutical care. 
 
Providing “pharmaceutical care” is a core function of pharmacists, according to Good 
Pharmacy Practice (GPP) in South Africa standards, published by the South African 
Pharmacy Council (SAPC) (South Africa. SAPC, 2010a: 3), a statutory body 
overseeing pharmacy practice in the country.  This 2010 version of the GPP 
standards is the fourth edition; pharmaceutical care has been the guiding paradigm 
                                                            
1
  A “retail pharmacy” is also referred to as a “community pharmacy”. 
2
  The owner-manager can also be referred to in this case as the “responsible pharmacist” or 
“managing pharmacist”. 
3
  “Patients” and “customers” will be used interchangeably in this report. 
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of pharmacy practice expressed in GPP standards since at least the second edition, 
published in 2004 (South Africa. SAPC, 2004).  The GPP standards outline 
standards for the provision of pharmaceutical care; Human Resource Management 
(HRM) and general management standards for pharmacies that facilitate the 
provision of pharmaceutical care; the scope of practice of pharmacists, pharmacist 
interns and pharmacist’s assistants; and other standards regulating pharmacy 
practice in South Africa.  The GPP standards have their genesis in the Pharmacy Act 
53 of 1974 (South Africa. National Parliament, 1974) and the Medicines and Related 
Substances Act 101 of 1965 (South Africa. National Parliament, 1965). 
 
Pharmaceutical care is a highly patient-centred approach to providing 
pharmaceutical services and aims to provide quality, safe and optimal 
pharmacotherapy to patients.  According to GPP standards (South Africa. SAPC, 
2010a), a pharmacist and not a pharmacist’s assistant provides pharmaceutical care.  
The SAPC (South Africa. SAPC, 2010a: 3) describes pharmaceutical care as “taking 
responsibility for the patient’s medicine4-related needs and being accountable for 
meeting these needs”.   
 
Pharmaceutical care is thus not limited to the relatively technical function of 
processing a prescription, either manually or on computer, and issuing medication to 
a patient.  According to GPP standards, it also encompasses other functions, such 
as (South Africa. SAPC, 2010a):  
(i) Ensuring that each patient’s pharmacotherapy is appropriate, for example in 
terms of dosage and medical condition(s);  
(ii) Detecting drug interactions amongst various drugs that a patient may be 
taking;  
(iii) Detecting adverse effects;  
(iv) Determining whether patients are compliant5 with their pharmacotherapy;  
                                                            
4
  “Medicine”, “medication” and “drug” will be used interchangeably in this report. 
5
  Patient compliance refers to whether patients take their medication exactly as prescribed 
(see glossary on page 276). 
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(v) Counselling6 patients adequately about their medication so that medication is 
used safely and correctly;  
(vi) Counselling patients regarding possible dietary modifications;  
(vii) Liaising with other health-care professionals, such as prescribers, when 
necessary; and 
(viii) Performing a medication review of a patient’s pharmacotherapy, for example if 
requested to do so by a patient or other health-care professional.  This review 
would include an assessment phase, formulation of a care plan and a follow-
up evaluation to assess patient outcomes. 
 
These, and additional, standards also apply to the provision of over-the-counter 
(OTC) medication to patients (South Africa. SAPC, 2010a). 
 
It is evident that providing pharmaceutical care is time-intensive, as time is required 
to elicit all the required information from a patient, analyse each patient’s 
pharmacotherapy and provide adequate patient counselling.  Given the focus of the 
current PMS of XXX Pharmacy on efficiency, pharmacists are faced with the 
challenge of finding sufficient time for this information exchange that is necessary 
between pharmacist and patient in order for pharmaceutical care to be provided.  
GPP standards also stipulate that cheaper, generic medication be offered to patients 
(South Africa. SAPC, 2010a).  Under the current PMS, pharmacists and the 
pharmacist’s assistant are expected to follow the working practices and preferences 
of the owner-manager, one of which does not encourage generic substitution unless 
the patient requests it or the patient’s medical aid does not cover the original brand.   
 
The PMS for front-shop assistants is highly formalised and structured, with written 
job descriptions and regular performance appraisals.  However, there are no written 
job descriptions for dispensary staff (i.e. pharmacists and the pharmacist’s assistant) 
and no regular performance appraisals for these employees.  This contrasts with the 
requirements for HRM practices in Chapter 3 of the GPP standards (South Africa. 
                                                            
6
  In the context of pharmaceutical care, “counselling” refers to providing patients with 
information and advice (see glossary). 
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SAPC, 2010a).  The absence of written job descriptions, with clearly-defined roles 
and responsibilities, increases the risk that the pharmacist’s assistant works outside 
her scope of practice, as defined by GPP standards (South Africa. SAPC, 2010a).  
Furthermore, although GPP standards outline the responsibilities of pharmacists in 
the sale of OTC medication, in this pharmacy front-shop assistants usually manage 
the sale of these.  A consultant developed a comprehensive set of Standard 
Operating Procedures (SOPs) for the pharmacy, which are closely aligned with GPP 
standards and came into effect in August 2009.  There are no employee signatures, 
however, to confirm that employees have read and are aware of these SOPs.   
 
Non-compliance with GPP standards has potentially serious implications for 
individual pharmacists, the pharmacist’s assistant and the pharmacy.  These include 
legal and professional risks, which could be costly, as well as the increased risk of 
patient morbidity or mortality due to drug-related problems (DRP). 
 
1.2 Problem review 
 
Appendix H contains a mind-map showing the unravelling of the research problem.  
From this mind-map, the following emerging themes highlight the dissonance 
between the way in which the performance of pharmacists and the pharmacist’s 
assistant is managed in the pharmacy, and GPP standards for the provision of 
pharmaceutical care to patients outlined by the SAPC (South Africa. SAPC, 2010a). 
 
1.2.1 Adoption of a strategy of increased operational efficiency 
 
The current PMS for pharmacists and the pharmacist’s assistant focuses on 
operational efficiency and increasing sales revenue.  The latter is in alignment with 
the organisation’s existence as a profit-seeking entity.  The imperative for efficiency 
has arisen due to the high patient load and shortage of dispensary employees.  
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According to the owner-manager, an average of 250-280 prescriptions is dispensed 
daily, in addition to OTC medication.  There are two full-time pharmacists, including 
the owner-manager; one locum pharmacist, who works twice a week; and one 
pharmacist’s assistant.  The owner-manager ascribes the shortage of dispensary 
staff to individuals being unwilling to work his long trading hours of thirteen hours 
daily.  It also reflects the national shortage of pharmacists and pharmacist’s 
assistants highlighted by the Department of Labour (South Africa. Department of 
Labour, 2008). 
 
There are a total of twenty front-shop assistants, who work different shifts.  Front-
shop assistants are the first and last points of contact between the pharmacy and 
patients or customers.  The fact that the PMS for these employees is so well-
developed, with a key role in the job description of these employees being to ensure 
efficiency and quality customer services, reflects the strategic focus on efficiency.   
 
1.2.2 Limitations of the current choice of KPIs 
 
The KPIs used are primarily financial and quantitative in nature.  The use of sales 
figures, for example, as well as the preferences of the owner-manager, has the 
potential to discourage pharmacists from offering generic medication (see 1.2.3).  
Another KPI used is the number of prescriptions processed daily and monthly; this 
has the potential to discourage pharmacists from spending time with patients, as 
pharmacists work more speedily to accumulate higher prescription totals.   
 
Performance standards for the dispensary include the time to process a prescription 
on computer and collect the required medication, which is not expected to exceed a 
few minutes.  Current practices minimise communication time between pharmacists 
or the pharmacist’s assistant and individual patients, thus decreasing queuing times, 
increasing efficiency and allowing more prescriptions to be processed, thereby 
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increasing revenue.  The performance standards and KPIs used thus do not reflect 
the qualitative components of the pharmaceutical service provided.  Furthermore, it 
is not known whether pharmacists view the provision of pharmaceutical care as a 
key performance area, since there are no performance standards and KPIs for this, 
and no job descriptions that would highlight pharmacists’ key performance areas.   
 
1.2.3 Potential non-compliance with GPP standards for professional services 
 
The tension created between the current organisational drive for efficiency, 
increased profitability and rapid patient turnover, and the need to have sufficient time 
to provide pharmaceutical care, raises the question whether the current PMS allows 
pharmacists time and a supportive framework within which to comply fully with the 
standards for professional services in Chapter 2 of the GPP standards (South Africa. 
SAPC, 2010a).  These include analysing each prescription for drug interactions, 
appropriateness for the individual patient, and providing adequate patient 
counselling, so that optimal pharmaceutical care is provided. 
 
Although providing pharmaceutical care is a function of pharmacists, it is within the 
scope of practice of pharmacist’s assistants (South Africa. SAPC, 2010a) to provide 
patient counselling regarding pharmacotherapy, a key aspect of pharmaceutical 
care, under the supervision of a pharmacist.  It is not known whether performing this 
function is viewed as a key performance area for the pharmacist’s assistant, since 
she does not have a written job description. 
 
Finally, not offering patients the option of generic substitution infringes s2.7.3.11 of 
the GPP standards (South Africa. SAPC, 2010a), as well as s22F of the Medicines 
and Related Substances Act 101 of 1965 (South Africa. National Parliament, 1965), 
which state that generics must be offered except in certain circumstances, such as if 
the prescriber writes next to the item on the prescription that it cannot be substituted, 
Dr Layla Cassim 72076984  Research Report MBA 5932 
7 
 
the cost of the generic is higher than that of the original product, or the item has 
been declared non-substitutable by the Medicines Control Council.   
 
1.2.4 Potential non-compliance with GPP standards for management 
practices 
 
Chapter 3 of the GPP standards (South Africa. SAPC, 2010a) focuses on standards 
for HRM, whilst Chapter 4 includes general management standards.  These are 
intended to facilitate the provision of a high quality, efficient pharmaceutical service 
embodying the principles of pharmaceutical care (South Africa. SAPC, 2010a).  
Many of these standards are performance management-related, and thus of 
particular relevance in this research. 
 
Chapter 3 includes standards prescribing the scope of practice of pharmacy 
personnel; having written job descriptions for all pharmacy employees; orientation 
and training when employees are appointed; performance objectives being set, in 
consultation with employees, at least once a year; regular performance appraisals, 
which includes employees’ self-assessment of their performance; rewards reflecting 
performance outcomes; employee participation in the activities of professional 
bodies being promoted; a training plan and development programme for employees; 
employees having self-development plans; standards for continuing professional 
development (CPD); and pharmacists being covered by professional indemnity7 
(South Africa. SAPC, 2010a). 
 
Chapter 4 includes standards relating to having sufficient pharmacists and support 
staff to provide a pharmaceutical service; clearly allocating employee responsibilities 
and duties; compliance with all SAPC standards and relevant legislation; having a 
                                                            
7
  Professional indemnity is a form of insurance which would cover the pharmacist to a 
certain monetary value in the event of him/ her facing a legal risk arising from his/ her 
professional work.  An example of such a legal risk is a patient suing the pharmacist.  
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mission statement that is understood by all employees and aligned with the 
principles of pharmaceutical care; having quality and business objectives, which 
should be reviewed at least once a year; standards for a Quality Improvement Plan, 
including the development of SOPs, which must be adhered to; monitoring the 
effectiveness of the pharmacy, including the health outcomes of patients; and 
developing inter-professional relationships with other health-care professionals 
(South Africa. SAPC, 2010a). 
 
It is not known to what extent the pharmacy is compliant with all the above 
standards.  There is the risk that the pharmacist’s assistant and front-shop assistants 
perform functions outside their scope of practice, with the latter often managing the 
sale of OTC medication.  There are no written job descriptions, regular performance 
appraisals or a structured induction and orientation programme for the pharmacists 
and pharmacist’s assistant.  There is a shortage of dispensary staff; there is no 
mission statement; and employees have not signed the SOPs developed for the 
pharmacy, leading one to assume that they have not read these.  This indicates that 
many of the required performance management-related tools are not in place. 
 
It is not known whether the pharmacy is required to be compliant with the 
Employment Equity Act 55 of 1998 (South Africa. National Parliament, 1998), 
another standard in Chapter 3 of the GPP standards.  This is because although there 
are fewer than 50 employees, it is not known whether the pharmacy’s annual 
turnover exceeds R15 million, in which case it would have to comply with this Act.  
Fifteen million Rand is the threshold for retail trade in schedule 4 of the Employment 
Equity Act.  Retail trade in pharmaceuticals is classified under retail trade in the 
Standard Industrial Classification of All Economic Activities (Statistics South Africa, 
1993).  The pharmacy’s turnover is unknown as the owner has not divulged financial 
results (see 1.6).  All dispensary employees, however, are from designated groups8.   
  
                                                            
8
  “Designated groups” are defined in s1 of the Employment Equity Act 55 of 1998 as Black 
people, women and people with disabilities (South Africa. National Parliament, 1998). 
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1.2.5 Risks associated with non-compliance with GPP standards 
 
Non-compliance with GPP standards outlined by the SAPC (South Africa. SAPC, 
2010a), besides potentially leading to patient harm and an increase in the incidence 
of DRP, has legal and professional risks.  Although, according to the owner-
manager, there have been no complaints to the SAPC about the pharmacy, s35A(d) 
of the Pharmacy Act 53 of 1974 (South Africa. National Parliament, 1974) mandates 
the SAPC to inspect pharmacies.  Non-compliance with GPP standards could lead to 
disciplinary action being taken against individual pharmacists, the pharmacist’s 
assistant and/ or the pharmacy.   
 
1.3 Research statement 
 
“The current PMS for pharmacists and the pharmacist’s assistant undermines 
compliance with GPP standards for the provision of pharmaceutical care to patients”. 
 
1.4 Research objectives 
 
The objectives of this research are: 
i) To examine whether the pharmaceutical services provided by pharmacists 
and the pharmacist’s assistant comply fully with GPP standards for 
pharmaceutical care; 
ii) To assess whether patients’ perceptions of whether various pharmaceutical 
care services are performed by the pharmacy vary with the demographic 
profile of patients; 
iii) To determine whether pharmacists view the provision of pharmaceutical care 
as a key performance area; and 
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iv) To investigate which aspects of the implementation of the PMS are viewed by 
pharmacists and the pharmacist’s assistant as enabling or undermining the 
provision of pharmaceutical care. 
 
1.5 Significance of the study 
 
This research could potentially identify areas of non-compliance with GPP standards 
for pharmaceutical care, as outlined by the SAPC (South Africa. SAPC, 2010a).  
Such non-compliance poses legal and professional risks to pharmacists, the 
pharmacist’s assistant and the pharmacy.  Identifying possible areas of non-
compliance is thus a necessary first step in taking appropriate corrective action, so 
that the compliance of the pharmacy and its employees with the standards 
surrounding pharmacy practice in South Africa is enhanced further. 
 
Moreover, identifying aspects of the PMS that undermine the provision of 
pharmaceutical care highlights weaknesses in the current PMS that need to be 
addressed in order to improve individual and organisational performance in providing 
optimal pharmaceutical care.  Increased compliance with GPP standards for 
pharmaceutical care has the potential to enhance the quality of pharmaceutical 
services provided to patients, contributing towards enhanced patient safety, 
therapeutic efficacy and customer satisfaction.   
 
Finally, there is a scarcity of literature on PMSs in small, medium and micro 
enterprises (SMMEs), particularly in the retail pharmacy environment.  There is no 
literature published, to the author’s knowledge, on whether patients’ perceptions and 
expectations of pharmaceutical care vary with the demographic profile of the patient, 
or the effects of a PMS on the provision of pharmaceutical care in South Africa.  It is 
hoped that this research thus contributes to knowledge creation in these areas.   
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1.6 Delineation of the research 
 
This research is conducted in the retail sector of pharmacy practice.  The many other 
sectors of pharmacy practice, such as the hospital, institutional and industrial 
sectors, will not be included.  This study is also conducted in the private sector, and 
not in a public-sector pharmacy. 
 
The research is conducted at one independently-owned retail pharmacy in 
Johannesburg, South Africa.  There were two reasons for choosing an 
independently-owned pharmacy:  
(i) Independently-owned pharmacies in South Africa have been under increasing 
competition since 2004 from private-sector retailers, such as New Clicks 
Holdings, Shoprite and Pick ‘n Pay, which have opened pharmacies in their 
stores (Shevel, 2008; New Clicks Holdings, 2008).  Due to their larger 
purchasing power, these retailers are able to offer lower prices, leading to the 
closure of many small, independently-owned pharmacies (Shevel, 2008).  It 
was thus decided to investigate performance management within a pharmacy 
facing these competitive pressures; and 
(ii) There are not many studies reported in the literature on PMSs in SMMEs, 
particularly in the retail pharmacy environment (see 1.5).   
 
The pharmacy in this study was chosen primarily due to the willingness of the owner-
manager for this research to be conducted at his pharmacy.  The name of the 
pharmacy, however, cannot be disclosed, due to a confidentiality agreement with the 
owner-manager.  He has also declined to share financial information with the author. 
 
XXX Pharmacy will be referred to as operating in the SMME sector, but it cannot be 
classified further as a medium, small, very small or micro enterprise according to the 
schedule in the National Small Business Act 102 of 1996 (South Africa. National 
Parliament, 1996), because the pharmacy’s total annual turnover is not known. 
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The PMS that is investigated is that for pharmacists and the pharmacist’s assistant 
only.  XXX Pharmacy does not employ any pharmacist interns at the time of this 
research.  Front-shop assistants were not interviewed, as according to GPP 
standards (South Africa. SAPC, 2010a) the provision of pharmaceutical care is the 
responsibility of pharmacists.  Information on whether front-shop assistants are 
providing pharmaceutical services, which is the function of pharmacists and 
pharmacist’s assistants according to GPP standards (South Africa. SAPC, 2010a), is 
obtained through the questionnaire administered to patients and interviews with 
pharmacists and the pharmacist’s assistant. 
 
The legislation referred to is legislation passed by the National Parliament of the 
Republic of South Africa.  Reference to an Act also includes amendments made to 
the Act. 
 
Sections 3(c), 3(e)(iii)-(iv) and 35A of the Pharmacy Act 53 of 1974 (South Africa. 
National Parliament, 1974) require the SAPC to establish GPP standards in South 
Africa.  The compliance of pharmacists and the pharmacist’s assistant in XXX 
Pharmacy with a selection of these standards is assessed.  The questions asked in 
the questionnaire are limited to probing compliance with selected, relevant standards 
in Chapter 2 (“Professional standards for services: minimum standards for services 
provided in a pharmacy”) (South Africa. SAPC, 2010a: 43-190) and Appendix A 
(“Scope of practice of pharmacy personnel”) of the GPP standards (South Africa. 
SAPC, 2010a: 222-231).  In order to keep the questionnaire short and user-friendly, 
as patients might not otherwise be willing to complete it, compliance with only a 
selection of GPP standards has been investigated.  The probing of standards that 
are specifically non-technical in nature, i.e. those related to the analysis of 
pharmacotherapy to ensure it is appropriate for individual patients and those related 
to patient counselling, were selected, because these relate more specifically to the 
“expanded role” of pharmacists, as described by Assa-Eley and Kimberlin (2005: 
44), as providers of pharmaceutical care.  GPP standards relating to other sectors of 
pharmacy practice, such as the institutional and wholesale sectors, were excluded, 
as many of these are not relevant for a retail pharmacy.   
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The interview questions are based on selected, relevant standards in Chapter 2, 
Chapter 3 (“Professional standards for pharmacy human resources: minimum 
standards for human resources in (sic) pharmacy”), Chapter 4 (“Professional 
standards for pharmacy management: minimum standards for management of the 
pharmacy/ pharmaceutical service”) and Appendix A of the GPP standards (South 
Africa. SAPC, 2010a: 43-231).  In order to keep the interview relatively short, given 
the time commitments of all interviewees, compliance with only selected GPP 
standards is probed.  There is more of a focus on standards in Chapters 3 and 4, as 
there is greater emphasis on performance management in these chapters.   
 
Chapters 3 and 4 (South Africa. SAPC, 2010a) consider a PMS holistically and in an 
integrated manner with other business-related processes, including the planning 
phase; the development of relevant business documentation, such as job 
descriptions and performance objectives; performance appraisal; quality 
management; training and development (T&D); and rewards.  All these aspects of an 
integrated PMS are considered in this research. 
 
Compliance with Chapter 1 (“Professional standards for premises: minimum 
standards for pharmacy premises, facilities and equipment”) of the GPP standards 
(South Africa. SAPC, 2010a: 9-42) is not considered, with the exception of sections 
1.2.1(e) and 1.6.1(g), which state that a pharmacist and post-basic pharmacist’s 
assistant, respectively, must wear a name tag that identifies the individual to the 
public and states his/ her designation.  These two standards are included in the 
present study, as the identification of the designation of these individuals reflects the 
scope of practice of pharmacists and pharmacist’s assistants, which is a component 
of this research. 
 
Finally, the patients participating in this study had to be functionally literate in 
English, in order to complete the questionnaire by themselves.  Patients also had to 
be eighteen years or older.  Employees of the pharmacy were not permitted to 
complete a questionnaire. 
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1.7 Definition of terms 
 
“Pharmaceutical care” is described by the SAPC (South Africa. SAPC, 2010a: 3) as 
“taking responsibility for the patient’s medicine-related needs and being accountable 
for meeting these needs”.  A “drug-related problem” (DRP) is defined by the 
Pharmaceutical Care Network Europe (PCNE) Foundation (2010: 2) as “an event or 
circumstance involving drug therapy that actually or potentially interferes with desired 
health outcomes”.  A glossary of other pharmaceutical terminology used in this report 
is provided on page 276. 
 
1.8 Assumptions 
 
The appropriateness of GPP standards (South Africa. SAPC, 2010a) will not be 
evaluated.  This research assumes that since GPP standards are legally mandatory 
for dispensary employees, any PMS is obliged to promote compliance with these 
standards.  Many of the same questions or statements have also been posed to the 
interviewees and patients, in order to detect discrepancies.  Nevertheless, it is 
assumed that all participants will be honest in their responses.   
 
1.9 Chapter overview 
 
In the second chapter, two business models will be applied to the research problem.  
Chapter three is a literature review, whilst chapter four details the research design 
and methodology employed.  Chapter five will present the results of this study, and 
these will be discussed in chapter six.  This research report will conclude with 
chapter seven, in which the summary of research findings, commendations, final 
conclusions, recommendations, possible barriers to implementing these 
recommendations and ways in which these can be addressed, as well as 
suggestions for future research, will be provided.    
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CHAPTER TWO: PROBLEM ANALYSIS 
 
2.1 Introduction 
 
Cameron’s (2006a: 120) “elaborated model” of a PMS and Parasuraman, Zeithaml & 
Berry’s (1985) “quality gaps model” cited in Stapleton (2007: 122) will be applied to 
the research problem in this chapter, in order to gain deeper understanding of the 
complexity of the research problem.  It should be noted that the information related 
to the pharmacy provided in this chapter and in the preceding chapter, is preliminary 
information.  This preliminary information is based on the author having spent time in 
the pharmacy; familiarising herself with the layout, processes and practices in the 
pharmacy; having had several informal discussions with the owner-manager in 
recent years; and from reviewing relevant business documentation, such as the 
minutes of staff meetings, SOPs and the job descriptions of front-shop assistants.   
 
2.2 Analysing the pharmacy’s PMS 
 
In Cameron’s (2006a: 120) “elaborated model’, there is the horizontal integration of 
processes such as individual objective setting, T&D, performance appraisal and 
rewards; and the vertical integration of organisational strategy, departmental goals 
and individual objectives.  This model is applied to the pharmacy in Figure 1 on the 
next page.  Each component will subsequently be discussed in more detail.  A 
limitation of the model is that it does not refer to staffing.  Section 4.1(b) of the GPP 
standards (South Africa. SAPC, 2010a) states that there must be sufficient 
pharmacists and support staff to provide pharmaceutical services.  Including 
pharmaceutical care, which is time-intensive (see 1.1), as a key performance area 
may necessitate employing additional pharmacists and pharmacist’s assistants, in 
order to maintain operational efficiency.  The model has also been adapted by 
including the vision of the pharmacy as impacting on its strategies.   
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Figure 1: Analysing the pharmacy’s PMS by adapting Cameron’s (2006a: 
120) “elaborated model” 
  
Develop and communicate the 
pharmacy's strategies:  
Strategy of increased operational 
efficiency developed due to high 
patient load & shortage of dispensary 
staff. Strategy is well communicated to 
employees verbally.  Another strategy 
is increasing sales revenue. No 
strategy to allow for & enhance 
provision of pharmaceutical care to 
patients.
Dispensary strategies, goals:  
Strategies of increased operational 
efficiency in dispensing prescriptions & 
increasing sales revenue.  Goals include 
decreasing time to process prescriptions & 
collect medication, & decreasing patient 
waiting times. No strategies & goals for 
providing pharmaceutical care.
Individual objective setting 
for pharmacists & the 
pharmacist's assistant:  No 
written job descriptions or regular 
discussions to agree on individual 
objectives.  Employees have not 
signed to confirm that they have 
read SOPs, which emphasise 
compliance with GPP standards. 
No SOPs for dispensing 
prescriptions & provision of OTC 
medication. Main KPIs are sales 
figures & prescription totals. No 
KPIs, objectives & performance 
standards for provision of 
pharmaceutical care. Task of 
dispensing prescription not 
expected to exceed a few minutes.    
Performance evaluation/ 
appraisal:  No regular performance 
appraisals.  Owner-manager has 
informal discussions with 
pharmacists/  pharmacist's assistant 
if performance does not meet his 
expectations, or if he receives 
negative feedback from patients.  
Performance is not measured against 
SOPs, which would promote 
compliance with GPP standards.
T&D: No regular skills needs 
analyses or structured T&D 
programme, which would 
contribute to pharmacists being 
technically competent to 
provide pharmaceutical care & 
also developing necessary non-
pharmaceutical skills. 
Rewards  
(financial & non-financial):  
Pharmacists & pharmacist's assistant 
receive a salary; locum pharmacist is 
paid for number of hours worked. No 
specific incentive to provide 
pharmaceutical care.  Minutes of 
meetings do not reflect that excellent 
individual performance is recognised at 
staff meetings, held approximately 
every 1-2 months.
Career advancement:  
Limited potential for career advancement, 
as pharmacy is small & owner is also the 
manager.  Assuming added responsibilities 
of pharmaceutical care thus unlikely to 
result in career progression within 
pharmacy, & arguably cannot be viewed in 
this light as pharmaceutical care is 
mandatory.  
Agree on new 
objectives: 
No regular 
discussions to 
assess 
appropriateness of 
objectives, or set 
new objectives. 
Pharmacy’s 
vision:   
No explicitly-stated 
vision.  There is no 
mission statement 
which, according to 
GPP standards 
(South Africa. 
SAPC, 2010a), 
should be closely 
aligned to the 
principles of 
pharmaceutical 
care.  Thus no top-
level expression of 
commitment to the 
philosophy of 
pharmaceutical 
care. 
Review PMS:  Not performed in a structured manner, on a regular basis.  Owner-
manager addresses specific components if he feels it is necessary, usually in response 
to his assessment of underperformance in that area.  This approach does not promote 
gaps in the PMS, such as provision of pharmaceutical care not being a key 
performance area, from being proactively detected. 
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2.2.1 Pharmacy’s vision 
 
Organisational vision is not a component of the model, but rather provides the 
strategic direction for the PMS.  It is not known whether XXX Pharmacy has a vision 
and what this is, as there is no written vision advertised to patients and the wider 
public, for example as a slogan on the dispensary wall.  There is thus no explicitly-
stated commitment to the provision of pharmaceutical care, or an expressed 
recognition of the interests of a wide range of stakeholders, such as patients, the 
community and other health-care professionals, that is reflected in the principles of 
pharmaceutical care, as described by the SAPC (South Africa. SAPC, 2010a).   
 
Furthermore, there is no explicit mission statement, which would reflect the 
pharmacy’s vision and which should be in alignment with the principles of 
pharmaceutical care, according to s4.2.1.1(e) and s4.2.1.1(f) respectively of the GPP 
standards outlined by the SAPC (South Africa. SAPC, 2010a).  This could result in 
ambiguity for employees and patients regarding the pharmacy’s core functions. 
 
2.2.2 Organisational strategy 
 
Following the lack of an explicitly-stated vision of pharmaceutical care, there is no 
articulated organisational strategy to ensure the provision of pharmaceutical care, 
suggesting that providing pharmaceutical care is not regarded as a strategic priority. 
 
2.2.3 Functional strategy and goals 
 
In the dispensary, there are also no written, explicitly-stated strategies for the 
provision of pharmaceutical care.  There is thus no guidance to pharmacists on how 
to provide pharmaceutical care, or what the goals of such a service are.  The owner-
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manager revealed to the author that he does not have any strategic and business 
plans for the dispensary or the pharmacy. 
 
2.2.4 Individual objective setting 
 
This component is particularly problematic.  The absence of written job descriptions 
for dispensary staff and regular discussions to agree on performance objectives, 
required in s3.2.1(a) and s3.2.2(a) of the GPP standards (South Africa. SAPC, 
2010a), respectively, has the potential to result in uncertainty regarding roles, 
responsibilities and the execution of key performance areas.  This could adversely 
affect employee motivation and effective teamwork.  There is also an increased risk 
that pharmacists do not fulfil all their responsibilities outlined in GPP standards 
(South Africa. SAPC, 2010a) and that the pharmacist’s assistant and non-dispensary 
employees perform pharmaceutical functions that they are not entitled to perform.   
 
There are no objectives for the delivery of pharmaceutical care.  Cameron (2006a) 
classifies two types of objectives, namely tasks and targets.  Although providing 
pharmaceutical care includes a number of tasks (see 1.1 and the next page), there 
are no clearly-articulated tasks and targets relating to pharmaceutical care in XXX 
Pharmacy.  There are also no specific KPIs and performance standards for the 
provision of pharmaceutical care, which increases the likelihood that pharmacists do 
not view the provision of pharmaceutical care as a key performance area.   
 
As discussed in 1.2.2, the KPIs and performance standards do not promote 
pharmacists spending time communicating with patients.  The use of primarily 
quantitative, financial KPIs and performance standards undermines the importance 
of qualitative aspects of pharmaceutical service delivery, such as whether patients 
understand how to take medication correctly.  These qualitative aspects are critical in 
providing pharmaceutical care. 
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The expectation that pharmacists follow the owner-manager’s working preferences is 
a form of managerial control.  Whilst this may be advantageous in promoting 
consistency in service delivery and maintaining the quality standards set by the 
owner-manager, a disadvantage is that preferences of the owner-manager that are 
in conflict with GPP requirements (see 1.2.3), become established.   
 
Since the SOPs became effective in August 2009, there have been no signatures 
confirming employee awareness of these SOPs.  This highlights that ensuring 
adherence to these SOPs has not been a strategic priority for the dispensary, or a 
key performance area for pharmacists and the pharmacist’s assistant.  Furthermore, 
the owner-manager’s practice of not always offering generic medication contrasts 
with the SOP for generic substitution, indicating that he does not view compliance 
with this SOP as important. 
 
Analysis of the SOPs reveals that whilst there are SOPs for the handling of 
medication and whilst the SOPs mention the need to adhere to GPP standards, none 
of these includes the procedure to be followed in dispensing a prescription or 
providing OTC medication.  According to s2.7.1 of the GPP standards (South Africa. 
SAPC, 2010a), dispensing consists of three phases: (i) prescription interpretation 
and assessment; (ii) preparing and labelling medication; and (iii) patient counselling.  
Phase (i) is not within the scope of practice of a pharmacist’s assistant, according to 
s1.2(g) in Appendix A of the GPP standards (South Africa. SAPC, 2010a).  Phases 
(i) and (iii) are particularly important in ensuring that pharmaceutical care is provided, 
as described in s1.5.1(a) of Appendix A of the GPP standards (South Africa. SAPC, 
2010a).  Whilst not suggesting that an SOP covering these three phases should be 
overly prescriptive, some guidelines for the pharmacists and pharmacist’s assistant 
to follow could be beneficial in creating a structure and paradigm of practice that 
facilitates the provision of pharmaceutical care, by ensuring that the focus is not 
predominantly on the primarily technical phase (ii).   
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The absence of an SOP for dispensing a prescription could thus contribute to 
difficulty and potential inefficiency in providing pharmaceutical care, as there are no 
practical, agreed-upon steps to be followed.  Although there is likely to be variability 
in information exchanges between pharmacists or the pharmacist’s assistant and 
patients, a standard set of questions and responses could promote efficient, effective 
information exchange.  An SOP for the provision of OTC medication could, likewise, 
introduce a structured way of practice that facilitates pharmacists and the 
pharmacist’s assistant complying with requirements for the provision of OTC 
medication in s2.12 of the GPP standards (South Africa. SAPC, 2010a). 
 
The fact that the pharmacy has not developed SOPs for dispensing prescriptions 
and providing OTC medication mirrors the fact that s4.2.3.3.1 of the GPP standards 
(South Africa. SAPC, 2010a), which lists the SOPs a retail pharmacy should have, 
does not include these as required SOPs and also does not list an SOP for the 
provision of pharmaceutical care as being required.  This highlights a weakness of 
the GPP standards; if pharmaceutical care is a core function of pharmacists, then its 
provision is undermined by it not being compulsory for pharmacies to have and 
comply with SOPs covering all the key aspects of providing pharmaceutical care.   
 
2.2.5 Performance appraisal 
 
According to s3.2.2(a) of the GPP standards (South Africa. SAPC, 2010a), 
performance objectives and job descriptions are the yardsticks against which 
performance should be assessed.  As there are no written job descriptions for 
dispensary employees and performance objectives are not clearly stated and 
assessed on a regular basis and in consultation with employees, it is thus possible 
that there may be problems in implementing effective performance appraisals.   
 
Performance is also appraised on a reactive basis, if a problem is detected by the 
owner-manager.  Waiting until such a situation develops could result in problems 
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becoming more difficult to resolve and having a potentially greater adverse effect on 
individual, team and organisational performance.  Furthermore, when the owner-
manager is off-shift, he would not be present to detect and address problems. 
 
It is likely to be difficult to assess whether a pharmacist is providing pharmaceutical 
care or whether the pharmacist’s assistant is providing patient counselling, and the 
quality of this, since there are no performance objectives, standards and KPIs 
related to pharmaceutical care.  Since compliance with SOPs is not emphasised by 
the owner-manager and he has not ensured that dispensary staff have read the 
SOPs, it would be problematic for him to assess their performance against these 
SOPs.  If he had made compliance with SOPs a key performance area, however, the 
need for dispensary employees to comply with GPP standards, as described by the 
SAPC (South Africa. SAPC, 2010a), would be promoted. 
 
2.2.6 T&D 
 
The pharmacy does not have a training plan and structured development 
programme, which are required in s3.2.3(a) of the GPP standards (South Africa. 
SAPC, 2010a).  T&D activities, such as the attendance of medical talks at the nearby 
hospital, are undertaken on an irregular basis, if there is time.   
 
Chapter 3 contains standards for CPD.  Section 3.4.1.1(c) states that a qualification 
as a pharmacist or pharmacist’s assistant does not imply competence in performing 
the required functions, and that additional training may be necessary.  The owner-
manager of XXX Pharmacy is responsible for evaluating the T&D needs of his 
employees, according to s3.4.1.1(j) of the GPP standards (South Africa. SAPC, 
2010a).  The absence of a T&D plan and a structured programme to assess and 
proactively develop the skills needs of pharmacists and the pharmacist’s assistant 
could result in critical skills gaps being overlooked.   
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Providing pharmaceutical care, as described by GPP standards (South Africa. 
SAPC, 2010a), requires a vast amount of pharmacotherapeutic expertise.  There is 
the possibility that pharmacists may be reluctant to provide pharmaceutical care due 
to a lack of specific knowledge and/ or skills.  For example, pharmacists may not 
know a new drug profile and might thus be reluctant to question the appropriateness 
of a prescription for the drug.  Or, a pharmacist may have forgotten drug knowledge 
learnt at university.  This could undermine confidence in analysing a patient’s 
pharmacotherapy and/ or in providing patient counselling, serving as a deterrent in 
performing these tasks.  Similarly, a pharmacist’s assistant may be reluctant to 
provide patient counselling due to a lack of knowledge, perhaps regarding a 
particular medication and/ or medical condition. 
 
There could also be non-pharmaceutical skills gaps, such as in customer relations, 
problem-solving, communication and/ or time-management skills.  The Introduction 
to the GPP standards (South Africa. SAPC, 2010a) highlights the need for improved 
communication skills.  A gap in these “softer” skills could undermine confidence in 
asking patients questions probing their pharmacotherapy and/ or in providing patient 
counselling.  In the South African context, additional skills, such as diversity 
management, are particularly relevant.  Diversity-related issues such as race, 
culture, gender and socioeconomic status, between the pharmacist or pharmacist’s 
assistant and a patient could add further complexity to the patient encounter. 
 
2.2.7 Rewards 
 
There are no financial or non-financial rewards for providing pharmaceutical care.  It 
could be argued that pharmacists should not be rewarded additionally for providing 
pharmaceutical care, as this is mandatory according to GPP standards outlined by 
the SAPC (South Africa. SAPC, 2010a).  This raises the question whether 
pharmacists’ salaries, in this pharmacy and more broadly in South Africa, adequately 
reflect the responsibilities inherent in providing pharmaceutical care.   
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In recent years, besides pressures exerted on independently-owned retail 
pharmacies by large chain stores (see 1.6), profit margins on medication decreased 
due to Single Exit Pricing, introduced in 2004 in terms of the Medicines and Related 
Substances Act 101 of 1965 (South Africa. National Parliament, 1965).  This could 
have served as a disincentive to greatly increase the financial rewards to 
pharmacists and pharmacist’s assistants, as doing so would further decrease 
pharmacies’ net operating profit.  This raises the question whether managing 
pharmacists may possibly not encourage pharmacists to provide pharmaceutical 
care in the belief that pharmacists would expect greater financial rewards.  Finally, 
individual performance not being recognised at staff meetings could potentially serve 
as a disincentive to provide pharmaceutical care. 
 
2.2.8 Potential for career advancement 
 
It could be argued that providing pharmaceutical care cannot be rewarded by career 
advancement, as it is a core function of pharmacists (see 2.2.7).  The assumption of 
the additional responsibilities inherent in providing pharmaceutical care (see 1.1) is 
unlikely to result in career advancement for pharmacists in XXX Pharmacy, as there 
is only one level between pharmacists and the owner-manager (see the organogram 
in Figure 2 on the next page).  The pharmacist’s assistant’s potential for career 
advancement is also limited, as she does not possess a pharmacy degree. 
 
2.2.9 Agreeing on new objectives and reviewing the PMS 
 
There are no regular discussions to assess the appropriateness of performance 
objectives.  According to s3.2.2(a) of the GPP standards (South Africa. SAPC, 
2010a), the managing pharmacist should develop performance standards at least 
once a year, with input from individual employees.  In XXX Pharmacy, there is thus 
inadequate dialogue and analysis of individual performance objectives, and whether 
these remain appropriate and reflective of key stakeholder interests.  This is unlikely 
Dr Layla Cassim 72076984 
to promote discussions about pharmaceutical care, how to introduce this as a key 
performance area and the kinds of objectives that would facilitate the provision of 
this service.  Similarly, not reviewing the PMS on a regular basis does not promote 
the owner-manager proactively d
recognition of the importance of pharmaceutical care as a key performance area 
from a regulatory perspective, or the need for a structured T&D programme.
 
Figure 2: Organogram of the pharmacy
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Figure 3: Analysing potential quality gaps by adapting 
(1985) model cited in Stapleton (2007: 122)
 
2.3.1 Gap 1: Between patients’ expectations and the owner
perceptions of these 
 
The owner-manager believes
perception has added impetus to 
Patients' expectations of a pharmaceutical 
service:
Do patients expect to receive pharmaceutical care?  
Do they know what this is?  Would patients be 
prepared to spend more time in the pharmacy, if it 
meant that pharmacists would fulfil all GPP 
requirements for pharmaceutical care described by 
SAPC (South Africa. SAPC, 2010a)?  Do patients 
know that they can request a medication review, 
which includes the development of a care plan?
Patients' experience of the 
pharmaceutical service provided by 
the pharmacy:
Do patients believe that they have received 
pharmaceutical care?  Does the pharmacy 
comply with all GPP standards for the 
provision of pharmaceutical care described 
by SAPC (South Africa. SAPC, 2010a)?
Specifications for  pharmaceutical care by GPP standards 
(South Africa. SAPC, 2010a):
GPP standards clearly state a comprehensive set of requirements for 
pharmaceutical care (see 1.1), e.g. analysis of patient's pharmacotherapy 
to ensure it is safe and effective, determining patient compliance, 
counselling patients to ensure safe and correct use of medication.  Current 
PMS does not include these as objectives for pharmacists; PMS expresses 
the owner-manager's focus on increasing operational efficiency.  GPP 
standards also include HRM and general management specifications (e.g. 
quality management) that must be in place in the pharmacy, to facilitate 
provision of pharmaceutical care (see 1.2.4).
Owner-manager's perceptions of patients' 
expectations of a pharmaceutical service:
Does the owner-manager believe that patients 
expect pharmaceutical care?  Does he believe that 
patients know what pharmaceutical care is?  
Owner-manager believes patients want an 
efficient, speedy pharmaceutical service, and the 
current PMS focuses on achieving this.
GAP 1 
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 that patients expect an efficient, speedy service.  This 
the PMS’s strategic focus on operational efficiency.  
External 
communications to 
patients:
What kind of 
pharmaceutical service 
does the pharmacy promise 
to its patients, e.g. through 
advertising?  Does the 
pharmacy promise the 
provision of pharmaceutical 
care, or components of 
this?  Limited advertising, 
which focuses on 
operational matters.  The 
lack of advertised 
commitment to 
pharmaceutical care reflects 
the omission of this in PMS.
GAP 2 
GAP 3 
GAP 4 
GAP 5 
 
25 
 
et al.’s 
-manager’s 
Dr Layla Cassim 72076984  Research Report MBA 5932 
26 
 
He also believes that many patients do not want to receive counselling about their 
pharmacotherapy.  The owner-manager’s perceptions thus reflect the view that 
patients do not want to receive pharmaceutical care.  These perceptions could offer 
justification for not including the provision of pharmaceutical care as a key 
performance area for pharmacists and not developing relevant KPIs and 
performance standards for this (see 2.2.4), as the owner-manager believes that his 
customers do not consider pharmaceutical care important.   
 
Expectations are not the same as wants.  A patient may, for example, want certain 
elements in a service, but may not expect that these will be delivered, perhaps due 
to prior negative experiences.  An individual’s level of knowledge is also important in 
shaping expectations.  For example, a patient may not expect certain elements in a 
service, not necessarily because the patient does not want these, but because the 
patient does not know that these elements exist, or that a particular service provider 
can deliver these elements (see 2.3.5). 
 
Parasuraman, et al.’s (1985) model cited in Stapleton (2007: 122) refers to 
expectations.  The question arises whether patients expect to receive 
pharmaceutical care.  It is unclear whether the owner-manager believes that patients 
do not expect pharmaceutical care, in addition to his perception that patients do not 
want to receive this service.  The implication is that one of the reasons that patients 
continue to patronise the pharmacy is because they do not expect, from the owner-
manager’s perspective, to receive pharmaceutical care there.   
 
If patients expect pharmaceutical care and the owner-manager’s perception is that 
they do not, a gap arises.  As described in 2.2, the PMS of XXX Pharmacy does not 
emphasise and evaluate performance in providing pharmaceutical care.  If patients 
expect pharmaceutical care, this could lead to service quality not meeting patients’ 
expectations, potentially resulting in patient dissatisfaction.  This could potentially 
have an adverse effect on customer or patient retention (see 2.3.5). 
Dr Layla Cassim 72076984  Research Report MBA 5932 
27 
 
2.3.2 Gap 2: Between the owner-manager’s perceptions of patients’ 
expectations and specifications for pharmaceutical care 
 
The SAPC’s specifications for pharmaceutical care are outlined in GPP standards 
(South Africa. SAPC, 2010a) (see 1.1).  These specifications have arisen in 
response to the SAPC’s vision “to ensure that pharmaceutical services are the best 
to meet the health care needs of the people” (South Africa. SAPC, 2010a: 1).  This 
vision of the SAPC is not echoed in a vision for the pharmacy; or its strategies, 
goals, objectives for pharmacists and the pharmacist’s assistant or other 
components of the PMS (see 2.2). 
 
Assuming responsibility and accountability for meeting patients’ medication-related 
needs, as described by the SAPC’s definition of pharmaceutical care (South Africa. 
SAPC, 2010a) (see 1.7), and complying with GPP standards to ensure that patients’ 
pharmacotherapy is individualised in terms of appropriateness and counselling, 
promotes the development of relationships between pharmacists and patients, 
characterised by a pharmacy’s commitment to deliver a high quality service and the 
recognition of patients as primary stakeholders.   
 
This creates a gap with the owner-manager’s perceptions that patients expect a 
speed-oriented service; and also with the current PMS, which focuses on achieving 
such efficiency.  If the owner-manager decides to strategically focus on fulfilling what 
he perceives patients’ expectations to be, instead of including compliance with GPP 
standards for pharmaceutical care as a key performance area, substandard 
pharmaceutical services could result (see 2.3.3). 
 
Sections 3.4.1.1(d), 4.1, 4.2.2.2(e) and 4.2.3 of the GPP standards (South Africa. 
SAPC, 2010a) state that pharmaceutical services should be provided efficiently.  The 
management standards in Chapters 3 and 4 are thus supposed to promote efficient 
service delivery.  Complying with GPP standards should therefore facilitate achieving 
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the pharmacy’s strategic priority of increased operational efficiency.  Theoretically, 
there thus does not have to be tension between efficiency and compliance with GPP 
standards, as these are two complementary components of providing 
pharmaceutical care.  The dominant focus on the former, however, in the current 
PMS, has the potential to widen the gap between these two components, thereby 
undermining the provision of pharmaceutical care. 
 
2.3.3 Gap 3: Between patients’ experiences and GPP standards for 
pharmaceutical care 
 
The SAPC (South Africa. SAPC, 2010a: 1) states that, 
“The vital element in this [the SAPC’s] vision is the commitment of the 
pharmacy profession to promote excellence in practice for the benefit of 
those they serve.  The public and other professions will judge the 
pharmacy profession on how that commitment is translated into the 
practice they observe”. 
 
According to the SAPC (South Africa. SAPC, 2010a), service excellence is promoted 
by pharmacies complying with GPP standards.  The question that arises is whether 
patients experience this “excellence in practice”, as described by the SAPC (South 
Africa. SAPC, 2010a: 1).  If not, there is a quality gap between patients’ experiences 
and GPP specifications for the provision of pharmaceutical care, leading to the 
delivery of substandard pharmaceutical services.  This may lead to patients judging 
that the pharmacy is not committed to promoting excellence in pharmaceutical 
service delivery. 
 
The PMS does not include formal quality standards for the pharmacists and 
pharmacist’s assistant.  As mentioned in 2.2.4, having to follow the owner-manager’s 
working preferences can represent a form of quality control, but if these preferences 
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do not promote compliance with GPP standards, as outlined by the SAPC (South 
Africa. SAPC, 2010a), poor quality pharmaceutical services could result.   
 
A shortcoming of the PMS is that adherence to SOPs is not a key performance area 
for dispensary employees.  Section 4.2.2.1(k) of the GPP standards (South Africa. 
SAPC, 2010a) stipulates that all employees be trained in SOPs.  If this was so, and 
compliance with SOPs thus promoted, the quality gap between patients’ experiences 
and GPP specifications would potentially be narrowed.  There is also no Quality 
Improvement Plan, the requirements of which are detailed in s4.2.2.1(a) of the GPP 
standards (South Africa. SAPC, 2010a), which could also narrow this gap. 
 
2.3.4 Gap 4: Between patients’ experiences and external 
communications to patients 
 
In this gap, patients do not receive what they have been promised by a service 
provider.  The pharmacy has undertaken limited advertising to patients.  There is no 
mission statement (see 2.2.1), so patients do not know what the pharmacy commits 
to in pharmaceutical service delivery.  The pharmacy’s vision and goals are not on 
public display, so patients are not informed of these.  A possible reason for the 
pharmacy not advertising its vision and goals is that if these are profit-oriented, it 
might offend patients’ sensibilities to have these clearly displayed.   
 
The advertising undertaken includes a prominent sign notifying passersby that the 
pharmacy has long trading hours.  There is also a board in the dispensary listing the 
pharmacy’s services, such as the provision of blood pressure testing, the hiring of 
rehabilitative equipment, a nurse on Saturday mornings and the provision of patient 
counselling for prescription and OTC medication.  Quality standards, pharmaceutical 
care or desired health outcomes are not mentioned.  The limited advertising thus 
focuses primarily on operational matters, which is in alignment with the pharmacy’s 
strategic focus on operational efficiency.  A potential advantage of limiting 
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advertising primarily to operational matters, and not conveying a vision, mission 
statement, goals, quality-related information or commitments regarding 
pharmaceutical care, is that the scope of what is promised to patients is narrower.  
Patients’ expectations are thus not heightened and it is potentially easier for the 
pharmacy to deliver on what has been promised.   
 
The owner-manager emphasises punctuality; trading hours are observed and this 
aspect of the advertised services are provided.  With the exception of patient 
counselling, there is thus no quality gap between the pharmacy’s advertising and 
patients’ experiences.  However, this does not imply that patients’ experiences 
necessarily reflect a high quality service; it instead reflects that the pharmacy has not 
committed, in its advertising, to deliver a high quality pharmaceutical service 
embodying the principles of pharmaceutical care described by the SAPC (South 
Africa. SAPC, 2010a).  This omission mirrors the PMS not committing to providing 
pharmaceutical care (see 2.2).  If patients do not receive counselling, there is a gap 
between patients’ experiences and the pharmacy’s advertising, with the latter not 
delivering on a commitment it has made, which could lead to patient dissatisfaction. 
 
2.3.5 Gap 5: Between patients’ experiences and their expectations 
 
If patients’ experiences do not meet their expectations, dissatisfaction and a loss of 
customer loyalty could result.  Alternatively, if patients’ experiences positively exceed 
their expectations, increased customer satisfaction and loyalty could ensue. 
 
The pharmacy’s PMS is designed to ensure that patients receive a speedy, efficient, 
transactional service.  There is minimal time for patient counselling regarding 
pharmacotherapy and the development of relationships between pharmacists or the 
pharmacist’s assistant, and patients.  If this is the pharmaceutical service that 
patients experience, does it meet their expectations?  As discussed in 2.3.1, 
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experiences, whether occurring to the patient or to others, can shape expectations.  
If patients have never received pharmaceutical care, they may be unaware that 
pharmacists can provide this service and therefore might not expect to receive it.  
Patients might also not know what pharmaceutical care is, or what pharmacists’ 
responsibilities are in this regard, as described by the SAPC (South Africa. SAPC, 
2010a).  Patients might not know, for example, that they can request a pharmacist to 
perform a medication review (see 1.1).  Patients’ expectations would thus be set at 
the level of their experiences, and the quality gap between experiences and 
expectations would be narrow. 
 
The question that arises is whether patients would like to receive pharmaceutical 
care.  Would patients be willing to perhaps spend more time queuing in the 
pharmacy, if this meant that when it was their turn to be served, the pharmacist 
would analyse their pharmacotherapy thoroughly and counsel them appropriately?  If 
this was so, and patients experienced optimal pharmaceutical care, their 
expectations could potentially be raised.  It would then be even more imperative that 
all aspects of the PMS promoted the optimal provision of pharmaceutical care, as 
otherwise the quality gap between patients’ experiences and expectations would 
widen. 
 
2.4 Summary 
 
In this chapter, individual components of the pharmacy’s PMS for pharmacists and 
the pharmacist’s assistant were analysed.  The lack of an explicitly-stated, written 
vision that commits the organisation publicly to providing pharmaceutical care has 
cascaded to all stages of the PMS, in particular on individual objective setting.  The 
potential effects of the PMS on quality gaps in pharmaceutical service delivery to 
patients were then explored, with major potential quality gaps being that between the 
owner-manager’s possible perceptions of patients’ expectations and GPP standards 
for pharmaceutical care, and between these standards and patients’ experiences.   
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CHAPTER THREE:  LITERATURE REVIEW 
 
3.1 The nature of performance management 
 
Bruden (2010: 109) describes performance management as “a discipline that assists 
in establishing, monitoring and achieving individual and organisational goals”.  This 
author identifies the following three problematic areas in current performance 
management practices (Bruden, 2010): 
(i) There is poor development of standards for the classification, definition and 
use of performance management tools, which makes it difficult to apply 
performance management principles.  Performance measurement, for 
example, is often used interchangeably with performance management; 
(ii) There is tension between two contrasting paradigms of performance 
management practice, namely the “command and control” paradigm (Bruden, 
2010: 110), which was characteristic of the previous century, and the systems 
paradigm, which has evolved in the current era (see 3.1.2.2); and 
(iii) The predominant focus on performance measurement and rewards, instead of 
learning and development (Bruden, 2010).  Neely (2005), in his history of the 
evolution of performance measurement, argues that the focus on 
quantification and the use of outdated performance measures in recent 
decades undermines long-term organisational performance.  Many of these 
performance measures may no longer be appropriate, given the rapidly-
changing business environment, as suggested by Kennerley and Neely 
(2003).  Performance measures may be inappropriate by not having a 
strategic direction, not considering customer desires or competitors’ practices 
sufficiently, and by ensuring conformance to specified standards rather than 
encouraging continuous improvement (Neely, Gregory & Platts, 2005). 
 
In discussing various approaches to defining performance management, Bruden 
(2010) cites Wholey (1996), who describes performance as socially constructed, 
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subjective and open to various interpretations, thus necessitating the need for there 
to be some kind of performance measurement.  Folan, Browne & Jagdev (2007) 
cited in Bruden (2010) believe that organisations evaluate performance primarily 
against objectives that have been developed and agreed-upon internally, instead of 
objectives that have been developed externally.  This could also contribute to some 
of the aforementioned limitations of many performance measures.  Neely, et al. 
(2005), for example, highlight the importance of the external environment, in 
particular competitors and customers, as well as the internal environment of an 
organisation in influencing performance measurement. 
 
The different levels of performance management, as well as contrasting paradigms 
of the nature of this field of management practice, will now be explored. 
 
3.1.1 The evolution of performance management 
 
Performance management has evolved on an individual, operational and strategic 
level, according to Bruden (2010), as discussed below.   
 
3.1.1.1 The evolution of individual performance management 
 
Individual performance management has the longest recorded history, with 
performance appraisals of family members of the Wei Dynasty emperors in China 
being conducted as far back as the third century (Banner and Cooke, 1984 and 
Coens and Jenkins, 2000, both cited in Bruden, 2010).  In industry, performance 
appraisals were introduced in Scottish cotton mills at the beginning of the 19th 
century (George, 1972 cited in Bruden, 2010).  Individual performance was assessed 
in terms of individuals performing functions within a group (Bruden, 2010).   
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The military developed the use of performance appraisal in the First World War, 
based on a man-to-man rating system developed at Carnegie-Mellon University 
(Bruden, 2010), and many army researchers were recruited by the business sector 
after the war (Wiese and Buckley, 1998 and Scott, Clothier & Spriegel, 1941, both 
cited in Bruden, 2010), thus facilitating the transfer of performance management 
practices developed in the military.  Civil rights and employment equity legislation in 
the United States of America (USA) in the 1970s and in Britain in the subsequent two 
decades prompted the need for organisations to introduce a system to manage 
performance (Bruden, 2010).  In the 1980s and 1990s, PMSs were used as tools to 
transform the culture of public sector entities (Furnham, 2004 cited in Bruden, 2010). 
 
In the 1990s, there was a shift towards self-assessment of individual performance 
(Bruden, 2010), which may have been due to an increase in the number of 
knowledge workers, who had greater autonomy over their work (Drucker, 1993 cited 
in Bruden, 2010).  Storey (2005, 2009) describes knowledge workers emerging as a 
class of workers due to a fundamental transformation in the nature of work from 
Industrial Age, Taylorist principles of efficiency and standardisation (see 3.1.2.1), to 
the current era, in which knowledge is regarded as a key intangible asset in many 
sectors.  Knowledge workers are discussed further in 3.1.2.1. 
 
Even though there may thus be increased awareness of self-assessment and a 
greater incidence of this, as mentioned above, the role of line managers in 
performance appraisal and other performance management-related practices 
nevertheless remains important, according to den Hartog, Boselie & Paauwe (2004) 
and Storey (2005).  According to den Hartog, et al. (2004), managers set objectives, 
provide employees with feedback on performance, can provide learning and 
developmental opportunities for employees and can contribute to developing a 
departmental subculture that emphasises high performance. 
 
Another development in individual performance management in the 1990s was the 
introduction of the Balanced Scorecard and similar tools (see 3.1.1.3), which aligned 
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individual performance management with organisational strategic performance, thus 
enhancing individual accountability for the achievement of the organisation’s 
strategies (Bruden, 2010).  Research conducted in the area of performance 
management has also changed.  Whereas traditionally research focused on 
determining whether supervisors’ ratings of employees were accurate, current 
research also investigates the social dimension of performance appraisal (Fletcher, 
2001 cited in den Hartog, et al., 2004). 
 
3.1.1.2 The evolution of operational performance management 
 
As described by Bruden (2010), the focus of operational performance management 
is on achieving functional or departmental objectives, usually by evaluating efficiency 
and effectiveness.  The evolution of this sphere of performance management has 
been influenced by developments in the management and accounting fields, due to 
the ease of applying quantitative, financial performance indicators (Bruden, 2010).  
Lebas (1995) cited in Bruden (2010) mentions that, for example, the performance of 
a Venetian sailing expedition in the 13th century was calculated as the amount of 
money invested by the ship’s owner less the amount gained by selling the goods 
brought back from the expedition.  
 
The development of management as a separate activity arose in the 19th century, 
when there was a separation of the roles of owners and managers (Dainty and 
Anderson, 2008 cited in Bruden, 2010).  This was followed in the early 20th century 
by Taylor’s (1911) development of the principles of scientific management (Drenth, 
Thuerry & Wolff, 2001 cited in Bruden, 2010; Giannetti, 2004) (see 3.1.1.1 and 
3.1.2.1), which were extended by Gilbreth and Gilbreth’s time and motion studies, in 
which all employee movements at work were measured (Radnor and Barnes, 2007 
cited in Bruden, 2010), to enhance efficiency.   
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With increasing environmental complexity, the abovementioned focus on the use of 
financial performance indicators gradually shifted towards an increasing recognition 
of the role of non-financial performance indicators, which contributed towards 
integrating operations management with other facets of management practice 
(Bruden, 2010).  This recognition of the role of non-financial indicators was 
stimulated by the Japanese notion of quality management in the 1950s, which, 
according to Busi and Bititci (2006) cited in Bruden (2010), contributed to the 
foundation of current performance management theories.  The concept of total 
quality management highlighted the need to improve operational effectiveness, and 
not just efficiency (Bruden, 2010).  This stimulated the advent of customer-oriented 
performance measures (Bruden, 2010), such as those used by General Motors in 
the 1970s (Johnson and Kaplan, 1987 cited in Bruden, 2010).   
 
In the late 1980s, there was increasing recognition of the need for operations 
performance management to consider performance from a number of perspectives 
(Bourne, Franco & Wilkes, 2000 cited in Bruden, 2010).  This led to the greater use 
of business intelligence software programmes, which allow users to access and 
integrate a wide range of organisational data, in the 21st century (Bruden, 2010). 
 
Neely, et al. (2005) classify performance measures as relating to quality, time, cost 
or flexibility.  These authors suggest that there needs to be consistency between 
performance measures, decision-making, actions undertaken at various levels of the 
organisation and the organisation’s strategies (Neely, et al., 2005).  Strategic 
performance management is discussed below. 
 
3.1.1.3 The evolution of strategic performance management 
 
Strategic performance management focuses on achieving organisational objectives, 
with strategy formulation and implementation being important related processes 
(Bruden, 2010).  There are numerous strategic performance management tools, 
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such as Kaplan and Norton’s famous Balanced Scorecard (described below) and the 
European Foundation for Quality Management’s (EFQM) Excellence Model, used to 
implement organisational strategies (Bruden, 2010).  The EFQM Excellence Model 
(EFQM, 2010) proposes that leadership; people; strategy; partnerships and 
resources; and processes, products and services are all enabling factors that allow 
results to be achieved for various stakeholders, with customers occupying central 
importance (Martίn-Castilla, 2002).   
 
As a discipline, strategic performance management has a relatively brief history 
compared to the other spheres of performance management, as it developed in the 
20th century (Bruden, 2010).  Its growth was stimulated by Drucker’s (1946) book, 
Concept of the Corporation, cited in Bruden (2010) and increasing interest in the 
1950s and 1960s amongst large organisations in the notion of “long-range planning” 
(Bruden, 2010: 114).  Key performance measures used, however, for example by 
General Electric, were still financial in nature (Eccles, 1991 cited in Bruden, 2010).   
 
Interest in strategic planning subsequently decreased until the 1990s, when Kaplan 
and Norton introduced their Balanced Scorecard, fuelling a resurgence of interest in 
the field (Bruden, 2010; Neely, 1999 cited in Bruden, 2010).  Originally introduced in 
1992, within four years it was classified as a strategic PMS which provided a 
framework for integrating organisational strategies, goals, budgeting, the allocation 
of resources, planning and employee learning and development (Kaplan and Norton, 
1996 cited in Bruden, 2010).  Bruden (2010) regards the Balanced Scorecard as 
currently the most popular PMS used for strategy implementation. 
 
A newly emerging perspective in strategic performance management is that of 
strategic management dynamics.  This is rooted in a resource-based view of 
strategy, and advocates that the only means by which management can influence 
strategic performance is by impacting on resource flows entering and leaving the 
organisation (Bruden, 2010).  There is a strong temporal component to this 
perspective, as it is necessary that resource flows be monitored over time, in better 
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understanding why performance is at its current level and how it could be managed 
and enhanced in the future, as described by Warren (2008) cited in Bruden (2010).  
Bruden (2010: 115) argues that this perspective of strategic performance 
management requires a paradigm shift from the traditional paradigm of “command 
and control”, towards one of “systems thinking”, as described in 3.1.2 below. 
 
3.1.2 Paradigms of performance management 
 
3.1.2.1 The “command and control” paradigm 
 
Performance management for most of the previous century reflected the “command 
and control” paradigm (Seddon, 2008 cited in Bruden, 2010: 115).  In this 
mechanistic approach to performance management, managers used financial 
performance indicators, set performance quotas for employees and measured 
whether these were completed (Bruden, 2010).  Work was divided into 
specialisations, and there was poor integration of different tasks and functions.  
Organisations were viewed as hierarchies, in which management exerted top-down 
control through the use of a large number of controls, such as administrative controls 
in the form of rules and procedures (Bruden, 2010).  The surge in customer demand 
for goods also led to an emphasis on product standardisation (Bruden, 2010).   
 
In the current era, however, the profile of the workforce, as well as the nature of work 
and customer expectations, has changed considerably.  There has been an increase 
in the proportion of educated, mobile employees with different job expectations 
(Bruden, 2010), the knowledge workers referred to in 3.1.1.1.  Customers have 
become more demanding, with diversified needs, and work has become increasingly 
complex (Bruden, 2010).  As discussed in 3.1.1.1, knowledge has come to be 
regarded as a key organisational asset.  By the 21st century, there has thus been a 
shift from the majority of the workforce being engaged in mechanical work in 
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industrial facilities, to working in technology- and knowledge-intensive services 
industries (Bruden, 2010; Drucker, 1999 cited in Bruden, 2010).   
 
These new workplaces require employees to interact with a variety of stakeholders 
and make decisions speedily (Drucker, 1999 cited in Bruden, 2010).  According to 
Fletcher, 2001 cited in den Hartog, et al. (2004) and den Hartog, et al. (2004), there 
is also greater collaboration between employees of different cultures and 
nationalities, as more organisations expand operations internationally and the use of 
new technology increases.  This necessitates employees developing additional skills, 
such as technological and diversity management skills.  Giannetti (2004) agrees, 
adding that employees also have career development, stress management and 
mentorship needs.   
 
Bruden (2010) argues that performance management practices have not kept pace 
with the changing work landscape, as described above.  Molleman and Timmerman 
(2003) cited in den Hartog, et al. (2004) share this view, noting that as performance 
indicators at an organisational level become more knowledge management- and 
innovation-oriented, employees work more interdependently and perform increasing 
amounts of non-routine work.  These authors argue that performance management 
criteria for employees at these lower levels should thus change to reflect employees’ 
changing working relations and roles (Molleman and Timmerman, 2003 cited in den 
Hartog, et al., 2004).  Schuler and Jackson (1987) cited in Storey (2009: 52) agree, 
arguing that, “Rather than emphasising managing people so they work harder (cost-
reduction strategy) or smarter (quality strategy) on the same products or services, 
the innovation strategy requires people to work differently” [emphasis in the original]. 
 
The predominant focus of current performance management practices is largely still 
on “command and control” measures which, Bruden (2010: 116) argues, can 
undermine optimal performance.  This is illustrated in Storey’s (2004: 23) model of 
the “vicious circle of control”, in which tight management controls result in increasing 
employee resistance, leading to a decline in performance.  When management 
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reacts to this by imposing additional controls, employee resistance is fuelled further, 
leading to an even more deleterious effect on performance (Storey, 2004). 
 
Storey (2005) and Tam, Korczynski & Frenkel (2002) argue that due to the distinct 
nature of knowledge workers, it is necessary to have different HRM policies for these 
workers.  Recruitment policies, for example, may be more effective at enticing 
knowledge workers if these policies highlight that employees would have T&D 
opportunities and greater autonomy over their work (Storey, 2005).  Ehin (2008: 337) 
agrees that knowledge workers should not be managed according to Industrial Age 
principles, and argues that knowledge workers should be “un-managed” from these 
Industrial Age practices, principles and structures.  He argues that in order for 
knowledge workers to optimally create social capital, a “shared-access system” 
should be developed; this is a non-hierarchical, self-organised structure in which 
knowledge and information are shared openly; there is a focus on developing 
interpersonal, collaborative relationships; and individuals feel personal commitment 
to their work, rather than being bound by compliance to directives (Ehin, 2008: 343).   
 
Current rewards for knowledge workers may also need to be reviewed, as suggested 
by Tam, et al. (2002).  Smith and Rupp (2003), for example, argue that in practice 
there is dissonance between merit increases that knowledge workers receive, and 
the performance ratings of these workers.  The majority of knowledge workers in 
their study perceived that their merit increases were not reflective of their 
performance ratings.  Receiving a low merit increase, although having a high 
performance rating, had a greater adverse effect on motivation for younger 
knowledge workers (Smith and Rupp, 2003).   
 
3.1.2.2 The systems paradigm 
 
As described by Seddon (2008) cited in Bruden (2010: 116), the systems paradigm, 
in contrast to the “command and control” paradigm, considers an organisation 
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holistically, as an integrated system in which employees can contribute meaningfully, 
and not as a hierarchy in which employees are controlled.  The purpose of an 
organisation as a set of interrelated components is considered, and progress in 
fulfilling this purpose is measured (Bruden, 2010).  Relationship management and 
learning are emphasised in this paradigm, which reflects McGregor’s Theory Y 
perspective (Eccles, Nohria & Berkley, 2003 cited in Bruden, 2010).  Ehin’s (2008: 
343) “shared-access system” (see 3.1.2.1) is an example of a systems paradigm. 
 
Bruden (2010: 116) describes shifting from the “command and control” paradigm to 
the systems paradigm as shifting “from performance management for control to 
performance management for learning”.  Bruden (2009) cited in Bruden (2010) 
contrasts the control- and learning-oriented paradigms according to a number of 
criteria; the control paradigm, for example, is characterised by “single loop” learning 
(see below), individual rewards, punishment for poor performance and the limited 
communication of business results.  The learning-oriented paradigm, on the other 
hand, is characterised by “double loop learning”, group rewards, dialogue to enhance 
performance and open communication (Bruden, 2009 cited in Bruden, 2010: 117).  
As described by Argyris (1976: 363), “single-loop learning” involves individuals’ 
performance against set criteria being measured, whereas “double-loop” learning 
also entails a critical examination of the appropriateness of these criteria. 
 
Bruden (2010: 116) acknowledges the difficulty in organisations and individuals 
shifting from the “command and control” paradigm to the systems paradigm, one of 
the reasons for this being that new skills are required of employees.  Examples of 
these are communication, stakeholder management and decision-making skills, as 
described by Drucker (1999) cited in Bruden (2010).  Reflecting a contingency 
perspective, Bruden (2010: 116) suggests that a “command and control” paradigm 
may be more appropriate in certain environmental conditions, given particular 
organisational resources and in certain contexts, for example the military.  Chenhall 
(2003) agrees, reporting that, during periods of external pressure, organisations may 
choose tight management controls as a survival mechanism. 
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Another difficulty in shifting to the systems paradigm is management’s commitment 
to the status quo.  Greenwood and Hinings (1996: 1025) argue that certain 
“templates”, or paradigms, of management practices and structures are accepted 
unconsciously by management, over time, as being the best way to manage, even 
though this may not necessarily be correct, and that the preference for organisational 
stability further establishes these “templates” into the culture of the organisation. 
 
National cultures are also important.  In his paper on the socio-economic perspective 
of management control, for example, Verstegen (2011) mentions that performance 
management in organisations may vary due to the influence of different national 
cultures.  He mentions that Anglo-Saxon cultures may place greater emphasis on the 
performance management of individuals compared to European cultures, which may 
place greater importance on managing team performance (Verstegen, 2011).  
Verstegen (2011) also suggests that historical events in an organisation play a role 
in influencing how employees behave and the nature of organisational controls and 
performance management.  He warns that if management ignores that employees 
are “authentic human beings” with social and cultural differences, and instead views 
employees as solely “economic m[e]n” motivated only by financial incentives, the 
effectiveness of management control could be undermined (Verstegen, 2011: 114). 
 
3.1.2.3 An integrated model of performance management 
 
Bruden (2009) cited in Bruden (2010: 119) proposes an integrated model of 
performance management, in which “command and control” measures, systems 
thinking and other approaches to performance management, such as goal-setting, 
agency and contingency theories, are integrated with the strategic, operational and 
individual levels of performance management.  Bruden (2010) suggests that this 
model could potentially assist in better aligning individual and organisational 
performance. 
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According to Roberts (2001) cited in den Hartog, et al. (2004), performance 
management encompasses objective setting on a variety of levels, T&D, 
performance appraisal, coaching, rewards, career planning, culture management 
and reviewing the effectiveness of the PMS.  DeNisi (2000) and Baron and 
Armstrong (1998), both cited in den Hartog, et al. (2004), also offer similar definitions 
of an integrated PMS as enhancing organisational effectiveness.   
 
Den Hartog, et al. (2004) argue that all HRM practices directly associated with 
performance management should be aligned, and that this could impact on other 
HRM practices, such as recruitment and selection.  Murphy and Olsen (2009), 
adopting a resource-based view of organisations, agree and suggest that the link 
between HRM and performance management results in competitive advantage.  
These authors discuss “high performance management systems”, a particular 
paradigm that recognises managers and employees as human capital and 
knowledge workers (see 3.1.1.1) who can create value for organisations, instead of 
as a cost (Murphy and Olsen, 2009: 839).  A “high performance management 
system” comprises a wide range of components, including T&D, work/ life balance, 
the sharing of information, diversity, the use of self-managed teams, incentive pay 
and high wages, and internal promotion (Murphy and Olsen, 2009: 848). 
 
At the heart of both performance management and HRM, according to den Hartog, 
et al. (2004), is the nature of the employment contract in the organisation.  This can 
be viewed as: (i) a psychological contract, in which the human or employee 
perspective is highlighted; (ii) a legal contract, which emphasises the legal 
perspective; or (iii) a transactional contract, which reflects the organisational 
perspective (den Hartog, et al., 2004).  There are different types of psychological 
contracts.  O’Donohue, Sheehan, Hecker & Holland (2007), for example, highlight 
that psychological contracts based on professional and altruistic ideologies are 
particularly relevant to knowledge workers, rather than more traditional relational or 
transaction-based psychological contracts.  The nature of the employment contract 
can impact on employees’ perceptions of the organisation, commitment and 
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performance (den Hartog, et al., 2004).  The model proposed by den Hartog, et al. 
(2004) thus integrates performance management and HRM. 
 
The issue of commitment is taken further by Farndale, Hope-Hailey & Kelliher (2011: 
6) in their paper on “high commitment performance management”, which these 
authors describe as encompassing performance management practices that 
encourage employee involvement and development, which is expected to result in 
increased commitment to the organisation.  Examples of such activities include 
employees choosing remuneration options and T&D needs being identified through 
performance appraisal (Farndale, et al., 2011).   
 
These authors argue, however, that whether such performance management 
practices result in greater employee commitment depends on the notion of 
“organisational justice”, namely whether employees perceive performance 
management practices as being fair, in terms of procedural, interactional and 
distributive justice (Farndale, et al., 2011: 6).  Procedural and distributive justice refer 
to whether the process and outcomes of performance management practices, 
respectively, are perceived as fair by employees (Farndale, et al., 2011), whilst 
interactional justice refers to the way in which managers treat employees during 
these performance management practices (Chang, 2005 cited in Farndale, et al., 
2011). It was also found that the extent to which employees trust the employer 
influences employees’ perceptions of whether performance management practices 
are fair, and that trust impacts on employee commitment (Farndale, et al., 2011). 
 
3.1.3 Performance management in SMMEs 
 
Matlay (2002: 311) notes that industrial relations practices in SMMEs are often 
“primitive”, characterised by long working hours for employees, low remuneration 
and poor conditions of employment, often due to owner-managers attempting to 
decrease costs.  Employees in this sector in Britain have been identified as being 
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particularly vulnerable to these practices as, unlike European employees, they are 
not protected by collective bargaining (ENSR, 1997 cited in Matlay, 2002).  This 
could be exacerbated by many employees being part-time and casual workers, and 
a relatively small proportion belonging to trade unions, as found by Matlay (2002). 
 
Matlay (2002) found that the extent to which the owner-manager is responsible for 
the control of industrial relations processes varies between SMMEs.  In micro-sized 
businesses, which are defined as having between 1-10 employees, 100% of owner-
managers indicated that they were responsible for management controls (Matlay, 
2002).  This figure decreased to 84.07% for small businesses, defined as having 
between 11-49 employees; in this category of businesses, owner-managers were 
increasingly delegating authority for industrial relations to personnel managers.  The 
owner-manager is responsible for controlling industrial relations in only 17.72% of 
medium-sized businesses, which have between 50-250 employees, with personnel 
managers and training managers largely responsible for this function (Matlay, 2002).   
 
The abovementioned findings suggest that as organisational size decreases, owner-
managers are increasingly individually responsible for controlling industrial relations 
processes and practices.  Matlay (2002) also found that as organisational size 
decreases, owner-managers increasingly prefer an informal management style.  This 
style indicates the owner-manager’s approach to recruitment, T&D, disciplinary 
issues, rewards and other management practices (Matlay, 2002). 
 
Although owner-managers have significant control over performance management 
practices in SMMEs, as described above, customers and suppliers also play an 
influential role in shaping such practices, as highlighted by Kinnie, Purcell, 
Hutchinson, Terry, Collinson & Scarbrough (1999).  These authors point out that 
small- and medium-sized enterprises are often dependent on a small base of 
customers and suppliers, and that pressures exerted by these stakeholders can 
have a profound effect on employment relations within the organisation.  An example 
is provided of a medium-sized organisation which enhanced its T&D efforts in 
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response to a customer’s expectations regarding customer services and total quality 
management (Kinnie, et al., 1999).  Sometimes tension arises between the 
abovementioned stakeholder pressures, for example for greater employee flexibility 
and speed in decision-making, and current performance management practices 
within the SMME, which are geared towards ensuring tighter management controls, 
as described by Kinnie, et al. (1999). 
 
Garengo, Biazzo & Bititci (2005) have reviewed the use of performance 
measurement systems in small- and medium-sized enterprises.  Their description of 
these, however, reflects what has hitherto been described as an integrated 
performance management system (see 3.1.2.3).  This demonstrates Bruden’s (2010) 
concern about the lack of clarity in the literature in distinguishing between 
performance management and measurement (see 3.1).  Due to the similarities in 
Garengo, et al.’s (2005) description of performance measurement systems and an 
integrated PMS, these authors’ review of performance measurement systems can be 
regarded as a review of performance management systems.  There is also an 
instance in Garengo, et al.’s (2005: 40) paper in which the terms “performance 
measurement” and “performance management” are used interchangeably.   
 
Garengo, et al. (2005) note that not many studies have been reported in the 
literature on performance measurement systems in small- and medium-sized 
enterprises; and suggest that performance measurement systems designed for 
larger organisations may not be appropriate for small- and medium-sized 
enterprises.  These authors identify the following barriers to implementing 
performance measurement systems in these organisations (Garengo, et al., 2005):  
(i) Insufficient human resources (HR) to implement a performance measurement 
system, with existing employees being too occupied with the operational 
running of the organisation; 
(ii) Inadequate attention to developing managerial capabilities, with individuals, 
such as the owner-manager, occupying multiple positions; 
(iii) A reactive approach to management practices, in which there are problems in 
strategic planning.  Furthermore, there is inadequate realisation of what 
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organisations’ critical success factors are (Greatbanks and Boaden, 1998 
cited in Garengo, et al., 2005); 
(iv) Limited financial resources to invest in a performance measurement system.  
Neely, et al. (2005) agree, citing an earlier study by Neely and Mills (1993), in 
which the managers of small- and medium-sized enterprises identified the 
perceived cost of performance measurement as a key barrier to the 
implementation of such systems; 
(v) The benefits of having a performance measurement system not being fully 
appreciated, with many small- and medium-sized enterprises perceiving such 
a system as potentially inhibiting organisational flexibility (Hvolby and 
Thorstenson, 2000 cited in Garengo, et al., 2005); and 
(vi) The lack of formal managerial systems and processes; and the prevalence of 
tacit knowledge, which is difficult to share (Jennings and Beaver, 1997 cited in 
Garengo, et al., 2005). 
 
Garengo, et al. (2005) conclude that performance management is largely not 
practiced in small- and medium-sized enterprises, even though there is a need for 
this, and for performance measurement systems to be utilised. 
 
Another barrier to implementing PMSs could be that the managers and/ or owners of 
SMMEs may possess inadequate knowledge of business practices, as found by 
Visara and Hunt (2008) cited in Banomyong and Supatn (2011). 
 
3.2 Paradigms of pharmacy practice 
 
Classical job design theories, such as Taylorism, are well aligned with the traditional 
paradigm of pharmacists as primarily technical dispensers9 of medication (Giannetti, 
2004).  The focus of these theories (see 3.1.1.1 and 3.1.2.1) is on ensuring 
                                                            
9
  This notion of dispensing differs from that described by the SAPC, as discussed on the 
next page. 
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efficiency, accuracy and employees obeying commands (Giannetti, 2004).  With the 
shift towards pharmaceutical care, however, many pharmacists may have “higher-
order needs” for, and expectations of, greater autonomy, professionalism and being 
able to practice pharmaceutical care (Giannetti, 2004: 216). 
 
The shift in paradigms of pharmacy practice, from a product-oriented paradigm to the 
paradigm of pharmaceutical care, as described below in 3.2.1 and 3.2.2, can thus be 
seen to mirror the shift in paradigms of performance management discussed in 3.1.  
The traditional paradigm of pharmacists as primarily technical dispensers and 
controllers of medication use (see 3.2.1) can be seen as reflecting the control 
approach to performance management, in which financial performance indicators are 
primarily used to assess performance and there is a predominant focus on efficiency.  
Pharmaceutical care, on the other hand, reflects a systems approach to performance 
management, as it entails, for example, providing holistic care that considers all 
aspects of a patient’s actual and potential pharmacotherapy, liaising with a variety of 
stakeholders and pharmacists acting as knowledge workers and being open to 
learning and development.  These issues will be explored in more depth below. 
 
3.2.1 The shift from a product- to a care-based paradigm 
 
Al-Shaqha and Zairi (2001) classify the history of pharmacy practice into three 
phases, namely: (i) compounding10 and dispensing; (ii) clinical pharmacy; and (iii) 
pharmaceutical care, each of which will be discussed in the next few pages.  These 
authors’ (2001: 282) reference to these phases as representing “pharmacy practice 
evolution” may be misleading, as this implies that the majority of pharmacists 
currently practise pharmaceutical care and that this latest phase has replaced earlier 
ways of practice.  As discussed in 3.4.1, this is not necessarily the case.  It might 
thus be more accurate to regard Al-Shaqha and Zairi’s (2001) three phases as each 
representing a different paradigm of pharmacy practice.   
                                                            
10
  “Compounding” refers to combining different ingredients, for example by mixing (see 
glossary). 
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These paradigms reflect a shift in viewing the role of pharmacists as performing 
primarily technical, product-oriented tasks towards the acceptance of responsibility 
for patient outcomes and provision of patient counselling inherent in providing 
pharmaceutical care (Al-Shaqha and Zahiri, 2001; van Mil, Schulz & Tromp, 2004).  
Assa-Eley and Kimberlin (2005: 44) refer to this shift towards pharmaceutical care as 
representing an “expanded role” for pharmacists.   
 
The first paradigm, of compounding and dispensing medication, typified pharmacy 
practice for centuries (Al-Shaqha and Zairi, 2001).  It is important to note that this 
view of dispensing is narrower than the SAPC’s description of dispensing as 
consisting of the three phases of (i) prescription assessment and evaluation, (ii) 
preparing and labelling medication, and (iii) patient counselling (South Africa. SAPC, 
2010a) (see 2.2.4).  Al-Shaqha and Zairi’s (2001) description of dispensing 
corresponds to phase (ii) of the SAPC’s description only; phases (i) and (iii) of the 
SAPC’s description of dispensing reflect tasks that Al-Shaqha and Zairi (2001) 
describe as components of pharmaceutical care. 
 
As the pharmaceutical industry began to compound more medication, pharmacists 
had more time to engage in other services, which contributed to the development of 
the second paradigm of pharmacy practice, clinical pharmacy, in the mid-1960s (Al-
Shaqha and Zairi, 2001).  Clinical pharmacy became more predominant in the 
hospital rather than the retail pharmacy sector, and was characterised by 
pharmacists collaborating more with other health-care professionals, in particular 
doctors and nurses, to ensure optimal clinical outcomes for patients.  Pharmacists 
began to assume the role of critically evaluating the appropriateness of drug use, for 
example in terms of patient safety and efficacy (Al-Shaqha and Zairi, 2001). 
 
Although clinical pharmacy had increased the scope of pharmacy practice, there was 
a growing realisation of the limitations of adopting a solely clinical paradigm, such as 
the predominant focus on controlling drug use (Al-Shaqha and Zairi, 2001; Elenbaas, 
2008).  Inadequate attention was given to developing a “philosophy of practice” (Al-
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Shaqha and Zairi, 2001: 286) and a management system that holistically considered 
patients’ pharmacotherapeutic needs and pharmacists’ responsibilities in this regard, 
according to Strand (1997) cited in Al-Shaqha and Zairi (2001).  The timeline in 
Figure 4 below illustrates how the concept of pharmaceutical care has developed 
over the last few decades, and the major authors responsible for this.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: A timeline of some evolving definitions of pharmaceutical care 
(based on van Mil, 1998; Al-Shaqha and Zairi, 2001; and van Mil, et al., 2004) 
“The care that a given patient requires and receives which assures safe and rational drug 
usage” (Mikeal, Brown, Lazarus & Vinson, 1975 cited in van Mil, 1998) 
1975 
1980 
“Pharmaceutical care includes the determination of drug needs for a given individual and 
provision not only of the drug required but also necessary services (before, during and after 
treatment) to assure optimally safe and effective therapy.  It includes a feedback mechanism 
as a means of facilitating continuity of care by those who provide it.”  (Brodie, Parish & 
Poston, 1980 cited in van Mil, 1998) 
1987 
“A convenantal (sic) relationship between a patient and a pharmacist in which the pharmacist 
performs drug-use control functions (with appropriate knowledge and skill) governed by 
awareness of and commitment to the patients (sic) interest” (Hepler, 1987 cited in van Mil, 
1998) 
1990 
“Pharmaceutical care is the responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality of life.  These outcomes are: 
1. Cure of disease; 
2. Elimination or reduction of a patient’s symptomatology; 
3. Arresting or slowing of a disease process; or 
4. Preventing a disease or symptomatology.”  (Hepler and Strand, 1990 cited in Al-Shaqha 
and Zairi, 2001: 286 and in van Mil, 1998) 
1992 “Pharmaceutical care is that component of pharmacy practice which entails the direct 
interaction of the pharmacist with the patient for the purpose of caring for that patient’s drug-
related needs.”  (Strand, Cipolle & Morley, 1992 cited in van Mil, 1998) 
1997 “A practice for which the practitioner takes responsibility for a patient’s drug therapy needs 
and is held accountable for this commitment” (Cipolle, Strand & Morley, 1997 cited in van Mil, 
et al., 2004: 303) 
1998 “A service which systematically and continuously monitors the clinical and psychosocial 
effects of drug therapy on a patient” (Munroe and Dalmady-Israel, 1998 cited in van Mil, 
1998) 
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Van Mil (1998) notes that Brodie, et al.’s (1980) definition (see Figure 4) introduced 
awareness of the social dimension of pharmaceutical care, with the recognition that 
patients do not solely require tangible medication, but also services to ensure that 
this is used optimally.  This was developed by Hepler (1987) cited in van Mil (1998), 
who used the word “relationship” for the first time to describe the interactions 
between patients and pharmacists in particular, and recognised patients’ interests 
explicitly in his definition.   
 
This contributed to Hepler and Strand’s seminal (1990) definition of pharmaceutical 
care cited in Al-Shaqha and Zairi (2001: 286), in which responsibility for patient 
outcomes is highlighted (see Figure 4).  Cipolle, et al.’s later (1997) definition cited in 
van Mil, et al. (2004: 303) extended this emphasis on practitioner responsibility and 
accountability for the pharmacotherapeutic needs of patients.  Van Mil, et al. (2004: 
303) describe Cipolle, et al.’s (1997) definition as reflective of a “humanistic” school 
of thought, whereas earlier definitions (notably Hepler, 1987 and Hepler and Strand, 
1990, both cited in van Mil, 1998) are more technical (van Mil, 1998).  The SAPC’s 
description of pharmaceutical care (South Africa. SAPC, 2010a) (see 1.7) closely 
mirrors Cipolle, et al.’s (1997) definition cited in van Mil, et al. (2004). 
 
The inclusion of the word “care” in “pharmaceutical care” is significant, according to 
Al-Shaqha and Zairi (2001: 286), who argue that, “The idea of professional care 
goes beyond the idea of professional service.  While both indicate actions, care adds 
a dimension of concern and commitment.”  This is echoed by Elenbaas (2008), who 
argues that a demonstration of pharmacists’ commitment to caring for patients has 
the potential to contribute to creating demand from patients and other health-care 
professionals for a highly patient-centred approach to pharmacy practice. 
 
Hepler and Strand’s (1990) definition cited in Al-Shaqha and Zairi (2001: 286) 
suggests that pharmaceutical care involves pharmacists having to apply their 
knowledge, judgement and skills more intensively.  Van Mil, et al. (2004) believe that 
the knowledge and academic background that pharmacists possess should compel 
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pharmacists to provide pharmaceutical care.  The more intensive use of knowledge 
and expertise, which are intangible resources, suggests that, in providing 
pharmaceutical care, pharmacists are expected to function as knowledge workers 
(see 3.2), according to Giannetti (2004).  As discussed in 3.4.1, this use of 
pharmacists’ knowledge to provide pharmaceutical care and thus transform the 
nature of pharmacy practice is currently not occurring widely.  
 
Desselle (2004: 9) has developed a classification of five “pharmaceutical care 
practice domains”, each of which he believes adds credibility to his assertion that 
pharmaceutical care is strongly influenced by the managerial sciences.  According to 
Desselle (2004), there is a synergistic relationship between good business practices 
and pharmaceutical care.  He argues that pharmaceutical care is essentially about 
managing patients and their pharmacotherapy.  The abovementioned five domains 
are (Desselle, 2004: 9): 
(i) Risk management, which includes calculating dosages and reporting adverse 
effects; 
(ii) Patient advocacy, involving patient counselling and attempting to address the 
factors that could lead to patient non-compliance with pharmacotherapy; 
(iii) Disease management, including providing patients with information relating to 
their medical conditions and monitoring patient outcomes; 
(iv) Pharmaceutical care services marketing, which involves functions such as 
liaising with prescribers and active involvement in the activities of professional 
associations that espouse the philosophy of pharmaceutical care; and  
(v) Business management, which includes ensuring operational efficiency in 
pharmacies and optimally utilising support staff to perform technical functions. 
 
3.2.2 A commercial versus a professional paradigm of pharmacists 
 
The different paradigms of a product- and a pharmaceutical care-based approach to 
pharmacy practice, as discussed in 3.2.1, can also be regarded as reflecting the 
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differences between a commercially- and a professionally-oriented paradigm, 
respectively.  According to Panitch and Leys (2009), capitalism has given rise to the 
commoditisation of health-care services.  Within this paradigm, pharmacists and 
patients are perceived as income generators for organisations.  In his history of the 
pharmaceutical profession in Canada, Malleck (2004) notes that the intrusion of 
capital market pressures on the professional ideals of pharmacy practice was 
demonstrated as far back as the 1860s.   
 
Market pressures have intensified since then, an example of which is the growing 
number of retail chain stores offering pharmaceutical services (URCH Publishing, 
2009; Desselle, 2004) (see 1.6).  Schmidt and Pioch (2005) highlight the increasing 
competitive pressures faced by independent pharmacies in the United Kingdom 
(UK), for example by supermarkets and chain stores also selling medication; these 
authors state that such pressures have contributed to 20% of pharmacies in the UK 
facing financial collapse.  In Germany, the struggle facing many pharmacies to 
survive financially, for example due to low profit margins on medication and political 
reform, and the subsequent need for pharmacies to offer differentiated services has 
led Pioch and Schmidt (2001) to question whether pharmacists are merchants or 
professionals.  Incidents such as that of a pharmacist who diluted anticancer drugs in 
order to decrease stock costs (Stafford, 2002 cited in Desselle, 2004) add to the 
perception that pharmacists’ commercial interests are not compatible with 
professional ethics, as described by Desselle (2004).   
 
Ehlert (2004) believes that a professional, by nature, places the interests of the 
public above his/ her own interests.  The tension arising between meeting such 
ethical imperatives and commercial pressures may potentially contribute to 
pharmacists suffering from the high levels of “moral distress” found by Sporrong, 
Höglund, Hansson, Westerholm & Arnetz (2005: 223).  Desselle (2004) believes that 
sound managerial skills, however, can potentially assist pharmacists in successfully 
navigating the stresses arising from pharmacy practice. 
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3.3 Pharmaceutical care and DRP 
 
According to the PCNE Foundation (2010: 4), there are four categories of DRP:  
(i) Treatment not being effective; 
(ii) Adverse drug reactions; 
(iii) Treatment costs, including pharmacotherapy being more expensive than it 
 should be; and 
(iv) Others, such as patients not being satisfied with their pharmacotherapy. 
 
There are eight primary domains that can cause DRP (PCNE Foundation, 2010: 5): 
(i) Drug selection, such as a drug that is contraindicated being prescribed; 
(ii) Drug form, in which an inappropriate dosage form is used; 
(iii) Dose selection, for example overdosage or underdosage; 
(iv) Treatment duration, which may be inappropriately long or short; 
(v) Drug use process, such as a dose not being taken at the appropriate time; 
(vi) Logistics, such as the occurrence of prescribing and dispensing errors; 
(vii) Patient factors, such as the patient forgetting to take a dose; and 
(viii) Other causes, which may not be known. 
 
In a Spanish study, Muñoz, Miguez, Pérez, Escribano, Garcia & Saez (2010) found 
that more than 45% of medication errors11 involved prescription errors.  It has been 
found that patients with medication errors have a mortality rate of almost twice that of 
patients not affected by medication errors (Classen, Pestotnik, Evans, Lloyd & 
Burke, 1997 cited in Muñoz, et al., 2010).  The mortality and morbidity costs of DRP 
are thus likely to be significant.  The costs of DRP in the USA alone for ambulatory 
patients in 2000 were greater than $177.4 billion (Ernst and Grizzle, 2001).  This 
represents an increase of more than $100.8 billion from that reported in Johnson and 
Bootman’s landmark (1995) study cited in Ernst and Grizzle (2001).  The costs of 
DRP in South Africa are at present unknown. 
                                                            
11
  Medication errors were defined in this study as, “Events caused by inappropriate use of 
medication, which could harm the patient, while the medication is under the control of the 
healthcare professional or patient” (National Coordinating Council for Medication and 
Prevention, 1998 cited in Muñoz, et al., 2010: 329). 
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Pharmaceutical care has the potential to allow for the detection and resolution of 
DRP by enabling pharmacists to actively intervene in the possible causes of DRP 
described previously.  Banerjee (2009) argues that pharmacists have a crucial role to 
play, particularly with regard to liaising with prescribers and in communicating with 
patients, in improving the benefit-to-risk ratio of medication.  Furthermore, the 
positive effects of pharmacists on decreasing the costs of DRP are well-documented.  
Gillespie, Alassaad, Henrohn, Garmo, Hammarlund-Udenaes, Toss, Kettis-Lindblad, 
Melhus & Mörlin (2009), for example, found that the inclusion of pharmacists in a 
hospital health team led to a 16% decrease in hospital visits by patients over the age 
of 80 years.  A 34% decrease in the incidence of adverse drug reactions and 
medication errors12 amongst outpatients with cardiovascular disease subsequent to 
pharmacists’ interventions has also been reported (Murray, et al., 2009).  The direct 
costs of DRP are expected to fall by 59% with the adoption of pharmaceutical care, 
according to Johnson and Bootman’s (1995) pharmacoeconomic analyses cited in 
Bootman and Harrison (1997). 
 
3.4 The extent to which pharmaceutical care is practised 
 
3.4.1 Frequency of pharmacist interventions  
 
The International Pharmaceutical Federation released a set of standards in 1998 that 
includes the provision of pharmaceutical care as a GPP requirement (van Mil, et al., 
2004), thus sending out a signal internationally that pharmaceutical care should be 
practised routinely by pharmacists.  Pioch and Schmidt (2001) report that the 
German pharmacists in their study view pharmaceutical care as the core offering of 
their pharmacies, and have a strong sense of professionalism in this regard.  Van 
Mil, et al. (2004) also cite various studies showing that, in several European 
countries, pharmacists intervene to address actual and potential DRP.  However, 
                                                            
12
  In this study, “medication errors” refers to prescribing errors and errors in monitoring 
pharmacotherapy, defined as the sum of potential and preventable adverse drug reactions 
(Murray, Ritchey, Wu & Tu, 2009). 
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closer examination of several of these studies referred to by van Mil, et al. (2004) 
reveals that either the frequency of these reported pharmacists’ interventions is 
relatively low, or the frequency was not reported.  In the study by Leemans, 
Veroeveren, Bulens, Hendrickx, Keyenberg, Niesten, Vandeberg, Van Hoof & 
Laekeman (2003), for example, it was reported that Flemish pharmacists in the study 
only intervened in 4.05% of prescriptions.   
 
Similarly, Buurma, de Smet, van den Hoff & Egberts (2001) reported an intervention 
frequency of 4.3% for all prescriptions, whilst Hawksworth, Corlett, Wright & 
Chrystyn (1999) report a lower frequency of 0.75%.  This suggests that either the 
remaining large proportion of prescriptions were error-free, or pharmacists were 
reluctant to intervene more often.  Leemans, et al. (2003) report, furthermore, that 
similar investigations have shown frequencies of between 0.8% and 6.2%.  Chamba, 
Bauguil & Gallezot (1999), also referred to in van Mil, et al. (2004), whilst disclosing 
that the French pharmacists in the study reported 727 acts of intervention, which 
cover various aspects of pharmaceutical care, have not reported how many 
prescriptions in total were processed by these pharmacists.   
 
In a Brazilian study, d’Ávila, Assunção, Belisário & de Abreu (2010) found that the 
provision of information to patients only occurred in 43% of dispensing encounters, 
and that less information was provided as the number of dispensing encounters 
increased, suggesting that time pressures in pharmacies and the volume of patients 
play a role in determining whether drug-related information is provided by 
pharmacists to patients.  These authors also highlight that taking time to provide 
information to patients allows health-care professionals to detect errors in dispensing 
(d’Ávila, et al., 2010), thus decreasing the potential for DRP. 
 
The abovementioned studies thus suggest that pharmaceutical care is not widely 
practised.  Van Mil, et al. (2004) acknowledge this in the epilogue to their article, and 
this view is shared by others, including Elenbaas (2008), Assa-Eley and Kimberlin 
(2005) and Cipolle and Strand (1998) cited in Giannetti (2004).  
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3.4.2 Demographic variables and pharmaceutical care 
 
To the author’s knowledge, there are no reported studies in the literature on 
determining whether patients’ perceptions of pharmaceutical services or 
pharmaceutical care vary according to demographic variables, such as gender and 
race.  Hanna, White & Yanamandram’s (2010) study (see 3.5.3) investigated 
whether certain demographic variables are related to patients’ willingness to pay for 
a diabetes disease management service, which is a pharmaceutical care-related 
service.  In the abovementioned study, the potential effects of demographic variables 
were thus limited to willingness to pay.  Assa-Eley and Kimberlin’s (2005) report on 
patients’ perceptions of pharmaceutical care (see 3.5.2) only describes the 
demographic profile of the authors’ patient sample group in terms of gender and age, 
and does not include an investigation into whether there was a relationship between 
different demographic variables and patients’ perceptions of pharmaceutical care. 
 
3.4.3 Levels of pharmaceutical care 
 
Smith and Benderev (1991) cited in Al-Shaqha and Zairi (2001) propose that 
different levels of pharmaceutical care be provided, to correspond with the primary, 
secondary and tertiary levels of health care respectively.  The United Kingdom 
Clinical Pharmacy Association (UKCPA, 2009) also suggests that different kinds of 
pharmaceutical care may be more appropriate for different groups of patients and 
clinical scenarios.  In primary pharmaceutical care, which represents the most basic 
level and which should be provided by retail and outpatient hospital pharmacies, 
typical functions provided by pharmacists include monitoring pharmacotherapy for 
effectiveness and safety, detecting drug interactions and adverse drug reactions, 
and providing drug information to patients and other health-care professionals (Smith 
and Benderev, 1991 cited in Al-Shaqha and Zairi, 2001).  Al-Shaqha and Zairi (2001) 
further add that primary pharmaceutical care also involves monitoring patient 
compliance, a greater focus on patient counselling and assisting prescribers in 
selecting appropriate pharmacotherapy for patients. 
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If a patient’s medical condition is more complex than can be treated with primary 
care, secondary care is provided, usually in acute-care hospitals and facilities such 
as hospices (Al-Shaqha and Zairi, 2001).  Secondary pharmaceutical care involves 
the basic functions involved in primary pharmaceutical care and additional services, 
such as pharmacists performing pharmacokinetic services, in which drug 
concentrations are measured; and managing a patient’s pharmacotherapy (Al-
Shaqha and Zairi, 2001).  For patients whose medical conditions are yet more 
complex, tertiary care is appropriate; this is usually provided at in-patient, critical-
care hospitals, many of which are teaching hospitals.  Tertiary pharmaceutical care 
entails the most comprehensive and in-depth pharmaceutical care, for example 
detailed clinical pharmacy services, as described by Al-Shaqha and Zairi (2001). 
 
Whilst health-care in the public sector in South Africa is organised according to the 
primary, secondary and tertiary levels, there is no differentiation by the SAPC (South 
Africa. SAPC, 2010a) in the levels of pharmaceutical care that should be provided by 
pharmacists, as described above. Furthermore, although pharmaceutical care is 
mandatory in South Africa, it is possible that individual pharmacies may respond 
differently to this legal imperative.  Azzone and Palermo (2011), for example, found 
that the organisations in their study have differing responses to statutory 
requirements, and that these responses are influenced by the resources 
organisations possess, time pressures and the motives of the organisation. 
 
3.5 Barriers to implementing pharmaceutical care 
 
Various reasons have been cited for pharmacists not intervening more often, in order 
to provide pharmaceutical care.  Al-Shaqha and Zairi (2001: 296) identify four 
barriers to implementing pharmaceutical care, namely: (i) system-related barriers; (ii) 
pharmacist-related barriers; (iii) demand-related barriers; and (iv) pharmacy 
management-related barriers.  Each of these will be discussed in more detail next. 
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3.5.1 System-related barriers 
 
Al-Shaqha and Zairi (2001) describe the fragmentation of the health-care system, 
with differences between services that patients receive whilst in hospital as 
inpatients, and those received as outpatients.  In a study comparing progress in 
addressing fragmentation of health-care systems in South Africa, the United 
Republic of Tanzania and Ghana, McIntyre, Garshong, Mtei, Meheus, Thiede, 
Akazili, Ally, Aikins, Mulligan & Goudge (2008) conclude that South Africa has made 
the least progress.  These authors define fragmentation as “the existence of a large 
number of separate funding mechanisms [...] and a wide range of health-care 
providers paid from different funding pools” (McIntyre, et al., 2008: 871).   
 
In South Africa, the underlying fragmentation arising from the country’s colonial and 
apartheid past have been exacerbated by an escalation in the number of private-
sector insurance companies (McIntyre, et al., 2008), which provide cover to the 
wealthiest proportion of the population (McLeod, 2005 cited in McIntyre, et al., 2008).  
In addition to differences between public and private health-care services in South 
Africa, there are also inequalities between rural and urban areas, and between 
provinces (Heywood, 2006).  According to Louie and Robertson (1993) cited by Al-
Shaqha and Zairi (2001), fragmentation does not promote continuity of patient care.   
 
Another system-related barrier is poor development of processes and guidelines to 
establish desired drug therapy outcomes, for individual patients as well as the wider 
patient population (Al-Shaqha and Zairi, 2001); as mentioned in 3.2.1, 
pharmaceutical care emphasises taking responsibility for patient outcomes.  Al-
Shaqha and Zairi (2001) also highlight that the physical location and layout of 
pharmacies often serves as a physical barrier to the provision of pharmaceutical 
care.  Frequently, there is no dedicated patient counselling area (Al-Shaqha and 
Zairi, 2001), and patient privacy may thus not be protected.   
 
Furthermore, pharmacists are geographically removed from the place at which 
choices regarding drug therapy for patients are often made, thus decreasing their 
Dr Layla Cassim 72076984  Research Report MBA 5932 
60 
 
involvement in this key phase (Al-Shaqha and Zairi, 2001).  This contributes to 
distance developing between prescribers and pharmacists, as described by Van Mil, 
et al. (2004).  Instead of collaborating with prescribers to decide on the most 
appropriate therapy for patients, pharmacists are, according to Van Mil, et al. (2004), 
thus in the position of detecting DRP only once a prescription has been written, and 
contacting a prescriber to highlight prescription errors could damage professional 
relations between pharmacists and prescribers.  Chamba, et al. (1999) highlight that 
collaboration between pharmacists and prescribers is essential for pharmaceutical 
care interventions to be effective; these authors have found that there was tension 
between pharmacists and prescribers in discussions regarding changing prescribed 
doses.  This suggests that another factor discouraging pharmacists from intervening 
upon detecting DRP could be potentially adversarial relationships with prescribers. 
 
The abovementioned limitation in pharmacists’ involvement in drug therapy 
decisions, due to the pharmacy’s location, may also reinforce the belief that patients 
may have that their prescriber is solely responsible for patient care and that 
pharmacists only perform the technical task of issuing medication (Penna, 1990 cited 
in Al-Shaqha and Zairi, 2001). 
 
A final system-related barrier is inadequate access that pharmacists have to patients’ 
medical information (Al-Shaqha and Zairi, 2001), such as diagnoses and laboratory 
results (May, 1993 cited in Al-Shaqha and Zairi, 2001).  This makes it more difficult, 
time-consuming and costly for pharmacists to liaise with prescribers and/ or patients 
to determine what patients’ drug therapy outcomes are (Louie and Robertson, 1993 
cited in Al-Shaqha and Zairi, 2001), and provide pharmaceutical care that is in 
alignment with these outcomes (Al-Shaqha and Zairi, 2001).   
 
Cooksey, Knapp, Walton & Cultice (2002) conclude that the current drug product-
oriented market paradigm (see 3.2.2) is geared towards ensuring convenience for 
customers, as opposed to providing integrated and holistic patient health-care 
services, of which pharmaceutical care is a component. 
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3.5.2 Pharmacist-related barriers 
 
A major barrier cited is the lack of time to provide pharmaceutical care (Al-Shaqha 
and Zairi, 2001).  Hawksworth, et al. (1999) found that pharmacies with a high 
prescription load reported lower frequencies of pharmacists’ interventions to address 
DRP; this suggests that pharmacists did not take time to intervene in cases of DRP, 
as their focus was on increasing operational efficiency in processing prescriptions 
and minimising patient waiting times.  This is supported by d’Ávila, et al. (2010) who 
report that an increase in the number of dispensing encounters is associated with the 
provision of less information to patients (see 3.4.1).  Hawksworth, et al. (1999) also 
suggest that inexperience and inadequate training may play a role in pharmacists not 
intervening to address DRP.   
 
Van Mil, et al. (2004) believe that university curricula do not prepare pharmacists 
adequately for providing pharmaceutical care, and that there are critical knowledge 
and skills gaps, for example in detecting DRP, in social and clinical pharmacy and in 
communication, that contribute to pharmacists being hesitant about practising 
pharmaceutical care.  These authors argue that the focus of European university 
curricula still reflects the traditional compounding and dispensing paradigm of 
pharmacy practice (see 3.2.1) (van Mil, et al., 2004).   
 
Another significant barrier is many pharmacists still espousing the technical, product-
oriented paradigm of pharmacy practice, as described in 3.2.1, and not having 
shifted towards accepting the paradigm of pharmaceutical care, with its focus on 
individualised care and patient outcomes (Al-Shaqha and Zairi, 2001).  Louie and 
Robertson (1993) cited in Al-Shaqha and Zairi (2001) believe that this is due to poor 
understanding by some pharmacists of the significance of accepting responsibility for 
patient outcomes as a component of pharmaceutical care.  These authors also 
believe that some pharmacists may wish to provide pharmaceutical care, but that 
their attempts to do so do not exploit their pharmacotherapeutic expertise (Louie and 
Robertson, 1993 cited in Al-Shaqha and Zairi, 2001).  This reflects inadequate 
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understanding of the practicalities of implementing pharmaceutical care, and the lack 
of guidelines and processes described in 3.5.1.  It is also important for pharmacists 
to know and be able to relate to their patients, in order for patients to trust the 
services offered by the pharmacist, as highlighted by Desselle (2004).   
 
Agnihotri, Rapp & Trainor (2009) argue that in buyer-seller encounters, the 
knowledge and communication skills of sellers enhance the information-exchange 
process, contributing to greater customer satisfaction.  Although medication cannot 
be regarded as an ordinary commodity of trade due to the difficulty in quantifying 
health-related products and activities, as pointed out by d’Ávila, et al. (2010), which 
makes pharmacists more than just sellers, Agnihotri, et al.’s (2009) findings can 
nevertheless be applied to the pharmacy setting.  This application suggests that the 
knowledge and communication skills possessed by pharmacists have the potential to 
result in greater patient satisfaction.  Gill and White (2009) sound a note of warning, 
however, on the use of patient satisfaction as an indicator of the perceived quality of 
a health-care service.  Some reasons for this include the questionable validity of 
many tools used to assess patient satisfaction (Gill and White, 2009), the subjective 
nature of satisfaction (Crowe, Gage, Hamson, Hart, Kimber, Storey & Thomas, 2002 
cited in Gill and White, 2009) and the complexity involved in patient interactions with 
health-care professionals (Lengnick-Hall, 1995 cited in Gill and White, 2009). 
 
Although Al-Shaqha and Zairi (2001) believe that older pharmacists may be more 
resistant to adopting pharmaceutical care as a way of practice due to an ingrained 
product-oriented paradigm and inadequate skills and knowledge, Leemans, et al. 
(2003) found that younger pharmacy graduates did not intervene to address DRP 
any more often than older pharmacists did.  However, Leemans, et al. (2003) also 
report that even though older pharmacists may possess greater experience than 
younger pharmacists, the former did not intervene more often to address DRP.  
 
Assa-Eley and Kimberlin (2005) have reported that a major barrier to pharmacists 
implementing pharmaceutical care is their perception that patients do not want such 
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a service, whereas patients have expressed interest in learning more about their 
medication.  This failure to recognise and meet patients’ needs reinforces the 
traditional view of patients, as reported by Assa and Shepherd (2000), that 
pharmacists perform a merely technical role in dispensing medication.  
 
Using the interpersonal perception method to investigate the perceptions that 
pharmacists and patients have of each other and of the benefits of pharmaceutical 
care, Assa-Eley and Kimberlin (2005) have found that patients have low 
expectations of pharmaceutical services and are unaware of the benefits of 
pharmaceutical care.  These authors suggest that these low patient expectations 
could have arisen due to patients not having experienced pharmaceutical care and 
not understanding the role of pharmacists in performing pharmaceutical care-related 
functions (Assa-Eley and Kimberlin, 2005).  This is supported by Hanna, et al.’s 
(2010) finding that patients expressed a neutral opinion of the ability of pharmacists 
to provide diabetes disease management services (see 3.5.3). 
 
The abovementioned finding by Assa-Eley and Kimberlin (2005) that patients are 
unaware of the benefits of pharmaceutical care was confirmed by the finding that 
those patients who reported that their pharmacist often asked them if they 
experience problems with their medication viewed pharmaceutical care as having 
greater benefit than those patients whose pharmacists did not ask them this question 
(Assa-Eley and Kimberlin, 2005).  This has led the authors to conclude that patients 
begin to appreciate the value of pharmaceutical care-related services after having 
experienced these, and that if pharmacists provided pharmaceutical care more often, 
patients’ expectations of pharmaceutical services and their demand for 
pharmaceutical care could be increased (Assa-Eley and Kimberlin, 2005).   
 
Although Practice Profile (1994) cited in Al-Shaqha and Zairi (2001) reveals that 
providing pharmaceutical care has resulted in increased satisfaction for some 
pharmacists, there have been some perhaps unexpected effects, as discussed next, 
that might potentially serve as a disincentive or deterrent to pharmacists providing 
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pharmaceutical care.  One of these, as reported by Gidman, Hassell, Day & Payne 
(2007), is that the increase in pharmacists’ responsibilities in providing 
pharmaceutical care, and an increase in patient load, have been cited as reasons for 
female community pharmacists in the UK feeling that their work environments are 
increasingly stressful, leading to lower job satisfaction and adverse effects on 
pharmacists’ wellbeing.  Giannetti (2004) also points out the issue of stress 
experienced by pharmacists, in particular those with a Type A personality as 
described by Freidman and Rosenman (1974) cited in Giannetti (2004).  Employee 
wellbeing and health is important not just to employees, but also to organisations, as 
described by Edington and Schultz (2008).  These authors suggest that increased 
employee productivity and lower absenteeism rates and workers’ compensation 
costs are some examples of benefits to organisations (Edington and Schultz, 2008). 
 
Another challenge facing pharmacists is that the increased patient contact time and 
pharmacists’ responsibilities towards patients resulting from providing 
pharmaceutical care, has contributed to the “moral distress” and ethical dilemmas 
experienced by pharmacists in a Swedish study (Sporrong, et al., 2005: 223) (see 
3.2.2).  A prominent example of this mentioned by Sporrong, et al. (2005) is that, due 
to the layout of pharmacies, the counselling that a patient receives may be 
overheard by other customers, thus violating the patient’s right to privacy.  The 
pharmacist thus faces an ethical dilemma, as the responsibility to provide patient 
counselling conflicts with the professional imperative to protect patient confidentiality.  
 
Finally, Hepler (1996) cited in Al-Shaqha and Zairi (2001) advocates that it is 
essential for pharmacists to document the pharmaceutical care provided, in order to 
record patients’ information and evaluate the effectiveness of pharmaceutical care.  
Penna (1990) cited in Al-Shaqha and Zairi (2001) reports that many pharmacists do 
not value the significance of such documentation.  Similarly, Pioch and Schmidt 
(2001) report an indifferent or antagonistic view to the use of information technology 
as a support tool to facilitate the provision of pharmaceutical care, for example the 
use of databases to detect contraindications to drug use.   
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3.5.3 Demand-related barriers 
 
As highlighted by Elenbaas (2008) (see 3.2.1), Assa-Eley and Kimberlin (2005) (see 
3.5.2) and Al-Shaqha and Zairi (2001), there is currently low demand from patients, 
other health-care professionals, medical aids and government agencies for 
pharmacists to provide pharmaceutical care.  The latter point about government 
agencies is not applicable in South Africa, as the SAPC, a statutory body, views 
pharmaceutical care as a key responsibility for pharmacists (see 1.1). 
 
Al-Shaqha and Zairi (2001) believe that the low demand for pharmaceutical care is 
because the value and benefits of pharmaceutical care are not fully understood and 
appreciated by the abovementioned stakeholders, largely because pharmacists have 
not communicated this effectively and there are not many well-controlled studies 
reported on the advantages of pharmaceutical care.  Van Mil, et al. (2004) agree with 
this assertion that other professions do not value the importance of pharmaceutical 
care.  Other health-care professionals may, according to Al-Shaqha and Zairi (2001), 
also believe that pharmaceutical care undermines their role, instead of viewing it as 
a complementary service that assists in the overall optimisation of patient outcomes.   
 
Hanna, et al. (2010) cite a study by Larson (2000), which highlights that a major 
barrier to providing pharmaceutical care is that many pharmacists perceive that 
patients are unwilling to pay more for additional services, and thus believe that there 
is a lack of patient demand for pharmaceutical care.  This perception was found to 
be incorrect in Hanna, et al.’s (2010) study of Australian retail pharmacies, in which 
these authors found that although patients are neutral in their perceptions of the 
abilities of pharmacists to provide additional diabetes disease management services 
(see 3.5.2), most patients are nevertheless willing to pay more for such a service.   
 
Patients were willing to pay a median of approximately 30 Australian dollars for an 
initial half-an-hour consultation with a pharmacist that led to a 50% improvement in 
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their diabetes control, and a median of approximately 40 Australian dollars for a 
similar consultation that led to a 100% improvement (Hanna, et al., 2010).  Patients 
were willing to pay a median of approximately 20 Australian dollars for a follow-up 
half-an-hour consultation leading to a 50% improvement in their diabetes control, 
and a median of approximately 30 Australian dollars for a follow-up consultation 
leading to a 100% improvement (Hanna, et al., 2010).  This study indicates that there 
is a demand from patients for pharmaceutical care-related services. 
 
3.5.4 Management-related barriers 
 
Elenbaas (2008) indicates that the nature of the PMS has the potential to undermine 
the provision of pharmaceutical care being provided to patients.  He suggests that if 
pharmacy support staff are not utilised optimally in performing technical functions, 
then pharmacists’ difficulty in finding the time to provide pharmaceutical care is 
exacerbated.  Elenbaas (2008) also argues that the nature of how the performance 
of pharmacists is measured needs to change, as the current use of the number of 
prescriptions processed as a key performance measure discourages pharmacists 
from focusing on their responsibilities to patients and patient outcomes.  Gouveia 
(1993a) cited in Al-Shaqha and Zairi (2001) agrees, highlighting that the criteria used 
for performance appraisal and job descriptions for pharmacists are still based on 
traditional key performance areas, and not pharmaceutical care. 
 
Al-Shaqha and Zairi (2001) note that managing pharmacists are frequently not held 
accountable for the outcomes of pharmacotherapy.  The overriding accountability is 
to meet traditional financial goals (Louie and Robertson, 1993 cited in Al-Shaqha and 
Zairi, 2001), such as decreased operating costs (Al-Shaqha and Zairi, 2001).  The 
irony highlighted by Al-Shaqha and Zairi (2001) is that the benefit of pharmaceutical 
care in terms of decreasing the costs of DRP (see 3.3) is not considered.  Managing 
pharmacists also often do not have the time required to plan for implementing 
pharmaceutical care (Al-Shaqha and Zairi, 2001); this, and the lack of protocols or 
guidelines on how to measure the effect of pharmaceutical services on patient 
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outcomes, and insufficient resources being directed towards this (Hepler, 1990 cited 
in Al-Shaqha and Zairi, 2001), are barriers to the practice of pharmaceutical care. 
 
Gouveia (1993a) cited in Al-Shaqha and Zairi (2001) points out that organisational 
organograms often allocate clinical care responsibilities to some pharmacists, and 
responsibilities for drug distribution and other product-oriented responsibilities to 
others.  Pharmaceutical care should, however, be the responsibility of all 
pharmacists, as suggested by Gouveia (1993a) cited in Al-Shaqha and Zairi (2001) 
(see 3.6.3).  Other reasons cited for pharmacists not intervening to address DRP 
include a shortage of pharmacy staff and a lack of additional remuneration for 
providing pharmaceutical care (Anonymous, 2000; Shibley and Pugh, 1997; and 
Hawksworth and Chrystyn, 1999; all cited in Leemans, et al., 2003).  Van Mil, et al. 
(2004) and Rossing, Holme Hansen & Krass (2001) cited in van Mil, et al. (2004) 
also highlight the lack of remuneration for pharmaceutical care as a barrier.   
 
In South Africa, as mentioned in 1.2.1, pharmacists and pharmacist’s assistants are 
regarded as scarce-skill professionals (South Africa. Department of Labour, 2008).  
The shortage of pharmacists has also been highlighted as limiting the potential of a 
national chain store to increase its number of pharmacies (Enslin-Payne, 2011).   
 
The shortage of pharmacists in the USA, which has outpaced the slight increase in 
the number of new pharmacists, is discussed in detail by Cooksey, et al. (2002), who 
associate the shortage of pharmacists with the following five factors: 
(i) An increase in the use of prescription drugs, evidenced in a 35% increase in 
the annual number of prescriptions dispensed by community pharmacists 
between 1992 and 2000 (Health Resources and Services Administration, 
2000 cited in Cooksey, et al., 2002); 
(ii) The expansion of pharmacists’ roles into new job markets, such as the 
wholesale industry and business sector, leaving fewer pharmacists to practise 
in the retail and hospital sectors; 
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(iii) The large proportion of female pharmacists and those working shorter hours.  
The proportion of female practising pharmacists increased from 12% in 1970 
to 46% in 2000 (Gershon, et al., no date cited in Cooksey, et al., 2002).  
Female pharmacists work approximately seven hours per week less than 
male pharmacists; and 28% work on a part-time basis, compared to 11% of 
male pharmacists (Walton and Cooksey, 2001 cited in Cooksey, et al., 2002); 
(iv) The limited use of pharmacy support staff and automation, such as dispensing 
robots.  In response to the shortage of pharmacists, there has been a 
significant increase in the number of pharmacy support staff, such as 
assistants and technicians, from 123 000 in 1996 to 247 000 in 2000 (Cosca, 
2002 cited in Cooksey, et al., 2002).  However, many pharmacists are 
reluctant to make optimal use of these support staff, due to the limited training 
that they receive (American Society of Health-System Pharmacists (ASHP) 
and the American Pharmaceutical Association, 1996 cited in Cooksey, et al., 
2002).  The situation in South Africa, however, may be different.  An 
anonymous writer to the South African Pharmaceutical Journal, for example, 
discusses pharmacist’s assistants practising outside their scope of practice 
and reading, evaluating and dispensing prescriptions (A community 
pharmacist, 2010).  The writer states that sometimes pharmacist’s assistants 
dispense more than 250 prescriptions daily.  He/ she suggests that this 
situation has developed because it is less costly for pharmacy owners to 
employ pharmacist’s assistants instead of additional pharmacists, and due to 
the drive for increased sales volume.  The writer furthermore states that the 
SAPC is not vigilant, when inspecting pharmacies, in investigating who 
dispenses prescriptions (A community pharmacist, 2010).  The prevailing 
culture that allows pharmacist’s assistants to perform the duties of 
pharmacists is illustrated in an incident reported by Osman (2010: 4), in which 
a pharmacist’s assistant told her that she was an “assistant pharmacist”; and 
(iv) Workplace and health-system inefficiencies, which do not make optimal use of 
pharmacists.  System-related problems (see 3.5.1), such as difficulty in 
accessing patients’ medical records, are barriers to providing pharmaceutical 
care, according to Cooksey, et al. (2002) and Al-Shaqha and Zairi (2001).   
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A further management-related barrier arises from considering the work of Moore and 
McAuliffe (2010).  These authors point out that the incidence of errors by health-care 
workers is high, and argue that an inadequate management response to whistle-
blowing in hospitals promotes the underreporting of such errors.  In particular, whilst 
86% of staff nurses had witnessed an incident of poor care, only 65% of these 
nurses reported the incident (Moore and McAuliffe, 2010).  Furthermore, only one 
third of this 65% of staff nurses reported the incident in a documented incident report 
form.  The main reason cited for the underreporting of incidents of poor care is fear 
of victimisation.  Nurses have also expressed dissatisfaction with the manner in 
which incident reports are handled (Moore and McAuliffe, 2010).   
 
These authors warn that if nurses are not encouraged to report incidents of poor 
care, and a proper system is not put into place to deal effectively with such reports, 
“there is a real danger of perpetuating a culture of silence and an acceptance of poor 
quality” (Moore and McAuliffe, 2010: 177).  The question that arises, based on this 
study, is whether pharmacists and pharmacist’s assistants may also be reluctant to 
report incidents of poor care and/ or non-compliance with standards for 
pharmaceutical care, to pharmacy management and/ or the SAPC for the same 
reasons cited by Moore and McAuliffe (2010).  This could potentially result in non-
compliance with standards for pharmaceutical care being perpetuated. 
 
3.6 A PMS for pharmaceutical care 
 
Al-Shaqha and Zairi (2001) emphasise the need for a sound management system to 
be in place in order for pharmaceutical care to be implemented successfully and 
sustainably.  These authors have developed a framework of such a management 
system, based on earlier work by Phillips, Strand, Chesteen & Morley (1987) cited by 
these authors.  The key elements of this management system (Al-Shaqha and Zairi, 
2001: 289) will be discussed next.  Although Al-Shaqha and Zairi (2001) do not 
specify that this management system is a “performance management system”, it 
shall be discussed here as a PMS, as all the components that are part of this 
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management system are considered to be a part of an integrated PMS, as described 
in 3.1.2.3.   
 
3.6.1 A philosophy and mission statement reflecting pharmaceutical care 
 
Al-Shaqha and Zairi (2001) believe that the first step of a management system for 
pharmaceutical care is developing a philosophy and mission for the pharmacy that 
recognises the responsibilities of the pharmacy as providing the appropriate 
medication, as well as the appropriate related information, to patients.  This 
philosophy should be expressed in the mission statement, goals and objectives of 
the pharmacy.  Strategic and operational plans should be developed for the delivery 
of pharmaceutical care and these, together with the mission statement, should be 
monitored and reviewed on a continuous basis (Al-Shaqha and Zairi, 2001).   
 
It is noteworthy that Al-Shaqha and Zairi (2001) omit mentioning the organisation’s 
vision as having to reflect the principles of pharmaceutical care.  Schumock and 
Wong (2004a: 66) highlight the importance of pharmacies conducting strategic 
planning (see 3.1.1.3), which includes developing a “vision statement”.  Examples of 
the benefits gained by strategic planning include pharmacies being able to offer 
additional value and services to patients; and increased sales figures, leading to 
enhanced profitability (Harrison and Bootman, 1994; Harrison and Ortmeier, 1995, 
1996; all cited in Desselle, 2004).  Having the provision of pharmaceutical care as a 
priority in the vision and strategic plan of a pharmacy would thus be important in 
guiding all strategic initiatives and conveying high-level commitment to the practice. 
 
3.6.2 Short- and long-term goals 
 
Business, or operational, plans should also be in place, detailing how specific new 
services are to be provided (Schumock and Wong, 2004b); an example of such a 
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service is pharmaceutical care.  The short- and long-term goals of the pharmacy, 
expressed in its strategic and business plans, should be in alignment with the new 
mission statement espousing pharmaceutical care, as recommended by Al-Shaqha 
and Zairi (2001).  These authors suggest that goals provide a practical framework 
and influence the type of structures adopted by the organisation for the provision of 
pharmaceutical care (Al-Shaqha and Zairi, 2001) (see 3.6.4). 
 
3.6.3 Pharmacists’ responsibilities 
 
Al-Shaqha and Zairi (2001) propose that job responsibilities for pharmacists be 
founded on the types of activities and standards of pharmacy practice expected for 
individual patients.  It is suggested by Al-Shaqha and Zairi (2001) that a paradigm 
shift may be required for pharmacists in this step, in acknowledging the additional 
responsibilities placed upon them by adopting the paradigm of pharmaceutical care.   
 
Gouveia (1993b) cited in Al-Shaqha and Zairi (2001) recommends that pharmacists 
be empowered to make decisions that are in the best interests of their patients, 
rather than function under micromanagement.  This author suggests that current 
practices in which set responsibilities are assigned to different pharmacists should 
be changed, so that all pharmacists can contribute to patient monitoring (Gouveia, 
1993b cited in Al-Shaqha and Zairi, 2001).  Instead of certain pharmacists being 
responsible solely for drug distribution, for example, and others for purchasing, all 
should be responsible for pharmaceutical care (Al-Shaqha and Zairi, 2001). 
 
The following broad steps, which are reminiscent of the SAPC’s description of a 
medication review (South Africa. SAPC, 2010a) (see 1.1), should be performed by 
pharmacists in providing pharmaceutical care (Al-Shaqha and Zairi, 2001): 
(i) Evaluation of each patient’s pharmacotherapeutic needs; 
(ii) Collaboration with the patient and other health-care professionals to develop a 
plan that allows the patient’s therapeutic goals to be achieved;  
(iii) Implementation of the abovementioned pharmaceutical care plan; and 
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(iv) Performing a follow-up comparison of actual and desired patient outcomes, 
which evaluates the effectiveness of the pharmacist’s intervention(s).  This 
step could potentially be highly beneficial in patients with chronic medical 
conditions (Al-Shaqha and Zairi, 2001). 
 
In addition to the above, Desselle’s (2004) five domains of pharmaceutical care (see 
3.2.1) can also serve as a framework for determining pharmacists’ responsibilities.   
 
The need for the activities and tasks performed in providing pharmaceutical care to 
be standardised was highlighted by the ASHP (1993) cited in Al-Shaqha and Zairi 
(2001) who, in 1996 published Guidelines on a Standardised Method for 
Pharmaceutical Care (Al-Shaqha and Zairi, 2001).  Hutchinson and Schumock 
(1994) cited in Al-Shaqha and Zairi (2001) agree, stating that if individual 
pharmacists and pharmacies define pharmaceutical care in their own way, the 
provision of pharmaceutical care in general will not be sustainable.  Standardisation 
furthermore promotes continuity of care (Al-Shaqha and Zairi, 2001).  An example of 
an activity to be standardised is the manner in which pharmacists collect information 
from patients in order to allow DRP to be detected (Al-Shaqha and Zairi, 2001). 
 
Giannetti (2004: 217) argues that providing pharmaceutical care is facilitated by 
pharmacists having “enrich[ed]” jobs, which also contributes towards greater job 
satisfaction and motivation.  Giannetti (2004) further recommends that Hackman and 
Oldham’s (1975) job characteristics model, cited in Giannetti (2004: 217), be applied 
to determine how pharmacists’ jobs within various pharmaceutical contexts could be 
enriched, so that the provision of pharmaceutical care is facilitated.   
 
Hackman and Oldham’s (1975) job characteristics model cited in Giannetti (2004: 
217) proposes that three critical psychological states, namely (i) the experienced 
meaningfulness of work, (ii) experienced responsibility for work outcomes and (iii) 
knowledge of the results of work, lead to intrinsic motivation.  These critical 
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psychological states arise from five core job characteristics or dimensions, namely 
(Hackman and Oldham, 1975 cited in Giannetti, 2004: 217): 
(i) Skill variety, in which the employee is able to utilise a range of different skills 
to perform job-related tasks; 
(ii) Task identity, in which the employee is completely responsible for all aspects 
of a certain task; 
(iii) Task significance, in which the employee appreciates the importance of his/ 
her tasks to other stakeholders; 
(iv) Autonomy, which describes the freedom that an employee possesses to 
utilise his/ her individual judgement in carrying out a task; and 
(v) Feedback, or the extent to which the employee receives feedback on his/ her 
performance.  Silva and Ferreira (2010), in a study of primary health-care 
services in Portugal, for example, highlight that nurses were the only group of 
employees that held regular meetings to address performance-related issues 
and to promote collective learning, and that these meetings had led to 
enhanced performance, according to a general practitioner.  
 
Pharmacists’ need for the above “enriching characteristics” is individualised, with 
some pharmacists preferring jobs that are not highly “enrich[ed]” (Giannetti, 2004: 
217).  Those pharmacists likely to prefer “enrich[ed]” jobs are those who desire 
learning and individual achievement (Giannetti, 2004: 217).  The extent to which the 
redesigning of pharmacists’ jobs to optimise the abovementioned job characteristics 
can be achieved may also be limited by contextual factors, such as the pharmacy’s 
available resources; the type of sector in which the pharmacy operates; and the 
organisation’s degree of openness towards innovation and, by extension, readiness 
for change, as suggested by Giannetti (2004).  A key responsibility of managing 
pharmacists should be the management of innovation (Giannetti, 2004).   
 
Giannetti (2004) warns that if workplace realities in pharmacies, which often do not 
promote the provision of pharmaceutical care (see 3.4), are in dissonance with the 
education and training received by pharmacists, which emphasises pharmaceutical 
care in many cases (van Mil, et al., 2004 do not agree with this, as mentioned in 
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3.5.2), and the professional ideals of pharmacists, which may be to provide 
pharmaceutical care and act as knowledge workers, there is the potential for 
pharmacists to experience disillusionment with the pharmacy profession.  Giannetti 
(2004) argues that if job design for pharmacists does not align these key aspects of 
education, professional ideals and workplace realities, it is likely that pharmacists, 
particularly new graduates, may experience job dissatisfaction. 
 
3.6.4 Organisational structure 
 
As noted by Al-Shaqha and Zairi (2001), it is necessary to have an organisational 
structure that facilitates the provision of pharmaceutical care, as well as the technical 
dispensing functions that, whilst no longer being the predominant focus of pharmacy 
practice, remain an important component of this.  Al-Shaqha and Zairi (2001) 
suggest a decentralised decision-making structure, with pharmacists feeling that they 
possess sufficient autonomy to creatively practise pharmaceutical care.  Gouveia 
(1993b) cited in Al-Shaqha and Zairi (2001) suggests that organograms be changed, 
with patients occupying the central position and the pharmacy’s structure being 
flatter, allowing pharmacists greater empowerment (see 3.6.3). 
 
A hospital pharmacy may need to be transferred from the basement (Smith and 
Mackewicz, 1972 cited in Al-Shaqha and Zairi, 2001), an isolated geographical 
position, to a location in which pharmacists are more easily involved as part of the 
health-care team and better able to contribute to patients’ clinical outcomes.  The 
costs associated with relocation may be a barrier to this occurring.  Relocation can 
also be viewed in a metaphorical light, as suggested by Smith and Mackewicz (1972) 
cited in Al-Shaqha and Zairi (2001), as reflecting the need for pharmacists to change 
their practice style to one involving greater integration with that of other health-care 
professionals.  As suggested by Smith and Mackewicz (1972) cited in Al-Shaqha and 
Zairi (2001), systems should be developed that allow for patient safety to be 
monitored, in addition to providing an efficient and effective pharmaceutical service. 
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3.6.5 Resources 
 
All necessary resources should be present, including the human, infrastructure and 
financial resources necessary to provide optimal pharmaceutical care (Al-Shaqha 
and Zairi, 2001).  An important HR is support staff, and Al-Shaqha and Zairi (2001) 
emphasise that having a sufficient number of pharmacy support staff is essential, 
and note that one of their roles is to aid the flow of patients through a pharmacy, thus 
assisting in the provision of an efficient service.  Elenbaas (2008) points out that 
pharmacy support staff and technology (see 3.5.4) should be used more effectively, 
for example to perform more technical functions, thus allowing pharmacists more 
time to provide pharmaceutical care.  Finally, recruitment and selection should 
prioritise hiring pharmacists who are able to provide pharmaceutical care, and 
ongoing T&D should cultivate this competence (Al-Shaqha and Zairi, 2001). 
 
3.6.6 Performance appraisal  
 
Al-Shaqha and Zairi (2001) categorise performance appraisal together with rewards, 
but due to the critical role played by each in a PMS, these will be considered in 
greater depth separately.  Performance appraisal must be reflective of the new 
philosophy of pharmaceutical care, and, as suggested by Al-Shaqha and Zairi 
(2001), should focus on evaluating performance in providing more pharmaceutical 
care services as well as performance in traditional dispensing functions.   
 
Smith (1988) cited in Al-Shaqha and Zairi (2001) proposes that the performance of 
managing pharmacists be evaluated in terms of how they manage pharmaceutical 
care activities.  The benefits to patients and other health-care professionals, and 
pharmacists’ job satisfaction, should be KPIs, as suggested by Smith (1988) cited in 
Al-Shaqha and Zairi (2001).  Elenbaas (2008) and Giannetti (2004) also highlight the 
need to shift away from using the number of prescriptions dispensed as a KPI for 
pharmacists, towards indicators reflecting patient outcomes and pharmacists’ overall 
responsibilities to patients.  Desselle and Tipton (2001) cited in Desselle (2004) 
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report that feedback from managers and managers’ ability to enhance the job 
satisfaction of pharmacists was a factor in determining whether pharmacists 
perceived that they were complying with standards for pharmaceutical care. 
 
3.6.7 Rewards 
 
The choice of rewards should reflect the philosophy of pharmaceutical care, 
according to Al-Shaqha and Zairi (2001).  Elenbaas (2008) mentions the importance 
of financial viability for pharmacies and points out that currently pharmacists receive 
payment primarily for drug products and the technical function of dispensing.   
 
Van Mil, et al. (2004) note that payment for pharmaceutical care has been initiated in 
some European countries, such as The Netherlands, and that in this country some 
insurance companies have started reimbursing pharmacists for providing 
pharmaceutical care for selected medical conditions.  According to Elenbaas (2008), 
in the USA, funders such as medical aid schemes and the government are being 
approached to change payment policies, so that recognition and remuneration is 
provided to pharmacists for providing pharmaceutical care.  In Germany, the largest 
health insurance fund agreed to remunerate pharmacists for providing 
pharmaceutical care in 2003 (Eickhoff and Schulz, 2006). 
 
In South Africa, the SAPC gazetted new rules in 2010 (South Africa. SAPC, 2010b) 
detailing the services for which pharmacists may charge a fee, in addition to the fee 
that patients have to pay for medication.  In terms of procedure code 0001(a), 
pharmacists may charge a fee for evaluating the appropriateness of prescribed 
medication, in accordance with sections 2.7.1-2.7.4 of the GPP standards; whilst 
procedure codes 0001(c) and 0008 state that a pharmacist can charge a fee for 
providing patients with instructions and advice, in accordance with GPP standards, in 
particular s2.8 (South Africa. SAPC, 2010b).  Pharmacists may also charge a fee for 
reviewing a patient’s entire pharmacotherapy, in terms of procedure code 0011, in 
accordance with s2.25 of the GPP standards; and for providing pharmacist-initiated 
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therapy13, according to procedure code 0028 (South Africa. SAPC, 2010b).  These 
services are all components of providing pharmaceutical care (see 1.1). 
 
However, financial rewards are unlikely to lead to pharmacists feeling more 
motivated to provide pharmaceutical care, as financial rewards are a “hygiene factor” 
necessary for job satisfaction, according to Herzberg’s (1987) two-factor theory cited 
in Hendriks (1999: 95).  As Giannetti (2004: 217) points out, financial rewards may 
contribute to short-term organisational commitment, but do not address the longer-
term sense of stagnation that pharmacists could experience as a result of not having 
“enrich[ed]” jobs promoting the provision of pharmaceutical care (see 3.6.3).  
 
Azzone and Palermo (2011) highlight the potential difficulties in linking rewards to 
performance appraisal; one of these problems is that there may be 
overcompensation of excellent performance and the ignoring of substandard 
performance.  Although the overcompensation of pharmacists may be unlikely in a 
retail pharmacy in South Africa, given the financial pressures faced by these 
pharmacies (see 1.6 and 2.2.7), ignoring substandard performance could be 
motivated by a desire not to have to financially reward employees if their 
performance improved.  Subsequent “failure costs” (Campanella and Corcoran, 1983 
cited in Neely, et al., 2005: 1232) that could occur are discussed in 3.6.8.2. 
 
3.6.8 Further requirements 
 
3.6.8.1 The managing pharmacist’s role 
 
Al-Shaqha and Zairi (2001: 291) highlight the importance of the pharmacy manager 
espousing the philosophy of pharmaceutical care and its potential benefits to 
                                                            
13
  This refers to the provision of OTC medication (see glossary). 
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patients, and acting as a “role model” for pharmacists and support staff in providing 
pharmaceutical care.  Gouveia (1993a, b) cited in Al-Shaqha and Zairi (2001) 
suggests that managing pharmacists be held responsible for patient outcomes.  
Another role of managing pharmacists is enabling the CPD of pharmacists, so that 
pharmacists remain competent and able to provide and use the additional drug 
information necessary in delivering pharmaceutical care (Al-Shaqha and Zairi, 2001).   
 
Providing pharmaceutical care also entails administrative tasks, such as capturing 
the costs and resource requirements of providing pharmaceutical care, and 
evaluating these against patient outcomes (Smith, 1988 cited by Al-Shaqha and 
Zairi, 2001).  The documentation of pharmaceutical care activities also needs to be 
performed (see 3.5.2).  The managing pharmacist needs to ensure that these 
functions are performed. 
 
The role of the managing pharmacist in driving the implementation of the PMS and 
an organisational culture that appreciates the value of such a PMS is also important.  
In a Malaysian government-linked company that instituted a new PMS, for example, 
Norhayati and Siti-Nabiha (2009: 243) found that PMS-related practices became 
“decoupled” from organisational practices, as the new practices were viewed as a 
separate, routine activity related to performance appraisal.  This resulted in the new 
PMS not resulting in a meaningful change in employee practices and performance 
(Norhayati and Siti-Nahiba, 2009).  These authors suggest that senior management 
has a key role to play in addressing the barriers that the prevailing organisational 
culture could play in introducing changes to PMSs (Norhayati and Siti-Nahiba, 2009). 
 
3.6.8.2 Quality management system 
 
Neely, et al. (2005) highlight that considerations of quality should also include the 
costs of failing to meet quality standards.  This includes “internal” and “external 
failure costs” (Campanella and Corcoran, 1983 cited in Neely, et al., 2005: 1232).  
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An example of the former, in the context of retail pharmacy, could be the cost of 
redoing the preparation of a patient’s medication prior to the patient receiving it, 
because an error had been detected, whilst an example of an “external failure cost”, 
as described by Campanella and Corcoran (1983) cited in Neely, et al. (2005: 1232) 
could be the costs involved in addressing a complaint or the cost of a DRP resulting 
from a patient receiving incorrect medication.  The costs of preventing quality 
problems and evaluating quality are also important (Feigenbaum, 1961 cited in 
Neely, et al., 2005).  Benchmarking can be used to detect areas of the pharmacy’s 
current practices that could be improved, as suggested by Neely, et al. (2005). 
 
This can be addressed by having a structured quality management system.  There is 
synergy between pharmaceutical care and quality management.  The UKCPA 
declares that, “Pharmaceutical care results from the application of the principles of 
quality management to the use of medicines” (UKCPA, 2009).  A quality 
management system should thus be developed in pharmacies, according to 
Schaefer and Verheyen (2003).   
 
This quality management system should focus on the following four key parameters, 
as outlined by the UKCPA (2009): 
(i) Dialogue with patients, in which a pharmacist assesses a patient’s 
pharmacotherapy, identifies actual and potential DRP and develops 
relationships with patients that will facilitate ongoing patient monitoring; 
(ii) Liaison and collaboration amongst health-care providers, who all appreciate 
the significance of pharmaceutical care and share relevant information, such 
as patient results and health outcomes.  Patient commitment for this to occur 
is a key objective and it is also necessary for pharmacists to document all 
necessary information, interventions and outcomes (UKCPA, 2009); 
(iii) The clear definition of processes to achieve pharmaceutical care, which can 
lead to the allocation of roles and responsibilities in the pharmacy and the 
enhancement and maintenance of standards relating to patient care; and 
(iv) The recording and measurement of data, such as patient outcomes and 
details of pharmacists’ interventions, so that pharmaceutical care can be 
continuously improved and continuity of patient care promoted.  According to 
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the UKCPA (2009), subjective measures such as quality of life, should also be 
measured, to enable a more holistic understanding of patient outcomes.  
Furthermore, as suggested by the UKCPA (2009), the pooling of data can be 
beneficial in determining outcomes for groups of patients, for example those 
with a particular medical condition or falling into a certain demographic profile.  
This can identify areas of drug use that need to be improved, stimulating the 
continuous enhancement of pharmaceutical care services (UKCPA, 2009). 
 
Adoption of the EFQM Excellence Model (see 3.1.1.3) as a quality management tool 
by health-care teams in various countries, such as Germany (Moeller, 2001) and 
Spain (Sánchez, Letona, González, Garcίa, Darpόn & Garay, 2006), has led to 
improvements in service quality.  Stewart (2003) notes that the EFQM model offers a 
structured means to improve the quality of pharmaceutical services. 
 
The UKCPA (2009) advocates that a multidisciplinary quality management system 
for patients be developed, in which various health-care professionals are involved 
and pharmacists assume responsibility for each patient’s use of medication.  A key 
quality assurance measure should be whether a patient’s use of medication reflects 
that patient’s drug therapy needs (UKCPA, 2009).  According to the UKCPA (2009), 
developing a culture within the health-care sector that supports the implementation 
of quality management systems can be facilitated by pharmacists espousing quality 
assurance measures and techniques in alignment with pharmaceutical care, such as 
the four parameters discussed above, and applying these to everyday practice.   
 
In a study of the effects of organisational culture on quality improvement practices in 
a Jordanian hospital, Ababaneh (2010) found that an innovative subculture had a 
greater impact than a supportive subculture, which emphasises effective teamwork 
and interpersonal relations, or a bureaucratic subculture, which is characterised by 
decision-making being centralised in the hospital manager.  Ababaneh (2010) thus 
recommends that an innovative subculture, in which employees are encouraged to 
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think creatively and continually seek to improve performance, should be 
institutionalised and reflected in organisational values and practices.   
 
Alhatmi (2010) argues that conducting quality audits are an essential component of 
improving the quality of health-care services, and cites Deming’s four-stage cycle of 
“plan, do, check and act” (Bedi, 2006 cited in Alhatmi, 2010: 114).  In describing the 
beneficial effects of conducting internal quality audits at her hospital, Alhatmi (2010) 
highlights the importance of quality being reflected in the organisation’s vision and 
mission, as well as the usefulness of providing change management training to 
address employees’ potential resistance to quality audits.  There should, 
furthermore, be a structured approach with which management effectively addresses 
reports or complaints by pharmacists and pharmacist’s assistants on issues of poor 
care, as suggested by the work of Moore and McAuliffe (2010) (see 3.5.4).  A culture 
that supports the implementation of quality management systems thus has the 
potential to enhance the delivery of pharmaceutical care, leading to an improvement 
in patients’ quality of life, as suggested by the UKCPA (2009).   
 
3.7 Summary 
 
In this literature review, different paradigms of pharmacy practice were shown to 
mirror evolving paradigms of performance management.  The paradigm of 
pharmaceutical care, in particular, reflects and requires a systems approach to 
performance management.  The history and benefits of pharmaceutical care in 
addressing DRP were explored, and then focus was turned to assessing how widely 
pharmaceutical care is currently being practised.  Several barriers to implementing 
pharmaceutical care were analysed, and the requirements of an integrated PMS in 
optimally facilitating the provision of pharmaceutical care were considered.   
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CHAPTER FOUR: RESEARCH DESIGN AND METHODOLOGY 
 
4.1 Research design 
 
Appendix I contains an Ishikawa or fishbone diagram, adapted from Gwiazda (2005) 
cited in Gwiazda (2006: 440), which has been used to illustrate several main themes 
of this research and highlight important methodological considerations that have 
shaped how this research was conducted.  These methodological considerations 
and choices are discussed in detail in this chapter. 
 
4.1.1 Choice of research design 
 
A “methodological triangulation” approach, described by Easterby-Smith, Thorpe & 
Lowe (2002: 146) as including the use of both a quantitative and a qualitative 
research method, was adopted in this research.  The quantitative research method 
used involved the completion of survey questionnaires by patients of the pharmacy 
under study, to ascertain whether or not the pharmaceutical services provided by the 
pharmacy comply with GPP standards for the provision of pharmaceutical care, as 
outlined by the SAPC (South Africa. SAPC, 2010a).   
 
The qualitative research method used comprised holding semi-structured one-on-
one interviews with all three pharmacists and the pharmacist’s assistant, in order to 
determine their perceptions of whether the provision of pharmaceutical care is a key 
performance area, and which aspects of the implementation of the PMS facilitate or 
undermine the provision of pharmaceutical care.  Both of these methods are 
discussed in more detail in 4.2.1 and 4.2.2 respectively. 
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4.1.2 Rationale for a triangulation approach 
 
A triangulation approach was adopted, as this is a synergistic approach that allows 
the advantages of both the quantitative and qualitative research methods to be 
utilised in a complementary manner, thus allowing a more comprehensive, in-depth 
appreciation of the research problem, as described by Gani (2004) and Easterby-
Smith, et al. (2002).  The quantitative method used allows for a mathematical 
assessment of whether the pharmacy complies with a variety of GPP standards for 
pharmaceutical care, as outlined by the SAPC (South Africa. SAPC, 2010a), from 
the perspective of patients.  Patients’ demographic details were also captured.  This 
allowed the first two research objectives (see 1.4) to be achieved.   
 
As highlighted by Laxton (2004), since questionnaires can be completed in a 
relatively shorter period of time compared to qualitative data-gathering tools such as 
interviews, a large sample of patients can be surveyed.  This larger sample size 
enhances the representivity of the sample, thus potentially increasing the accuracy 
and credibility of research findings (see 4.2.1.2.4).  Additional advantages of using 
survey questionnaires, as suggested by Laxton (2004), are that lower costs are 
involved and patients can complete the questionnaires anonymously. 
 
A disadvantage of administering questionnaires is that they do not fully capture the 
reasoning behind certain findings; in this case, the questionnaire does not provide 
insight into why the pharmacy under study complies, or does not comply, with GPP 
standards for the provision of pharmaceutical care.  Other disadvantages include the 
impersonal nature of questionnaires, the danger that bias can occur if questions are 
not worded carefully and the usually low response rates to questionnaires (Laxton, 
2004).  Furthermore, not all information can be reduced to numerical data. 
 
This motivated the decision to also use semi-structured interviews, to gain an in-
depth, qualitative understanding of pharmacists’ and the pharmacist’s assistant’s 
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perceptions of the PMS, and probe the potential PMS-related barriers to providing 
pharmaceutical care from their perspective.  This allowed the third and fourth 
research objectives (see 1.4) to be achieved.  Laxton (2004) identifies this ability to 
obtain in-depth information as a major advantage of interviews.  The interviews were 
semi-structured in nature, as this offered flexibility in being able to follow up 
individual interviewees’ responses whilst maintaining consistency in the kinds of 
questions asked.  Disadvantages of interviews include the time required to conduct 
and analyse interviews; and the potential for interviewers to lead interviewees to 
certain responses, thus introducing bias (Laxton, 2004). 
 
The use of a triangulation approach thus offered the benefit of being able to quantify, 
in a mathematical manner, whether the pharmacy complies with GPP standards for 
pharmaceutical care as stipulated by the SAPC (South Africa. SAPC, 2010a), and 
then gaining insight from key employees and the owner-manager into the reasons for 
this from a performance management perspective.  Charlesworth (2003a) suggests 
that triangulation also enhances the reliability of data that is obtained (see 4.2.1.5), 
as consistencies are confirmed and inconsistencies highlighted. 
 
4.2 Research methodology 
 
The data-gathering tools, or research instruments, that were used were survey 
questionnaires to patients and semi-structured interviews with dispensary 
employees, each of which will be discussed in detail below.  The interviews, although 
described after the questionnaires in this chapter, were held first (see 4.2.2) whilst 
the author was in Cape Town, and the questionnaires administered to patients 
approximately a week later, as the author was only able to travel to Johannesburg 
for a period of approximately two weeks to perform this (see 4.2.1.2.4).  The 
questionnaires will be discussed first as a more comprehensive overview of relevant 
theory is provided with regard to the use of this research instrument.  
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4.2.1 Patient questionnaires 
 
4.2.1.1 Questionnaire design 
 
The questionnaire that was used was designed by the author, following Laxton’s 
(2004) advice that researchers aiming to utilise questionnaires write the kinds of 
questions to be used in their research themselves.  This advice was particularly 
relevant for the current study, as the statements had to reflect South African GPP 
standards, as stipulated by the SAPC (South Africa. SAPC, 2010a) and, to the 
knowledge of the author, no similar study has been conducted in South Africa to 
date.  The statements in the questionnaire are in alignment with those statements 
covering the core elements of pharmaceutical care posed by Assa-Eley and 
Kimberlin (2005: 47) in their study of patients’ and pharmacists’ perceptions of 
pharmaceutical care in the USA. 
 
The questionnaire was designed by modifying Cant, Gerber-Nel, Nel & Kotzé’s 
(2008: 148) seven-step process, as detailed below.  The questionnaire that was 
developed is subsequently provided, on page 93.  In the questionnaires distributed to 
patients, the name of the pharmacy was included, but this has been omitted from the 
questionnaire on page 93 because of the confidentiality agreement with the owner-
manager of the pharmacy (see 1.6). 
 
4.2.1.1.1 Step 1: Specifying the required information 
 
The purpose of using questionnaires was to determine if the pharmacy complies with 
GPP standards for the provision of pharmaceutical care, as stipulated by the SAPC 
(South Africa. SAPC, 2010a).  As discussed in 1.6, the questionnaire focused on 
standards from Chapters 2-4, Appendix A and sections 1.2.1(e) and 1.6.1(g) in 
Chapter 1 of the GPP standards. 
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4.2.1.1.2 Step 2: Specifying the content of questions  
 
As mentioned in 1.6, emphasis was given to selected GPP standards within the 
abovementioned chapters that cover analysing a patient’s pharmacotherapy and 
providing patient counselling, as these relate more specifically to the provision of 
pharmaceutical care instead of the technical aspects of dispensing medication.   
 
It was also deemed useful to ask patients in the questionnaire to indicate whether 
patients would like the pharmacist to perform the various services involved in 
pharmaceutical care.  This was included in the questionnaire to highlight what 
patients desire from a pharmaceutical service, which could provide useful feedback 
to the owner-manager of the pharmacy, who believes that patients do not want to 
receive pharmaceutical care (see 2.3.1).  Patients were also asked whether they 
would like to receive these services so that the questionnaire does not appear to be 
a fault-finding checklist, but rather as something more positive that serves a purpose 
as it attempts to convey what patients’ needs are. 
 
It was also decided to include questions and statements relating to the scope of 
practice of various pharmacy employees, for the following reasons:  
(i) To ascertain whether the distinction in identity and role between pharmacists 
and the pharmacist’s assistant in the pharmacy is clear to patients.  According 
to sections 1.2.1(e) and 1.6.1(g) of the GPP standards (South Africa. SAPC, 
2010a), pharmacists and post-basic pharmacist’s assistants must wear a 
name tag identifying them and their designation to members of the public; 
(ii) To determine whether or not the pharmacist’s assistant always works under 
the direct supervision of a pharmacist, as perceived by patients.  This 
supervision is compulsory under sections 1.1 and 1.2 of Appendix A in the 
GPP standards (South Africa. SAPC, 2010a);  
(iii) To determine whether OTC medication is being selected for patients by front-
shop assistants.  This would constitute an infringement of sections 1.5.1(a)(v) 
and 1.2(a) of Appendix A of the GPP standards (South Africa. SAPC, 2010a), 
Dr Layla Cassim 72076984  Research Report MBA 5932 
87 
 
which state that pharmacists and post-basic pharmacist’s assistants working 
under the direct personal supervision of a pharmacist are responsible for the 
sale of Schedule 1 and 2 medication14; and 
(iv) Adherence by various pharmacy employees to their scope of practice, so that 
pharmaceutical care can be provided, is an important component of the GPP 
standards, as outlined by the SAPC (South Africa. SAPC, 2010a). 
 
Finally, it was decided to include a short demographic section, in order to:  
(i) Achieve the second research objective (see 1.4), namely to assess whether 
patients’ perceptions of the pharmaceutical services provided by the 
pharmacy as well as patients’ expectations of pharmaceutical services differ, 
depending on the race or gender of the patient.  A sentence was included 
explaining the reason for asking patients to disclose their race, and 
permission for this was also obtained in the written consent forms that 
patients signed prior to completing the questionnaire (see 4.2.1.7).  Other 
demographic details could not be ascertained, as it was deemed important to 
keep the questionnaire as short as possible (see Step 6).  Asking patients for 
their demographic details has also been performed by other researchers, 
such as Hanna, et al. (2010), in their Willingness To Pay study (see 3.5.3); 
(ii) Demonstrate a measure of the internal validity of the questionnaire (see 
4.2.1.6) by showing that the questionnaire was used by respondents with 
different demographic profiles; and  
(iii) Allow for sample representivity to be assessed (see 4.2.1.2.2). 
 
4.2.1.1.3 Step 3: Specifying the structure of questions 
 
A closed-ended question structure was chosen, in order to make it quicker for 
patients to complete the questionnaire.  It was anticipated that given the busy nature 
of the pharmacy, the time commitments of patients and the likelihood that many 
                                                            
14
  Schedule 1 and 2 medication is OTC medication (see glossary). 
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patients may not be feeling physically well when approached to complete the 
questionnaire, a questionnaire that was as quick and easy as possible to complete 
would most likely be associated with a higher response rate.   
 
It was decided to have as many “dichotomous close ended questions” as possible; 
these are described by Cant, et al. (2008: 151) as questions that only have two 
answers, such as “Yes” and “No”.  Where it would be necessary to have more than 
two response options, “multiple category close ended questions” (Cant, et al., 2008: 
151) were used.  An example of the latter included a question asking respondents for 
their race.  It was also recognised that particular pharmaceutical care services may 
be provided occasionally, instead of “Yes, always provided” or “No, never provided”, 
thus necessitating such questions having three possible responses. 
 
The questions relating to whether patients receive various pharmaceutical care 
services were formulated as statements, and patients had to indicate whether they 
had received these.  This question thus resembled a checklist of various GPP 
standards for pharmaceutical care.  In order to conserve space, additional columns 
were added to the right of patients’ responses to each statement, asking patients to 
indicate whether they wanted to receive each of these services. 
 
It was decided to structure the questionnaire into three components, covering 
demographics, pharmaceutical care services and the scope of practice of pharmacy 
employees.  The ordering of these is discussed in Step 5.   
 
4.2.1.1.4 Step 4: Careful wording of questions 
 
As mentioned in Step 3, a checklist of statements, each describing a core feature of 
pharmaceutical care, was developed.  The statements and possible responses were 
kept short, simple and specific.  An example of the latter is that instead of stating that 
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a service was provided “occasionally” or “sometimes”, this was defined as “once or 
twice”, as suggested by Cant, et al. (2008).  This minimised the risk of different 
interpretations by respondents.  The final pharmaceutical service mentioned in 
section 2 was formulated as a close-ended question instead of a statement, as 
patients were asked whether they had ever requested a pharmacist to perform a 
medication review.  A short description of what a medication review entails was 
included, as patients may be unfamiliar with this phrase. 
 
Leading statements making inferences on the quality of pharmaceutical services 
provided to patients were avoided, so as to decrease the potential to evoke 
emotional responses from patients or to pre-empt particular responses.  Due to the 
space limitations in the questionnaire (see Step 6), the questions related to 
demographic details were formulated as asking the respondent to tick the relevant 
box.  Laxton (2004) mentions that asking respondents to tick a box leads to less 
confusion than asking respondents to circle their chosen response.  The statement 
explaining why patients were asked to disclose their race, namely to determine if 
patients from different racial groups have differing experiences or expectations of 
pharmaceutical services, had to be worded carefully in order not to offend patients. 
 
4.2.1.1.5 Step 5: Determining the sequence of questions 
 
It was decided to start with the demographic details of the respondent, to encourage 
respondents to provide this data and also because this section was very short and 
starting with personal information, instead of questions that require the respondent to 
think deeply, may make the respondent feel more at ease.  There is disagreement 
amongst various authors over where demographic details should be asked in a 
questionnaire.  Laxton (2004), for example, states that demographic questions 
should be placed at the beginning of a questionnaire, whereas Cant, et al. (2008) 
feel that these and other personal questions should be placed later on in the 
questionnaire.   
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The second section of the questionnaire included the statements describing various 
pharmaceutical care services.  Statements related to analysing a patient’s 
pharmacotherapy were grouped together first, and then statements related to patient 
counselling were listed.  This was done to introduce some order into the sequencing 
of statements, and to make the sequence reflective of the steps that could potentially 
be followed by pharmacists in providing pharmaceutical care to patients.  The third 
and final section of the questionnaire comprised statements specifically related to the 
scope of practice of pharmacy employees.   
 
4.2.1.1.6 Step 6: Determining the layout of the questionnaire 
 
It was decided to make the questionnaire not longer than one page, in order to make 
it more user-friendly and encourage completion.  Dividing the questionnaire clearly 
into three thematic sections (see Step 3) was thought to make the questionnaire 
appear less crowded.  The words “demographic details” in the first section were 
emboldened, so respondents could more easily see what this first section was about.  
Similarly, the questions asked in the second section and possible responses in the 
third section were emboldened.  The phrase “medication review” in part 11 of section 
2 was also emboldened, in order to make it stand out from the description of what 
this is.  The questions asking whether patients wanted to receive the various 
pharmaceutical services were placed in boxes with extra thick borders, in order to 
clearly separate these from the questions as to whether these services are being 
provided, thus minimising ambiguity and the potential for confusion. 
 
An introductory section at the beginning of the questionnaire explained to 
respondents the author’s motivation for conducting the research, and emphasised 
that patients’ responses were anonymous and confidential.  Likewise, after the third 
section of the questionnaire, a note of gratitude to respondents for participating in the 
research was included, as well as the author’s contact telephone number.  The latter 
was also provided in the written one-page summary of the project that all 
respondents received (see 4.2.1.7), in case patients desired further information.   
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Due to the one-page limitation on the length of the questionnaire, the introductory 
and concluding sections had to be kept short.  It was, nevertheless, believed 
important to include these sections, in order to make the questionnaire less 
impersonal.  Laxton (2004) also includes these sections as necessary components 
of a questionnaire.  The margins on the questionnaire were reformatted, to allow the 
content to fit into one page and to allow the font size in section 2 to be slightly larger 
than the rest of the questionnaire.  This was to allow respondents to read this 
section, the main component of the questionnaire, more easily. 
 
4.2.1.1.7 Step 7: Pilot testing the questionnaire 
 
Pilot testing of questionnaires is essential in checking whether individuals from the 
same sample group (see 4.2.1.2.2) as those who will be administered the 
questionnaire understand the contents of the questionnaire in the manner intended 
by the researcher (Cant, et al., 2008).  Pilot testing is also useful in detecting layout 
and presentation problems that could contribute to the target group 
misunderstanding statements or questions and/ or being reluctant to complete the 
questionnaire.  Pilot studies thus play an important role in proactively detecting and 
correcting errors and ambiguities in questionnaires, as described by Cant, et al. 
(2008), which could adversely influence the quality of data that will be collected. 
 
The questionnaire that was developed through the previous six steps was pilot 
tested to ten patients of the pharmacy under study over a period of one day, through 
convenience sampling, as described later in 4.2.1.2.3.  Six patients were approached 
individually as they waited in or were leaving the pharmacy, and asked to participate 
in the pilot study.  Four patients were approached as they waited in the consultation 
rooms of nearby doctors in the medical complex in which the pharmacy is situated 
(see 4.2.1.2.2).  Permission from the owner of the pharmacy and the relevant 
doctors was obtained prior to the pilot study (see Appendices A and B).  The greater 
proportion of patients approached in the pharmacy, as opposed to in the doctors’ 
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rooms, reflects the sample group having a higher proportion of patients sampled in 
the pharmacy (see 4.2.1.2.2). 
 
Patients agreeing to participate in the pilot study were asked to sign a written 
consent form (see Appendix C) and were handed a one-page summary explaining 
the project (see Appendix D), before they were handed the questionnaire to assess 
(see 4.2.1.7).  The participants of the pilot study were assured of the anonymity and 
confidentiality of their feedback and participation in the pilot study.  Participants were 
asked how they interpreted the various questions and sections in the questionnaire, 
whether the questionnaire was clear and easy to understand, and whether the 
presentation and format were user-friendly and encouraged completion.  Patients 
were also asked to comment on the appropriateness of questions, and whether they 
thought that additional questions should be included.  Several patients thought that 
they were required to complete the questionnaire, and the author thus had to explain 
to them that this was not so, and that their role was to evaluate the questionnaire. 
 
All ten pilot participants agreed that the questionnaire was simple and easy to 
understand.  Participants agreed that the questions were clear, straight-forward and 
appropriate.  Nine out of the ten pilot participants did not have any changes to 
recommend, or problems with the questionnaire presentation or content.  The 
remaining participant felt that certain questions were not appropriate, as in his view 
doctors perform these tasks, not pharmacists.  This reflects inadequate awareness 
of the roles and responsibilities of pharmacists in providing pharmaceutical care-
related services, as found by Assa-Eley and Kimberlin (2005) (see 3.5.2).  The 
author thus explained the concept of GPP standards, as outlined by the SAPC 
(South Africa. SAPC, 2010a), to this particular participant and informed him that 
pharmacists were thus supposed to perform all the particular tasks referred to in the 
questionnaire.  Based on pilot participants having difficulty in easily seeing the 
author’s telephone number on the written summary sheet of the project (see 4.2.1.7 
and Appendix D), it was decided to underline and embolden this.  From the seven-
step model described by Cant, et al. (2008: 148) thus far, the questionnaire on the 
next page emerged and was subsequently used in the research.   
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Dear Respondent, thank you for being part of this research.  As part of my MBA studies, I would like to ask you 
to please complete the following short questionnaire.  Your responses are confidential and anonymous. 
 
1 Demographic details: please tick the appropriate box. 
Gender Male Female 
Race* African Indian/ Asian Coloured White 
*  Included to determine if patients from different racial groups have different experiences or expectations. 
 
2 Please tick below whether you have received the following services at XXX Pharmacy, and whether you 
would like to receive these services. 
 
Do you receive this service at XXX 
Pharmacy? 
Would you like to 
receive this service? 
 Yes, 
always 
Yes, once 
or twice 
No, never Yes No 
1. The pharmacist asks me whether I am 
allergic to any medication. 
     
2. The pharmacist contacts my doctor to 
clarify my prescription, or discuss my 
medication. 
     
3. The pharmacist asks me what other 
medication I am taking. 
     
4. The pharmacist asks me what other 
illness or medical conditions I have. 
     
5. The pharmacist offers me generic 
medication. 
     
6. The pharmacist asks me whether I am 
experiencing any side-effects to my 
medication. 
     
7. The pharmacist asks me how often I am 
taking my medication. 
     
8. The pharmacist asks me whether my 
medical condition is improving or is 
controlled. 
     
9. The pharmacist or pharmacist’s assistant 
explains to me how to take my medication 
correctly. 
     
10. The pharmacist or pharmacist’s assistant 
gives me advice or information about my 
medication. 
     
11. Have you ever requested a pharmacist to 
perform a medication review for you?  In 
a medication review, the pharmacist 
assesses the appropriateness of all your 
medication, develops a care plan for you 
and does a follow-up evaluation to see if 
your condition is improving. 
Yes No   
 
3 Please tick the appropriate box. 
1. I know who the pharmacists are. Yes No 
2. I know who the pharmacist’s assistant is. Yes No 
3. The pharmacist’s assistant always prepares my prescription 
under the direct supervision of the pharmacist. 
Yes  No Not 
sure 
4. The pharmacist or pharmacist’s assistant always selects over-
the-counter medication for me. 
Yes No. Front-shop 
assistant selects this. 
Thank you very much for your participation.  Dr Layla Cassim   074 999 5847   
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4.2.1.2 The sampling process 
 
Sampling is used as it is often too resource-intensive to include all the members of a 
target population in a study.  A sample is a smaller group of members from this 
target population, and should be representative of this population (Laxton, 2004; 
Cant, et al., 2008).  In order for a sample to be representative of the target 
population, it has to adequately reflect the latter’s heterogeneity, for example in 
terms of geographic, demographic, biological and other variables, as described by 
Taylor (2003).  Cant, et al. (2008) have developed a five-step model to describe the 
sampling process.  This model was used, as described below, to define the sample 
group of patients asked to complete the questionnaire developed in 4.2.1.1.   
 
4.2.1.2.1 Step 1: Defining the target population 
 
The target population in this study is all the patients of XXX Pharmacy.  “Patients” 
are defined as all individuals who have bought medication, namely prescription and/ 
or OTC medication, from this pharmacy.  The pharmacy is located in a residential 
area, but patients from outside this area also frequent the pharmacy, due to its 
location in a medical centre and opposite a hospital.  As mentioned in Step 4, this 
target population is an infinite one, as the pharmacy gains new patients daily. 
 
4.2.1.2.2 Step 2: Determining the sampling frame 
 
A sampling frame is the sample group that is drawn from the target population and, 
as mentioned in 4.2.1.2, needs to be representative of this larger population.  The 
sampling frame to be used in this study should thus include as many different types 
of patients as are found in the target population.  The demographic profile of the 
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sampling frame, for example in terms of gender, race, age, educational level and 
socioeconomic status, should ideally mirror the profile of the target population.   
 
This may be difficult to achieve in practice.  It may be challenging to determine the 
socioeconomic status of patients, for example, and personal questions to this effect 
may be perceived as offensive by patients.  Another challenge in obtaining a 
sampling frame that is well representative of the target population is that the method 
and timing of sampling may influence when particular groups of patients are likely to 
visit the pharmacy, which could result in bias (see 4.2.1.3).  Elderly patients, for 
example, may be more likely to visit the pharmacy in the morning whereas younger 
people might be at work and may be more likely to visit later in the day after work. 
 
The sampling frame in this study included patients visiting the pharmacy during the 
approximately two weeks of the study, as well as patients waiting in the adjacent 
doctors’ rooms who have also bought medication from the pharmacy under study.  
The reason for this was to counter the risk of relying solely on patients in the 
pharmacy, who might be unwilling to complete the questionnaire.  Patients were 
sampled in the adjacent consultation rooms of three doctors (one general practitioner 
and two specialists) and one dentist, in the same medical complex as the pharmacy.  
As mentioned in 1.6, patients had to be functionally literate in English and eighteen 
years or older.  Employees of the pharmacy were not permitted to complete a 
questionnaire, in order to decrease the potential for bias. 
 
4.2.1.2.3 Step 3: Selecting a sampling technique 
 
There are many different possible sampling techniques, or ways in which the sample 
group can be selected.  Cant, et al. (2008) describe various probability and non-
probability sampling methods, single stage and multistage methods, single-unit and 
cluster sampling, equal unit probability and unequal probability sampling, and 
stratified and unstratified methods of sampling. 
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It was decided to use convenience sampling in this study.  This is an example of a 
non-probability sampling method, in which respondents happen to be at the place of 
sampling when this occurs (Cant, et al., 2008).  In this study, the author was 
physically present at the pharmacy and adjacent medical rooms for a period of 
approximately two weeks, and the stipulated number of questionnaires (see Step 4 
for sample size) was given to patients for completion during this period.  This is a 
non-probability method, as patients who did not visit the pharmacy or adjacent 
medical rooms during this period did not have the opportunity to be included in the 
sample.  Patients were also selected at the convenience of the author, for example 
when she had finished talking to the previous respondent (see Step 5). 
 
As noted by Cant, et al. (2008), the advantage of convenience sampling is that it is 
the most convenient and the least time-consuming and costly sampling method.  The 
main disadvantage of this method, however, is the potential for bias in the selection 
of the sample (Cant, et al., 2008), as those patients selected may not be 
representative of the target population.  It was mentioned in Step 2, for example, that 
if sampling was performed in the morning, there may possibly be a larger proportion 
of elderly people as opposed to younger, working people included in the sample.  
The issue of bias and how this was addressed is discussed in detail in 4.2.1.3. 
 
In addition to the advantages of convenience sampling mentioned previously, this 
method was also chosen instead of the other sampling methods described by Cant, 
et al. (2008), for the following reasons: 
(i) Quota sampling, another non-probability method, could not be performed as 
the characteristics of the target population, such as the demographic profile, 
were not known and would have taken time to investigate.  This would have 
been made more difficult by the target population being infinite (see Step 4); 
(ii) Judgement sampling, a non-probability method, was not chosen as it was 
believed to have a greater potential for subjectivity and selection bias on the 
part of the author; 
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(iii) Snowball sampling, also a non-probability method, was not selected as it 
would have taken time to follow up on potential respondents suggested by 
current respondents; 
(iv) Simple random sampling and systematic sampling, both examples of 
probability sampling methods, were also not chosen.  In the case of simple 
random sampling, each member of the population has an equal chance of 
being selected in the sample group; this would have been time-consuming 
and may have involved having to make house visits to patients, as these 
patients may not have visited the pharmacy during the approximately two 
weeks of the study.  Systematic sampling, for example of every fifth or tenth 
patient, was not chosen as the waiting involved may have been more time-
consuming and it may be difficult to monitor the order in which patients enter 
or leave XXX Pharmacy, since there are multiple entrances; and 
(v) Stratified and cluster sampling, both probability methods, were not selected as 
the characteristics of the target population were not well known by the author 
(see (i) above), thus making it difficult to define different strata and clusters of 
patients, respectively.  The computer software used to process prescriptions 
and the sale of OTC medication also does not readily facilitate the 
classification of the target population in terms of strata, for example 
demographic profiles, or clusters, such as patients residing in different areas. 
 
4.2.1.2.4 Step 4: Determining an appropriate sample size 
 
In order for a sample to accurately represent the target population, it has to be of an 
appropriate size (Laxton, 2004).  As the sample size increases, its representivity of 
the target population is enhanced.  The following factors influence the choice of 
sample size (Laxton, 2004):  
(i) Whether the target population is infinite or finite.  In this study, the target 
population can be regarded as infinite, as the pharmacy gains new patients 
every day and the target population is thus continually expanding; 
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(ii) Resource constraints, for example time.  As mentioned in Step 3, the author 
only had approximately two weeks to pilot test the questionnaire and collect 
all data, due to her employment commitments in another province;  
(iii) The number and complexity of characteristics or variables that have to be 
reflected in the sample.  Patients have many differing characteristics, for 
example demographic profiles and medical conditions.  The characteristics of 
the target population have not been defined (see Step 3), but the population is 
expected to be heterogeneous and have a complexity of characteristics; and 
(iv) The desired precision and accuracy of sample results.  Precision refers to the 
variability in responses within the sample group, whereas accuracy refers to 
how closely sample responses reflect the truth in the target population.  
Larger sample sizes increase precision and accuracy, thereby enhancing data 
integrity.  Cant, et al. (2008) state that in probability sampling, appropriate 
sample sizes are calculated mathematically using formulae, whereas with 
non-probability sampling, additional considerations such as the resources 
available and the number of subgroups to be included, are important.   
 
In light of the abovementioned considerations, a sample size of 200 was chosen.  A 
total of 200 questionnaires thus had to be completed by different patients.  This is 
above the minimum sample size of 30 suggested by Taylor (2003) as being suitable 
for management research, and also more than the sample size of 150 patients used 
in Assa-Eley and Kimberlin’s (2005) study. 
 
4.2.1.2.5 Step 5: Carrying out the sampling process 
 
In this stage, the data collection was performed by the author over a period of 
approximately two weeks, at two sites, namely: (i) the pharmacy; and (ii) adjacent 
consultation rooms of three doctors and one dentist (see Step 2).  A total of 160 
questionnaires, representing 80% of the sample, were completed by patients in the 
pharmacy.  A total of 40 questionnaires, representing 20% of the sample size, were 
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completed by patients in the adjacent consultation rooms.  The author was the only 
individual who administered questionnaires. 
 
At the pharmacy, convenience sampling was carried out at different times between 
08h00 and 21h00, the pharmacy’s trading hours from Monday to Saturday, for a 
period of seven consecutive days.  The trading hours on the Sunday on which 
patients were sampled were from 09h00 to 21h00.  Patients were approached either 
whilst waiting in the pharmacy or after they had paid for their medication and were 
about to exit the pharmacy.  Patients were asked to complete the questionnaire there 
and then, as this would ensure a 100% response rate.  The response rate is likely to 
have been lower if patients were allowed to take the questionnaire away, complete it 
in their own time and then return it to the author.  Patients approached in the 
pharmacy were approached individually, as soon as the previous respondent had 
returned his/ her questionnaire to the author, so that the author could keep track of 
who was completing a questionnaire, in order to ensure a 100% response rate.   
 
Patients in the adjacent doctors’ and dentist’s rooms in the medical complex, the 
second site of data collection, were sampled after the above week, for a period of 
three consecutive days.  Sampling was performed at various times from 08h00 to 
18h00.  These hours were fewer than those in which patients were sampled in the 
pharmacy, as the doctors’ and dentist’s rooms were open for a shorter period each 
day than the pharmacy.  Patients were asked if they had bought medication from the 
pharmacy under study.  Only those answering in the affirmative were then asked to 
participate in the study and it was mentioned to them that the owner-manager of the 
pharmacy as well as the relevant doctor or dentist had given permission for patients 
to be approached in this manner.  Patients were also asked to complete the 
questionnaire at that moment, instead of returning it to the author at a later time.   
 
All patients signed a consent form (see Appendix C) and were given a one-page 
summary of the project (see Appendix D) before they completed the questionnaire 
(see 4.2.1.7). 
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4.2.1.3 Addressing issues of sampling error and sampling bias 
 
As described by Laxton (2004), sampling bias is the tendency to choose certain 
individuals over others for inclusion in a sample group.  The sample group is thus not 
reflective of the target population, as some types of individuals may be over- or 
under-represented.  In this study, examples of sampling bias would be if the 
researcher preferentially approached female patients, or elderly patients, to complete 
the questionnaire.  This bias could occur intentionally, as a result of the researcher’s 
prejudices or perhaps ulterior motives; or subconsciously.  Sampling bias has the 
potential to seriously undermine the integrity of data that is collected. 
 
Sampling bias is a cause of sampling error (Laxton, 2004).  As described by Laxton 
(2004), sampling error reflects the variance in data obtained from a sample group, 
with a high sampling error indicating that there is high intra-sample variability.  
Sampling error decreases the accuracy with which a sample represents the target 
population and can also be caused by chance or random error (Laxton, 2004).  
Sampling bias can be minimised by carefully designing a sampling method that 
attempts to consciously include as many different types of members of the target 
population in the sample group (Laxton, 2004).  Sampling error can be decreased by 
using a large sample.  As sample size increases, the variation in data decreases, as 
the increasing frequency of data falling within the normal sampling distribution and 
aggregating around the mean dilutes the effects of outliers (Laxton, 2004).  
 
The potential for sampling bias was addressed by approaching as many different 
subgroups of patients as possible.  Patients of both genders, all the racial groups 
indicated on the questionnaire and across a range of ages from eighteen years of 
age to the elderly, were selected.  Patients who had purchased OTC medication as 
well as those who had purchased prescription medication at the time of sampling 
were selected, in order to enhance representivity.  In order to minimise the risk of 
only sampling during a particular period in the day or only on one day, which may be 
associated with over- or under-representation of a particular subgroup of patients 
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(see 4.2.1.2.2), sampling was conducted at both the pharmacy and adjacent doctors’ 
rooms at different times over an entire working day, for several days.   
 
Sampling was conducted at the pharmacy for seven consecutive days, in order to 
include particular subgroups of patients who might prefer to frequent the pharmacy 
on particular days; an example of this may be mothers of young children, who might 
be attracted to the nursing service, which includes administering vaccinations, 
provided by the pharmacy on Saturday mornings (see 2.3.4).  The potential for 
sampling error was addressed by attempting to have as large a sample size as was 
considered feasible.  As mentioned in 4.2.1.2.4, a sample size of 200 was used. 
 
4.2.1.4 Addressing issues of non-sampling error 
 
Non-sampling, or measurement, error occurs from the way in which responses or 
data are obtained and can also result in samples being unrepresentative of the target 
population (Laxton, 2004).  This error can arise from the following (Laxton, 2004): 
(i) Biased observations, for example in the data-measurement tools used; 
(ii) Biased communication, such as patients providing incorrect responses to 
favourably influence the researcher.  Biased communication can also result 
from the perceived purpose of the study.  If patients, for example, perceived 
that the study aimed to discredit the pharmacy at which they are loyal patrons, 
they may be less willing to be truthful in their responses; and 
(iii) Induced bias.  The researcher, for example, due to his/ her personal 
preferences and prejudices, may have designed the questionnaire so as to 
focus only on specific types of questions, thus potentially distorting the 
impression that is gained of the respondent’s experiences or perceptions. 
 
The potential for non-sampling error was addressed by spending a few minutes 
explaining the purpose of the study to all potential respondents before handing 
respondents a questionnaire for completion, in order to minimise biased 
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communication.  It was explained to patients that the owner-manager was in full 
support of the study and that their responses were anonymous and confidential.  The 
fact that different patients were used in the pilot study and in the actual survey also 
decreases the potential for bias.  Pilot study participants were requested not to 
complete the questionnaire but rather to assess it (see 4.2.1.1.7); the author had 
interacted with pilot study participants, explaining the project and discussing the 
various questions or the rationale for including these.  This may have influenced 
these participants’ responses, leading to bias, had they completed the questionnaire. 
The risk of induced bias was addressed by holistically covering various components 
of pharmaceutical care in the questionnaire and by discussing the appropriateness of 
questions and statements with pilot study participants.  This also enhanced content 
validity (see 4.2.1.6). 
 
4.2.1.5 Enhancing the reliability of data 
 
Data is reliable if it is without bias (Lawton, 2003) and, importantly, if it is consistent 
(Laxton, 2004).  Reliability is thus improved if sampling bias and sampling error are 
minimised.  It should be noted that although reliability contributes to data integrity, it 
does not necessarily always lead to accuracy (Guler, 2004) and validity (see 
4.2.1.6).  Data may be highly precise and consistently reflect a certain response, but 
may be inaccurate, perhaps because the data-gathering tool has been incorrectly 
designed, as described by Guler (2004).  In order to enhance the reliability of the 
data to be collected, a sample size that was as large as possible, given the resource 
constraints of the author, was chosen, namely 200 completed questionnaires. 
 
4.2.1.6 Enhancing the validity of data 
 
Validity, a reflection of the accuracy of data obtained from a sample, can be 
classified into two types, namely (Guler, 2004; Laxton, 2004): 
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(i) Internal validity, which refers to the accuracy of a specific study’s findings and 
the clear illustration of cause-and-effect relationships (Laxton, 2004).  
Concerns related to internal validity could include whether each respondent 
had only completed one questionnaire, whether any questionnaires were 
spoilt and whether the survey was conducted in a manner that did not pre-
empt or influence respondents to provide certain responses.  Internal validity 
may be undermined by several factors, as suggested by Laxton (2004):  
a. Testing effects such as the placebo effect, in which a particular 
psychological response, which may be unjustifiable, is elicited; 
b. Respondents dropping out of the study, or not completing a questionnaire; 
c. Bias in the selection of the sample group; and 
d. Environmental changes occurring after the study has begun.  An example 
of this in the current study could be publicity in the media about a mistake 
that a pharmacist made, which has impaired the quality of life of a patient.  
Such media reports could generate feelings of suspicion amongst patients, 
which may influence how they respond to the questionnaire; and 
(ii) External validity, which reflects the extent to which the findings of a study can 
be extrapolated or applied to other situations (Laxton, 2004).  External validity 
could be undermined by the nature of study participants, the time-period or 
place at which the study is conducted, which all have the potential to make 
the data obtained unrepresentative of the target population (Laxton, 2004).   
 
The validity of the current study was enhanced by: 
(i) Educating prospective study participants about the nature and purpose of the 
study (see 4.2.1.4).  Such participant education was conducted to encourage 
respondents to complete the questionnaire.  The phrase “pharmaceutical 
care” was avoided, as this may have influenced patients’ responses.  Patients 
may also not be aware of what pharmaceutical care is, and if discussions 
occurred with the researcher on the nature of this, patients’ responses may 
well have been influenced, thus introducing bias into the sample data;  
(ii) Consciously attempting to minimise bias in the selection of the sample group, 
by including as many different types of patients as possible and sampling 
patients throughout the working day and week (see 4.2.1.3); and 
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(iii) Improving the questionnaire’s content validity, or the ability of the research 
instrument to comprehensively assess the area it purports to investigate 
(Guler, 2004).  Content validity was enhanced by the questionnaire holistically 
covering various aspects of pharmaceutical care (see 4.2.1.4). 
 
4.2.1.7 Guiding ethical principles and considerations 
 
All research was designed and conducted in accordance with UNISA’s Policy on 
Research Ethics, in particular part 2 (“Guidelines for research involving human 
participants”) (UNISA, 2007: 9-17).  Patient privacy was protected by making the 
questionnaires anonymous and confidential; and patients were informed of this at the 
outset, in the questionnaire and again after completing the questionnaire.  In order to 
further protect patient privacy, patients were asked to fold and drop the completed 
questionnaire into a thick opaque envelope that the researcher was holding, 
containing all completed questionnaires from that day, so that the researcher could 
not see an individual patient’s responses.  Furthermore, the researcher stood at a 
distance of several metres from the respondent whilst the latter completed the 
questionnaire, thus protecting the confidentiality of the patient’s responses. 
 
As mentioned in 4.2.1.6, patients were informed of the nature and purpose of the 
study, and were told that it was a component of the researcher’s MBA degree.  
Patients were also informed that the study had the permission of the owner of the 
pharmacy; as well as the relevant doctors, in the case of patients sampled in the 
doctors’ and dentist’s waiting rooms.  The above was explained so that patients 
would not feel as though a study was being performed to find fault with the pharmacy 
and that their responses would be used to incriminate the pharmacy’s employees. 
 
The permission granted from the owner-manager of the pharmacy to conduct the 
research at his pharmacy, and from the adjacent doctors and dentist to approach 
patients in their waiting rooms, was obtained in writing (see Appendices A and B).  
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The names of the individuals concerned and the pharmacy have been blocked out, 
in order to protect the confidentiality of the owner-manager and his pharmacy, and 
the relevant doctors and dentist.  These letters of permission were carried with the 
author when conducting sampling, in case patients requested proof that the owner-
manager and relevant doctors and dentist had granted such permission. 
 
In compliance with UNISA’s (2007) Policy on Research Ethics, written informed 
consent was obtained from all the patients who completed questionnaires, prior to 
patients filling out the questionnaire.  Appendix C contains the statement of informed 
consent that each patient who was willing to participate in the study signed; this 
statement also included specific consent for the author to ask the patient about his/ 
her gender and race in the questionnaire, for the purposes of the research.  This 
statement of informed consent was not attached to the questionnaire, in order to 
prevent patients’ questionnaire responses from being identified.   
 
Patients were told about the nature and purpose of the research, and also provided 
with written information providing further details of the research project, as stipulated 
by UNISA’s (2007) Policy on Research Ethics.  The kind of written information 
provided is in accordance with section 3.6 of Part 2 of UNISA’s Policy on Research 
Ethics (2007: 12), in particular.  This written information is included in Appendix D, 
and includes the potential risks and benefits of the study, as well as the details of the 
researcher and the reasons why XXX Pharmacy had been chosen for the study.  
Patients were also told that they did not have to participate in the research, or 
complete the whole questionnaire once they had started.   
 
No coercion was used or inducements provided to patients, and patients thus 
provided free and informed consent as defined by UNISA’s (2007) Policy on 
Research Ethics.  It was only once patients had been told about the project and had 
signed the informed consent form that they were given the questionnaire to 
complete.  All the above measures to protect patient privacy, confidentiality and 
anonymity also applied to those patients who participated in the pilot study. 
Dr Layla Cassim  Research Report MBA 5932 
106 
 
4.2.1.8 Data analysis 
 
The 200 completed questionnaires yielded a combination of nominal and interval 
data.  Nominal data is described by Laxton (2004) and Taylor (2002) as data that 
falls into categories that are discrete, not in any order and without any quantifiable 
differences between the various categories.  Nominal data thus yields the least 
amount of information (Laxton, 2004).  The demographic questions in section 1 of 
the questionnaire provided nominal data.  Interval data, on the other hand, allows for 
differences between data to be made with greater precision (Taylor, 2002), and thus 
yields more information than nominal data (Laxton, 2004).  Interval data occurs on a 
scale or continuum, in this case from “Yes, this service is always provided”, to “Yes, 
it is provided once or twice”, to “No, it is never provided”.  The interval scales used in 
sections 2 and 3 of the questionnaire were “semantic” interval scales (i.e. in word 
form), as opposed to “numerical” interval scales, as described by Laxton (2004: 65). 
 
The above primary data was first analysed using descriptive statistics, performed 
using Microsoft Office Excel 2007.  The demographic profile of the sample group 
was determined, in terms of the proportion of men and women and the races listed in 
the questionnaire.  Pie graphs were used to illustrate these profiles.  For sections 2 
and 3 of the questionnaire, the proportion of respondents who ticked the various 
responses for each statement was illustrated through the use of bar graphs.   
 
Composite bar graphs were constructed for Statements 1-10 in section 2 and 
Statements 1-4 in section 3 of the questionnaire, to determine the mean percentage 
of responses for these sections.  Inferential statistical analysis was then performed.  
In particular, a one-way analysis of variance (ANOVA), followed by the Newman-
Keuls multiple comparison test, a commonly-used post-hoc test, was performed on 
the composite results to determine if there is a statistically significant difference in 
mean responses.  ANOVA is performed if there are more than two groups to be 
compared.  An unpaired t-test was used to determine if there is a statistically 
significant difference in the mean percentage of respondents who state that they 
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have not received the combined services and those who would like to receive these 
services.  ANOVA could not be used here as there were only two sample groups.  
 
GraphPad Prism 5 software was used to perform 
The chi-squared test could not be performed for the composite race and gender 
results, even though it is the most 
data (Gani, 2004), as there were respondents who did not indicate their race or 
gender, thus making the race and gender categories used 
and thereby undermining the validity of this 
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4.2.2 Semi-structured interviews with dispensary employees 
 
4.2.2.1 Design of interview questions 
 
As mentioned in 4.1.2, a semi-structured interview format was selected, as described 
by Charlesworth (2003b), as this provided consistency and standardisation between 
interviews, and also allowed flexibility in probing individual interviewee’s responses 
further or in explaining particular questions to interviewees.  Laxton (2004) also 
notes that having standardised questions promotes quicker interviews and makes it 
easier to compare responses obtained in different interviews.   
 
The aim of these interviews was to determine whether interviewees perceived that 
the provision of pharmaceutical care was a key performance area and their 
perceptions of whether the implementation of various components of the PMS 
facilitated or undermined the provision of pharmaceutical care.  Another aim of the 
interviews was to ask interviewees whether they perform various components of 
pharmaceutical care in their everyday practice.  Interviewees’ responses could then 
be compared to patients’ responses to the questionnaire.   
 
Asking both patients and dispensary employees whether certain services are 
provided thus provides a useful cross-check, and allows possible inconsistencies to 
be detected.  Pharmacists, for example, could state that they always ask patients 
whether patients would prefer generic medication, but the patient questionnaires 
could reveal that patients have indicated that they were not asked this question.  
This cross-checking technique, an advantage of adopting a triangulation approach, 
thus has the potential to highlight areas of inconsistency and possible bias in study 
participants’ responses and thereby improve the validity of the overall research (see 
4.1.2).  A possible limitation is that patients were not matched to particular 
pharmacists or the pharmacist’s assistant, as suggested by Assa-Eley and Kimberlin 
(2005); this would have allowed inconsistencies to be shown more conclusively.  
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However, it would have been difficult to perform this practically, as pharmacists 
would have had to be interviewed after each patient encounter, and patients would 
also have to have been approached then, in order to assess if there were differences 
in responses to whether the patient had received pharmaceutical care services.  
Given the busy nature of the pharmacy and the fact that there was only one 
researcher involved, this would not have been feasible. 
 
Pharmacists and the pharmacist’s assistant were not shown the patient 
questionnaire, in order to decrease the potential for bias, as explained in 4.2.2.3.  
This could have arisen due to interviewees potentially changing their behaviour, in 
order to provide the kinds of services patients were asked about in the questionnaire. 
 
4.2.2.1.1 Topics covered in the interview questions 
 
In order to elicit the kind of information described above, the following topics were 
covered in the interviews, as described by Laxton (2004): 
(i) Behaviours of the interviewee, the owner-manager and other pharmacy 
employees.  Examples of this include how pharmacists and the pharmacist’s 
assistant practise pharmacy; 
(ii) Knowledge of GPP standards and pharmaceutical care, as outlined by the 
SAPC (South Africa. SAPC, 2010a); 
(iii) Perceptions, values and opinions, for example of the PMS and whether 
certain components facilitate the provision of pharmaceutical care or not; and 
(iv) Some background information, such as how long the dispensary employee 
has been practising as a pharmacist or pharmacist’s assistant and, in the 
case of the latter, whether she is a basic or post-basic pharmacist’s assistant.  
Questions asking for demographic information, such as age, gender or race, 
were not asked, as this would have made the interview longer. 
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4.2.2.1.2 Structure of the interviews 
 
The interviews started with the author thanking the interviewee for agreeing to be 
interviewed, briefly explaining the purpose of the research, and assuring the 
interviewee that his/ her responses would be completely confidential and 
anonymous.  Interviewees were informed that they did not have to participate in or 
complete the interview, and that the study was conducted in accordance with 
UNISA’s Policy on Research Ethics, which could be made available to them.  
Interviewees were then asked if they had any questions, before the interview 
commenced.  Further ethical considerations are discussed in detail in 4.2.2.4. 
 
In sequencing the interview questions, Laxton’s (2004) advice of starting with fact-
based questions before asking interviewees for their perceptions, in order to allow 
interviewees to feel more at ease, was followed.  The initial questions asked were 
thus the background questions.  Questions relating to past events were also asked 
later in the interview, as it is easier for interviewees to start by discussing current 
issues and then remembering historical ones (Laxton, 2004).  The interviews ended 
with interviewees being asked if they wished to mention anything else, as suggested 
by Laxton (2004), so that issues that the author had not considered or been aware of 
that may be relevant to the research problem could have surfaced. 
 
It was decided to keep the interviews to approximately one and a half hours in 
duration.  This was to allow the author to comprehensively probe the many different 
aspects of an integrated PMS with interviewees, without encroaching too much on 
interviewee time.  Interviewees were informed of this time-period when the author set 
up the dates and times for the interviews (see 4.2.2.2).  These one-and-a-half hour 
interview sessions were shorter than the two-hour interview sessions conducted by 
Naudé (2007) in his research on performance measurement in the information and 
communications technology sector.   
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4.2.2.1.3 Wording of interview questions 
 
In wording the interview questions, a combination of close- and open-ended 
questions was used.  Many questions were first posed as close-ended questions, 
requiring a “Yes” or “No” response; this was then followed up by asking the 
interviewee to motivate his/ her response.  This was done to keep the interview 
questions as simple and clear as possible, and to facilitate later analysis of 
interviewee responses.  Questions were asked one after the other, as suggested by 
Laxton (2004); for certain questions with multiple parts, one part at a time was 
asked, in order to minimise interviewee confusion and possible ambiguity.  
Questions were kept neutral, and leading or emotive questions were avoided. 
 
There were minor differences between the interview questions for the owner-
manager, the other pharmacists and the pharmacist’s assistant, to reflect their 
different roles and responsibilities.  It was decided not to over-emphasise patient 
counselling in the pharmacist’s assistant’s interview, as this might introduce non-
sampling error (see 4.2.2.3) by making it appear as though her primary role is to 
provide patient counselling, whereas her scope of practice, outlined in s1.2 of 
Appendix A of the GPP standards (South Africa. SAPC, 2010a), includes primarily 
technical roles.  The author designed the interview questions herself.  As mentioned 
in 1.5, there have been no reported studies, to the author’s knowledge, investigating 
the impact of a PMS on the provision of pharmaceutical care in South Africa. 
 
4.2.2.1.4 Pilot study of interview questions 
 
A small pilot study was performed, to assess the appropriateness of interview 
questions, on two interviewees with a similar background to those who would later 
be interviewed by the author.  One of these interviewees is a practising pharmacist, 
who does locum work in the retail sector.  The second interviewee has a pharmacy 
degree but is not registered with the SAPC as a pharmacist, as she has not 
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performed her community service15.  She has, however, worked as a pharmacist’s 
assistant in the retail sector in South Africa.  These particular individuals were 
chosen for the pilot study due to their experience in retail pharmacy.  The second 
individual also has extensive experience in qualitative research involving patients 
and health-care professionals.  The pilot study participants were assured of the 
anonymity and confidentiality of their feedback and participation, and provided the 
author with written informed consent to participate in the pilot study (see 4.2.2.4). 
 
The pilot study was considered important in enhancing the ability of the interview 
questions to elicit the desired information from the pharmacists and pharmacist’s 
assistant who would later be interviewed.  In the pilot study, which was conducted 
separately with each participant, participants were asked how they interpreted the 
various questions, and whether these were simple, easy to understand, clear and 
appropriate.  Participants were asked whether there were any further questions that 
should be added to the interview.  The length of the interview was also discussed.  
The pilot study was conducted telephonically, as both participants were located at 
considerable geographical distance from the author.  It was also beneficial to 
perform the pilot studies telephonically as the pharmacists and pharmacist’s 
assistant who were interviewed later were interviewed telephonically (see 4.2.2.2), 
so it was deemed useful to try this method of interviewing beforehand.   
 
Based on the abovementioned pilot study and the feedback obtained from the two 
participants, the modifications listed in the next two pages were made to the 
interview questions, content and structure of the interviews.  The interview questions 
for pharmacists other than the owner-manager were used as the focal point of the 
pilot studies.  Similar questions in the interview questions for the owner-manager and 
pharmacist’s assistant were subsequently modified.  It should be noted that the 
question numbers referred to in the next few pages were those used in the interview 
questions originally used for the pilot study; these do not correspond to the final 
                                                            
15
  Community service for pharmacists is a year of working as a pharmacist in the public 
sector in South Africa, which is a prerequisite for registration as a pharmacist in the country, 
according to s14A(1) of the Pharmacy Act 53 of 1974 (South Africa. National Parliament, 
1974). 
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numbering of the interview questions in Appendices E-G, as the interview questions 
in the appendices are the final interview questions and include questions that were 
added as a result of feedback from the pilot study.  The inclusion of these questions 
necessitated a renumbering of the interview questions. 
 
The modifications made to the interview questions thus included the following: 
(i) Questions 17 and 18 were reworded, as it was felt that there was repetition; 
(ii) A question asking pharmacists to quantify their working hours was added, as 
pilot study participants felt that having to work long hours and thus being tired 
could discourage pharmacists from providing pharmaceutical care; 
(iii) A question asking interviewees whether they think that the number of 
pharmacists and pharmacist’s assistants is adequate was added, as the 
number of dispensary employees present could play an important role in 
determining whether pharmaceutical care can be provided; 
(iv) A question on the number of pharmacists on duty at any point in time was 
added.  Follow-up questions on whether interviewees believe that this is 
sufficient to provide pharmaceutical care, and to directly supervise the 
pharmacist’s assistant, were also included; 
(v) Question 4 was reworded to include a statement that the author was not 
looking for a technical definition of pharmaceutical care, but rather the 
practices involved in providing pharmaceutical care.  One of the pilot study 
participants thought that this was important to clarify, as some interviewees 
may not remember the technical definition of pharmaceutical care and this 
might lead them to feeling judged.  Since this question occurs relatively early 
in the interview, any alienation of interviewees could potentially adversely 
affect the nature and quality of their responses for the remainder of the 
interview; 
(vi) An introductory comment was included informing interviewees that the 
interview was not being recorded, but that the author was taking notes and 
that she could send a copy of this to the interviewee, for the interviewee to 
verify the responses ascribed to the interviewee, if the interviewee wished; 
(vii) A question was included asking whether the design or layout of the pharmacy 
promotes or hinders the provision of pharmaceutical care.  This was not 
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addressed in further detail, because Chapter 1 of the GPP standards (South 
Africa. SAPC, 2010a), which includes standards for pharmacy premises, falls 
outside the scope of the current study, with the exception of the two standards 
mentioned in 1.6 and 4.2.1.1.1; 
(viii) The phrase “managing style” in question 23 was removed, as interviewees 
may not be familiar with what this means.  The question was reworded to 
explain this concept in simpler language; 
(ix) After the culture-related questions, an additional question asking interviewees 
whether they had good working relationships with their colleagues and the 
managing pharmacist was added, and what factors promoted or hindered this.  
A follow-up question asked whether these working relationships promoted or 
hindered the interviewee in providing pharmaceutical care; 
(x) A question asking interviewees whether they were able to develop good 
relationships with patients was added, and what factors promoted or hindered 
this.  A follow-up question asked whether these relationships with patients 
promoted or hindered the interviewee from providing pharmaceutical care; 
(xi) Greater variety was introduced in the wording of questions.  Instead of saying 
“Please elaborate” for almost all of the questions, it was decided to sometimes 
say, “Please motivate your response”, “Please tell me more about this” or 
“Please provide me with an example of....”  The latter option also had the 
advantage of allowing interviewees to provide more details to the author; 
(xii) A specific question asking interviewees to describe the questions they ask 
patients and the counselling they provide, if any, in providing OTC medication 
to patients was added; 
(xiii) Question 48 was reworded so that it was more positive, as one pilot study 
participant felt that the current wording was judgemental.  The wording was 
thus changed to ask interviewees for suggestions on how the PMS could be 
improved, rather than focusing on what was problematic about it; and 
(xiv) At the point in the interview when there are ten questions left, interviewees 
were informed that the interview was almost over and thanked for their 
participation thus far.  This was included to attempt to focus interviewees, in 
case they were getting impatient or were losing concentration. 
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Apart from the above concerns, both the pilot study participants were satisfied that 
the interview questions were clear, simple and easy to understand.  They also 
agreed that the interview could be conducted in approximately an hour and a half. 
 
From the interview design process described thus far, including the feedback 
received in the pilot study, the interview questions in Appendices E, F and G were 
formulated for pharmacists other than the owner-manager, the owner-manager and 
the pharmacist’s assistant, respectively, and later used in the research (see 4.2.2.2).  
These questions have been placed in the appendices due to their length. 
 
4.2.2.2 The census procedure 
 
Since all the members of the target population, namely the pharmacists and 
pharmacist’s assistant, were interviewed, a census was performed, according to 
Cant, et al. (2008).  This was possible, due to the small target population size, 
namely three pharmacists, including the owner-manager, and one pharmacist’s 
assistant.  The advantage of having performed a census is that the results obtained 
are completely representative of the target population, as all members were 
included.  Often target populations are larger, which makes it difficult, time-
consuming and costly to perform a census (Cant, et al., 2008). 
 
All interviewees were told by the author about the research study and asked whether 
they would be willing to be interviewed.  All interviewees were keen to be interviewed 
and indicated that they would prefer being interviewed after hours, as it was very 
busy in the pharmacy.  The interviews had to be conducted telephonically, as the 
author was in a different province due to work commitments and was not able to 
come to Johannesburg to conduct the interviews.  This was agreeable to all 
interviewees, and the author then made arrangements to telephone each interviewee 
after hours, at a time convenient to the interviewee.  All interviews were conducted 
over a period of one week.  Interviewees were told that the interview would not 
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exceed approximately one and a half hours.  When the interviews were conducted, 
all the interviews were approximately this duration, with the shortest interview being 
that with the locum pharmacist, which was one hour long.  The interview questions 
used were those designed in 4.2.2.1 and provided in Appendices E, F and G. 
 
Potential disadvantages of conducting an interview telephonically, instead of face-to-
face, are that the interviewer cannot see the reactions of interviewees; it might be 
more difficult to build up rapport between interviewer and interviewee; and the 
telephone costs involved.  However, it was the only method of interviewing available 
to the author, given the impossibility of her travelling to Johannesburg during that 
period.  The author did not wish to conduct the interviews whilst she was in 
Johannesburg later on, in the last two weeks of February, as this time was set aside 
to pilot test the questionnaire and administer questionnaires to patients (see 4.2.1) 
and there would not have been sufficient time to also conduct interviews with the 
dispensary employees then.  Finally, the interviews were not recorded, as the author 
made copious shorthand notes of interviewees’ responses during the interviews, 
which were typed up immediately after the interview, as suggested by Laxton (2004). 
 
4.2.2.3 Addressing issues of non-sampling error 
 
By definition, it was not possible for sampling error to occur, as a census was 
performed and no samples were used.  It was still possible, however, for non-
sampling error (see 4.2.1.4) to occur.  This was addressed by explaining the purpose 
of the study to interviewees at the start of the interview, so as to minimise biased 
communication.  Interviewees were informed that the owner-manager was in full 
support of the study and that their responses were anonymous and confidential.   
 
An advantage of conducting the interviews when the interviewees were off-shift is 
that interviewees may have felt more forthcoming and at ease, knowing that the 
owner-manager was not in earshot.  Similarly, the owner-manager may also have felt 
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more at ease, knowing that his employees were not in earshot.  This could also have 
minimised biased communication, and interviewees feeling under pressure to 
respond to questions in a particular manner.  Interviewees were also not shown the 
questionnaire that would later be distributed to patients (see 4.2.1), and were thus 
unaware of the contents of this questionnaire.  This was to prevent influencing 
interviewees’ responses, which could have introduced bias (see 4.2.2.1). 
 
The risk of induced bias was addressed by holistically covering the various 
components of pharmaceutical care and an integrated PMS in the interview 
questions, instead of only probing specific components, and in discussing the 
appropriateness of the choice of questions with the participants of the pilot study.  
This also enhanced the content validity (see 4.2.1.6) of the interview questions. 
 
The above measures addressing possible non-sampling error contributed towards 
enhancing the reliability and validity of interview data.  The validity of the research 
method chosen was also enhanced by the way in which content analysis was 
applied in analysing interview data (see data analysis later in 4.2.2.5). 
 
4.2.2.4 Guiding ethical principles and considerations 
 
The interviews were conducted in accordance with UNISA’s Policy on Research 
Ethics, in particular part 2 (“Guidelines for research involving human participants”) 
(UNISA, 2007: 9-17) (see 4.2.1.7).  The privacy of interviewees was protected by 
keeping their responses anonymous and confidential; and interviewees were 
informed of this at the outset and end of the interview.  It was correctly anticipated 
that the pharmacist’s assistant might be particularly concerned about the 
confidentiality of her responses, since she is the only pharmacist’s assistant working 
at the pharmacy and she could thus be identified easily.  All interviewees were told 
that the owner-manager would not find out their responses, and that the author 
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would provide him with a summary of the general research findings at the end of the 
project, but would not disclose specific employees’ responses.   
 
Interviewees were told that they did not have to participate in the interview, and that 
they did not have to complete the interview, if they did not wish to do so.  When 
asked whether the author should send interviewees a typed copy of that 
interviewee’s responses, for the interviewee to check its accuracy, only the owner-
manager and pharmacist’s assistant said that they wished to receive this.  The 
interview questions and responses were emailed to these individuals within a few 
hours of the interview concluding and neither the owner-manager nor the 
pharmacist’s assistant made any changes.  As mentioned in 4.2.2.5, no interviewee 
names were included in the typed interview notes, to protect interviewee anonymity. 
 
Interviewees and the pilot study participants provided the author with written 
informed consent and interviews were only arranged after this permission was 
received.  The written informed consent was in the form of cellular phone text 
messages sent to the author.  Written permission had to be obtained in this manner, 
as the interviews were to be conducted telephonically and the author thus did not 
have the opportunity to ask the interviewee to sign a form.  As mentioned in 4.2.2.2, 
it was not possible for the author to travel to Johannesburg any earlier.  The 
interviewees also did not all have ready access to email facilities or private facsimile 
facilities.  According to UNISA’s (2007) Policy on Research Ethics, permission had to 
be obtained prior to participant involvement in the research.  Cellular phone text 
messages were thus seen as the most practical, convenient and appropriate method 
of obtaining written informed consent, given the circumstances.  UNISA’s (2007) 
Policy on Research Ethics does not stipulate what form the written informed consent 
should take, and it is thus the view of the author that this does not exclude the use of 
cellular phone text messages.   
 
Participants were also provided with information about the project from the author, 
both verbally and via text message.  As no demographic details were asked, as 
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described by UNISA’s (2007) Policy on Research Ethics, no specific written informed 
consent relating to such questions had to be obtained.   
 
No coercion was used or inducements provided to interviewees, and interviewees 
thus provided free and informed consent as described by UNISA’s (2007) Policy on 
Research Ethics.  Finally, all the measures to protect the privacy, confidentiality and 
anonymity of interviewees described in 4.2.2.4 also applied to the participants of the 
pilot study. 
 
4.2.2.5 Data analysis 
 
As mentioned in 4.2.2.2, shorthand interview notes containing the primary data 
collected in the interviews were typed up in full immediately after each interview.  
The typed data was then subjected to content analysis, a technique often used to 
analyse qualitative data.  The following steps were used, based on Charlesworth 
(2003a: 14): 
(i) In each response to each question, key words were highlighted.  This 
included “Yes” and “No” responses, as well as words relating to particular 
issues, topics or themes.  The author decided not to have a predetermined list 
of themes or words and check interviewees’ responses against this, as this 
might have introduced bias and overlooked issues that interviewees may have 
raised but which were not on the author’s list.  Instead, it was decided to use 
interviewees’ responses as a starting point and distil the key words from 
these.  Succinct direct quotations were also included where possible, as 
Charlesworth (2003a) suggests that including these in the final research 
report could play a role in substantiating the findings and conclusions made 
by the author.  Different individuals’ responses were highlighted in different 
colours, in order to allow the author to keep track of interviewees’ responses, 
as no names were typed, in order to protect participants’ anonymity; 
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(ii) A table was created using Microsoft Office Word 2007, in which all the key 
words by all interviewees for each question were placed in a different cell.  
Various key words of a similar nature or theme were then grouped together, 
leading to a number of different subgroups.  Each subgroup was then given a 
name, based on its theme.  These names were regarded as codes; 
(iii) The various codes that emerged from all interviewees’ responses were listed.  
Codes that covered similar issues were put together, creating a broader code, 
in order to make the analysis easier.  Categories were then defined for each 
code, into which data could easily be assigned; 
(iv) All the interview data from all interviewees was then gone through again 
carefully, with data assigned to the appropriate code and category.  Each 
piece of data was assigned to only one category.  Charlesworth (2003a) 
acknowledges that this step is particularly time-consuming, but being 
thorough here allowed a greater yield of information to be obtained from the 
interview data; and 
(v) Finally, a coding frame was constructed, in which the various categories were 
listed, as well as the frequency with which data fell into each category.  This 
allowed nominal or categorical data to be obtained (see 4.2.1.8).  The top five 
categories with the highest frequency counts were also listed in a separate 
table.  Comparisons and conclusions were then made based on the data 
obtained from the coding frame and the list of the top five-ranked categories.   
 
There are some limitations to the use of content analysis.  Robson (1993) and Scott 
(1990), both cited in Charlesworth (2003a), for example, highlight that a particularly 
important piece of data may only have occurred once and could be diluted if 
emphasis was placed on comparing the frequency with which data fell into each 
defined category.  Bias and other weaknesses in the identification of codes and 
definition of categories could also undermine the accuracy and validity of research 
findings.  It was thus important that the author did not predetermine what the codes 
should be, but rather used interviewees’ responses as a starting point to determine 
these.  This approach enhanced the validity of the chosen research method. 
  
Dr Layla Cassim 
4.2.2.6 Summary of the research methodology employed in interviewing 
pharmacists and the pharmacist’s assistant
Figure 6: Summary of the use of interviews with 
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CHAPTER FIVE: RESULTS
 
In this chapter, the results of the 
interviews with pharmacists and the pharmacist’s assistant will be presented, in 5.1 
and 5.2 respectively.  These results will be discussed in the next chapter.
 
5.1 Patient questionnaires
 
5.1.1 Demographic profile 
 
Figures 7 and 8 show the demographic profile of the sample group in terms of race 
and gender respectively, which was asked for in section 1 of the questionnaire.
shown in Figure 7, the majority of respondents 
African (21.50%).  Coloureds ma
8 on the next page shows that the sample group 
This is more than double the proportion of
percent of respondents did not indicate their race or gender
accuracy of the abovementioned figures, as these could have been higher
Figure 7: A pie graph showing the percentage of respondents from different 
racial groups 
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No race given 
16.50%
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Figure 8: A pie graph showing the percentage of respondents 
genders 
 
5.1.2 Compliance with GPP standards for pharmaceutical care
 
5.1.2.1 Overall results per statement
 
Figure 9 on the next page shows the total percentage of respondents indicating 
whether the services provided in 
had been provided to them.  A bar graph for each statement is subsequently 
provided in Figures 10-20 (pages 
would like to receive that particular service.
responses to whether a service is provided, namely “Yes, always” and “Yes, once or 
twice”, are shown individually as well as in combin
combination of responses should be used with caution.
abovementioned graphs are described on page 13
chapter. 
  
Female 56.50%
No gender given 
16.50%
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  In Figures 10-19, the favourable 
ation.  As discussed in 6.
  The results depicted in the 
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Male 27.00%
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Figure 9: A bar graph illustrating 
receive each of the pharmaceutical care services
questionnaire 
* S11 was a question asking
review, not whether this service is provided.  The possible res
statement were “Yes” or “No” only.
 
Figure 10: A bar graph showing patients’ responses to statement 1, “The 
pharmacist asks me whether I am allergic to any medication”
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Figure 11: A bar graph showing 
pharmacist contacts my doctor to clarify my prescription, or discuss my 
medication” 
 
Figure 12: A bar graph showing patients’ responses to statement 
pharmacist asks me what other medication I am taking”
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Figure 13: A bar graph showing patients’ responses to statement 
pharmacist asks me what other illness or medical conditions I have
 
Figure 14: A bar graph showing patients’ responses to statement 
pharmacist offers me generic medication”
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Figure 15: A bar graph showing patients’ responses to statement 
pharmacist asks me whether I am experiencing any side
medication” 
 
Figure 16: A bar graph showing patients’ responses to statement 
pharmacist asks me how often I am taking my medication”
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Figure 17: A bar graph showing patients’ responses to statement 
pharmacist asks me whether my medical condition is 
controlled” 
 
Figure 18: A bar graph showing patients’ responses to statement 
pharmacist or pharmacist’s assistant explains to me how to take my 
medication correctly”   
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Figure 19: A bar graph showing patients’ responses to statement 
pharmacist or pharmacist’s assistant gives me advice or information about my 
medication” 
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As shown in Figure 9, a greater percentage of respondents view the following four 
pharmaceutical care services, ranked in descending order, as always being 
provided, compared to the percentage who view these services as not being 
provided: 
(i) Statement 9:  The pharmacist or pharmacist’s assistant explains to me how to 
take my medication correctly.  As shown in Figure 18, 75.50% of respondents 
view this service as always being provided, compared to 6.50% who view this 
service as not being provided; 
(ii) Statement 10:  The pharmacist or pharmacist’s assistant gives me advice or 
information about my medication.  Figure 19 illustrates that 53.00% of 
respondents view this service as always provided, whereas 14.50% do not; 
(iii) Statement 1:  The pharmacist asks me whether I am allergic to any 
medication.  A total of 46.00% of respondents indicate that this service is 
always provided, compared to 17.00% of respondents who indicate that this 
service is not provided, as revealed in Figure 10; and 
(iv) Statement 5:  The pharmacist offers me generic medication.  A total of only 
34.50% of respondents state that this service is always provided, compared to 
20.50% who indicate that this service is not provided, as shown in Figure 14. 
 
On the other hand, the following six pharmaceutical care services, ranked in 
descending order, are viewed by a greater proportion of respondents as not being 
provided: 
(i) Statement 6:  The pharmacist asks me whether I am experiencing any side-
effects to my medication.  As shown in Figure 15, 54.50% of respondents 
indicate that this service is not provided, compared to 15.50% who state that 
this service is always provided; 
(ii) Statement 8:  The pharmacist asks me whether my medical condition is 
improving or is controlled.  A total of 53.00% of respondents view this service 
as not being provided, whereas 17.00% view this service as always being 
provided, as illustrated in Figure 17; 
(iii) Statement 7:  The pharmacist asks me how often I am taking my medication.  
Figure 16 reveals that 49.00% of respondents view this service as not being 
provided, compared to 18.00% who state that this service is always provided; 
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(iv) Statement 4:  The pharmacist asks me what other illness or medical 
conditions I have.  A total of 46.50% of respondents reveal that this service is 
not provided by the pharmacy, whereas less than half of this percentage (i.e. 
21.00%) state that this service is always provided, as shown in Figure 13; 
(v) Statement 2:  The pharmacist contacts my doctor to clarify my prescription, or 
discuss my medication.  Figure 11 illustrates that 40.50% of respondents view 
this service as not provided, whereas only 23.00% of respondents view this 
service as being provided; and 
(vi) Statement 3:  The pharmacist asks me what other medication I am taking.  
Approximately one third of respondents (33.50%) state that this service is not 
provided.  This is marginally more than the 33.00% of respondents who state 
that this service is always provided. 
 
A large majority of respondents (84.00%) indicate that they have not requested a 
medication review (Statement 11), as illustrated in Figures 9 and 20.  For each of the 
eleven pharmaceutical care services in section 2 of the questionnaire, and as shown 
in Figures 10-20, a greater proportion of patients indicate that they wish to receive 
these services, compared to the proportion who do not wish to receive these 
services.  Nevertheless, the former is below 50% for each statement.  There is, in 
general, a high non-response rate for the questions asking patients whether they 
would like to receive each pharmaceutical care service, evidenced in the proportion 
of “Did not indicate” responses being greater than 50% for statements 2-5, 7 and 9-
11 (see Figures 11-14, 16 and 18-20). 
 
The three pharmaceutical care services drawing the largest proportion of 
respondents indicating that they wish to receive these services are, in descending 
order: 
(i) Statement 1:  The pharmacist asks me whether I am allergic to any 
medication.  As shown in Figure 10, 45.50% of respondents wish to receive 
this service, compared to 8.50% who do not; 
(ii) Statement 9:  The pharmacist or pharmacist’s assistant explains to me how to 
take my medication correctly.  Figure 18 illustrates that this service is desired 
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by 44.50% of respondents, whereas 2.00% of respondents do not wish to 
receive this service; and 
(iii) Statement 10:  The pharmacist or pharmacist’s assistant gives me advice or 
information about my medication.  A total of 43.00% of respondents wish to 
receive this service, whereas only 4.00% do not wish to receive this service, 
as revealed in Figure 19. 
 
The lowest proportion of respondents desires the service in Statement 2, namely the 
pharmacist contacting the patient’s doctor to discuss a prescription.  A total of 
31.50% of respondents would like to receive this service, whereas 15.50% of 
respondents would not, as evidenced in Figure 11. 
 
The service that the highest proportion of respondents do not wish to receive is that 
in Statement 7, namely the pharmacist asking the patient how often he/ she is taking 
his/ her medication.  Figure 16 shows that a total of 16.50% of respondents do not 
wish to receive this service, whereas almost double this percentage of respondents 
(32.50%) wishes to receive this service. 
 
5.1.2.2 A composite of Statements 1-10 
 
Figure 21 on the next page shows a composite bar graph, in which Statements 1-10 
have been grouped together and the mean percentage for each response has been 
calculated.  For example, the mean percentage of all ten “Yes, always” percentages 
was determined; the same was done for “Yes, once or twice”, “No, never” and “No 
response”.  Statement/ question 11 has not been included, as this reflects a service 
requested by patients, rather than one necessarily initiated by pharmacists.  A 
composite graph has been drawn in order to arrive at an overall assessment of 
whether XXX Pharmacy complies with the GPP standards for the provision of 
pharmaceutical care in section 2 of the questionnaire.   
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Inferential statistical analysis has been performed to determine if there is a 
statistically significant difference in mean patient responses.  The statistical test used 
is a one-way ANOVA, followed by the Newman-Keuls multiple comparison test (see 
4.2.1.8).  This analysis was performed using GraphPad Prism 5 software, and the 
level of significance was accepted as p<0.05.   
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Figure 21: A composite bar graph showing the mean percentage of 
responses to Statements 1-10 in section 2 of the questionnaire 
“Yes combined” is the sum of “Yes, always” and “Yes, once or twice” responses. 
@ p<0.05 compared to “Yes, always” and “No, never”; ** p<0.001 compared to “Yes 
combined”; @@ p<0.05 compared to “Yes combined”, after analysis by ANOVA 
followed by the Newman-Keuls multiple comparison test.  Each bar represents the 
mean ± standard error of the mean (SEM) 
 
As shown in Figure 21, a mean percentage of 33.65% of respondents indicate that 
the composite pharmaceutical care services are always provided, whereas a similar 
mean percentage (33.55%) state that these services are not provided.  This 
difference of 0.10% is not statistically significant, as revealed by the ANOVA 
analysis.  There is also no statistically significant difference between the mean 
percentage of “Yes, once or twice” responses and the mean percentage of “No, 
never” responses.  However, when the “Yes, always” and “Yes, once or twice” mean 
percentages are combined, giving a mean percentage of 55.90%, there is a 
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statistically significant difference between this mean combined favourable response 
and the mean percentage of respondents who state that these pharmaceutical care 
services are not provided.  Likewise, there is a statistically significant difference 
between the mean percentage of this “Yes combined” column and the individual 
mean percentages of “Yes, always” and “Yes, once or twice”. 
 
A composite graph, Figure 22, was also similarly created of patients’ responses to 
whether they would like to receive the combined pharmaceutical care services in 
Statements 1-10.  Although Statement 11 could have been included as well, it was 
decided not to do so in this graph, in order to allow for easier direct comparison with 
Figure 21, which does not include responses to Statement 11.  A one-way ANOVA, 
followed by the Newman-Keuls multiple comparison test, was used to detect any 
statistically significant differences in the mean percentages of responses.  As shown 
in Figure 22 below, there is a statistically significant difference in the mean 
percentage of respondents who wish to receive the combined services (38.05%) and 
the mean percentage of those who do not desire these services (10.65%). 
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Figure 22: A composite bar graph showing the mean percentage of 
responses to whether patients would like to receive the services in Statements 
1-10 in section 2 of the questionnaire 
@ p<0.001 compared to “Did not indicate whether would like to receive service”;     
** p<0.001 compared to “Yes”, after analysis by ANOVA followed by the Newman-
Keuls multiple comparison test.  Each bar represents the mean ± SEM 
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In order to identify whether a gap exists between whether patients state that they 
have not received a particular service and whether they would like to receive this 
service, the mean percentage of “No, never” responses shown in Figure 21 is 
compared to the mean percentage of “Yes, would like to receive services” indicated 
in Figure 22.  These two groups are analysed using an unpaired t-test (see 4.2.1.8).  
The confidence level was set at 95%, and GraphPad Prism 5 software was used to 
perform the analysis.  The t-test reveals that there is no statistically significant 
difference between the two groups shown in Figure 23 below, with the p value being 
0.4487.  A p value of less than 0.05 is required for statistical significance. 
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Figure 23: A bar graph showing the mean proportion of respondents who 
state that the combined pharmaceutical care services in Statements 1-10 are 
not provided, compared to the mean proportion who would like to receive 
these combined services 
 
5.1.2.3 Results per racial group 
 
Figures 24-34, on pages 136-141, show the various races’ responses to individual 
statements in section 2.  A composite graph is provided in Figure 35.  It is not 
possible to perform the chi-squared test, the most commonly-used inferential, non-
parametric statistical test for one-sample cases involving nominal categories (Gani, 
2004) because some respondents have not indicated their race.  This decreases the 
extent to which the categories of races used are mutually exclusive, as the data 
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captured under “No race given” should be allocated to one of the racial categories 
provided.  Mutually-exclusive categories are required for the chi-squared test to be 
performed (University of Pennsylvania, 2008).   
 
Figure 24: A bar graph showing the responses of patients from different 
racial groups to statement 1, “The pharmacist asks me whether I am allergic to 
any medication” 
 
Figure 25: A bar graph showing the responses of patients from different 
racial groups to statement 2, “The pharmacist contacts my doctor to clarify my 
prescription, or discuss my medication” 
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Figure 26: A bar graph showing the responses of patients from different 
racial groups to statement 3, “The pharmacist asks me what other medication I 
am taking” 
 
Figure 27: A bar graph showing the responses of patients from different 
racial groups to statement 4, “The pharmacist asks me what other illness or 
medical conditions I have” 
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Figure 28: A bar graph showing the responses of patients from different 
racial groups to statement 5
Figure 29: A bar graph showing the responses of patients from different 
racial groups to statement 6
experiencing any side-effects to my medication”
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Figure 30: A bar graph showing the responses of patients from different 
racial groups to statement 7, “The pharmacist asks me how often I am taking 
my medication” 
 
Figure 31: A bar graph showing the responses of patients from different 
racial groups to statement 8, “The pharmacist asks me whether my medical 
condition is improving or is controlled” 
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Figure 32: A bar graph showing the responses of patients from different 
racial groups to statement 9
explains to me how to take my medication correctly”
Figure 33: A bar graph showing the responses of patients from different 
racial groups to statement 10
me advice or information about my medication”
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Figure 34: A bar graph showing the responses of patients from different 
racial groups to question 11, “Have you ever requested a pharmacist to 
perform a medication review for you?”   
 
Figure 35: A composite bar graph showing the mean percentages of 
responses from the different racial groups to whether they receive the 
pharmaceutical care services in Statements 1-10, as well as whether they 
would like to receive these services 
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Figure 35 shows that there are generally few large variations in the mean 
percentages of responses per race.  Some prominent results in Figures 24-35, which 
are limited by the non-exclusivity of the racial categories, include the following: 
(i) The lowest proportion of patients who state that they always receive the 
combined pharmaceutical care services (22.31%), as well as the highest 
proportion of patients who state that they do not receive these services 
(50.77%), are Coloured, as shown in Figure 35; 
(ii) The highest mean percentage of patients who state that they always receive 
the combined pharmaceutical care services are African (43.72%) (see Figure 
35); 
(iii) All the racial groups have a higher percentage of respondents stating that the 
services in Statements 1, 9 and 10 are always provided, compared to the 
percentage of respondents stating that these services are not provided, as 
illustrated in Figures 24, 32 and 33, respectively; 
(iv) There is also consistency in all the racial groups having a higher proportion of 
respondents stating that the services in Statements 2, 4, 6, 7 and 8 are not 
provided, compared to the proportion stating that these services are always 
provided.  This is shown in Figures 25, 27, 29, 30 and 31, respectively; 
(v) There is inconsistency in the different races’ responses to whether the 
services in Statements 3 and 5 are always provided or not.  A higher 
proportion of Africans (53.49%) indicate that the service in Statement 3 is 
always provided, whereas the other races disagree with this, as reflected in 
Figure 26.  With regard to Statement 5 (see Figure 28), a higher proportion of 
Africans (30.23%) and Whites (37.63%) state that this service is always 
provided, whereas a higher percentage of Coloureds (46.15%) state that this 
service is not provided, and an equal percentage (27.78%) of Indians/ Asians 
have ticked each of these two responses; 
(vi) Figure 34 reveals that all racial groups have a larger proportion of 
respondents indicating that they have not requested a pharmacist to perform 
a medication review; 
(vii) There is consistency amongst all racial groups that a higher proportion of 
each would like to receive each of the services in Statements 1-11, with the 
exception of Statement 2.  A higher proportion of Coloureds do not wish for 
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the service in Statement 2 (30.77%), compared to the proportion of Coloureds 
who do (15.38%), as reflected in Figure 25; and 
(viii) There is an overall low response rate across the races to whether patients 
would like to receive the various pharmaceutical care services, as shown in 
the relatively high percentages of the “Did not indicate” columns in the 
extreme right-hand corner in Figures 24-35. 
 
5.1.2.4 Results per gender 
 
Figures 36-46, on pages 143-148, show the different genders’ responses to 
individual statements in section 2 of the questionnaire.  A composite graph is 
provided in Figure 47 on page 149.  Key results are subsequently highlighted.  As 
with the results per race in 5.1.2.3, it is not possible to perform a chi-squared test, 
because some respondents have not indicated their gender, thus making the gender 
categories not mutually-exclusive.   
 
 
Figure 36: A bar graph showing the responses of patients of different 
genders to statement 1, “The pharmacist asks me whether I am allergic to any 
medication” 
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Figure 37: A bar graph showing the responses of patients of different 
genders to statement 2, “The pharmacist contacts my doctor to clarify my 
prescription, or discuss my medication” 
 
Figure 38: A bar graph showing the responses of patients of different 
genders to statement 3, “The pharmacist asks me what other medication I am 
taking” 
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Figure 39: A bar graph showing the responses of patients 
genders to statement 4, “The pharmacist asks me what other illness or 
medical conditions I have” 
Figure 40: A bar graph showing the responses of patients 
genders to statement 5, “The pharmacist offers me generic medication”
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Figure 41: A bar graph showing the responses of patients of different 
genders to statement 6, “The pharmacist asks me whether I am experiencing 
any side-effects to my medication” 
 
Figure 42: A bar graph showing the responses of patients of different 
genders to statement 7, “The pharmacist asks me how often I am taking my 
medication” 
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Figure 43: A bar graph showing the responses of patients of different 
genders to statement 8, “The pharmacist asks me whether my medical 
condition is improving or is controlled” 
 
Figure 44: A bar graph showing the responses of patients of different 
genders to statement 9, “The pharmacist or pharmacist’s assistant explains to 
me how to take my medication correctly”   
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Figure 45: A bar graph showing the responses of patients of different 
genders to statement 10, “The pharmacist or pharmacist’s assistant gives me 
advice or information about my medication”
Figure 46: A bar graph showing the 
genders to question 11, “Have you ever requested a pharmacist to perform a 
medication review for you?”
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Figure 47: A composite bar graph showing the mean percentages of 
responses from the different genders to whether they receive the 
pharmaceutical care services in Statements 1-10, as well as whether they 
would like to receive these services 
 
As shown in Figure 47, there are generally few large variations in the mean 
percentages of responses per gender.  Prominent results in Figures 36-47, which are 
limited by the non-exclusivity of the gender categories, include the following: 
(i) A greater mean percentage of males indicate that the composite 
pharmaceutical care services are always provided (37.22%) compared to the 
proportion of males who believe that these services are not provided 
(33.52%).  Meanwhile, a slightly higher mean percentage of females indicate 
that these services are not provided (35.04%), compared to the 32.48% of 
females who indicate that these services are always provided (see Figure 47); 
(ii) There is consistency in both genders having a higher percentage of 
respondents stating that the services in Statements 1, 9 and 10 are always 
provided, compared to the percentage of respondents stating that these 
services are not provided, as illustrated in Figures 36, 44 and 45, respectively; 
(iii) There is also consistency in both genders having a higher proportion of 
respondents stating that the services in Statements 2, 4, 6, 7 and 8 are not 
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provided, compared to the proportion stating that these services are always 
provided.  This is shown in Figures 37, 39, 41, 42 and 43, respectively; 
(iv) There is inconsistency in the different genders’ responses to whether the 
service in Statement 3 is always provided or not.  A higher proportion of males 
(48.15%) indicate that this service is always provided, whereas 22.22% of 
males state that this service is not provided.  A higher proportion of females 
(40.71%), however, state that this service is not provided compared to the 
proportion stating that it is always provided (25.66%) (see Figure 38); 
(v) With regard to Statement 5 (see Figure 40), a higher proportion of females 
(37.17%) state that this service is always provided compared to the proportion 
of females who state that this service is not provided (17.70%), whereas an 
equal percentage of males (25.93%) tick each of these two responses; 
(vi) Figure 46 reveals that both genders have a larger proportion of respondents 
indicating that they have not requested a medication review; 
(vii) There is consistency amongst both genders that a higher proportion of each 
gender would like to receive each of the services in Statements 1-11; and 
(viii) There is an overall low response rate across genders as to whether patients 
would like to receive the various pharmaceutical services listed in section 2 of 
the questionnaire, as shown in the relatively high percentages of the “Did not 
indicate” columns in the extreme right-hand corner in Figures 36-47. 
 
5.1.3 Scope of practice 
 
5.1.3.1 Overall results per statement 
 
Figure 48 on the next page shows the total results for each of the four statements in 
the final, third section of the questionnaire, which relates to the scope of practice of 
pharmacists and the pharmacist’s assistant.   
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Figure 48: A bar graph illustrating patients’ responses to Statements 1-4 
related to the scope of practice of pharmacists and the pharmacist’s assistant 
in section 3 of the questionnaire 
 
Figure 48 shows that the majority of patients respond favourably to each statement.  
A total of 73.50% of respondents know who the pharmacists are (Statement 1), 
whereas a lower percentage (58.50%) indicate that they know who the pharmacist’s 
assistant is (Statement 2) and 40.00% indicate that they do not know who the 
pharmacist’s assistant is.  Whilst almost two-thirds of respondents (65.00%) state 
that the pharmacist’s assistant always prepares their prescription under the direct 
supervision of a pharmacist (Statement 3), a total of 9.50% disagree and 22.00% of 
respondents are not sure whether this direct supervision occurs.  A similar total 
percentage of 22.50% of respondents indicate that front-shop assistants select OTC 
medication, whereas 64.00% of respondents indicate that this is always performed 
by a pharmacist or pharmacist’s assistant (Statement 4). 
 
A composite graph showing the mean percentages of responses for all four 
statements is provided next and analysed by a one-way ANOVA followed by the 
Newman-Keuls multiple comparison test.  The level of significance was accepted as 
p<0.05.  The “Not sure” response in Statement 3 was omitted, as there is no such 
0
10
20
30
40
50
60
70
80
90
100
S1 S2 S3 S4
No response
Yes
No  
Not sure (S3)
Percentage 
(n = 200)
Statement (represented by "S")
Dr Layla Cassim  Research Report MBA 5932 
152 
 
option for the other statements and ANOVA cannot be performed on a group size of 
one.   
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Figure 49: A composite bar graph showing the mean percentage of 
responses to the scope-of-practice-related Statements 1-4 in section 3 of the 
questionnaire 
@ p<0.001 compared to “Yes”; ** p<0.05 compared to “No”, after analysis by 
ANOVA followed by the Newman-Keuls multiple comparison test.  Each bar 
represents the mean ± SEM.  Responses do not total 100%, as there was an option 
of “Not sure” for Statement 3, which has been omitted from the graph. 
 
As reflected in Figure 49, there is a statistically significant difference in the mean 
percentage of respondents who agree with the composite four statements (65.25%), 
compared to the mean percentage of respondents who disagree (24.38%). 
 
5.1.3.2 Results per racial group 
 
Figures 50-53 in the next few pages illustrate the responses of the various racial 
groups to the four statements in section 3.  As shown in these Figures, there is 
consistency in the responses of the various racial groups, with over 50% of all racial 
groups agreeing with each statement.  The statement drawing the highest 
percentage of “Yes” responses across all the racial groups, with the exception of 
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Coloureds, is Statement 1 (see Figure 50), namely that patients know who the 
pharmacists are.  Coloureds respond most favourably (84.62%) to Statement 4 (see 
Figure 53), namely that pharmacists or the pharmacist’s assistant always selects 
OTC medication for them.  All racial groups are unanimous in responding most 
negatively to Statement 2, which has the highest percentage of “No” responses (over 
30% for all categories) amongst the four statements.  This shows that over 30% of all 
categories of respondents shown in Figure 50 do not know who the pharmacist’s 
assistant is.  A composite graph is shown in Figure 54 on page 155. 
 
Figure 50: A bar graph illustrating the responses of patients of various racial 
groups to Statement 1, “I know who the pharmacists are” 
 
Figure 51: A bar graph illustrating the responses of patients of various racial 
groups to Statement 2, “I know who the pharmacist’s assistant is” 
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Figure 52: A bar graph illustrating the responses of patients of various racial 
groups to Statement 3, “The pharmacist’s assistant always prepares my 
prescription under the direct supervision of the pharmacist” 
 
 
Figure 53: A bar graph illustrating the responses of patients of various racial 
groups to Statement 4, “The pharmacist or pharmacist’s assistant always 
selects over-the-counter medication for me” 
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Figure 54: A composite bar graph showing the mean percentage of 
responses of the various racial groups to all the scope of practice statements 
in section 3 of the questionnaire  
 
Figure 54 above, which gives the mean percentage of responses to a combination of 
the four statements, shows that the highest mean percentage of “Yes” responses 
comes from Africans (73.26%), whereas the lowest comes from White respondents 
(62.63%).  As shown in Figures 50-54, a number of respondents do not provide their 
race, thus making the categories non-exclusive (see 5.1.2.3).  For this reason, a chi-
squared test has not been performed on the composite results. 
 
5.1.3.3 Results per gender 
 
The responses of the different genders to each statement in section 3 are shown in 
Figures 55-58 in the next few pages.  A composite of the mean responses to all 
these statements is subsequently illustrated in Figure 59 on page 158. 
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Figure 55: A bar graph illustrating the responses of patients of different 
genders to Statement 1, “I know who the pharmacists are” 
 
 
Figure 56: A bar graph illustrating the responses of patients of different 
genders to Statement 2, “I know who the pharmacist’s assistant is” 
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Figure 57: A bar graph illustrating the responses of patients of different 
genders to Statement 3, “The pharmacist’s assistant always prepares my 
prescription under the direct supervision of the pharmacist” 
 
 
Figure 58: A bar graph illustrating the responses of patients of different 
genders to Statement 4, “The pharmacist or pharmacist’s assistant always 
selects over-the-counter medication for me” 
  
0
10
20
30
40
50
60
70
80
90
100
No response Yes No Not sure
Male
Female
No gender 
given
Percentage 
(n = 200)
Response
0
10
20
30
40
50
60
70
80
90
100
No response Yes No
Male
Female
No gender 
given
Percentage 
(n = 200)
Response
Dr Layla Cassim  Research Report MBA 5932 
158 
 
 
Figure 59: A composite bar graph showing the mean percentage of 
responses of the different genders to all the scope of practice questions in 
section 3 of the questionnaire  
 
As shown in Figures 55-58, there is consistency among the genders with more than 
50% of each gender indicating that all of the statements in section 3 of the 
questionnaire are correct.  The highest proportion of males (70.37%) respond 
favourably to Statement 4, as shown in Figure 58, agreeing that pharmacists or the 
pharmacist’s assistant selects OTC medication for them.  On the other hand, the 
highest proportion of females (81.42%) agree with Statement 1 (see Figure 55), 
namely that they know who the pharmacists are.  The highest proportion of both 
males (42.59%) and females (38.05%) disagree with Statement 2, as reflected in 
Figure 56, indicating that they do not know who the pharmacist’s assistant is. 
 
Figure 59 illustrates that the highest mean percentage of favourable responses to 
the combined statements is from females (67.48%); this is slightly greater than the 
mean percentage of males who agree with these statements (64.81%).  As with the 
composite results per race (see 5.1.3.2), a chi-squared test was not performed on 
these results, as there are respondents who do not indicate their gender. 
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5.2 Interviews with the pharmacists and pharmacist’s assistant 
 
Content analysis as described by Charlesworth (2003a) was applied to interview 
data (see 4.2.2.5).  The table used, which included all interviewee responses and 
key quotations, with the responses of different individuals highlighted in different 
colours, is not provided in this dissertation, due to its length.  This table was used to 
construct a coding frame (see 4.2.2.5), which is shown below in Table 1.  The 
percentage frequencies in the column in the extreme right are low, as the total 
number of data counts (i.e. 480) and the number of categories is large.  Each 
frequency count is expressed as a percentage of the total number of data counts.  
Those categories with frequency counts of four and more, representing the top 19 
categories that data falls into most frequently, are ranked in descending order in 
Table 2 on pages 171-172.  Key findings, and data with a low frequency count but 
which may nevertheless be important, are subsequently highlighted on page 172. 
 
Table 1: A coding frame of the categories of responses emerging from 
semi-structured interviews with three pharmacists and the one pharmacist’s 
assistant at XXX Pharmacy, and the frequency of data counts in each category 
 
Theme/ code Category Frequency 
(count) 
Frequency  
(%) 
1. Years of 
practice 
 
Less than 5 years 
 
1 0.21 
  Between 5 and 10 years 1 0.21 
  More than 10 years 2 0.42 
2. Length of 
service at XXX 
Pharmacy 
 
 
Less than 5 years 
 
 
1 0.21 
  Between 5 and 10 years 2 0.42 
  More than 10 years 1 0.21 
3.Understanding 
of pharmaceutical 
care 
 
 
Diagnosis 
 
 
1 0.21 
  Patient counselling 6 1.25 
  Evaluation of pharmacotherapy 4 0.83 
  Providing a professional service 1 0.21 
  Giving correct medication 1 0.21 
  Patient outcomes and safety 3 0.63 
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4. Whether 
pharmaceutical 
care is a key 
responsibility 
 
 
 
Yes 
 
 
 
5 1.04 
  No  0 0 
  Is a core professional duty 3 0.63 
  To comply with law  0 0 
  For customer service 1 0.21 
5. Awareness of 
GPP standards for 
pharmaceutical 
care 
 
 
 
Yes 
 
 
 
3 0.63 
  No  0 0 
  Can give example(s) 0 0 
  Cannot give example(s) 3 0.63 
  Pharmacist's assistant is aware of GPP 
standards, which outline her scope of 
practice 
 
 
1 0.21 
6. Compliance 
with GPP 
standards for 
pharmaceutical 
care 
 
 
 
 
Yes 
 
 
 
 
4 0.83 
  No  0 0 
  There is nothing that prevents me from fully 
complying with GPP standards 
 
2 0.42 
7. Patient 
counselling 
(pharmacist’s 
assistant) 
 
 
 
Is a key responsibility 
 
 
 
1 0.21 
  Is not a key responsibility  0 0 
  Important for customer service 1 0.21 
  I add more details to labels 1 0.21 
  Promotes patients trusting you 1 0.21 
  Barrier is patients on cellular phones 1 0.21 
  Barriers are racism and/ or sexism 1 0.21 
8. Knowledge of 
pharmacy’s vision 
 
Providing a personal, clinical service 
 
1 0.21 
  Sustainability and providing good quality 
care 
 
1 0.21 
  Does not know what the vision is 2 0.42 
9. Knowledge of 
pharmacy’s 
mission statement 
 
 
Yes there is a mission statement 
 
 
2 0.42 
  No there is no mission statement 2 0.42 
  I do not know what the mission statement is 1 0.21 
10. How 
performance is 
managed 
 
 
Expected to be present for shifts 
 
 
1 0.21 
  Expected to do things correctly and comply 
with pharmacy law 
 
1 0.21 
11. Whether there 
are job 
descriptions 
 
 
Yes 
 
 
 0 0 
Dr Layla Cassim  Research Report MBA 5932 
161 
 
  No 3 0.63 
  Using job description from previous owner, 
six years ago 
 
1 0.21 
12. Awareness of 
roles and 
responsibilities 
 
 
Dispensing prescriptions 
 
 
2 0.42 
  Patient counselling 2 0.42 
  Ordering stock 2 0.42 
  Supervision of front-shop assistants 1 0.21 
  Maintaining GPP standards 1 0.21 
  The pharmacist’s assistant’s role is seen as 
like a pharmacist’s, but under supervision 
 
 
1 0.21 
  Providing quick, efficient service 1 0.21 
  Providing professional service 1 0.21 
  Compliance with law  0 0 
 Compliance with owner-manager’s 
standards 
 
2 0.42 
  Told employees verbally about their roles 
and responsibilities 
 
1 0.21 
13. Awareness of 
SOPs 
 
Yes 
 
2 0.42 
  No 2 0.42 
  Only pharmacists know, not the pharmacist's 
assistant 
 
1 0.21 
14. Compliance 
with SOPs 
 
Yes 
 
2 0.42 
  No  0 0 
  Comply because it’s law 1 0.21 
 Comply because it helps us be sustainable 1 0.21 
  Difficult to comply with SOPs 1 0.21 
 Have been told by the managing pharmacist 
to comply with these SOPs 
 
1 0.21 
  Have not been told by the managing 
pharmacist to comply with these SOPs 
 
2 0.42 
15. Usefulness of 
SOPs 
 
Provide standardisation 
 
1 0.21 
  Only a guideline, are sometimes non-
compliant 
 
2 0.42 
  Compliance helps me to perform my job 
better and provide a more efficient, 
beneficial service 
 
 
1 0.21 
16. Whether there 
was training, 
orientation and 
induction 
 
 
 
Yes 
 
 
 
2 0.42 
  No 2 0.42 
  Not much information is provided 1 0.21 
17. Impact of 
training, 
orientation and 
induction, or the 
lack of this 
 
 
 
Lack of this has not had an impact, as I have 
my professional knowledge 
 
 
 
 
1 0.21 
  Contributes to enhancing services 1 0.21 
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18. Whether there 
are performance 
appraisals and the 
impact of these 
 
 
 
Yes 
 
 
 
 0 0 
  No 4 0.83 
  Difficult to perform for pharmacists 2 0.42 
  Having performance appraisals would lead 
to clarity and eliminate hassles 
 
1 0.21 
  Lack of performance appraisals does not 
compromise standards 
 
1 0.21 
  I challenge myself to go beyond my contract, 
SOPs 
 
1 0.21 
  Have phased out people with different 
working style 
 
2 0.42 
19. Whether 
dispensary 
employees give 
input in 
performance 
appraisal 
 
 
 
 
 
Yes 
 
 
 
 
 
 0 0 
  No 2 0.42 
20. Performance 
objectives 
 
Accuracy in dispensing prescriptions 
 
1 0.21 
  Patient counselling and care 2 0.42 
  Customer service 1 0.21 
  Figures 1 0.21 
  I do not know; no guidance provided 1 0.21 
  Providing pharmaceutical care  1 0 
  Following the working style of the owner-
manager 
 
1 0.21 
21. Performance 
targets 
 
Yes 
  
0 0 
  No 3 0.63 
  I do not know; no guidance provided 1 0.21 
  Expected to think in the same way as the 
owner-manager 
 
1 0.21 
  Ensure no unprofessional service 1 0.21 
  Employees give input in developing 
performance targets/ objectives 
 
1 0.21 
  Employees do not give input in developing 
performance targets/ objectives 
 
1 0.21 
  Does not say whether employees give input 
in developing performance targets/ 
objectives 
 
 
1 0.21 
  Provide total care 1 0.21 
  Serve customers as quickly and efficiently as 
possible 
 
5 1.04 
  Acknowledgement of patients 1 0.21 
  Paediatric care 1 0.21 
22. Working hours Working hours are fine 3 0.63 
  Working hours are not fine  0 0 
  I have to sometimes work overtime 1 0.21 
  Long hours hinder pharmaceutical care 0 0 
  Hours do not affect the provision of  
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pharmaceutical care 3 0.63 
23. Whether 
number of 
dispensary 
employees is 
sufficient to 
provide 
pharmaceutical 
care 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
2 0.42 
  No 4 0.83 
  Shortage of dispensary employees makes it 
more difficult to provide pharmaceutical care 
 
2 0.42 
  Whether employee fits in with our working 
style is more important than just getting 
another employee 
 
 
1 0.21 
  Number of pharmacists is sufficient to 
supervise pharmacist’s assistant 
 
4 0.83 
  Number of pharmacists is not sufficient to 
supervise pharmacist’s assistant 
 
 0 0 
24. Training and 
development 
The managing pharmacist identifies an 
employee's T&D needs 
  
0 0 
  The managing pharmacist has not identified 
any T&D needs on an employee's part 
 
3 0.63 
  I identify my own T&D needs 2 0.42 
  The managing pharmacist has sent me on 
T&D activities 
 
 0 0 
  The managing pharmacist has not sent me 
on T&D activities 
 
1 0.21 
  The managing pharmacist has done 
something about the T&D needs I told him 
about 
 
 
 0 0 
  The managing pharmacist has not done 
anything about the T&D needs I told him 
about 
 
 
1 0.21 
  I encourage dispensary employees to tell me 
about their T&D needs 
 
1 0.21 
  I try to get in-house training organised 1 0.21 
  Quality of in-house training is questionable 1 0.21 
  I think that sending my employees for T&D 
activities in itself is insufficient; employees 
must be able to apply their knowledge 
 
 
1 0.21 
25. Self-
development 
plans 
 
 
I have a self-development plan 
 
 
2 0.42 
  I do not have a self-development plan 2 0.42 
  This self-development plan is beneficial to 
me 
 
1 0.21 
  This self-development plan is not beneficial 
to me 
 
 0 0 
  I know if my dispensary employees have a 
self-development plan 
 
 0 0 
  I do not know if my dispensary employees 
have a self-development plan 
 
1 0.21 
26. Problem with 
performance 
The managing pharmacist has told a 
dispensary employee that he had a problem 
with his/ her performance  
 
 
2 0.42 
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  The managing pharmacist has not told a 
dispensary employee that he had a problem 
with his/ her performance 
 
 
2 0.42 
  I manage by direct supervision 1 0.21 
  I deal with situations of performance-related 
problems there and then 
 
1 0.21 
  Current pharmacists require much 
supervision 
  
0 0 
  Current pharmacists do not require much 
supervision 
 
1 0.21 
27. Staff meetings There are regular staff meetings 2 0.42 
  Staff meetings only occur if there is a 
problem 
 
2 0.42 
  Staff meetings primarily deal with front-shop 
matters 
 
3 0.63 
  Staff meetings deal with all issues facing the 
pharmacy 
 
1 0.21 
  Staff meetings are useful 1 0.21 
  Staff meetings are not useful 1 0.21 
28. Dispensary-
related meetings 
There are meetings that specifically deal 
with dispensary-related issues 
 
1 0.21 
  There are no meetings that specifically deal 
with dispensary-related issues 
 
3 0.63 
  There are no such meetings because there 
are no major dispensary-related problems 
 
1 0.21 
  Lack of dispensary-related meetings makes 
it difficult to provide pharmaceutical care 
 
 0 0 
  Lack of dispensary-related meetings does 
not affect the provision of pharmaceutical 
care 
 
 
2 0.42 
29. Management 
style 
The managing pharmacist treats all 
employees the same 
 
 0 0 
  The managing pharmacist does not treat all 
employees the same 
 
3 0.63 
  The managing pharmacist's management 
style encourages pharmacists to provide 
pharmaceutical care 
 
 
3 0.63 
  The managing pharmacist's management 
style does not encourage pharmacists to 
provide pharmaceutical care 
  
 
0 0 
  I lead by example, not by giving advice 2 0.42 
  Managing pharmacist's management style 
could be improved 
 
1 0.21 
  The managing pharmacist does not take 
time to explain objectives or tell us things 
 
2 0.42 
  Managing pharmacist treats employees as 
friends, rather than as employees, and this 
leads to problems 
 
 
1 0.21 
  There is inadequate control over patients’ 
access to scheduled medication 
 
2 0.42 
  The managing pharmacist does not rush me 
if I am dealing with a sensitive issue 
 
1 0.21 
  I ask employees for feedback on my 
management style 
 
0 0 
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30. Whether 
pharmacists have 
to follow working 
style of managing 
pharmacist 
 
 
 
 
Yes 
 
 
 
 
1 0.21 
  No 2 0.42 
  I have had to adapt to the working style of 
the managing pharmacist 
 
1 0.21 
  Following the working style of the managing 
pharmacist helps pharmacists provide 
pharmaceutical care 
 
 
1 0.21 
31. Culture Culture is positive, enjoyable, easygoing 
and/ or flexible 
 
2 0.42 
  Tasks fulfilled without nagging employees 1 0.21 
  Family culture 2 0.42 
  We learn from each other 1 0.21 
  Problems are not addressed 3 0.63 
  No gratitude for what you do 1 0.21 
  I get sly comments from colleagues if I 
spend time talking to patients 
 
2 0.42 
32. Working 
relationships 
 
I have good working relationships 
 
6 1.25 
  I do not have good working relationships  0 0 
  I have had problems in my working 
relationships  
 
1 0.21 
  I was depressed due to the way the 
pharmacy operates, but had to learn to 
adapt 
 
 
1 0.21 
 We accommodate each other 2 0.42 
  There is mutual respect 1 0.21 
  I am not respected sufficiently 1 0.21 
  We understand each other 2 0.42 
  Communication promotes good working 
relationships 
 
2 0.42 
  I make time for my employees if they want to 
talk 
 
1 0.21 
  The greatest reward is the professionalism 
of colleagues 
 
1 0.21 
  My working relationships promote the 
provision of pharmaceutical care 
 
4 0.83 
  My working relationships do not promote the 
provision of pharmaceutical care 
 
1 0.21 
33.Relationships 
with patients 
 
I have good relationships with patients 
 
3 0.63 
  I do not have good relationships with 
patients 
  
0 0 
  I have had difficulty in developing good 
relationships with patients 
 
1 0.21 
  Relationships with patients promotes 
patients having trust in me and me feeling 
more confident 
 
 
2 0.42 
  Your level of knowledge assists in 
developing relationships with patients 
 
1 0.21 
  Relationships with patients promotes the 
provision of patient counselling and/ or other 
aspects of pharmaceutical care 
 
 
4 0.83 
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  Relationships with patients promotes growth 
of the pharmacy 
 
1 0.21 
  Making time for patients promotes the 
development of relationships 
 
2 0.42 
  Patients sometimes wish to speak to me on 
female matters as I am the only female in 
the dispensary, and this promotes the 
development of relationships 
 
 
 
1 0.21 
  I know patients well 3 0.63 
  I don't know patients well 1 0.21 
34. Satisfaction 
with remuneration 
 
I am satisfied with my remuneration 
 
1 0.21 
  I am not completely satisfied with my 
remuneration 
 
2 0.42 
  Pharmacists are underpaid generally 1 0.21 
  My dispensary employees are satisfied with 
their remuneration 
 
1 0.21 
  My remuneration adequately reflects the 
extra responsibilities in providing 
pharmaceutical care (or the patient 
counselling aspect of this) 
 
 
 
1 0.21 
  My remuneration does not adequately reflect 
the extra responsibilities in providing 
pharmaceutical care (or the patient 
counselling aspect of this) 
 
 
 
2 0.42 
  Remuneration amongst different employees 
is perceived as unfair 
 
1 0.21 
  Front-shop staff were given an extra cash 
reward, whilst dispensary employees did not 
receive this 
 
 
1 0.21 
 If I provided more pharmaceutical care (or 
more of the patient counselling component 
of this), I would like my financial rewards to 
increase 
 
 
 
2 0.42 
  If I provided more pharmaceutical care (or 
more patient counselling), I would not expect 
my financial rewards to increase 
 
 
2 0.42 
35. Whether 
remuneration is 
regular 
 
 
Yes 
 
 
1 0.21 
  No 2 0.42 
36. Other financial 
rewards 
 
Yes 
 
1 0.21 
  No 4 0.83 
   
Financial rewards are a motivating factor  
 
2 0.42 
   
Financial rewards are not a motivating factor  
 
4 0.83 
37. Non-financial 
rewards 
 
There are some non-financial rewards 
 
2 0.42 
  There are no non-financial rewards 2 0.42 
  Non-financial rewards are a motivating factor 1 0.21 
  Non-financial rewards are not a motivating 
factor 
 
3 0.63 
38. PSSA activities Employees are encouraged to participate in 
PSSA activities 
 
1 0.21 
  Employees are not encouraged to participate 
in PSSA activities 
 
3 0.63 
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  Involvement in PSSA activities assists in 
providing pharmaceutical care 
 
3 0.63 
  Involvement in PSSA activities does not 
assist in providing pharmaceutical care 
 
 0 0 
39. CPD activities I participate in CPD activities 4 0.83 
  I do not participate in CPD activities  0 0 
  I encourage dispensary employees to 
participate in CPD activities 
 
1 0.21 
  The need to be involved in CPD activities 
needs to come from employees as well 
 
1 0.21 
  CPD activities promote the provision of 
pharmaceutical care and/ or help me to do 
my job better 
 
 
2 0.42 
  We have had a meeting to discuss CPD 
being compulsory 
 
1 0.21 
  We have not had a meeting to discuss CPD 
being made compulsory 
 
3 0.63 
  There is a plan to ensure that employees are 
compliant with CPD requirements 
 
3 0.63 
  There is no plan to ensure that employees 
are compliant with CPD requirements 
 
1 0.21 
40. Professional 
indemnity 
 
I have professional indemnity 
 
2 0.42 
  I do not have professional indemnity 2 0.42 
  I do not know whether my dispensary 
employees have professional indemnity 
 
1 0.21 
  The managing pharmacist did nothing when 
I mentioned my need for professional 
indemnity 
 
 
1 0.21 
41. Generic 
substitution 
I always offer generics, unless I cannot by 
law 
 
2 0.42 
  I do not always offer generics 2 0.42 
  Does not offer a clear answer 1 0.21 
42. Analysis of 
appropriateness 
of prescribed 
medication 
 
 
I routinely analyse the appropriateness of 
dosages 
 
 
 
3 0.63 
  I routinely assess the appropriateness of 
prescribed medication in terms of allergies 
 
3 0.63 
  I routinely assess the appropriateness of 
prescribed medication in terms of drug 
interactions 
 
 
2 0.42 
  I analyse OTC medication in more detail 
than I do prescribed medication 
 
1 0.21 
  I assume the doctor has performed the 
analyses 
 
1 0.21 
43. Other 
pharmaceutical 
care services 
 
 
I routinely counsel patients 
 
 
6 1.25 
 Some patients do not want to receive 
counselling 
 
1 0.21 
  The time pressures and/ or other 
practicalities in the pharmacy make it difficult 
to provide patient counselling and/ or other 
aspects of pharmaceutical care 
 
 
 
10 2.08 
  I tend to not counsel patients who have been 
on chronic medication for a while 
 
1 0.21 
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I tend to provide more counselling to patients 
who receive OTC medication rather than 
patients on prescribed medication 
 
 
 
1 0.21 
  I routinely assess whether medication is 
controlling/ improving a patient’s condition 
 
2 0.42 
   
I do not routinely assess whether medication 
is controlling/ improving a patient's condition 
 
 
1 0.21 
  I assess whether medication is controlling/ 
improving a patient's condition, based only 
on what is prescribed 
 
 
1 0.21 
  I assess whether medication is controlling/ 
improving a patient's condition, based on 
what is prescribed as well as by questioning 
the patient 
 
 
 
 0 0 
  I assume the doctor is assessing whether 
medication is controlling/ improving a 
patient’s condition 
 
 
1 0.21 
  I routinely assess whether patients are 
compliant with their pharmacotherapy 
 
2 0.42 
 I do not routinely assess whether patients 
are compliant with their pharmacotherapy 
 
1 0.21 
  It is difficult to assess patient compliance 1 0.21 
  I have performed a medication review 1 0.21 
  I have not performed a medication review 1 0.21 
   
The usefulness of a medication review is 
limited by the prescriber having the power 
not to want to change a patient's prescription 
 
 
 
1 0.21 
  Performing a medication review assists in 
patient counselling and leads to greater 
patient satisfaction  
 
 
1 0.21 
44.Communication 
with other health-
care professionals 
 
I regularly liaise with other health-care 
professionals 
 
 
3 0.63 
  I do not regularly liaise with other health-care 
professionals 
 
1 0.21 
  The managing pharmacist encourages 
dispensary employees to liaise with other 
health-care professionals 
 
 
3 0.63 
  The managing pharmacist does not 
encourage me to liaise with other health-
care professionals 
 
 
1 0.21 
  Liaising with other health-care professionals 
assists me in doing my job better 
 
1 0.21 
  Liaising with other health-care professionals 
promotes the development of relationships 
and the provision of pharmaceutical care 
 
 
1 0.21 
  Liaising with other health-care professionals 
allows one to understand their prescribing 
behaviour 
 
 
2 0.42 
45. Supervision of 
pharmacist’s 
assistant 
The pharmacist’s assistant always works 
under the direct personal supervision of a 
pharmacist 
 
 
3 0.63 
  The pharmacist’s assistant does not always 
work under the direct personal supervision of 
a pharmacist 
 
 
3 0.63 
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The pharmacist's assistant's work is checked 
only as medication is being dispensed 
 
 
1 0.21 
  The pharmacist's assistant's work is checked 
on an ongoing basis 
 
2 0.42 
  Supervision of the pharmacist's assistant 
focuses primarily on the patient counselling 
she provides 
 
 
2 0.42 
  Supervision of the pharmacist's assistant 
focuses on more than just the patient 
counselling she provides 
  
 
0 0 
  I am moulding the pharmacist's assistant to 
ease my load 
 
1 0.21 
  The pharmacist’s assistant always practices 
within her scope of practice 
 
1 0.21 
  The pharmacist’s assistant does not always 
practice within her scope of practice 
 
1 0.21 
  The managing pharmacist is a registered 
tutor 
  
0 0 
  The managing pharmacist is not a registered 
tutor 
 
1 0.21 
46. Identification 
of dispensary 
employees 
 
All dispensary employees wear a name tag 
with their name and designation 
 
 
2 0.42 
  Dispensary employees do not all wear a 
name tag with their name and designation 
 
3 0.63 
  Name tags contain the incorrect designation, 
which leads to confusion 
 
1 0.21 
  Patients can differentiate between the 
pharmacists and the pharmacist's assistant 
 
2 0.42 
  Patients cannot differentiate between the 
pharmacists and the pharmacist's assistant 
  
0 0 
47. OTC sales OTC medication is always selected by a 
pharmacist or pharmacist’s assistant 
 
3 0.63 
  OTC medication is often selected by front-
shop assistants 
 
1 0.21 
  OTC medication is often selected by patients  1 0.21 
  Pharmacists have adequate control over 
OTC sales 
 
2 0.42 
  Pharmacists do not have adequate control 
over OTC sales 
 
1 0.21 
  Dispensary employees always obtain a 
patient history before OTC medication is 
sold 
 
 
1 0.21 
  Dispensary employees do not always obtain 
a patient history before OTC medication is 
sold 
 
 
1 0.21 
  Dispensary employees ask patients 
questions before OTC medication is sold 
 
4 0.83 
  Dispensary employees do not ask patients 
questions before OTC medication is sold 
 
 0 0 
  Front-shop assistants always liaise with 
pharmacists before selling OTC medication 
  
1 0.21 
  Front-shop assistants do not always liaise 
with pharmacists before selling OTC 
medication 
 
 
 0 0 
  Dispensary employees provide patient 
counselling regarding OTC medication 
 
4 0.83 
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  Providing patient counselling regarding OTC 
medication is relatively easy 
 
1 0.21 
   
There is a lack of standardisation of 
practices in providing OTC medication, 
which acts as a barrier to patient counselling 
 
 
 
1 0.21 
  Language and cultural differences can serve 
as barriers in providing patient counselling 
regarding OTC medication 
 
 
2 0.42 
  Patients insisting on getting certain 
medication can serve as a barrier in 
providing patient counselling regarding OTC 
medication 
 
 
 
1 0.21 
  A barrier to providing OTC medication 
according to GPP standards is that some 
patients expect to just get the medication off 
the shelf 
 
 
 
1 0.21 
48. Quality 
Improvement Plan 
 
Yes, there is 
 
1 0.21 
  No, there is not 2 0.42 
  I do not know 1 0.21 
  I am involved in this  0 0 
  My involvement in this is limited 1 0.21 
  The lack of a plan affects my ability to do my 
job 
  
0 0 
  The lack of a plan does not affect my ability 
to do my job 
 
1 0.21 
  I have quality control measures and 
standards in place in the pharmacy 
 
3 0.63 
  I do not have quality control measures in 
place in the pharmacy 
 
 0 0 
  Trying to expand services 1 0.21 
49. Pharmacy 
layout 
Promotes patient counselling and/ or other 
aspects of pharmaceutical care 
 
2 0.42 
  Does not promote patient counselling and/ or 
other aspects of pharmaceutical care 
 
1 0.21 
  Does not affect patient counselling and/ or 
pharmaceutical care 
 
1 0.21 
50. Improvements 
to PMS 
 
No improvements necessary 
 
1 0.21 
  Job descriptions and performance reviews 
should be instituted 
 
1 0.21 
  Follow-up measures could be improved 1 0.21 
  Will not answer 1 0.21 
51. Problems with 
PMS 
 
There are problems with the current PMS 
 
3 0.63 
  There are no problems with the PMS  0 0 
  Changes are not sustained 1 0.21 
  Problems with the staff in general 1 0.21 
  Problems with front-shop assistants 7 1.46 
  Problems with pharmacist’s assistant 1 0.21 
TOTAL 480 * 100.60 
* Does not total 100.00% due to rounding 
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Table 2: The top five-ranked categories emerging from the coding frame, 
with frequency counts of four and more, ranked in descending order 
Rank Theme/ code Category Frequency 
(count) 
Frequency 
(%) 
1 Pharmaceutical 
care services 
 
The time pressures and/ or other 
practicalities in the pharmacy 
make it difficult to provide patient 
counselling and/ or other aspects 
of pharmaceutical care 
 
 
 
 
10 2.08 
2 Problems with PMS Problems with front-shop 
assistants 
 
7 1.46 
3 Understanding of 
pharmaceutical 
care 
 
 
Patient counselling 
 
 
6 1.25 
3 Working 
relationships 
 
I have good working relationships 
 
6 1.25 
3 Pharmaceutical 
care services 
 
I routinely counsel patients 
 
6 1.25 
4 Whether 
pharmaceutical 
care is a key 
responsibility 
 
 
 
Yes 
 
 
 
5 1.04 
4 Performance 
targets 
 
 
Serve customers as quickly and 
efficiently as possible 
 
 
 
5 1.04 
5 Understanding of 
pharmaceutical 
care 
 
 
Evaluation of pharmacotherapy 
 
 
4 0.83 
5 Compliance with 
GPP standards for 
pharmaceutical 
care 
 
 
 
Yes 
 
 
 
4 0.83 
5 Whether there are 
performance 
appraisals and the 
impact of these 
 
 
 
No 
 
 
 
4 0.83 
5 Whether number of 
dispensary 
employees is 
sufficient to provide 
pharmaceutical 
care 
 
 
 
 
 
No 
 
 
 
 
 
4 0.83 
5 Whether number of 
dispensary 
employees is 
sufficient to provide 
pharmaceutical 
care 
 
 
 
Number of pharmacists is 
sufficient to supervise 
pharmacist’s assistant 
 
 
 
 
 
4 
 
 
 
 
 
0.83 
5 Working 
relationships 
My working relationships promote 
the provision of pharmaceutical 
care 
 
 
4 0.83 
5 Relationships with 
patients 
 
Relationships with patients 
promotes the provision of patient 
counselling and/ or other aspects 
of pharmaceutical care 
 
 
 
4 0.83 
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5 Other financial 
rewards 
 
No 
 
4 0.83 
5 Other financial 
rewards 
 
Financial rewards are not a 
motivating factor  
 
 
4 0.83 
5 CPD activities I participate in CPD activities 4 0.83 
5 OTC sales Dispensary employees ask 
patients questions before OTC 
medication is sold 
 
 
4 0.83 
5 OTC sales Dispensary employees provide 
patient counselling regarding OTC 
medication 
 
 
4 0.83 
 
From Table 1, the following findings emerge: 
(i) Two interviewees have been practising as pharmacists for more than a 
decade.  Two pharmacists have been working at the pharmacy for between 5-
10 years, and the owner-manager has worked there for more than a decade.  
The pharmacist’s assistant is the only interviewee practising for less than 5 
years and who has worked at XXX Pharmacy for less than this period of time; 
(ii) In probing interviewees’ understanding of pharmaceutical care, patient 
counselling comes up the most often, with a frequency count of six.  The next 
category, with a frequency count of four, is the evaluation of 
pharmacotherapy, followed by patient outcomes and safety (count of three); 
(iii) All interviewees unanimously agree that providing pharmaceutical care is a 
key responsibility, with the most frequently-cited reason for this (frequency 
count of three) being that pharmaceutical care is a core professional duty; 
(iv) Although all three pharmacists state that they are aware of the GPP standards 
for pharmaceutical care, none of them can provide any examples of these 
standards.  The pharmacist’s assistant, meanwhile, indicates that she is 
aware of the GPP standards, which outline her scope of practice; 
(v) There is unanimous agreement amongst interviewees that they comply with 
GPP standards for pharmaceutical care, and two frequency counts indicate 
that there is nothing preventing such compliance; 
(vi) The pharmacist’s assistant acknowledges that providing patient counselling is 
a key responsibility for her, and mentions that some barriers to providing this 
service include racism and/ or sexism from patients; 
(vii) There appears to be confusion regarding the pharmacy’s vision and mission 
statement, with two interviewees stating that they do not know what the 
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pharmacy’s vision is, and two stating that there is no mission statement.  The 
owner-manager says that the vision is “Sustainability and providing good 
quality care” and that the mission statement is “Passion for health”.  These 
responses are not echoed by any of the other interviewees; 
(viii) In terms of how performance is managed, being expected to be present for 
shifts and doing things correctly each receive a frequency count of one; 
(ix) There are three frequency counts indicating that there are no job descriptions, 
and one pharmacist says that he is using a job description from the time of the 
previous owner of the pharmacy, six years ago; 
(x) Dispensing prescriptions, patient counselling, ordering stock and complying 
with the owner-manager’s standards all tie at top place for code 12, relating to 
awareness of roles and responsibilities.  The owner-manager states that he 
has informed his employees of their roles and responsibilities verbally; 
(xi) There appears to be confusion regarding the pharmacy’s SOPs, with two 
frequency counts indicating that interviewees are aware of these, and two 
counts indicating that interviewees are not aware of these SOPs.  The owner-
manager states that only pharmacists are aware of these SOPs, and not the 
pharmacist’s assistant.  However, the locum pharmacist states that she is not 
aware of these SOPs, and the pharmacist’s assistant says that she is; 
(xii) When asked directly about compliance with SOPs (see code 14 in Table 1), 
there are two frequency counts stating that interviewees are compliant, 
compared to zero stating that this is not the case.  There are also two 
frequency counts stating that the owner-manager has not told employees to 
comply with these SOPs, compared to one count stating that he has done so; 
(xiii) When probed further, there are two counts indicating that interviewees are 
sometimes non-compliant with SOPs (see code 15 in Table 1).  This contrasts 
with (xii) above, indicating some inconsistency in interviewee responses; 
(xiv) Two interviewees state that there is training, induction and orientation, and 
two disagree that this occurs; 
(xv) There is unanimous agreement (frequency count of four) that there are no 
performance appraisals.  The locum pharmacist says that performance 
appraisals would help clarify performance-related issues, but the full-time 
pharmacist (other than the owner-manager) states that he challenges himself 
to go beyond his employment contract and the SOPs and that the lack of 
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performance appraisals does not affect his ability to provide pharmaceutical 
care.  There are two frequency counts, by the owner-manager, that he has 
“phased out” dispensary employees with different working styles; 
(xvi) Patient counselling and care is most frequently cited as a performance 
objective, with a frequency count of two.  Achieving certain financial figures 
and the provision of pharmaceutical care each have frequency counts of one; 
(xvii) The top-ranked performance target, with a frequency count of five, is serving 
customers as quickly and efficiently as possible.  Other performance targets 
only have a frequency count of one; 
(xviii) All interviewees agree that their working hours are fine, but the pharmacist’s 
assistant sometimes has to work overtime.  There is agreement that the 
quantity of working hours does not affect the provision of pharmaceutical care; 
(xix) Whilst the author was in the pharmacy administering questionnaires (see 
4.2.1), she noted that for approximately four out of the seven days, there was 
only one pharmacist on duty; 
(xx) There are four frequency counts indicating that the number of dispensary 
employees is not sufficient to provide pharmaceutical care, whereas there is 
only a count of two stating the opposite.  All interviewees believe that the 
number of pharmacists is sufficient to supervise the pharmacist assistant; 
(xxi) There is a frequency count of three indicating that the owner-manager has not 
identified any employee T&D needs, compared to a frequency count of zero 
that he has done so.  There are two frequency counts stating that employees 
identify their own T&D needs.  The pharmacist’s assistant reveals that the 
owner-manager did nothing about her T&D needs, which she identified and 
communicated to him.  The owner-manager, meanwhile, states that he has a 
problem with the quality of in-house training provided by some companies, 
and that sending employees for T&D activities in itself is not sufficient; he 
believes that employees must be able to apply what they learn; 
(xxii) Interviewees are split equally between those that have self-development plans 
and those that do not.  The owner-manager is not aware if dispensary 
employees have such a plan; 
(xxiii) There are two frequency counts stating that the owner-manager has told a 
dispensary employee that he has a problem with his/ her performance, and an 
equal frequency count stating that he has not.  The owner-manager believes 
Dr Layla Cassim  Research Report MBA 5932 
175 
 
that he manages by direct supervision, and that his current pharmacists do 
not require much supervision; 
(xxiv) There is disagreement over how regularly staff meetings are held and whether 
these are useful.  Two frequency counts indicate that these are held regularly, 
whereas there are also two counts indicating that these only occur if there is a 
problem.  All interviewees except for the owner-manager state that staff 
meetings address primarily front shop matters.  There are three frequency 
counts, including from the owner-manager, stating that there are no meetings 
specifically addressing dispensary-related problems, whereas there is one 
count stating that there are such meetings.  The owner-manager says that 
dispensary-related meetings are unnecessary because there are no major 
dispensary problems.  There are two counts indicating that the lack of 
dispensary meetings does not affect the provision of pharmaceutical care; 
(xxv) There is agreement that the owner-manager does not treat all employees in 
the same manner, evidenced by a frequency count of three for this category, 
compared to a frequency count of zero for the opposite category.  There is 
consensus that the owner-manager’s management style encourages the 
provision of pharmaceutical care, and one frequency count that he does not 
rush a pharmacist if she is busy with a sensitive issue.  There are two 
frequency counts stating that the owner-manager does not take time to 
explain things, such as performance objectives, to dispensary employees, in 
contrast to his statement that he makes time for employees if they want to 
talk.  There are also two frequency counts indicating that there is inadequate 
control over patients’ access to scheduled medication.  The pharmacist’s 
assistant provides an example of a patient speaking to the owner-manager 
and then obtaining schedule 4 or 5 medication without a prescription; 
(xxvi) There is a frequency count of two supporting the view that pharmacists do not 
have to follow the owner-manager’s working style, compared to one frequency 
count supporting the opposite view.  One pharmacist says that he has had to 
adapt to the working style of the owner-manager.  The owner-manager, 
meanwhile, says that he expects pharmacists to follow his working style, and 
that he believes that this helps them to provide pharmaceutical care; 
(xxvii) Although there are two frequency counts stating that the culture is enjoyable 
and also two counts stating that there is a family culture, there are three 
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frequency counts stating that problems are not addressed.  There is one 
frequency count for the category stating that there is no gratitude for what 
employees do and two counts for the category that sly comments from 
colleagues are received if the interviewee spends time talking to patients; 
(xxviii) There is, however, consensus that there are good working relationships, with 
this category eliciting six frequency counts, compared to zero counts for the 
category stating that interviewees do not have good working relationships.  
The pharmacist’s assistant acknowledges that she has had problems in her 
working relationships, and that she feels that she is not respected sufficiently.  
She also states that she became depressed when she started working at the 
pharmacy, and that she realised that she had to learn to adapt to the way 
things were done in the pharmacy.  There are two frequency counts each 
stating that there is accommodation and communication in working 
relationships, and four frequency counts indicating that these working 
relationships promote the provision of pharmaceutical care.  This is compared 
to one count stating that working relationships do not promote the provision of 
pharmaceutical care.  Interviewees mention that these relationships promote 
the development of understanding amongst dispensary employees, and a 
pleasant working environment that allows employees to give of their best; 
(xxix) There are three frequency counts each indicating that interviewees have good 
relationships with patients and know patients well.  One interviewee mentions 
that she has had difficulty in developing good relationships with patients.  
There is consensus that patient relationships promote the provision of 
pharmaceutical care, with two counts stating that such relationships enhance 
patients having trust in the interviewee and the interviewee’s confidence; 
(xxx) A greater proportion of interviewees are not completely satisfied with their 
remuneration, reflected in two frequency counts for this category compared to 
one frequency count indicating satisfaction.  This is in contrast to the owner-
manager’s perception that his employees are satisfied with their 
remuneration.  One pharmacist believes that pharmacists are underpaid 
generally.  There is also a greater proportion of data supporting the category 
stating that current remuneration does not adequately reflect the additional 
responsibilities in providing pharmaceutical care.  There is one frequency 
count stating that remuneration amongst employees is perceived as unfair.  
Dr Layla Cassim  Research Report MBA 5932 
177 
 
An example is provided of front-shop assistants receiving envelopes with a 
cash bonus in December 2010.  Dispensary employees did not receive this 
bonus, according to the interviewee, who said that she was hurt by this 
incident because dispensary employees work hard.  There is disagreement 
amongst interviewees over whether their financial rewards should be 
increased if they provided more pharmaceutical care, with two frequency 
counts supporting this and an equal number not expecting an increase; 
(xxxi) There are two frequency counts indicating that remuneration is not regular, 
compared to one count stating that it is.  One interviewee says that she lost 
her house and her debit orders bounced, and that it took the owner-manager 
eight days to rectify the latest delayed payment; 
(xxxii) There is also a greater frequency count of four stating that there are no other 
financial rewards, compared to one count stating that there are.  Although the 
owner-manager believes that financial rewards are a motivating factor for 
employees, there is consensus amongst all his three dispensary employees 
that financial rewards are not a motivating factor.  A typical response from 
interviewees is that patients’ health is more important than financial rewards; 
(xxxiii) Although the owner-manager says that he encourages his dispensary 
employees to participate in activities of the Pharmaceutical Society of South 
Africa (PSSA), a professional body for pharmacists, all his dispensary 
employees state that they have not been encouraged to do so; 
(xxxiv) There is a greater proportion of data (three frequency counts) stating that 
there have been no meetings to discuss CPD being made compulsory by the 
SAPC, compared to one count stating that there have been such meetings.  A 
frequency count of three nevertheless supports the view that there is a plan to 
ensure employee compliance with CPD requirements; 
(xxxv) Two dispensary employees have professional indemnity and the remaining 
two, namely the locum pharmacist and the pharmacist’s assistant, do not.  
The pharmacy also has professional indemnity.  The owner-manager says 
that he does not know whether dispensary employees have indemnity.  The 
pharmacist’s assistant, however, says that he did nothing when she told him 
that she would like such indemnity; 
(xxxvi) There is disagreement over whether generic medication is always offered to 
patients, unless not permitted by law.  There are two frequency counts stating 
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that this always occurs, and two frequency counts stating the opposite.  The 
racial prejudices and stereotypes of one interviewee are also revealed here, 
as she said that she gives generics to Black patients as she assumes that 
they cannot pay for original branded products; 
(xxxvii) In analysing the appropriateness of prescribed medication, the two 
categories most frequently cited, with three frequency counts each, are 
analysing the appropriateness of dosages and whether medication is 
appropriate given patient allergies.  Analysing drug interactions follows, with 
two frequency counts; one pharmacist says that she does not do this, as drug 
interactions are detected by the computer software and she assumes that the 
doctor has performed such analyses.  There is one frequency count stating 
that patients do not want to receive pharmaceutical care; 
(xxxviii) There are six frequency counts stating that patients are routinely 
counselled, and one pharmacist says that he counsels patients about how to 
take their medication correctly “60-80% of the time”.  Ten frequency counts 
support the view that time pressures and/ or other practicalities make it 
difficult to provide pharmaceutical care.  There are two frequency counts 
stating that patient compliance is routinely assessed, with lower frequency 
counts for the other pharmaceutical care services.  Although there are two 
frequency counts stating that the efficacy of medication in controlling or 
improving a patient’s medical condition is routinely performed, one pharmacist 
says he performs this solely based on what the patient is prescribed, and 
another pharmacist feels that this service could be improved.  She states 
furthermore that she assumes that the doctor is doing this.  There is only one 
frequency count stating that the interviewee has performed a medication 
review, and one frequency count stating that the interviewee has not.  One 
pharmacist feels that the usefulness of a medication review is limited by the 
prescriber having the power to not change a prescription; 
(xxxix) There are three frequency counts indicating that interviewees regularly liaise 
with other health-care professionals, compared to one count stating that this 
does not occur regularly.  There are also three frequency counts supporting 
the view that the owner-manager encourages such liaison, whereas one 
frequency count does not agree with this; 
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(xl) There is disagreement over whether the pharmacist’s assistant always works 
under the direct personal supervision of a pharmacist, with three frequency 
counts supporting the view that this occurs and three counts disagreeing.  
One pharmacist says that the pharmacist’s assistant “does her own thing”.  
There is also disagreement over whether the pharmacist’s assistant always 
practices within her scope of practice, with one frequency count agreeing and 
one disagreeing with this.  The pharmacist’s assistant asserts that she always 
works under the direct personal supervision of a pharmacist.  There are two 
frequency counts stating that the pharmacist’s assistant’s work is checked on 
an ongoing basis, compared to two counts stating that she is supervised 
primarily in terms of the counselling that she provides and one count stating 
that her work is only checked as medication is dispensed; 
(xli) Three frequency counts support the view that not all dispensary employees 
wear a name tag with their name and designation, compared to two frequency 
counts stating the opposite.  The pharmacist’s assistant alleges that her 
designation states “Pharmacist” instead of “Pharmacist’s assistant”, and says 
that she tends to not wear her name tag for this reason.  She also asserts that 
the front-shop assistants’ name tags state “Pharmacist’s assistant”.  However, 
when the author was in the pharmacy, she noted that although there were 
different types of name tags for front-shop assistants, she did not see any that 
said “Pharmacist’s assistant”.  The author is thus unable to comment on the 
credibility of this allegation.  She also did not see the pharmacist’s assistant’s 
name tag and is unable to confirm whether it states “Pharmacist”; 
(xlii) There is a greater proportion of frequency counts (two) that, nevertheless, 
support the view that patients are able to differentiate between the 
pharmacists and the pharmacist’s assistant, compared to zero frequency 
counts stating that patients are unable to make such differentiation; 
(xliii) There are three frequency counts stating that pharmacists or the pharmacist’s 
assistant always select OTC medication for patients, compared to one 
frequency count each stating that front-shop assistants or patients do this; 
(xliv) There is one frequency count stating that front-shop assistants always liaise 
with dispensary employees before selling OTC medication, with the owner-
manager stating that this is a policy.  However, one pharmacist states that he 
only has “50% control” over OTC sales and that this needs to be improved.  
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The locum pharmacist says that the current practice, in which front-shop 
assistants act as intermediaries between the dispensary and patients, can 
result in a “break in transmission” between pharmacist and patient; 
(xlv) There is agreement that dispensary employees ask patients questions before 
OTC medication is sold and provide patient counselling for this, with four 
frequency counts each for these two categories.  There is one frequency 
count stating that there is a lack of standardisation regarding the practices 
involved in providing OTC medication, and that this acts as a barrier to patient 
counselling.  There are two frequency counts stating that language and 
cultural differences also serve as barriers to patient counselling regarding 
OTC medication.  Some patients’ insistence on getting certain OTC products 
and the expectation of some patients that they can just pick OTC medication 
off the shelf are also cited as barriers, with one frequency count each; 
(xlvi) A greater proportion of interviewees (two frequency counts) state that there is 
no Quality Improvement Plan, with one frequency count indicating that the 
absence of such a plan does not affect the interviewee’s ability to perform her 
job.  There are three frequency counts indicating that there are quality control 
measures and standards in place in the pharmacy; 
(xlvii) There are two frequency counts stating that the pharmacy’s layout promotes 
patient counselling and/ or other aspects of pharmaceutical care.  One 
pharmacist, however, disagrees, arguing that patient privacy is not protected; 
(xlviii) There are low frequency counts related to suggested improvements to the 
PMS, with one interviewee declining to answer this question.  The introduction 
of job descriptions and performance reviews receives a frequency count of 
one, as do measures to follow-up patients’ progress; and 
(xlix) There are three frequency counts stating that there are problems with the 
PMS, compared to no frequency counts stating otherwise.  The greatest 
proportion of frequency counts (seven) relates to problems with front-shop 
assistants.  Some of these problems include the frequent turnover of front-
shop assistants undermining standardisation in service delivery and hindering 
front-shop assistants from sharing the vision, professionalism and attitudes of 
dispensary employees.  Other problems cited include front-shop assistants 
sometimes placing the incorrect medication into packets for patients and not 
telling patients that certain medication needs to be stored in a fridge. 
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Table 2 shows the top five-ranked categories, which account for almost one-fifth 
(19.38%16) of all data.  The top-ranked category, with ten frequency counts 
representing 2.08% of all interview data, is, “The time pressures and/ or other 
practicalities in the pharmacy make it difficult to provide patient counselling and/ or 
other aspects of pharmaceutical care”.  The second-ranked category, with seven 
frequency counts or 1.46% of data is, “Problems with front-shop assistants”.  There 
is a tie for third place amongst three categories, each representing 1.25% of data 
points.  These three categories include interviewees’ understanding of 
pharmaceutical care as involving patient counselling, interviewees affirming that they 
have good working relationships and that they routinely provide patient counselling.   
 
There is also a tie for fourth place, with two categories each having frequency counts 
of five.  These categories are interviewees’ confirmation that pharmaceutical care is 
a key responsibility and that customers should be served as quickly and efficiently as 
possible.  The remaining 12 categories in Table 2 tie in fifth place, each with four 
frequency counts representing 0.83% of data.  Key categories include interviewees’ 
assertions that they are compliant with GPP standards for pharmaceutical care, that 
there are no performance appraisals, that the number of dispensary employees is 
not sufficient to provide pharmaceutical care, that financial rewards are not a 
motivating factor and that dispensary employees ask patients questions before 
selling OTC medication and provide patient counselling regarding OTC medication. 
 
5.3 Summary 
 
In this chapter, the results of the two research instruments, namely the 200 
completed patient questionnaires and the interviews with the three pharmacists and 
pharmacist’s assistant, were presented and key findings highlighted.  These will be 
discussed in detail in the next chapter.    
                                                            
16
  If using the rounded-off percentages in Tables 1 and 2, this figure decreases slightly to 
19.33%. 
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CHAPTER SIX: DISCUSSION 
 
In this sixth chapter, the results presented in the previous chapter will be analysed 
and discussed. 
 
6.1 Research objective 1: To determine whether the pharmacy complies 
with GPP standards for pharmaceutical care 
 
As mentioned in 5.1.2.1, although the percentages of “Yes, always” and “Yes, once 
or twice” responses in Figures 10-19 can be combined to give an overall impression 
of whether patients believe a certain service is provided, this should be done with 
caution.  This is because some pharmaceutical care services may not need to be 
provided all the time, whereas others should be provided on a continuous basis.  It is 
thus necessary to distinguish between responses stating that services are always 
provided and that services are only provided once or twice. 
 
For example, asking patients whether they are allergic to any medication and other 
aspects of an overall medication review may not need to be performed every time 
the patient comes to the pharmacy, if such information has already been asked by 
the pharmacist and captured on the computer system or other records.  According to 
s2.25 of the GPP standards, as outlined by the SAPC (South Africa. SAPC, 2010a), 
an overall review of pharmacotherapy does not have to be provided to a patient at 
every pharmacy visit, but rather in certain situations, such as if the patient is on 
chronic pharmacotherapy; if the patient presents with a new prescription; if the 
patient has questions regarding his/ her pharmacotherapy or an adverse effect, or 
requests such a review; and if an actual or potential DRP is detected.  Similarly, a 
pharmacist may only need to contact a patient’s doctor if there is a problem with the 
patient’s prescription, and the frequency of this may vary.  On the other hand, the 
other pharmaceutical care services in section 2 of the questionnaire, such as asking 
a patient whether he/ she is experiencing adverse effects, or if his/ her medical 
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condition is controlled or improving, should be provided on a continuous basis, so 
that the safety and efficacy, respectively, of pharmacotherapy can be assessed. 
 
Making this distinction and determining when and how often to provide each of the 
pharmaceutical care services mentioned in the questionnaire, as well as others 
outlined in the GPP standards (South Africa. SAPC, 2010a) might thus be difficult for 
pharmacists, especially considering the fact that, as pointed out in 2.2.4, the GPP 
standards do not specify that a pharmacy should have an SOP for the provision of 
pharmaceutical care, or SOPs on how to dispense a prescription (including all three 
phases of dispensing, as described in 2.2.4) or OTC medication.  This lack of 
standardisation in practices is highlighted by one of the interviewees, who mentions, 
in particular, the difficulties associated with not having standardised practices for the 
sale of OTC medication (see (xlv) in 5.2).  This supports the argument made by Al-
Shaqha and Zairi (2001), highlighted in 3.6.3, that it is necessary to have 
standardised practices in providing pharmaceutical care so that all patients receive 
the same quality and continuity of care. 
 
In comparing the results of the patient questionnaires and the interviews with 
pharmacists and the pharmacist’s assistant, there is broad agreement amongst both 
patients (at least 50% of patients) and interviewees that the following two 
pharmaceutical care services are always provided: 
(i) Pharmacists or the pharmacist’s assistant providing patient counselling 
regarding how to take medication correctly (Statement 9); and  
(ii) Pharmacists or the pharmacist’s assistant giving advice or information about 
the medication (Statement 10).   
 
The first statement elicits a response of 75.50% of patients saying that this service is 
always provided (see Figure 18), whilst 53.00% state that the service in Statement 
10 is always provided (see Figure 19).  These findings are supported by interview 
data, in which the category stating that patient counselling is routinely provided has a 
frequency count of six, the third highest frequency count (see Table 2).  Furthermore, 
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an interviewee states that he counsels patients on how to take their medication 
correctly (Statement 9) about “60-80% of the time” (see (xxxviii) in 5.2). 
 
In addition to the above two pharmaceutical care services, there is agreement 
amongst patients (at least 50% of patients) and pharmacists that pharmacists ask 
whether the patient is allergic to any medication (Statement 1).  This statement has a 
combined favourable response of 73.00% from patients (see Figure 10) and three 
frequency counts for this category from interview data (see code 42 in Table 1).  
Patients’ favourable responses have been combined for this service, as this service 
does not need to be provided every time to a patient. 
 
Reinforcing the highly favourable responses from patient questionnaires, the 
provision of patient counselling emerges strongly from the interview data.  Table 1 
shows, for example, that providing patient counselling has the highest frequency 
count (of six) in code 3, relating to interviewees’ understanding of pharmaceutical 
care in code 3.  The pharmacist’s assistant also states that providing patient 
counselling is a key responsibility for her (see code 7 in Table 1).  Furthermore, 
Table 2 reflects that, according to interviewees, patient counselling regarding OTC 
medication is also routinely provided, with two categories relating to this ranked fifth 
out of all categories, with four frequency counts each.  Interestingly, Statement 9 
corresponds to Assa-Eley and Kimberlin’s (2005: 47) “Item A”, and these authors 
found that this item ranked highest in terms of both patients and pharmacists 
agreeing on the benefits of this service. 
 
Consideration should be given to the proportion of patients who state that the 
services in Statements 9, 10 and 1 are not provided.  Almost one fifth of respondents 
(17.00%), for example, indicate that pharmacists have not asked them whether they 
are allergic to any medication (see Figure 10).  The question is raised whether any of 
this 17.00% of patients are allergic to any medication that they have been dispensed, 
which could result in a DRP (see 3.3) and could result in patient morbidity or 
mortality. 
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As mentioned, patients and interviewees agree that patient counselling is provided.  
This is in contrast to what was expected by the author in the first two chapters of this 
dissertation, in which it was argued that the heavy patient load, shortage of 
dispensary employees and the strategic focus on efficiency do not promote 
dispensary employees having sufficient time to provide adequate patient counselling.  
The results found thus appear to disprove this expectation.  However, the top-ranked 
category from the interview results, with ten frequency counts as shown in Table 2, 
affirms that time pressures and/ or other practicalities in the pharmacy make it 
difficult for interviewees to provide patient counselling and/ or other aspects of 
pharmaceutical care.  This confirms Al-Shaqha and Zairi’s (2001) point that 
insufficient time is a common barrier to providing pharmaceutical care (see 3.5.2).  
The owner-manager also suggests that following up patients’ progress or outcomes 
could be improved (see xlviii in 5.2).  This suggests that the aforementioned 
preliminary analysis by the author may still have relevance.   
 
A total of 6.50% of respondents indicate that the service in Statement 9 is not 
provided, whilst 14.50% of respondents state that the service in Statement 10 is not 
provided, as shown in Figures 18 and 19 respectively.  This indicates that the patient 
counselling that occurs tends to focus more on how patients should take medication 
correctly (Statement 9), with broader counselling regarding the pharmacotherapy 
(Statement 10), perhaps relating to side-effects that could occur, taking place less 
often.  Considering that time pressures have been ranked as the top category 
amongst interview data, the above differences in patient responses to Statements 9 
and 10 may support d’Ávila, et al.’s (2010) finding that as a pharmacy gets busier, 
less information is provided to patients (see 3.4.1). 
 
Once again, having approximately three quarters of respondents (75.50%, as shown 
in Figure 18) stating that counselling regarding how medication should be taken 
correctly is provided should not be regarded as sufficient, as the remaining quarter of 
respondents either have not received this service or have only received it once or 
twice, and may thus have taken, or continue to take, their medication incorrectly, 
resulting in a DRP.  This raises an important issue, namely the difficulty in assessing 
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“compliance” with GPP standards and determining which degree of compliance with 
these standards is acceptable.  In order to prevent the abovementioned problem of a 
minority of patients perhaps being exposed to the risk of DRP if a particular GPP 
standard is not adhered to, is it not most correct to desire “full” compliance at all 
times?  How would this be assessed in terms of the proportion of respondents who 
would be expected to respond “Yes, always”; should this be 80 or 90% instead of the 
arbitrary 50% used in this analysis, as discussed below?  And could not the degree 
of compliance expected with GPP standards differ amongst different stakeholders?  
Perhaps patients and the SAPC might expect “full” compliance whereas pharmacists 
and management might be content with not all standards being adhered to?  How 
possible is it to quantify and measure compliance?  How realistic is it to expect “full” 
compliance and, furthermore, expect this to be reflected in patients’ perceptions?  
Moreover, there are numerous GPP standards, of which only a selection are probed 
in the patient questionnaire; what if the pharmacy is compliant with all other GPP 
standards except for the selected standards? 
 
The above analysis highlights that the results obtained from the patient 
questionnaires suggest that, according to at least 50% of respondents, the pharmacy 
always provides only two out of the ten pharmaceutical care services listed in 
Statements 1-10 in section 2 of the questionnaire.  When combining the favourable 
responses for Statement 1, this is also higher than 50%.  This demonstrates a gap, 
analogous to gap 3 in the adaptation of Parasuraman, et al.’s (1985) “quality gaps 
model” cited in Stapleton (2007: 122) discussed earlier (see Figure 3 and 2.3.3), 
between patients’ experiences of pharmaceutical services and GPP standards for 
pharmaceutical care as outlined by the SAPC (South Africa. SAPC, 2010a).   
 
The abovementioned findings contrast with interviewees’ assertions that they are 
fully compliant with GPP standards for pharmaceutical care; this assertion, with a 
frequency count of four, is one of the fifth-ranked categories emerging from interview 
results (see Table 2).  It is, however, difficult to understand how the pharmacists 
could assert that they are compliant with GPP standards for pharmaceutical care, 
given that none of them can provide examples of these standards (see (iv) in 5.2). 
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Two of the three GPP standards that the majority of patients state are provided (i.e. 
Statements 9 and 10) relate to patient counselling, and the other (Statement 1) to 
analysing the appropriateness of a patient’s pharmacotherapy.  The remaining seven 
standards relate to other aspects of analysing the appropriateness of a patient’s 
pharmacotherapy, such as detecting drug-drug and drug-disease interactions; 
assessing the safety and efficacy of pharmacotherapy and patient compliance; and 
generic substitution.  These standards, with the exception of generic substitution, 
outlined in s2.7.3.11 of the GPP standards (South Africa. SAPC, 2010a), together 
reflect sections 2.7.1.1(b)(i), 2.7.1.1(b)(ii) and 2.7.1.3.2(a) of the GPP standards.  
The finding that less than 50% of respondents indicate that these seven services are 
always provided suggests that the pharmacy is better at providing patient counselling 
compared to these other important aspects of pharmaceutical care.  This is 
substantiated by the locum pharmacist, who reveals that she does not routinely 
analyse prescribed medication for drug interactions (see (xxxvii) in 5.2).   
 
Code 3 in Table 1 shows that the evaluation of pharmacotherapy, although being 
ranked fifth in Table 2, has fewer frequency counts (a total of four) compared to 
providing patient counselling (which has six frequency counts), in relation to 
interviewees’ understanding of pharmaceutical care.  Patient safety and outcomes 
has even fewer frequency counts (three).  These findings suggest that evaluating the 
appropriateness of pharmacotherapy, ensuring patient safety and monitoring patient 
outcomes may be regarded by pharmacists as less important compared to providing 
patient counselling.  This supports the results of the patient questionnaires, which 
reveal, as mentioned before, that the majority of respondents report that patient 
counselling is provided, but not other important aspects of evaluating 
pharmacotherapy (other than pharmacists checking if patients are allergic to 
medication), patient safety and outcomes.  As mentioned in 3.2.1, accepting 
responsibility for patient outcomes is a key component of Hepler and Strand’s (1990) 
definition of pharmaceutical care cited in Al-Shaqha and Zairi (2001: 286).  The 
potential could thus exist for a variety of DRP to arise from neglecting to always 
provide the remaining pharmaceutical care services.  These DRP could potentially 
result in patient morbidity and/ or mortality. 
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Neglecting to check for drug interactions, for example, could result in the occurrence 
of adverse effects if two drugs have a similar adverse effect profile.  Or one drug 
may interfere with the therapeutic efficacy of another.  Not asking patients what other 
medical conditions they have may result in medication that is contraindicated for use 
in patients with certain conditions being dispensed.  Not asking patients if they are 
experiencing side-effects could allow these to go undetected.  Patients may not be 
aware of the side-effects associated with particular medication, so it thus becomes 
important for pharmacists to counsel patients about what kind of side-effects could 
potentially occur, and what to do in the event of these occurring, for example 
contacting the prescriber immediately.  Asking patients whether their medical 
condition is controlled (in the case of a chronic condition such as hypertension) or 
improving (for example in the case of a bacterial infection) allows the pharmacist to 
assess patient outcomes and whether the patient’s pharmacotherapy is effective. 
 
Of the remaining seven services, patients’ “Yes, always” and “Yes, once or twice” 
responses for Statement 2 can be combined, as pharmacists may only need to 
contact a prescriber if there is a problem with a prescription, as described in 
s2.7.1.1(c) of the GPP standards (South Africa. SAPC, 2010a).  Nevertheless, as 
shown in Figure 11, the combined favourable response is 43.50%, which is less than 
50% and is also only slightly greater than the 40.50% of respondents who state that 
this service is not provided.  It must be noted, however, that these responses are 
patients’ perceptions of whether the service is provided; it could be, for example, that 
the pharmacist did contact the doctor, but that the patient was unaware of this.  
Perhaps the patient was busy browsing the shelves in the front shop whilst this 
service was being performed.  The protocol in the pharmacy, however, is to inform 
patients before the pharmacist contacts the doctor, so that the patient is aware that 
there may be a delay in receiving his/ her medication.  The possibility exists that this 
protocol may not always be adhered to. 
 
Almost half of respondents (49.00%) state that the pharmacist does not ask them 
how often they are taking their medication (see Figure 16), an indicator of patient 
compliance with pharmacotherapy.  However, in the interviews with dispensary 
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employees, there is a frequency count of two for the category that patient 
compliance is routinely assessed and one frequency count stating that compliance is 
not routinely assessed (see code 43 in Table 1).  This indicates that a higher 
proportion of pharmacists view this service as being provided.  The question is then 
raised if pharmacists perhaps have another way of assessing patient compliance, if 
indeed this is performed; an example could be assessing when patients come in to 
the pharmacy for refills of chronic medication.  This question was not probed further 
in the interviews, which could be a limitation. 
 
As highlighted in Figure 14, a greater proportion of patients (34.50%) indicates that 
the pharmacist always offers them generic medication, compared to 20.50% who 
state that this service is not provided.  However, 34.50% is relatively low, 
representing just more than one third of respondents.  This is supported by the 
interview results, in which there is an equal split in the frequency count of data 
indicating that interviewees always offer generic medication, and data indicating that 
interviewees do not always offer generics (see code 41 in Table 1).   
 
The implications of this are that the more than one fifth of respondents (20.50%) who 
do not receive this service, and the approximately one third (33.00%) who state that 
they are only offered generics once or twice (see Figure 14), may thus have paid 
more money for original branded products.  This could have meant an increased 
cash cost for the patient, or a greater decrease in the patient’s medical aid savings 
than would have been the case if the patient had received a generic.  It would be 
interesting to perform a pharmacoeconomic analysis, to determine how much extra 
money patients have paid due to not being offered generics.  There is a minority of 
9.00% of patients who do not wish to be offered generics (see Figure 14), but for 
those who would like to receive this service, it would be interesting to investigate 
how much it has cost them not to be offered generics.  Patients may not be aware of 
generic substitutes, which is why s22F of the Medicines and Related Substances Act 
101 of 1965 (South Africa. National Parliament, 1965) makes it compulsory for 
pharmacists to offer generics, except in certain circumstances (see 1.2.3). 
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In code 42 in Table 1 there is a frequency count of three for pharmacists indicating 
that they routinely analyse the appropriateness of dosages.  This service was not 
included in the questionnaire, and thus whether patients perceive that it is provided 
cannot be commented on.  The reason it was not included was that it may be difficult 
for patients to know whether this service is provided, as a pharmacist usually checks 
dosages by him-/herself, perhaps mentally or by consulting reference material, and 
unless the pharmacist actually informs the patient that there is a problem with the 
dosage, the patient might thus be unaware that this service is provided. 
 
Figure 20 shows that a large majority of respondents (84.00%) have not requested a 
medication review.  Although the reasons for this were not probed in the 
questionnaire, possible reasons could be that patients are not aware that this service 
exists, that they can request such a service or furthermore that this service can be 
provided by pharmacists.  This may also be true for the other pharmaceutical care 
services listed in section 2 of the questionnaire; many patients might be unaware 
that pharmacists are supposed to perform these services.  This emerged in the pilot 
study, in which one participant expressed his view that some of the statements were 
not relevant as they relate to functions performed by doctors (see 4.2.1.1.7).   
 
This may contribute to the high non-response rate for the questions asking patients 
whether they would like to receive these pharmaceutical services.  For all eleven 
services, approximately 50% of respondents do not indicate whether or not they 
would like to receive the service.  A possible reason for this relatively high non-
response rate is that patients may not be sure whether they would like pharmacists 
to perform these services, as this may be outside their paradigms of the services 
pharmacists normally provide.  Patients may also have doubts about the ability and/ 
or willingness of pharmacists to perform these services and utilise the resulting 
information in a way that enhances patient outcomes.  In Hanna, et al.’s (2010) 
Willingness To Pay study, for example, it was found that patients have a neutral 
opinion of pharmacists’ ability to perform diabetes disease management services 
(see 3.5.3).  Cerulli (2002) cited in Hanna, et al. (2010) argues that patients have 
limited interactions with pharmacists, and thus have limited awareness of the latter’s 
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roles and responsibilities.  This is supported by others (Chewning and Schommer, 
1996 and Schommer, 1997, both cited in Assa-Eley and Kimberlin, 2005).  Hanna, et 
al. (2010: 351) suggest that the expertise of pharmacists is thus not utilised optimally 
by patients, and that the demand for pharmacists to provide a diabetes disease 
management service, and by extension other pharmaceutical care services, offers 
pharmacists an opportunity to enhance public awareness of their expertise and 
“expanding role” as providers of pharmaceutical care. 
 
It is possible that the relatively high non-response rate to the questions asking 
whether patients would like to receive the various pharmaceutical care services is 
due to patients perhaps not reading that section of the questionnaire, but this did not 
emerge as a possible problem in the pilot study.  It is interesting that the three 
pharmaceutical care services drawing the largest proportion of respondents 
indicating that they wish to receive these services are the three services that draw 
the most favourable responses from patients and which both patients and 
pharmacists agree are provided, namely the services in Statements 9, 10 and 1 (see 
Figures 18, 19 and 10).   
 
This raises the question whether patients want these particular services more 
because patients have been more exposed to these services and thus have a 
greater appreciation of their benefits.  Assa-Eley and Kimberlin (2005) report that 
exposure to pharmaceutical care services, notably pharmacists asking patients if 
they are experiencing any problems, is associated with patients showing a higher 
level of agreement with pharmacists regarding the advantages of pharmaceutical 
care compared to patients whose pharmacists do not ask this question. 
 
Assa-Eley and Kimberlin’s (2005) finding that patients who experience 
pharmaceutical care-related services are more positive about the benefits of 
pharmaceutical care may also be relevant for other findings of this research.  It is 
interesting, for example, that the lowest proportion of patients (31.50%) want 
pharmacists to contact their doctor regarding their prescription (see Figure 11).  
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Perhaps this is due to patients wanting their confidentiality protected.  This finding 
may reflect inadequate awareness by some patients of why such liaison may be 
necessary, for example to address prescribing errors.  Likewise, the highest 
proportion of patients (16.50%) does not want the pharmacist asking them how often 
they are taking their medication (see Figure 16).  However this question is important 
for pharmacists to ask in order to detect if a patient is taking medication correctly and 
is compliant with his/ her pharmacotherapy.  Furthermore, although 84.00% of 
respondents have not requested a medication review, only 34.50% of respondents 
want this service (see Figure 20); this could be because many respondents are 
unaware of the benefits of this service, having not experienced it. 
 
Assa-Eley and Kimberlin’s (2005) conclusions about exposure to pharmaceutical 
care services influencing whether patients want to receive these services illustrates 
the phenomenon of “adaptive preferences”, as described by Nussbaum (2001: 77).  
Nussbaum (2001: 78) argues that in this phenomenon, “individuals adjust their 
desires to the way of life they know”.  She cites the work of Sen (1995) in describing 
how a large proportion of women in a study in Calcutta “do not desire some basic 
human good [in the case of Sen’s work, good health] because they have been long 
habituated to its absence or told that it is not for such as them” (Nussbaum, 2001: 
79).  Sen (1995) cited in Nussbaum (2001) points out that the opposite is also true, 
namely that individuals who have become accustomed to receiving high quality care 
may become unhappy if this is no longer the case.  The possible effects of “adaptive 
preferences” (Nussbaum, 2001: 77) in patient responses, based on patient race or 
gender, will be explored in 6.2. 
 
Figure 21 reveals that there is no statistically significant difference in the mean 
percentage of patients who state that the combined pharmaceutical care services in 
Statements 1-10 are always provided (33.65%) and those who state that these are 
not provided (33.55%).  There is also no statistically significant difference between 
these responses and the mean percentage of respondents who state that these 
services are only provided once or twice (22.25%).  These results indicate that one 
cannot categorically state that XXX Pharmacy is fully compliant with the GPP 
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standards covered in the questionnaire or not, as only 33.65% of respondents state 
that these standards are always adhered to.  Combining the favourable responses 
gives a mean percentage of 55.90%, which is significantly higher than the other 
responses.  Comparing this “Yes combined” percentage to the percentage of 
respondents who state that these services are not provided would thus suggest that 
the pharmacy is compliant with the selected GPP standards for pharmaceutical care.  
However, as pointed out earlier, it is misleading to combine the favourable 
responses, as only two out of the first ten services (i.e. Statements 1 and 2) can be 
provided once or twice, whilst the rest need to be provided continually. 
 
Assa-Eley and Kimberlin (2005) have used interpersonal perception theory in their 
study.  According to this theory, there may be misunderstandings between parties 
due to the “assumption of agreement” (Assa-Eley and Kimberlin, 2005: 54).  For 
example, as pointed out by these authors, pharmacists may provide particular 
services that they believe patients will find beneficial, whilst patients may assume 
that pharmacists will provide the services that patients find beneficial.  Extending this 
argument, pharmacists may provide services that they believe patients want or 
expect, whilst patients may assume that pharmacists will provide the services they 
want or expect.  This could give rise to a gap, analogous to gap 1 in Parasuraman, et 
al.’s (1985) “quality gaps model” cited in Stapleton (2007: 122) (see 2.3.1), in which 
there is a gap between patients’ expectations and the owner-manager’s perceptions 
of these expectations.  The questionnaire used in this research did not probe 
whether patients expect to receive various pharmaceutical care services; it focused 
on whether these are provided and whether patients would like to receive these 
services, thus reflecting patients’ wants.  This was in order to keep the questionnaire 
short.  A limitation, however, is thus that patients’ expectations were not determined.   
 
Figure 22 shows that, although there is a high non-response rate for the questions 
asking patients whether they would like to receive the various pharmaceutical care 
services, the mean proportion of patients who want to receive the combined services 
in Statements 1-10 (38.05%) is significantly greater than the proportion who do not 
(10.65%).  Furthermore, although a large majority of patients (84.00%) have not 
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requested a medication review, approximately a third (34.50%) of patients want to 
receive this service (see Figure 20).  This suggests that there is desire on the part of 
patients to receive the pharmaceutical care services listed in section 2 of the 
questionnaire.  Figure 23 shows that although the mean percentage of respondents 
who want to receive the combined pharmaceutical care services in Statements 1-10 
(38.05%) is greater than the mean percentage who state that they have not received 
these services (33.55%), statistical analysis shows that this gap is not significant.  
This indicates that there is no significant gap between what patients are saying they 
are not receiving, and what they would like to receive.  As mentioned before, there is 
the possibility that what patients want and expect from a pharmaceutical service may 
be set at a low level, due to patients’ experiences. 
 
As mentioned in 4.2.1.1.2, various dispensary employees adhering to their scope of 
practice, so that pharmaceutical care can be provided, is an important component of 
the GPP standards, as described by the SAPC (South Africa. SAPC, 2010a).  Figure 
49 shows that the mean percentage of respondents responding favourably to the 
combined statements in section 3 of the questionnaire (65.25%) is significantly 
greater than the mean percentage of respondents responding negatively (24.38%).  
Almost two-thirds of respondents thus suggest that dispensary employees are 
practising within their scope of practice.  In particular, as shown in Figure 48, a 
higher proportion of respondents are able to differentiate between pharmacists and 
the pharmacist’s assistant, perceive the pharmacist’s assistant as always preparing 
their prescriptions under the direct supervision of a pharmacist, and state that OTC 
medication is always selected by pharmacists or the pharmacist’s assistant.   
 
Code 46 in Table 1 shows that dispensary employees believe that patients are able 
to differentiate between pharmacists and the pharmacist’s assistant, with two 
frequency counts in this category compared to zero frequency counts stating that 
patients cannot differentiate between these dispensary employees.  This perception 
is consistent with patient’s responses to Statements 1 and 2; as shown in Figure 48.  
However, Figure 48 also shows that Statement 2 draws the highest percentage of 
negative responses (40.00%) and the lowest percentage of favourable responses 
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(58.50%), suggesting that many patients cannot identify the pharmacist’s assistant.  
This is not surprising, given that in her interview, the pharmacist’s assistant says that 
she tends to not wear her name tag, and alleges that it incorrectly refers to her as a 
“Pharmacist” and not a “Pharmacist’s assistant” (see (xli) in 5.2 and later in 6.4.2.10).  
It is seemingly inconsistent that although only 58.50% of respondents state that they 
know who the pharmacist’s assistant is, a greater percentage (i.e. 65.00%) of 
respondents state that the pharmacist’s assistant always prepares their prescription 
under the direct supervision of a pharmacist.  If some respondents are unable to 
identify the pharmacist’s assistant, how can they then affirm that she is always 
working under the direct supervision of a pharmacist? 
 
Code 45 in Table 1 suggests that, from the perspective of pharmacists, the 
pharmacist’s assistant does not always practice within her scope of practice and 
does not always work under direct personal supervision.  As highlighted in (xl) in 5.2, 
one pharmacist says that the pharmacist’s assistant “does her own thing”, 
suggesting inadequate control over her performance, whereas the pharmacist’s 
assistant’s asserts that she always works under the direct personal supervision of a 
pharmacist.  This will be discussed later in 6.4.2.3. 
 
If there is substance to the pharmacist’s assistant’s allegation that front-shop 
assistants have a name tag that identifies them as a “Pharmacist’s assistant” (see 
(xli) in 5.2), then the possibility arises that some respondents could mistake the front-
shop assistants for pharmacist’s assistants, and this could have potentially 
influenced the responses to Statement 4 in section 3.  As it is, there is consistency 
between patients’ responses and interview data that pharmacists or the pharmacist’s 
assistant selects OTC medication for patients.  Code 47 in Table 1 shows that there 
is a frequency count of three for the category supporting this, whereas there is only 
one frequency count each for categories stating that front-shop assistants and 
patients select OTC medication.  As shown in Figure 48, 64.00% of respondents 
state that pharmacists or the pharmacist’s assistant performs this task.  This is 
contrary to the initial analysis of the author in the first two chapters.  There are three 
implications of these findings, as described in the next two pages: 
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(i) A relatively high proportion of more than one-fifth of respondents (22.50%) still 
state that front-shop assistants select OTC medication for them.  This is 
problematic, as the front-shop assistants have no formal training or 
qualifications in pharmacy, and thus do not possess the knowledge and skills 
required to ask individual patients the necessary questions to determine if 
particular OTC medication is safe and appropriate.  Some OTC products to 
treat influenza symptoms, for example, can increase blood pressure, and may 
thus not be appropriate for hypertensive patients.  The front-shop assistants 
would also not have the knowledge to be able to detect drug interactions or 
counsel patients adequately about OTC pharmacotherapy.  If front-shop 
assistants select OTC medication for patients, there could thus potentially be 
an increase in the incidence of DRP.  It should also be noted that not all 
patients who purchase OTC medication may read the package inserts 
associated with these; some patients, for example, may not be functionally 
literate in English, to be able to do so.  The technical language and 
pharmaceutical jargon used in these package inserts may also discourage 
patients from reading these.  The latter may be one of the reasons why 
s2.7.1.3.1(b) of the GPP standards, as outlined by the SAPC (South Africa. 
SAPC, 2010a), states that patient information leaflets should be available to 
patients at the point at which dispensing occurs.  Such leaflets would, in 
simpler language, explain important points about a particular product to 
patients.  No patient information leaflets are available in XXX Pharmacy;  
(ii) There appears to be some system in place in which dispensary employees 
are able to exert some control over the selection of OTC medication.  The 
owner-manager, in his interview, says that there is a policy that no OTC 
medication can be sold without the front-shop assistant liaising with 
dispensary employees (see (xliv) in 5.2).  Front-shop assistants thus function 
as intermediaries, exchanging information and questions between the 
dispensary employees at the back of the pharmacy, and patients at the OTC 
counter; from the information thus obtained, the pharmacists direct the front-
shop assistants as to which OTC product(s) to sell to the patient.  A potential 
problem associated with this approach is highlighted by the locum pharmacist, 
who says that there is a “break in transmission” or communication between 
pharmacists and patients (see (xliv) in 5.2).  It might take longer, for example, 
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for the pharmacist to obtain all necessary information about the patient, or 
there could be errors in what the front-shop assistant relays between the 
parties.  The full-time pharmacist other than the owner-manager feels that he 
does not have adequate control over OTC sales (see (xliv) in 5.2), although 
there is a higher frequency count for the category stating that pharmacists 
have adequate control over OTC sales (see code 47 in Table 1); and 
(iii) There are legal and professional risks associated with front-shop assistants 
selecting OTC medication for patients, as described below. 
 
Not complying with all selected GPP standards, the pharmacist’s assistant 
sometimes practising outside her scope of practice and not always under direct 
personal supervision, and front-shop assistants at times selecting OTC medication 
for patients all represent potential operational risks, in particular legal and 
professional risks.  These could occur, for example, if a patient experienced a DRP 
as a result of these occurrences and sued the pharmacy or individual dispensary 
employee, and/ or laid a complaint with the SAPC.  The SAPC may also inspect the 
pharmacy, detect non-compliance to particular GPP standards and institute penalties 
against those registered with the SAPC found guilty of misconduct.  As outlined in 
sections 45(1) and 45(2) of the Pharmacy Act 53 of 1974 (South Africa. National 
Parliament, 1974), these penalties could include a caution, a reprimand, suspension 
from practising, removal from the register of persons allowed to practise in South 
Africa and/ or a fine, and public gazetted notification of the offence.  Inspections by 
and complaints to the SAPC do occur, evidenced in the PSSA notifying its members 
in late April 2011 that two pharmacists were arrested for not complying with 
regulatory requirements (PSSA, 2011). 
 
Besides the abovementioned professional risk, financial risks could also arise if 
patients sue the pharmacy or dispensary employees.  Although the pharmacy, 
owner-manager and other full-time pharmacist have professional indemnity, which 
may provide cover to a particular monetary value in such circumstances, the locum 
pharmacist and pharmacist’s assistant do not (see (xxxv) in 5.2), and may suffer 
considerable financial costs in obtaining legal representation.   
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In addition to the above, there is the potential for patient harm to result from GPP 
standards, as described by the SAPC (South Africa. SAPC, 2010a), not being 
adhered to, which is difficult to quantify.  Such harm could result, for example, from a 
front-shop assistant selecting inappropriate OTC medication for a patient, or from the 
pharmacist’s assistant not preparing a particular prescription under the supervision 
of a pharmacist and a prescribing error perhaps being undetected, or from 
pharmacists not checking whether the patient has any co-morbidities that would 
exclude a certain prescribed drug from being used.  All these scenarios could give 
rise to DRP, which could result in patient morbidity and/ or mortality. 
 
6.2 Research objective 2: To assess whether patients’ perceptions of 
whether pharmaceutical care services are provided varies with demographic 
profile 
 
Figure 7 shows that the sample group is relatively diverse in terms of race, with all 
the racial groups indicated in section 1 of the questionnaire being represented.  
Likewise, both genders are represented, as shown in Figure 8.  This enhances the 
representivity of the sample group.  An advantage of having a large sample size of 
200 questionnaires is that such representivity is promoted.  As mentioned in 5.1.2.3, 
however, a limitation of the results is that there are respondents (16.50% for each 
demographic variable) who do not indicate their race or gender, and for this reason 
the chi-squared test, the most appropriate inferential statistical test, was not used to 
determine if there is a statistically significant difference in the responses of patients 
from different racial groups or genders, as the data categories are not exclusive. 
 
In hindsight, the author should have anticipated this problem of non-response, and 
its likely impact on the quality of analysis she was able to perform.  She could have 
countered this problem by writing down the race and gender of the patient on the 
back of the folded questionnaires that she could have asked patients to return to her, 
instead of asking them to drop directly into the opaque envelope she carried.  When 
capturing the questionnaire results onto computer, she could then have referred to 
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her written description of the race and gender of the patient on the back of the 
questionnaire if the patient had not provided these details in the questionnaire. 
 
Another limitation is that only two demographic variables were considered, in order 
to keep the questionnaire short and encourage completion.  It would have been 
interesting to have investigated the effects of other demographic variables, such as 
age, educational level and socioeconomic status, on patients’ responses.  As 
mentioned in 3.6.8.2, the UKCPA (2009) suggests that patient data should be 
pooled, so that outcomes can be assessed for patients who have a particular 
medical condition or fall into a certain demographic profile.  This could assist in the 
design of pharmaceutical care interventions, or the adaptation of pharmaceutical 
care services, to optimally meet the needs of different patients.  Low-literate patients, 
for example, may benefit from pictograms, as shown by Dowse, Ramela, Barford & 
Browne’s (2010) report on the use of pictograms in HIV/ AIDS patients with low 
levels of literacy, to communicate information about the side-effects of antiretrovirals.   
 
6.2.1 Results per racial group 
 
Figures 24, 32 and 33 show that all the racial groups have a higher percentage of 
respondents saying that the services in Statements 1, 9 and 10 are always provided, 
compared to respondents saying that these services are not provided.  This is 
consistent with the overall findings described in 6.1. 
 
Consideration should be given to the proportion of respondents from each racial 
group, however, who state that these services are not provided.  A total of 19.35% of 
White respondents and 13.95% of African respondents, for example, state that the 
pharmacist has not asked them if they are allergic to any medication (see Figure 24).  
These percentages may well include patients who might be allergic to a particular 
medication, and who might thus have experienced adverse effects if that medication 
had been dispensed.  Similarly, 23.08% of Coloured respondents indicate that the 
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pharmacist or pharmacist’s assistant has not told them how to take their medication 
correctly (Figure 32) and 38.46% of Coloured respondents state that they are not 
given advice or information about their medication (Figure 33).  The question is 
raised as to how many patients took their medication incorrectly, due to inadequate 
patient counselling by pharmacists or the pharmacist’s assistant. 
 
A higher percentage of respondents from all racial groups also agree that five 
pharmaceutical care services, namely the services in Statements 2, 4, 6, 7 and 8, 
are not provided (see Figures 25, 27, 29, 30 and 31).  If the favourable responses to 
Statement 2 are combined, as discussed in 6.1, a higher proportion of Indians/ 
Asians (50.00%), Coloureds (61.54%) and Whites (44.09%) still state that this 
service is not provided, whilst a higher proportion of Africans (48.84%) indicate that 
this service is provided (see Figure 25).   
 
The services in Statements 2, 4, 6, 7 and 8 relate to the evaluation of the 
appropriateness of pharmacotherapy, including assessing its safety and efficacy.  
This confirms the overall results described in 6.1, in which it was highlighted that 
questionnaire results suggest that the pharmacy is better at providing patient 
counselling than at evaluating the appropriateness of pharmacotherapy.  There is 
also consensus amongst the different racial groups that patients have not requested 
a medication review (see Figure 34), which is consistent with the findings in 6.1. 
 
Figure 35 shows that the highest mean percentage (43.72%) of respondents who 
state that they always receive the combined pharmaceutical care services in 
Statements 1-10 are African, followed by Indians/ Asians (33.33%) and then Whites 
(30.00%).  The lowest mean percentage indicating this belongs to Coloureds 
(22.31%).  It should be noted that the proportion of respondents giving their races as 
Coloured or Indian/ Asian is relatively low, at 6.50% and 9.00% respectively (see 
Figure 7).  These small sizes might amplify certain responses that may be atypical of 
the normal distribution of responses of the particular racial group, decreasing the 
accuracy of responses.  If the proportion of these racial groups was higher and one 
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also knew how many of the “No race given” category fell into these racial groups, 
then one could conclude with more certainty that the responses to the questionnaire 
are representative of the particular racial group in the target population. 
 
As it is, the highest proportion of respondents to respond favourably that the 
combined pharmaceutical care services are always provided is African.  One 
wonders if perhaps Nussbaum’s (2001: 77) description of “adaptive preferences” 
(see 6.1) could possibly play some role in explaining the overall positive responses 
from Africans.  Clearly, further research and statistical analysis on mutually-exclusive 
categories is necessary to comment on this with any degree of confidence, but let us 
nevertheless explore this scenario below.   
 
According to Sen (1995) cited in Nussbaum (2001), individuals from vulnerable 
groups may downplay their problems or the poor quality of care or services they 
receive, because they have become accustomed to this or may not believe that they 
deserve better.  According to this argument, one could then expect Black patients, 
which includes Africans, Indians/ Asians and Coloureds17, to respond more 
favourably compared to White patients when asked about a pharmacy that appears 
to be complying with only three out of ten GPP standards (see 6.1).  This would be 
due to the historical inequalities in health-care services provided to Black patients, 
which is well-documented.  Price (1986), for example, describes these inequalities, 
such as in health-care expenditure, and argues that these inequalities in health 
services were used to promote the ideologies of apartheid.  More recently, McIntyre, 
Gilson, Wadee, Thiede & Okarafor (2006) have also highlighted the historical 
inequalities in health-care services for different racial groups in South Africa, and 
note that by 2005 not much had changed.  McIntyre, et al. (2008) and Heywood 
(2006) have also written on health-care inequalities in South Africa (see 3.5.1). 
  
                                                            
17
  “Black” is defined as Africans, Coloureds and Indians in s1 of the Employment Equity Act 
55 of 1998 (South Africa. National Parliament, 1998).  This definition was extended to 
include South African Chinese people in 2008 (South Africa. High Court of South Africa, 
2008). 
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It cannot be concluded that the abovementioned expectation has been borne out in 
the present results, for the following reasons: 
(i) Not only did many patients not provide their race, but there are also patients 
from all categories who, for unknown reasons, did not respond to individual 
statement(s).  The highest mean percentage of individuals who have not 
responded to the combined services, which represents approximately one-fifth 
of respondents (20.61%), as shown in Figure 35, belongs to the category that 
has not provided their race.  This relatively high non-response rate could 
undermine the validity of the reported results; 
(ii) Although, as pointed out, the proportions of self-identified Indians/ Asians and 
Coloureds are low, the results in Figure 35 show that White patients are more 
positive in their assessment of whether the combined pharmaceutical care 
services are provided, compared to Coloured respondents.  According to 
Sen’s (1995) argument cited in Nussbaum (2001), one would have expected 
Coloured patients to respond more favourably than White patients; 
(iii) The mean percentages illustrated in Figure 35 are relatively close in value.  In 
particular, the mean percentage of Indians/ Asian patients who state that the 
combined pharmaceutical care services are always provided (33.33%) is only 
slightly higher than the mean percentage of White patients who give this 
response (30.00%).  It is not known if this difference is statistically significant, 
as inferential statistical analysis was not performed on the data; 
(iv) There may be additional factors influencing patients’ responses.  All 
pharmacists and the pharmacist’s assistant, for example, are Black, as 
defined by the Employment Equity Act 55 of 1998 (South Africa. National 
Parliament, 1998), and perhaps this may have influenced patients’ responses, 
as patients may also have racial preferences and prejudices; and 
(v) Patient expectations have not been probed (see 6.1).  Sen’s (1995) argument 
cited in Nussbaum (2001) suggests that if patients from a particular vulnerable 
group have not received a particular service, they may not expect to. 
 
So although Sen’s (1995) argument cited in Nussbaum (2001) is an interesting one, 
the limitations and results of the present study do not allow one to conclude that this 
argument is valid for the current study.  Further research is necessary to establish 
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whether there is an association between racial groups and the phenomenon of 
“adaptive preferences”, as described by Nussbaum (2001: 77), in terms of how this 
relates to perceptions and expectations of pharmaceutical care services. 
 
A greater proportion of all racial groups state that they want to receive the 
pharmaceutical care services in Statements 1 and 3-11, compared to those who do 
not, as shown in Figures 24 and 26-34.  This reflects the general consistency 
mentioned before amongst the racial groups in their responses.  The exception to 
this is Statement 2, namely the pharmacist contacting the patient’s doctor to clarify 
the prescription or discuss the patient’s medication.  The proportion of Coloureds 
who do not want this service (30.77%) is approximately double that of the proportion 
who want this service (15.38%) (see Figure 25).  It is not known why this may be so. 
 
As described in 5.1.3.2, there is also consistency amongst the racial groups in 
responses to Statements 1-4 in section 3 of the questionnaire, indicating that the 
majority of all racial groups agree that various dispensary employees practice within 
their scope of practice.  All the racial groups are also unanimous in responding most 
negatively to Statement 2, indicating that more than 30% of respondents from each 
category cannot identify the pharmacist’s assistant.  This is consistent with the 
overall results discussed in 6.1.  The anomaly mentioned in 6.1, namely that a higher 
proportion of respondents state that the pharmacist’s assistant always prepares their 
prescription under the direct supervision of a pharmacist (Statement 3) than the 
proportion of respondents who are actually able to identify the pharmacist’s 
assistant, also occurs with all the racial groups (compare Figure 52 to Figure 51). 
 
Figure 54 reveals that, consistent with the results for section 2 of the questionnaire, 
Africans respond most favourably to the scope-of-practice-related statements in 
section 3, with a mean percentage of 73.26% agreeing to the combined statements.  
In contrast to section 2, in which Coloureds are the racial group responding most 
negatively, in section 3 Whites have the highest mean percentage of responses 
disagreeing with the combined statements (27.15%), as shown in Figure 54. 
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Finally, racial prejudice and stereotypes are demonstrated by one of the 
interviewees, in her comment that she gives generics to Black patients as she 
assumes that they cannot pay for original branded products (see (xxxvi) in 5.2).  One 
wonders if she demonstrates any other prejudices towards certain patients, whether 
patients can detect these and the impact of these prejudices on patients and the 
development of relationships between patients and the interviewee.  This example of 
a racial prejudice expressed by a dispensary employee illustrates the point made in 
2.2.6 that, particularly in the South African context, additional skills such as in 
diversity management are required by dispensary employees.   
 
6.2.2 Results per gender 
 
As described in 5.1.2.4, the mean percentage of males who indicate that the 
combined pharmaceutical care services in Statements 1-10 in section 2 of the 
questionnaire are always provided (37.22%) is greater than the mean percentage of 
males who state that these services are not provided (33.52%).  This is in contrast to 
the results for females, which show that most females (35.04%) state that these 
combined services are not provided, compared to 32.48% of females who state that 
these services are always provided (see Figure 47).  This suggests that males are 
slightly more favourable in their responses to whether various pharmaceutical care 
services are provided by the pharmacy.  Statistical analysis could not be performed, 
however, to establish this with any confidence, as the categories were non-exclusive 
due to some respondents not indicating their gender.  Considering the 
abovementioned mean percentages, it could be noted that these percentages are 
relatively low.  What about the remaining proportions of males and females who 
state that they receive these pharmaceutical care services either only once or twice, 
or not at all?  How many of these patients have experienced DRP as a result of the 
pharmacy not providing these services? 
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There is consistency between the genders in their responses to Statements 1, 9 and 
10, with a higher proportion of each gender stating that these services are always 
provided, as shown in Figures 36, 44 and 45.  For Statement 1, the “Yes, always” 
and “Yes, once or twice” responses can be combined, as discussed in 6.1, resulting 
in a combined favourable response of 75.93% for males and 75.22% for females 
(see Figure 36).  This finding is consistent with the results in 6.1 and 6.2.1.   
 
There is also consistency between the genders that the pharmaceutical care 
services in Statements 2, 4, 6, 7 and 8 are not always provided (see Figures 37, 39, 
41, 42 and 43).  If the favourable responses to Statement 2 are combined, as 
discussed in 6.1, a slightly higher proportion of males (44.44%) still state that this 
service is not provided compared to the combined proportion who state that these 
services are provided (42.59%), whereas a higher combined percentage of females 
state that this service is provided (44.25%) compared to 42.48% of females who 
state that this service is not provided (see Figure 37).  As mentioned before, it is not 
known whether these differences are statistically significant or not.   
 
There is consistency between the genders in that most patients (88.89% of males 
and 84.96% of females) have not requested a medication review (see Figure 46).  
This is consistent with the results in 6.1 and 6.2.1, which show that the majority of 
respondents have not requested this service.  As with the results per racial group in 
6.2.1, there are differences in how both genders respond to Statements 3 and 5.   
 
As in 6.2.1, one cannot conclude that Sen’s (1995) argument cited in Nussbaum 
(2001) is applicable here.  It might be expected that females may have “adaptive 
preferences” (Nussbaum, 2001: 77), due to gender-based inequalities that may 
affect women’s demand for health-care services, as described by Paruzzolo, Mehra, 
Kes & Ashbaugh (2010) and also by Castro-Leal, Dayton, Demery & Mehra (2000).  
Woolard (2002) describes gender inequalities in South Africa.  It could be expected 
that such inequalities may affect females’ perceptions of pharmaceutical services, 
but the results of the present study do not support this, for the following reasons: 
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(i) As with the results per racial group, there are respondents who have not 
indicated their gender.  Furthermore, there are also patients who have not 
responded to statement(s), as shown in Figures 36-47, and this non-response 
rate could undermine the validity of the reported results; 
(ii) Figure 47 shows that the mean percentage of females responding that the 
combined pharmaceutical care services in Statements 1-10 are always 
provided (32.48%) is less than the mean percentage of females who state that 
these services are not provided (35.04%).  This mean percentage of females 
who state that these combined services are not provided is, furthermore, less 
than the mean percentage of males indicating this response (33.52%).  
According to Sen’s (1995) argument cited in Nussbaum (2001), one would 
expect females to respond more favourably in their assessment of the 
pharmacy, instead of more critically as indicated above; 
(iii) Inferential statistical analysis was not performed on the results per gender, so 
it is not possible to comment on whether the abovementioned differences in 
mean percentages are statistically significant; 
(iv) There may be additional complexities, such as race, influencing responses.  
The results have not been filtered to show, for example, the differences in 
responses between females from different racial groups, and between males 
from different racial groups.  Socioeconomic factors, which have not been 
probed, may also play a role in influencing patients’ responses; and 
(v) Patient expectations have not been probed in the questionnaire (see 6.2.1).   
 
There is consistency between genders in terms of whether respondents would like to 
receive the eleven pharmaceutical care services in section 2 of the questionnaire, 
with a higher percentage of each gender supporting this, as shown in Figures 36-47.  
This is consistent with the overall results (see 6.1) and the general results per racial 
group (see 6.2.1).  As with the results per racial group (see 5.1.2.3) and the overall 
results (see 6.1), there is a relatively large proportion of patients (a mean percentage 
of 47.22% for males, 50.71% for females and 60.00% for respondents who do not 
indicate their gender, as shown in Figure 47) who do not indicate whether they would 
like to receive the various pharmaceutical care services in section 2. 
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In section 3 of the questionnaire, there is agreement between the majority of 
respondents from both genders that dispensary employees practice within their 
scope of practice.  A larger proportion from each gender agrees that they can identify 
the pharmacists and pharmacist’s assistant, that the pharmacist’s assistant always 
prepares their prescription under the direct supervision of the pharmacist, and that 
pharmacists or the pharmacist’s assistant always selects OTC medication for them, 
as shown in Figures 55-58.  This is consistent with the overall results (see 6.1) and 
the results per racial group (see 6.2.1).  Also consistent with these earlier results, the 
majority of respondents respond most negatively to Statement 2 (see Figure 56), 
with 42.59% of males and 38.05% of females stating that they do not know who the 
pharmacist’s assistant is.  As highlighted in 6.1, this may be because she admits to 
not always wearing her name tag.  It is then surprising, given that only 57.41% of 
males and 61.06% of females can identify the pharmacist’s assistant (see Figure 
56), that a greater percentage of both males (62.96%) and females (66.37%) state 
that the pharmacist’s assistant always works under the direct supervision of a 
pharmacist (see Figure 57).  This anomaly was highlighted in 6.1 and 6.2.1. 
 
The composite graph, Figure 59, shows that for section 3, females give more 
favourable responses to the combined four statements, with a mean percentage of 
67.48%, compared to males, who have a mean percentage of 64.81%.  This 
suggests that females may respond more critically to whether certain services are 
provided by the pharmacy, but more positively to questions involving identifying 
particular individuals.  Once again, it cannot be said that these differences are 
statistically significant, as inferential statistical analysis was not performed. 
 
6.3 Research objective 3: To determine whether pharmacists view the 
provision of pharmaceutical care as a key performance area 
 
There is unanimous agreement amongst all pharmacists that pharmaceutical care is 
a key responsibility.  This category receives five frequency counts and is ranked 
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fourth (see Table 2).  There are three frequency counts indicating that providing 
pharmaceutical care is regarded as a core professional duty (see code 3 in Table 1). 
 
In the first two chapters, the author had questioned whether pharmaceutical care is 
regarded as a key performance area by pharmacists, since there are no job 
descriptions in which this would have been stipulated.  The interview results indicate 
that whilst interviewees agree that there are no job descriptions (see code 11 in 
Table 1), all pharmacists nevertheless view pharmaceutical care as an integral area 
of performance.  Whilst one cannot go so far as to suggest that these results confirm 
Tam, et al.’s (2002) suggestion that knowledge workers have greater occupational 
commitment than organisational commitment, the results described above highlight 
that pharmacists at least appear to be aware of their occupational commitment to 
provide pharmaceutical care, as stipulated by the SAPC (South Africa. SAPC, 
2010a).  This is supported by all pharmacists stating that they are aware of GPP 
standards for pharmaceutical care, even though none can give examples of these 
standards (see code 5 in Table 1) (see 6.1). 
 
6.4 Research objective 4: To investigate which aspects of the 
implementation of the PMS are viewed by pharmacists and the pharmacist’s 
assistant as enabling or undermining the provision of pharmaceutical care 
 
6.4.1 Factors promoting the provision of pharmaceutical care to patients 
 
From the interview results in Tables 1 and 2, the following ten factors emerge as 
positive aspects of the PMS that promote the provision of pharmaceutical care: 
(i) All pharmacists unanimously agree that pharmaceutical care is a key 
responsibility and state that they are aware of GPP standards for 
pharmaceutical care (see 6.3); 
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(ii) There are two frequency counts, from a pharmacist and the pharmacist’s 
assistant, stating that they are fully compliant with the pharmacy’s SOPs, 
compared to no frequency counts stating otherwise (see code 14 in Table 1).  
As mentioned in 1.1, these SOPs are aligned with the GPP standards for 
pharmaceutical care as outlined by the SAPC (South Africa. SAPC, 2010a), 
so compliance with these SOPs is expected to promote the provision of 
pharmaceutical care; 
(iii) Providing patient counselling and care is the only category under performance 
objectives (see code 20 in Table 1) that receives a frequency count of two; the 
others all have a count of one.  This indicates that the patient counselling 
aspect of pharmaceutical care, which corresponds to phase (iii) in the SAPC’s 
definition of dispensing (South Africa. SAPC, 2010a) (see 2.2.4), seems to 
receive emphasis from a performance management perspective.  It is then not 
surprising that, as highlighted in 6.1, both patients and dispensary employees 
rank this as the top aspect of pharmaceutical care provided; 
(iv) There is unanimous agreement that the number of pharmacists is sufficient to 
supervise the pharmacist’s assistant, indicated by a frequency count of four 
(see code 23 in Table 1).  This, theoretically, should promote pharmaceutical 
care, as the pharmacist’s assistant performs a primarily technical role (see 
4.2.2.1.3), thus allowing pharmacists more time to spend on analysing 
pharmacotherapy and providing patient counselling.  Furthermore, another 
role of the pharmacist’s assistant, as outlined by the SAPC (South Africa. 
SAPC, 2010a), is the provision of patient counselling, an important 
component of pharmaceutical care.  Disagreement over whether such 
supervision is always exerted is explored in 6.1 and later in 6.4.2.3; 
(v) There are three frequency counts stating that the owner-manager’s 
management style encourages pharmacists to provide pharmaceutical care 
(see code 29 in Table 1 and (xxv) in 5.2).  The owner-manager says that he 
“lead[s] by example” (see code 29 in Table 1); this suggests that he serves as 
a role model in the dispensary, and shows dispensary employees how he 
expects them to perform.  Al-Shaqha and Zairi (2001: 291) discuss the 
importance of the managing pharmacist espousing the philosophy of 
pharmaceutical care, driving its implementation and acting as a “role model” 
to employees in the provision of pharmaceutical care (see 3.6.8.1);  
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(vi) All interviewees state that they have good working relationships.  This 
category has six frequency counts and is the third-ranked category in Table 2.  
There are four frequency counts supporting the view that these good working 
relationships promote the provision of pharmaceutical care, and this category 
is ranked fifth (see Table 2).  As mentioned in (xxviii) in 5.2, reasons that 
interviewees have given for this include good working relationships promoting 
understanding amongst employees and the development of a pleasant work 
environment that is conducive to employees performing optimally; 
(vii) Interviewees also state that they have good relationships with patients.  This 
category receives three frequency counts (see code 33 in Table 1).  There is 
a high frequency count for categories indicating that interviewees know 
patients well; that relationships with patients promote patients trusting the 
dispensary employee more and the dispensary employee feeling greater 
confidence; and that the provision of patient counselling and/ or other aspects 
of pharmaceutical care are promoted (see (xxix) in 5.2).  As mentioned in 
3.5.2, Desselle (2004) mentions that knowing patients well is important in 
patients trusting pharmacists’ services.  The abovementioned findings also 
highlight the significance of “softer” skills, such as customer relations and 
communication skills.  The need for such skills is discussed in 2.2.6; as 
pointed out, the Introduction to the GPP standards (South Africa. SAPC, 
2010a) mentions the imperative to enhance communication skills.  It was also 
mentioned that a gap in these “softer” skills could potentially undermine the 
confidence of dispensary employees in providing patient counselling and/ or 
other aspects of pharmaceutical care.  Van Mil, et al. (2004) also discuss 
gaps in communication skills, which these authors believe reflects university 
curricula not adequately preparing pharmacists to provide pharmaceutical 
care (see 3.5.2).  It is thus interesting that an interviewee acknowledges that 
her relationships with patients results in her experiencing greater self-
confidence.  The question that is then raised is whether poor relationships 
with patients could undermine the confidence of pharmacists and the 
pharmacist’s assistant, thus inhibiting the provision of pharmaceutical care; 
(viii) There appears to be a high level of intrinsic motivation amongst dispensary 
employees, with higher frequency counts for the categories stating that 
financial and non-financial rewards are not motivating factors (see codes 36 
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and 37, respectively).  The category stating that financial rewards are not a 
motivating factor is ranked fifth, with four frequency counts (see Table 2), and 
a typical response from interviewees is that the patient’s health is more 
important than financial rewards (see (xxxii) in 5.2).  This suggests an intrinsic 
professional commitment to patients, which is also reflected in interviewees’ 
view of pharmaceutical care as a key professional duty and in Tam, et al.’s 
(2002) comment on the occupational commitment of knowledge workers (see 
6.3).  It is also reflected in a pharmacist saying that he “challenge[s]” himself 
to go beyond the SOPs and his employment contract, saying that, “If I could 
spend twenty-four hours there [in the pharmacy], I would”;  
(ix) There is a higher frequency count indicating that dispensary employees 
regularly liaise with other health-care professionals, and that the owner-
manager encourages this.  Each of these two categories has three frequency 
counts, compared to one frequency count for the categories stating otherwise 
(see code 44 in Table 1).  Interdisciplinary communication and collaboration 
with other health-care professionals is emphasised in the GPP standards 
(South Africa. SAPC, 2010a) (see 1.1).  Liaison with prescribers, for example, 
is important in addressing prescribing errors that the pharmacist has detected, 
which could prevent or resolve DRP, thereby improving patient outcomes; and 
(x) There is a higher frequency count (of two) supporting the view that the new 
layout of the pharmacy promotes the provision of pharmaceutical care (see 
code 49 in Table 1).  This suggests that the new layout which includes, for 
example, lower counters separating dispensary employees and patients, 
enhances the ability of the pharmacy to provide pharmaceutical care.  
However, one pharmacist is adamant that the pharmacy’s layout does not 
protect patient privacy (see (xlvii) in 5.2), which could undermine patient 
counselling and the delivery of pharmaceutical care and is cited as such a 
barrier by Al-Shaqha and Zairi (see 3.5.1).  Pharmacy layout can be regarded 
as falling under the category organisational structure, which is regarded as a 
component of a PMS by Al-Shaqha and Zairi (2001) (see 3.6.4). 
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6.4.2 Factors undermining the provision of pharmaceutical care to patients 
 
The following factors, highlighted in Tables 1 and 2, potentially undermine the 
provision of pharmaceutical care to patients.  These factors reflect those 
components of a PMS for pharmaceutical care proposed by Al-Shaqha and Zairi 
(2001) (see 3.6), integrated with some of the components in Cameron’s (2006a: 120) 
“elaborated model” (see 2.2) and modified by the author. 
 
6.4.2.1 Philosophy and mission statement reflecting pharmaceutical care 
 
Although, as mentioned in 6.1 and 6.3, there is consensus amongst pharmacists that 
pharmaceutical care is viewed as a key performance area and a core professional 
duty, and that they are aware of GPP standards and are compliant with these, none 
(including the owner-manager) are able to give examples of these GPP standards 
(see code 5 in Table 1).  This suggests that, whilst on a philosophical level there is 
an appreciation of the significance of pharmaceutical care, there appears to be a 
fundamental lack of knowledge, on a practical level, of what regulatory standards are 
in place in order to ensure that pharmaceutical care is provided.  This suggests a 
dissonance between philosophy and practice, which is worrying because the GPP 
standards provide a practical linkage between philosophy and practice.  Not knowing 
what these standards are makes it difficult to ensure that the pharmacy and 
individual dispensary employees are fully compliant with these standards in everyday 
practice, as failure to do so could lead to widespread risks, including operational and 
professional risks to the pharmacy and dispensary employees (see 1.2.5). 
 
This lack of adequate awareness of GPP standards, as outlined by the SAPC (South 
Africa. SAPC, 2010a), is also reflected in interviewees’ responses to code 3 in Table 
1, in which interviewees emphasise patient counselling in their responses to their 
understanding of pharmaceutical care, and other key components such as the 
evaluation of pharmacotherapy and patient outcomes and safety receive fewer 
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frequency counts.  This has an impact on what pharmaceutical care services are 
provided, with patients reporting that patient counselling services are provided more 
often than the other pharmaceutical care services in the questionnaire (see 6.1).  
Patient counselling is undoubtedly an important aspect of pharmaceutical care, but 
so are these other services. 
 
There is a higher frequency count showing that interviewees do not know what the 
vision of the pharmacy is, and there is also disagreement over whether there is a 
mission statement or not (see codes 8 and 9 in Table 1).  As mentioned in 2.2.1, a 
vision provides a strategic focus for an organisation’s PMS, and a mission statement 
expresses this vision and communicates it to stakeholders.  A mission statement in 
alignment with the principles of pharmaceutical care is also required in s4.2.1.1 of 
the GPP standards (South Africa. SAPC, 2010a) (see 2.2.1).  If there is substance to 
some interviewees’ claims that there is no mission statement, it thus infringes a GPP 
requirement.  Furthermore, the confusion over the pharmacy’s vision and mission 
statement is a key problem in the current PMS, as it indicates that dispensary 
employees are not sure of what the pharmacy stands for, what it commits to in terms 
of service delivery to patients, and what the employees are working towards.  
Patients and the wider community are also not informed of these because the vision 
and mission statement of the pharmacy are not on public display (see 2.3.4). 
 
The owner-manager’s description of the pharmacy’s vision is “Sustainability and 
providing good quality care” (see (vii) in 5.2).  This is not echoed by any of the other 
interviewees in their responses to what the pharmacy’s vision is (see code 8 in Table 
1).  Although “good quality care” can be regarded as reflecting pharmaceutical care, 
the owner-manager has not explicitly articulated “pharmaceutical care” as a 
component of his pharmacy’s vision.  The owner-manager is also the only 
interviewee to provide an answer to what the mission statement is, namely “Passion 
for health” (see (vii) in 5.2), and this also does not explicitly mention pharmaceutical 
care.  The confusion exhibited by employees in response to this question (see code 
8 in Table 1) suggests that the owner-manager has also not effectively 
communicated his vision or mission statement for the pharmacy to his employees. 
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The owner-manager’s vision includes the word “sustainability”, which can be 
interpreted as “financial” or “business sustainability”, a legitimate vision for an 
independently-owned business operating in the SMME sector.  In 2.3.4, the author 
raised the possibility that perhaps the vision is not on public display as it may be 
profit-related and thus may offend patients’ sensibilities.  This is found to not be the 
case, as there is a difference between sustainability and profitability.   
 
The dispensary employees appear to be unaware of the owner-manager’s vision of 
“sustainability”.  This is problematic, suggesting that important conversations, such 
as around the legal requirement to offer patients generic substitution (see 1.2.3), 
what “sustainability” means on a practical level and how this can be achieved within 
the limits of pharmacy law, may not be occurring.  This could be a contributory factor 
to the finding that generic medication is not always offered to patients (see 6.1). 
 
6.4.2.2 Short- and long-term goals 
 
The pharmacy’s goals were not probed, which may be considered a limitation of the 
interview questions.  Although the interviews were relatively long at approximately 
one and a half hours each in duration, interviewees could perhaps have been asked 
brief questions on what the short- and long-term goals of the pharmacy and 
dispensary are, their perceptions of progress towards achieving these goals and 
their perceptions of the factors that may promote or undermine the achievement of 
these goals.  Information on the pharmacy’s goals did not arise from interviewees’ 
responses to other questions.  The owner-manager, for example, discussed the 
pharmacy’s vision and mission statement, but did not mention any specific goals. 
 
Goals are important in providing a practical framework for a pharmacy in achieving 
the vision of pharmaceutical care, as suggested by Al-Shaqha and Zairi (2001) (see 
3.6.2).  Assessing the nature of the pharmacy and dispensary’s goals would thus 
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have been useful, as it was suggested in 6.4.2.1 that there seems to be poor 
appreciation of what pharmaceutical care is on a practical level.  Al-Shaqha and Zairi 
(2001) also note that goals should be expressed in strategic and business plans.  
The owner-manager does not have such plans (see 2.2.3), illustrating the lack of 
practical guidance to dispensary employees on what their overall performance 
should be geared towards.  The absence of these key documents could potentially 
contribute to interviewees’ confusion regarding the pharmacy’s vision and mission.   
 
6.4.2.3 The responsibilities of pharmacists and the pharmacist’s 
assistant 
 
The lack of clarity regarding the pharmacy’s overall direction and goals, described in 
6.4.2.1 and 6.4.2.2, is also evident at the level of individual dispensary employees.  
There is agreement amongst interviewees, including the owner-manager, that there 
are no job descriptions, with one pharmacist saying that he is using a six-year old job 
description that predates the current owner (see (ix) in 5.2).  The question is raised 
whether the latter job description is still relevant, given environmental changes such 
as changes to the Medicines and Related Substances Act in 2004 and subsequent 
regulations, and the updating of GPP standards in 2010.  The question is also raised 
whether the abovementioned job description is in alignment with what the current 
owner expects the performance of his pharmacists to be, whether the owner-
manager is aware that his pharmacist is using this job description, what the contents 
of this job description are and whether or it not it includes the provision of 
pharmaceutical care as a key performance area. 
 
A job description clarifies an employee’s roles, responsibilities and key performance 
areas.  It is required in s3.2.1(a) of the GPP standards (South Africa. SAPC, 2010a), 
and failure to have job descriptions thus infringes this management standard.  As 
mentioned in 3.6.3, Al-Shaqha and Zairi (2001) propose that job responsibilities be 
founded on the types of activities and standards of pharmacy practice expected for 
individual patients.  The owner-manager mentions that he has told employees 
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verbally about their roles and responsibilities (see code 12 in Table 1).  Relying on 
verbal communication and not outlining these roles and responsibilities in a written 
format, however, has the potential to result in confusion, a lack of clarity and different 
interpretations and standards regarding employees’ performance.  The low 
frequency counts of either one or two for the various categories of roles and 
responsibilities that pharmacists and the pharmacist’s assistant have self-identified 
suggests that there is a lack of overall agreement amongst interviewees as to what 
their specific roles and responsibilities are (see code 12 in Table 1).  
 
There are no frequency counts, for example, indicating that supervision of the 
pharmacist’s assistant is regarded as a pharmacist’s responsibility; it is thus not 
surprising that interview results suggest that the pharmacist’s assistant does not 
always work under a pharmacist’s direct personal supervision (see 6.1).  The 
pharmacist’s assistant also demonstrates a flawed understanding of her role; she 
says that she performs all the tasks of a pharmacist, but under the supervision of a 
pharmacist (see code 12 in Table 1).  This is incorrect because there are some 
tasks, such as phase (i) of dispensing a prescription, involving the evaluation of the 
appropriateness of a prescription (see 2.2.4), that do not fall into the scope of 
practice of a pharmacist’s assistant, as outlined in s1.2(g) in Appendix A of the GPP 
standards (South Africa. SAPC, 2010a).  Although the pharmacist’s assistant states 
that she is aware of the GPP standards outlining her scope of practice (see code 5 in 
Table 1), one of the pharmacists indicates that the pharmacist’s assistant practices 
outside this scope (see code 45 in Table 1).  The abovementioned misunderstanding 
of her role could contribute to this.  A job description would have been useful in 
clarifying to the pharmacist’s assistant what she is allowed to do by the SAPC.   
 
Although interviewees have mentioned various activities that fall within the ambit of 
the GPP standards being job responsibilities, only one interviewee has explicitly 
mentioned compliance with GPP standards as a job responsibility (see code 12 in 
Table 1).  This is not wholly consistent with pharmacists’ responses to an earlier 
question, in which the provision of pharmaceutical care as a key responsibility and 
core professional duty was highlighted (see 6.3 and 6.4.1).  This suggests that, on 
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an abstract or philosophical level, pharmacists agree that providing pharmaceutical 
care is important.  However, this abstract acknowledgement of the importance of 
pharmaceutical care does not seem to permeate their understanding of what the 
SAPC expects them to do in everyday practice.  This could be related to the failure 
of pharmacists to give examples of GPP standards (see 6.4.2.1).  This dissonance 
between philosophy and everyday practice has been discussed in 6.4.2.1.   
 
Another problem is that there is disagreement over whether dispensary employees 
are aware of the pharmacy’s SOPs (see (xi) in 5.2).  As highlighted in 1.1, there are 
no signatures at the end of each SOP, in the section asking employees to sign in 
order to indicate that employees have read the SOP.  There is a frequency count of 
two (see code 14 in Table 1) indicating that dispensary employees are compliant 
with these; one wonders then if employees did read the SOPs and omitted to sign 
these.  A way to test this could have been to have asked interviewees for some 
examples of SOPs, and the steps that should be followed in a particular SOP.  The 
owner-manager believes that only pharmacists, and not the pharmacist’s assistant, 
are aware of the SOPs, which was incorrect, as mentioned in (xi) in 5.2.  There is 
also a higher frequency count supporting the view that the owner-manager has not 
told dispensary employees to comply with these SOPs (see code 14 in Table 1). 
 
Since these SOPs are closely aligned to the GPP standards (see 1.1), they provide 
practical steps on how the pharmacy and individual dispensary employees should be 
compliant with these regulatory requirements.  There is one frequency count 
indicating that the SOPs provide standardisation in practices (see code 15 in Table 
1).  The range of SOPs is, however, limited to the range that s4.2.3.3.1 of the GPP 
standards (South Africa. SAPC, 2010a) stipulates the pharmacy should have (see 
2.2.4).  As mentioned in 2.2.4, a key weakness in this part of the GPP standards is 
that it is not stipulated that a pharmacy have an SOP for the provision of 
pharmaceutical care.  This could include the broad steps to be followed in 
undertaking the three phases of dispensing medication (see 2.2.4), as well as other 
facets of pharmaceutical care, such as how to monitor patient outcomes.  Since such 
an SOP is likely to be long, there could perhaps be a separate SOP on how to 
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dispense medication.  This would include the types of questions to ask patients, 
guidelines on how to analyse the appropriateness of a patient’s pharmacotherapy, 
how to counsel patients and the kind of information to provide to patients.   
 
Similarly, there should also be an SOP for the provision of OTC medication, which is 
also not required in s4.2.3.3.1 of the GPP standards as outlined by the SAPC (South 
Africa. SAPC, 2010a).  The absence of these SOPs could make it more difficult for 
pharmacists to provide pharmaceutical care, as they may not be sure of how this 
could be performed practically, on a step-by-step basis.  One of the interviewees 
complains of the lack of standardisation in how OTC medication is sold, which he 
believes serves as a barrier to patient counselling (see code 47 in Table 1).   
 
Another SOP that could potentially be useful is an SOP on how to supervise a 
pharmacist’s assistant, as the pharmacists seem to have different approaches to 
this; code 45 in Table 1, for example, shows that although there are two frequency 
counts indicating that the pharmacist’s assistant’s work is supervised on an ongoing 
basis, a pharmacist discloses that her work is only checked as the medication is 
being dispensed and there are two frequency counts indicating that the supervision 
focuses primarily on her patient counselling.  The owner-manager is not a registered 
tutor (see code 45 in Table 1).  A pharmacist does not have to be a registered tutor 
with the SAPC in order to supervise a pharmacist’s assistant, but this is compulsory 
if the pharmacist is to supervise a pharmacist intern, as stipulated in s2.28.1 of the 
GPP standards (South Africa. SAPC, 2010a).  So although the owner-manager does 
not have to be a registered tutor, perhaps this could be useful in familiarising him 
with guidelines for supervision and qualitative aspects of assessment, as the SAPC 
has documentation to guide tutors in supervising pharmacist interns.   
 
A worrying finding is that there are two frequency counts, the highest for code 15 in 
Table 1, for the category stating that the SOPs are only guidelines and that 
dispensary employees are sometimes non-compliant with these.  One of the 
pharmacists who has responded in this manner is the owner-manager, and this 
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suggests that compliance with the SOPs is not viewed by him as a key performance 
area for dispensary employees.  Another pharmacist says, “As much as you try to 
stick to SOPs, you have to bend the rules a bit”.  This suggests that at times 
dispensary employees are deliberately non-compliant with the SOPs and, by 
extension, GPP standards.  The example the pharmacist gave of such a situation is 
giving a patient scheduled medication without a prescription, because the patient 
was on holiday and was thus not able to visit his general practitioner.  It would have 
been interesting to have probed this further, and to have found out how often rules 
are “bent” and why the pharmacist believes that the rules “have to” be bent, instead 
of taking other measures outlined in the GPP standards and Medicines and Related 
Substances Act (South Africa. National Parliament, 1965), such as obtaining a 
telephonic prescription from the prescriber.  The abovementioned comment could 
also possibly give credence to the pharmacist’s assistant’s allegation that some 
patients receive highly scheduled medication without a prescription (see (xxv) in 5.2). 
 
Giannetti (2004: 217) argues that pharmacists’ jobs should be designed to include 
the “enriching characteristics” or core job dimensions in Hackman and Oldham’s 
(1975) job characteristics model cited by the former (see 3.6.3).  Although questions 
related to job design and motivation were not asked in the interviews, interview 
results suggest that the following core job dimensions of Hackman and Oldham’s 
(1975) model cited in Giannetti (2004: 217) could potentially be undermined: 
(i) Skill variety:  Pharmacists tend to focus on one aspect of pharmaceutical 
care, namely patient counselling, compared to optimally utilising skills that are 
necessary for other pharmaceutical care services, such as analysing the 
appropriateness of pharmacotherapy (see 6.1).  One pharmacist, for example, 
says that she does not analyse drug interactions for prescribed medication 
(see 6.1).  She thus does not routinely practise this particular skill.  Cox and 
Fitzpatrick (1999) cited in Seston, Hassell, Ferguson & Hann (2009) have 
found that retail pharmacists report greater underutilisation of their skills 
compared to hospital pharmacists and that those pharmacists reporting the 
underutilisation of their skills are more likely to experience job dissatisfaction; 
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(ii) Autonomy:  The owner-manager manages by direct supervision (see code 26 
in Table 1) and mentions that he has “phased out” those with different working 
styles (see code 18 in Table 1).  This is discussed in 6.4.2.5 and 6.4.2.10; 
(iii) Feedback:  A major problem with the PMS, as discussed in more detail in 
6.4.2.7, is that there are no performance appraisals (see code 18 in Table 1).  
Dispensary employees thus do not receive feedback from the owner-manager 
regularly and in a structured manner, on aspects of their performance. 
 
It is important for the owner-manager to address the abovementioned factors, 
because these could, according to Hackman and Oldham’s (1975) model cited in 
Giannetti (2004: 217), potentially undermine employee motivation in providing 
pharmaceutical care to patients.   
 
There is a frequency count of three supporting the view that there are no meetings 
that specifically address dispensary-related issues (see code 28 in Table 1).  The 
owner-manager says that such meetings are unnecessary, as according to him there 
are no major dispensary problems (see (xxiv) in 5.2).  It is thus difficult to understand 
why one pharmacist claims that there are such dispensary-related meetings, when 
the owner-manager states that these meetings do not occur (see code 28 in Table 
1).  Such meetings could be beneficial in allowing a platform for the owner-manager 
and dispensary employees to discuss issues such as the vision, plans and objectives 
of the pharmacy and dispensary; updates in the pharmacy profession, such as 
changes in regulations; dispensary-related problems, which the owner-manager may 
be unaware of, and ways of addressing these; and clarify roles and responsibilities.  
Such meetings may thus address the problem of poor communication and 
information-sharing (see 6.4.2.1, 6.4.2.3 and 6.4.2.10).  Although there is a higher 
frequency count (of two) for the category stating that the lack of dispensary-related 
meetings does not affect the provision of pharmaceutical care, perhaps interviewees 
have responded this way because they have not been exposed to these meetings 
and thus might not be aware of how they may prove beneficial (see code 28 in Table 
1).  Furthermore, one pharmacist states that the staff meetings that are held are 
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“useless”; perhaps this may be because these meetings primarily address front-shop 
matters and not dispensary-related issues (see code 27 in Table 1 and 6.4.2.10). 
 
6.4.2.4 Induction and orientation 
 
There is disagreement amongst interviewees over whether there is induction, 
orientation and training when they started working at the pharmacy, with two 
frequency counts stating that this does occur and two disagreeing (see code 16 in 
Table 1).  The locum pharmacist reveals that, when she started working at the 
pharmacy, she would come in when she was off-shift to familiarise herself with the 
pharmacy.  The owner-manager states that there is a brief, informal induction and 
orientation, but the pharmacist’s assistant states that not much information is 
provided to employees.  This suggests that the orientation and induction of new 
employees could be improved.   
 
By adapting Fowler’s (1996) checklist cited in Cameron (2006b: 84), induction and 
orientation can also be seen as involving imparting information to employees on a 
pharmacy’s vision, values, mission statement and approach to pharmacy practice, as 
well as employees’ specific roles, responsibilities and performance objectives, so 
that employees know what is expected of them and can direct their performance 
towards fulfilling these.  Employees would also be provided with basic information, 
such as where patient information and medication are stored and how to use the 
computer software.  The absence of such information could undermine the ability of 
the new dispensary employee to provide pharmaceutical care or aspects of this.   
 
6.4.2.5 Organisational structure 
 
Al-Shaqha and Zairi (2001) advocate a decentralised decision-making structure with 
pharmacists experiencing sufficient autonomy to practise pharmaceutical care (see 
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3.6.4).  The owner-manager, however, says that his management style is one of 
direct supervision (see code 26 in Table 1 and 6.4.2.3), saying that, “I try to keep my 
eye on everything” and that he expects pharmacists to follow his working style (see 
code 29 in Table 1), and also that he has “phased out” employees who do not do so 
(see code 18 in Table 1).  This direct supervision is consistent with Matlay’s (2002) 
findings (see 3.1.3) that as the size of an organisation decreases, the owner is 
increasingly personally responsible for management controls.  Despite such direct 
supervision, there is a higher frequency count supporting the view that pharmacists 
do not feel as though they have to follow the owner-manager’s working style (see 
code 30 in Table 1 and (xxvi) in 5.2).  This is discussed further in 6.4.2.10. 
 
6.4.2.6 Resources 
 
A key resource mentioned by Al-Shaqha and Zairi (2001) is HR, and in particular 
having a sufficient number of dispensary employees.  In the first two chapters of this 
dissertation, the author highlighted a shortage of pharmacists and pharmacist’s 
assistants as a potential problem.  This is confirmed by the interview results, in which 
there is a frequency count of four for the category stating that the number of 
dispensary employees is not sufficient to provide pharmaceutical care (see code 23 
in Table 1).  This is compared to a count of two for the category stating otherwise.   
 
Interviewees agree that there are either one or two pharmacists on duty at a time, 
with a full-time pharmacist mentioning that there tends to only be one pharmacist on 
duty.  This was supported by the author’s observation that there was one pharmacist 
on duty for approximately four out of seven days (see (xix) in 5.2).  The full-time 
pharmacist above states that the shortage of pharmacists on duty at any point in 
time makes it difficult to provide pharmaceutical care (see code 23 in Table 1).   
 
The owner-manager acknowledges there is a shortage of dispensary employees, but 
maintains that he will not hire extra employees for the sake of having extra 
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personnel, as these new employees may have a different working style and not fit 
into the pharmacy’s culture or comply with his standards (see code 23 in Table 1).  
The owner-manager would thus appear to prefer to work with a core team of 
pharmacists whom he trusts and has worked with for a number of years, as both 
other pharmacists have worked in the pharmacy for between five and ten years (see 
code 2 in Table 1), instead of actively recruiting new employees either in his own 
image, metaphorically speaking, or whom he can train.  The shortage of dispensary 
employees is also likely to be worsened by the relatively small labour pool of 
pharmacists and pharmacist’s assistants, as both these professionals are regarded 
as scarce-skill professionals in South Africa by the Department of Labour (see 1.2.1).   
 
The most frequently-cited category, with ten counts (see Table 2), is that stating that 
time pressures and/ or other practicalities make it difficult to provide pharmaceutical 
care.  It is possible that the shortage of dispensary employees contributes to these 
time pressures, as fewer dispensary employees are present at any point in time, 
leading to the development of queues, particularly at busy times.  Pharmacists may 
thus have less time with individual patients, to analyse their pharmacotherapy, 
provide patient counselling and other aspects of pharmaceutical care.   
 
The owner-manager has a potentially serious problem with regard to the shortage of 
dispensary employees.  He attempts to address this by working long hours himself, 
frequently being present for thirteen hours daily during the week.  The underlying HR 
problem, however, is not addressed.  What happens, for example, if the owner-
manager is ill or wishes to take leave?  Perhaps it is understandable for him to want 
to take direct control and not entrust his pharmacy to new employees whom he 
perhaps does not trust, but there is an underlying recruitment problem that the 
pharmacy faces.  Based on the owner-manager’s aforementioned reluctance to hire 
new employees, there does not seem to be an active recruitment strategy in place to 
attract dispensary employees.  Al-Shaqha and Zairi (2001) note that recruitment and 
selection should be geared towards hiring pharmacists who are able and, by 
extension committed, to providing pharmaceutical care, and that this could be 
cultivated through continuous T&D.   
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The category stating that the number of dispensary employees is not sufficient to 
provide pharmaceutical care is ranked fifth (see Table 2).  This shortage of key HR 
thus has the potential to become debilitating for the pharmacy, and impact adversely 
on its ability to provide pharmaceutical care.  Furthermore, there is the possibility that 
compliance with s4.1(b) of the GPP standards (South Africa. SAPC, 2010a), which 
states that a pharmacy must have sufficient pharmacists and support staff to provide 
a pharmaceutical service, may be undermined in the future.   
 
Elenbaas (2008) recommends that pharmacy support staff be used more optimally to 
perform technical functions, so that pharmacists have more time to provide 
pharmaceutical care.  Although the owner-manager mentions that he is attempting to 
“mould” the pharmacist’s assistant “to ease [his] load” (see code 45 in Table 1), the 
pharmacist’s assistant does not always seem to practice within her scope of practice 
(see 6.1).  By spending time performing functions outside her scope of practice, the 
pharmacist’s assistant has less time to perform tasks within her scope of practice, 
which could then contribute to the pharmacists being under greater work pressure.   
 
An alternative view is suggested by the anonymous, A community pharmacist 
(2010), who claims that some pharmacy owners deliberately use pharmacist’s 
assistants to perform functions outside their scope of practice, as this is less costly 
than hiring pharmacists (see 3.5.4).  One cannot comment on whether this claim is 
applicable to XXX Pharmacy as such questions were not posed to interviewees, but 
the operational risks and potential for DRP arising from the pharmacist’s assistant 
practising outside her scope of practice are valid concerns (see 1.2.5). 
 
6.4.2.7 Performance appraisal 
 
There is unanimous agreement amongst interviewees, including the owner-manager, 
that there are no formal performance appraisals.  This category has four frequency 
counts and is ranked fifth amongst all categories (see Table 2).  There appears to be 
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a reactive approach to performance evaluation, with the owner-manager saying that 
he prefers to address performance-related problems as they arise (see code 26 in 
Table 1) instead of him proactively preventing these from occurring or minimising the 
likelihood of occurrence.  This reactive approach to performance appraisal was 
highlighted as a possible problem in 2.2.5.  The absence of performance appraisals 
could contribute to employee confusion regarding their performance; this is 
supported by the locum pharmacist, who says that “having performance appraisals 
would lead to clarity and eliminate hassles” (see code 18 in Table 1).   
 
The owner-manager’s reason for not having performance appraisals, as shown in 
code 18 in Table 1, is that he asserts that these are “difficult” to perform for 
pharmacists.  It is not known why he considers these difficult; this is unlikely to be 
because he finds it difficult to give critical, perhaps negative, feedback to 
pharmacists, as he indicates that he has told dispensary employees in the past that 
he has a problem with their performance and that he prefers to deal with 
performance-related problems as they arise (see code 26 in Table 1).  Furthermore, 
the owner-manager mentions that he has “phased out” dispensary employees who 
do not have the same working style as him (see code 18 in Table 1).  He also 
mentions that the current pharmacists do not require much supervision, which is 
supported by the current pharmacists saying that he has not told them that he has a 
problem with their performance (see code 26 in Table 1), so one wonders why he 
then finds it difficult to introduce a formal performance appraisal system.  The 
insistence by the owner-manager that employees have the same working style as 
him could result in the benefits of different, innovative business and/ or professional 
practices or ways of addressing challenges not being introduced to the pharmacy. 
 
Perhaps there may be an underlying knowledge and skills gap on the part of the 
owner-manager in terms of how to introduce and implement a performance appraisal 
system.  Visara and Hunt (2008) cited in Banomyong and Supatn (2011), for 
example, have found that the managers and/ or owners of SMMEs may not have 
adequate knowledge of business practices (see 3.1.3).  As a pharmacist, the owner-
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manager would not have had much, if any, exposure to basic performance 
management principles in his university pharmacy curriculum.   
 
Section 3.2.2(a) of the GPP standards (South Africa. SAPC, 2010a) states that the 
performance of pharmacy employees should be evaluated against job descriptions 
and performance objectives, which are set annually, and that the results of these 
performance appraisals should be discussed with the employee and written on the 
employee’s personal record.  As mentioned previously, XXX Pharmacy does not 
have performance appraisals and there are no job descriptions for dispensary 
employees (see 6.4.2.3).  When asked about performance objectives, there was 
some confusion amongst interviewees, with a wide range of different performance 
objectives given.  All of these different categories, such as sales figures and 
following the working style of the owner-manager, have a frequency count of one, 
except for “patient counselling and care”, which has two frequency counts (see code 
20 in Table 1).  This suggests that there is a lack of broad agreement amongst 
interviewees as to what their performance objectives are.  One interviewee states 
that she does not know what the performance objectives are, as she says that the 
owner-manager does not provide any guidance or information on this (see code 20 
in Table 1).  The higher proportion of frequency counts for patient counselling is 
consistent with earlier findings (see 6.1) that the pharmacy seems to provide patient 
counselling more often than other pharmaceutical care services. 
 
There is only one frequency count, from the owner-manager, for the category stating 
that pharmaceutical care is a performance objective.  Incidentally, this is the only 
performance objective that the owner-manager mentions.  This suggests that the 
owner-manager expects dispensary employees to be providing pharmaceutical care 
on a practical level.  However, no other interviewees state that the provision of 
pharmaceutical care is a performance objective, indicating that dispensary 
employees are not aware of this performance objective that the owner-manager has, 
and that there has perhaps been inadequate communication of this from his side. 
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Interviewees similarly had difficulty in articulating their performance targets, with 
three frequency counts for the category that there are no performance targets.  As 
shown in code 21 in Table 1, there are several performance targets that interviewees 
mention, each with a frequency count of one, suggesting a lack of broad agreement 
amongst interviewees.  The exception to this is the category stating that customers 
must be served as quickly and efficiently as possible; this has five frequency counts 
and is ranked fourth out of all categories (see Table 2).  This suggests that there is 
strong agreement amongst interviewees regarding this particular performance target.  
It also supports earlier analysis by the author in the first two chapters of this 
dissertation, in which the focus on operational efficiency was highlighted.   
 
This perceived performance target of having to serve customers as quickly as 
possible could contribute to another finding that emerges strongly from interview 
data, namely that the time pressures in the pharmacy make the provision of 
pharmaceutical care difficult.  This latter category is the top-ranked category (see 
Table 2).  This suggests that this particular performance target, namely having to 
serve customers as quickly as possible, could potentially undermine the provision of 
pharmaceutical care to patients. 
 
There are no performance targets among those in code 21 in Table 1 that explicitly 
state pharmaceutical care.  The owner-manager mentions “total care” and speaks 
about providing “total care” being more important than the number of prescriptions 
dispensed, but he does not define or describe “total care” as being “pharmaceutical 
care”.  Interestingly, his comment about “total care” being more important than the 
number of prescriptions dispensed seems to contradict the author’s earlier analysis 
in the first two chapters of this dissertation about the dominance of quantitative, 
financial KPIs.  His comment is, however, belied by the high frequency counts for the 
categories stating that customers have to be served as quickly as possible and that 
time pressures and/ or other practicalities in the pharmacy make it difficult to provide 
pharmaceutical care (see above).   
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There is no mention of the supervision of the pharmacist’s assistant being a 
performance objective or having targets, which could account for the different 
approaches exhibited by various pharmacists in the extent to which they supervise 
her, and the finding that she does not always work under the direct personal 
supervision of a pharmacist and may not always practise within her scope of practice 
(see 6.4.2.3).  Likewise, there is no mention of compliance with the pharmacy’s 
SOPs being a performance objective or target.  This may perhaps reflect the owner-
manager’s view that these SOPs are merely “guidelines”, instead of having to be 
adhered to at all times (see 6.4.2.3).  Since these SOPs are closely aligned with the 
GPP standards outlined by the SAPC (South Africa. SAPC, 2010a) (see 1.1), not 
having compliance with these SOPs as performance objectives and targets could 
potentially undermine the provision of pharmaceutical care to patients.  It could also 
contribute to the confusion or lack of clarity surrounding how exactly pharmaceutical 
care is to be implemented on a practical level (see 6.4.2.1), as performance 
objectives and targets deconstruct an overriding vision and philosophy into smaller, 
perhaps more manageable, practical “chunks” that employees can strive towards. 
 
There is one frequency count for the category stating that employees give input in 
developing performance targets or objectives, and also one frequency count for the 
category stating that employee input is not provided (see code 21 in Table 1).  
Section 3.2.2(a) of the GPP standards (South Africa. SAPC, 2010a) states that 
consultation with employees in the determination of performance objectives is 
necessary; this consultation could be potentially beneficial in allowing employees to 
feel a greater sense of “ownership” over their performance objectives and targets. 
 
6.4.2.8 T&D 
 
A T&D programme is linked to performance appraisal, as T&D gaps that employees 
have which may be identified during performance appraisal need to be addressed.  
Since there is no performance appraisal process in XXX Pharmacy, it is thus 
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perhaps not surprising that there seems to be no formal structured T&D programme, 
which is compulsory in s3.2.3(a) of the GPP standards outlined by the SAPC (South 
Africa. SAPC, 2010a).  This absence of a formal T&D programme is consistent with 
Matlay’s (2002) findings that as the size of an organisation decreases, owners adopt 
an increasingly informal management style and approach to many practices, 
including T&D (see 3.1.3).  Employees unanimously state that the owner-manager 
has not identified any T&D needs that they may have (see code 24 in Table 1).  
There are two frequency counts indicating that employees identify their own T&D 
needs, and no frequency counts stating that the owner-manager has sent dispensary 
employees for any T&D activities.  This could perhaps be because of the 
reservations that the owner-manager expresses regarding the quality of some in-
house training, and his opinion that the benefits of T&D activities are limited if 
employees are not able to apply what they have learnt (see code 24 in Table 1).   
 
Although there may be merit in the owner-manager’s views, he could have 
addressed these concerns, such as perhaps finding a different training provider or 
sending employees on T&D activities that could assist them in applying what they 
have learnt, instead of appearing to shy away from T&D.  This reluctance to embark 
on T&D activities is also suggested by the finding that although the owner-manager 
says that he welcomes employees informing him of their T&D needs, an interviewee 
asserts that he did nothing when she told him about hers (see code 24 in Table 1).  
The owner-manager also reveals that he is not sure whether his dispensary 
employees have self-development plans, which is compulsory in s3.2.3(b) of the 
GPP standards, as outlined by the SAPC (South Africa. SAPC, 2010a) (see 1.2.4).   
 
It thus seems that employees take their own initiative in addressing their self-
identified T&D needs.  Interviewees mention, for example, undertaking additional 
courses, at their own expense.  There is also a higher frequency count indicating that 
the owner-manager does not encourage dispensary employees to participate in 
PSSA activities (see code 38 in Table 1).  That employees still do so suggests that 
employees take their own initiative in doing so.  This illustrates the occupational 
commitment of knowledge workers highlighted by Tam, et al. (2002) (see 6.3). 
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There is agreement amongst interviewees that involvement in PSSA activities 
assists in the delivery of pharmaceutical care (see code 38 in Table 1), with one 
pharmacist saying that the information provided in some PSSA activities assists her 
in providing better patient counselling.  Interviewees are unanimous in stating that 
they are involved in CPD activities, and there is a frequency count of two stating that 
such activities assist the interviewees in providing pharmaceutical care and/ or 
performing their jobs better, as shown in code 39 in Table 1.  Although there is a 
higher frequency count (of three) supporting the view that there has been no meeting 
to discuss CPD being compulsory according to the SAPC, there are also three 
frequency counts indicating that there is a plan to ensure that employees are 
compliant with CPD requirements (see code 39 in Table 1).  Upon closer 
questioning, a full-time pharmacist reveals that this plan will ensure that each 
pharmacist will do the minimum CPD activities necessary in order to be compliant.  
This suggests a reactive approach to CPD, in which the focus is more on doing the 
minimum required activities, as opposed to making the T&D needs of the individual 
dispensary employee the focal point, so that his/ her performance could be 
enhanced so that optimal pharmaceutical care can be provided to patients. 
 
Ongoing T&D is an important component of being able to provide pharmaceutical 
care, as highlighted in s3.2.3 and s3.4.1 of the GPP standards outlined by the SAPC 
(South Africa. SAPC, 2010a).  As discussed in 2.2.6 and 3.5.2, it is not just technical 
pharmaceutical knowledge and skills that are required, but also additional “softer” 
skills, such as in communication, as suggested by Van Mil, et al. (2004).  One 
interviewee discloses that she experiences racism and/ or sexism from certain 
patients, which makes it difficult for her to provide patient counselling (see (vi) in 
5.2).  This highlights the need for dispensary employees to perhaps have customer 
relations training in how to manage difficult or abusive patients, and how not to let 
such treatment from patients affect the psyche or self-esteem of the employee.  This 
also highlights the need to have a policy or SOP in the pharmacy on how to deal with 
such patients, to protect the rights of employees, such as the right to have their 
dignity respected and protected, which is stated in s10 of the Constitution of the 
Republic of South Africa (South Africa. Constitutional Assembly, 1996).  Such a 
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policy or SOP does not currently exist in the pharmacy and is not mentioned in the 
GPP standards (South Africa. SAPC, 2010a).   
 
Patients also have the right to dignity and equality, the latter stated in s9.4 of the 
Constitution of the Republic of South Africa (South Africa. Constitutional Assembly, 
1996), and these rights also need to be protected.  As mentioned in (xxxvi) in 5.2, 
the racial stereotypes of an interviewee were revealed; this could potentially impact 
on how she treats patients, so there is a need for employees to have some training 
in diversity management skills.  Interestingly, the GPP standards do not mention the 
need for such T&D activities, although “respect for population diversity” is the sole 
reference to diversity in the GPP standards and is mentioned in the context of 
emergency postcoital contraception (South Africa. SAPC, 2010a: 173).   
 
This highlights another gap in the GPP standards; there are no standards for how 
patients should be treated by dispensary employees, other than have their 
confidentiality protected.  There is no so-called “Patients’ charter”, or something 
resembling this, in the GPP standards.  Some universities in South Africa have an 
oath-taking ceremony after pharmacy students graduate, in which the new graduates 
take a “Pharmacist’s Oath”, which outlines some ethical guidelines and commitments 
to how the graduate will practise, but it is noteworthy that the GPP standards do not 
mention anything resembling this.  The SAPC has a Code of Conduct (South Africa. 
SAPC, no date) and has recently published “Ethical Rules” for persons registered 
with the SAPC (South Africa. SAPC, 2011), but it is interesting that these documents 
are not included in or referred to in the GPP standards. 
 
6.4.2.9 Rewards 
 
There are several misunderstandings and problems regarding the issue of rewards 
to dispensary employees.  The owner-manager has the following four perceptions, 
which are found to differ from employees’ perceptions: 
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(i) He is under the impression that dispensary employees are satisfied with their 
remuneration (see (xxx) in 5.2), but there are two frequency counts indicating 
that dispensary employees are not completely satisfied.  This is in contrast to 
only one frequency count stating that employees are completely satisfied with 
their remuneration (see code 34 in Table 1); 
(ii) Furthermore, the owner-manager believes that dispensary employees’ 
remuneration reflects the extra responsibilities in providing pharmaceutical 
care, whereas there is a higher frequency count (of two) for the category 
stating that employees’ remuneration does not adequately reflect these extra 
responsibilities in providing pharmaceutical care (see code 34 in Table 1).  
This could reflect a broader problem in the remuneration of dispensary 
employees in South Africa, with one pharmacist stating that pharmacists are 
generally underpaid (see code 35 in Table 1).  Providing pharmaceutical care, 
as described by the GPP standards (South Africa. SAPC, 2010a), is an 
intensive process in which pharmacists need to utilise a range of skills and 
apply in-depth knowledge and analysis to each patient’s pharmacotherapy.  
The potentially significant risks to patients, for example in terms of DRP and 
the implications of these for patient health if pharmaceutical care is not 
delivered optimally, might be expected to be reflected in pharmacists’ salaries.  
It is perhaps interesting that although there are two frequency counts for the 
category stating that if more pharmaceutical care is provided, the interviewee 
would like his/ her financial rewards to increase, there are also two frequency 
counts stating that interviewees do not expect that this increase would occur 
(see code 34 in Table 1).  This suggests a possible pessimism regarding the 
issue of dispensary employees’ remuneration.  Seston, et al. (2009) report 
that pharmacists in their study are least satisfied with their remuneration when 
compared to other aspects of their job; this dissatisfaction with remuneration 
is consistent with the findings of the current research;  
(iii) The third misperception by the owner-manager is that he believes that 
financial rewards are a motivating factor for his dispensary employees, 
whereas there is a higher frequency count of four for the category stating that 
financial rewards are not a motivating factor (see code 36 in Table 1).  This 
finding supports well-known earlier research by Herzberg, in which he 
classifies financial rewards as a “hygiene factor” as opposed to a “motivator” 
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(Herzberg, 1987 cited in Hendriks, 1999: 95) (see 3.6.7).  As mentioned in 
(viii) in 6.4.1, although the topic of motivation was not probed in much detail in 
the interviews, it appears that dispensary employees have a high level of 
intrinsic motivation, with several interviewees saying that patient health is 
more important to them than financial rewards; and 
(iv) The owner-manager says that he gives additional financial rewards (see code 
36 in Table 1), such as thirteenth and fourteenth cheques, but all dispensary 
employees are unanimous in saying that they have not received any 
additional financial rewards, with this category receiving four frequency counts 
and being ranked fifth amongst all interview categories (see Table 2). 
 
In addition to the above differences in opinions, the following problems have 
emerged from interviewee responses: 
(i) Remuneration does not appear to occur on a regular basis.  As highlighted in 
(xxxi) in 5.2, one interviewee claims that she lost her house because her 
salary was not paid regularly and that she considered leaving the pharmacy.  
She says that she was only paid eight days after the date she was supposed 
to have received her salary.  Her comment was, “I had to beg for my salary, 
which I felt was wrong”.  There are some serious implications of this claim.  
There is the risk of an employee taking legal action against the employer if the 
employee’s salary is not paid within seven days after completion of the period 
for which the remuneration is due, according to s32(3)(a) of the Basic 
Conditions of Employment Act 75 of 1997 (South Africa. National Parliament, 
1997).  Furthermore, there is the risk of psychological stress to the employee 
as a result of not being able to meet financial obligations as well as potential 
adverse effects on employee commitment to the organisation and his/ her job.  
The shortage of dispensary employees is a problem (see 6.4.2.6), and this 
could be worsened if there is a retention problem and an employee left; and 
(ii) An interviewee claims that front-shop assistants were given an extra cash 
bonus in December 2010, which was not extended to dispensary employees, 
and mentions how this made her feel (see (xxx) in 5.2).  If there is substance 
to this claim and there is such differential treatment of employees, this could 
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potentially adversely affect the motivation of dispensary employees.  This is 
because, according to Adams’s (1965) “equity theory” cited in Cameron 
(2007a: 139), employees compare their work inputs and rewards to those of 
others and if inequity is perceived, employees may embark on action to 
address these inequalities.  This might be demonstrated, for example, in 
employees decreasing their performance efforts (Cameron, 2007a).  
Employees may also perceive that there is a lack of “organisational justice”, 
which could impact adversely on employee commitment, as described by 
Farndale, et al. (2011: 6) (see 3.1.2.3). 
 
There is disagreement over whether there are non-financial rewards, such as 
recognition at staff meetings (see code 37 in Table 1).  The owner-manager claims 
that good performance is “applauded” and that such recognition occurs.  However, 
both other pharmacists state that they have not received any non-financial rewards.  
The pharmacist’s assistant mentions that she was recognised at the one staff 
meeting she was invited to attend.  All dispensary employees indicate that non-
financial rewards are not a motivating factor, evidenced in a frequency count of 
three.  This contrasts to the owner-manager’s response that the non-financial 
rewards he claims to provide are a motivating factor for dispensary employees, 
reflected in a frequency count of one for this category (see code 37 in Table 1).   
 
The abovementioned findings are consistent with the divergent perceptions of 
financial rewards between dispensary employees and the owner-manager discussed 
previously.  The owner-manager thus believes that he provides dispensary 
employees with both financial and non-financial rewards and that these motivate 
employees to provide pharmaceutical care.  The dispensary employees, on the other 
hand, state that such rewards are not provided and that these rewards are, 
furthermore, not motivating factors.  As mentioned before, dispensary employees 
seem to exhibit intrinsic motivation to want to provide pharmaceutical care.  
However, given the claims of unequal financial rewards between dispensary 
employees and front-shop assistants and employees not being paid on time, one 
wonders how sustainable employee effort, commitment and performance will be in 
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the long-term.  Financial rewards are regarded as a “hygiene factor”, according to 
Herzberg (1987) cited in Hendriks (1999: 95), and the absence of a “hygiene factor” 
can lead to dissatisfaction and demotivation (Hendriks, 1999).  This could potentially 
lead to problems in retaining dispensary employees, as suggested by the employee 
(see (i) on page 233) who said that she was looking for a new job due to her 
experiences of not being paid on time. 
 
6.4.2.10 The owner-manager’s role and organisational culture 
 
The importance of the managing pharmacist espousing the philosophy of 
pharmaceutical care and serving as a “role model” to other dispensary employees in 
providing pharmaceutical care, as suggested by Al-Shaqha and Zairi (2001: 291), 
has been discussed before (see (v) in 6.4.1).  It was also highlighted in 2.2.9 that the 
owner-manager should review the PMS regularly and assess the continued 
appropriateness of performance objectives and other components.  This does not 
appear to occur, with the owner-manager rather adopting a reactive approach to 
addressing performance-related problems (see 6.4.2.7). 
 
There is a higher frequency count (of three) for the category stating that the owner-
manager does not treat all employees in the same manner, compared to no 
frequency counts for the category stating otherwise (see code 29 in Table 1).  The 
example has been mentioned of a dispensary employee claiming that front-shop 
assistants were given an extra cash bonus (see 6.4.2.9); the same dispensary 
employee also claims that the owner-manager gives certain front-shop staff, who are 
below her in the pharmacy’s organogram (see Figure 2), powers that she does not 
have, for example access to the safe, so that the tills can be replenished with cash.  
This example highlights the value that job descriptions would have, as these would 
clearly outline what dispensary employees’ roles and responsibilities are.  Perhaps 
the owner-manager does not want dispensary employees to have access to the safe; 
this would then be clarified in the job description, which would not mention refilling 
tills as a responsibility for the particular dispensary employee. 
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Interestingly, another dispensary employee expresses the opinion that the owner-
manager is stricter with front-shop assistants compared to dispensary employees.  
Perhaps this may be because the front-shop assistants are usually the first contact 
that patients have with the pharmacy.  The owner-manager perhaps being stricter 
with front-shop assistants could also reflect the PMS for front-shop assistants being 
much better developed and more structured than that for dispensary employees, with 
the former having job descriptions and regular performance appraisals (see 1.1).  So 
despite dispensary employees disagreeing on whether the owner-manager seems to 
favour front-shop assistants or dispensary employees, there is agreement that the 
owner-manager does not treat all employees in the same manner. 
 
It is noteworthy to mention that the category stating that there are problems with 
front-shop assistants has a frequency count of seven and is the second-ranked 
category amongst all interview data categories (see Table 2).  Some specific 
problems cited with the front-shop assistants, as mentioned in (xlix) in 5.2, are the 
high turnover rates for these employees, which undermines front-shop assistants 
learning about and sharing the pharmacists’ vision and attitudes to service, as well 
as front-shop assistants placing the incorrect medication into packets for patients 
and not providing patients with storage information about their medication.   
 
However, front-shop assistants should not be expected to provide patient 
counselling, as they do not have the pharmaceutical training to know, for example, 
what medication should be stored in a fridge.  This kind of information has to be 
provided by pharmacists and pharmacist’s assistants.  The owner-manager thus has 
to ensure that dispensary employees do not abdicate their responsibilities in this 
regard.  Similarly, it is the responsibility of the pharmacist who dispenses a 
prescription to ensure that the correct medication is given to a patient.  This would be 
facilitated by having an SOP on how to dispense a prescription, as this could also 
stipulate how to package medication and how pharmacists and front-shop assistants 
should interact in this regard so that errors can be eliminated.   
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The problem of front-shop assistants not sharing pharmacists’ attitudes towards 
service delivery could suggest that the problem of inadequate sharing of information 
by the owner-manager discussed before (see 6.4.2.1 and 6.4.2.3) is not restricted to 
the dispensary, but also occurs in the front-shop.  It could also suggest that although 
the owner-manager may have developed a more structured PMS for front-shop 
assistants, there may be problems in integration between performance in the front-
shop and dispensary, as well as problems in communication between these two 
components of the pharmacy.  These problems could contribute to one of the full-
time pharmacists believing that he does not have adequate control over OTC sales 
(see (xliv) in 5.2).  Furthermore, the owner-manager needs to re-examine the 
practice of using front-shop assistants as intermediaries between the dispensary and 
patients, because the “break in transmission” that occurs, according to one 
pharmacist (see (xliv) in 5.2), can lead to misunderstandings and miscommunication 
that could result in DRP and thus undermine the provision of pharmaceutical care. 
 
The abovementioned problems in integration and communication could also be 
related to the issue of how often staff meetings occur and what gets discussed at 
these meetings.  As shown in code 27 in Table 1, there is disagreement over how 
regularly staff meetings are held and the usefulness of these staff meetings.  There 
is a higher frequency count (of three) for the category stating that primarily front-shop 
matters are discussed at these meetings, rather than overall issues facing the 
pharmacy (see code 27 in Table 1), which could contribute to the drift between the 
front-shop and dispensary.  This could be worsened by dispensary employees not 
always attending these staff meetings, as highlighted in the interviews. 
 
Another aspect of the owner-manager’s management style that could be problematic 
includes the claim that he treats employees as friends and does not have adequate 
employee-employer boundaries, which sometimes leads to problems (see code 29 in 
Table 1), such as certain employees “tak[ing] advantage” of the owner-manager, in 
the words of the interviewee, and getting additional time off work.  Perhaps this could 
add credibility to the owner-manager’s assertion in 6.4.2.7 that he finds it “difficult” to 
appraise the performance of pharmacists.   
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There is one frequency count for the category stating that the owner-manager’s 
management style could be improved, and two for the category stating that he does 
not take time to explain performance objectives to or share other necessary 
information with dispensary employees (see code 29 in Table 1), in contrast to the 
owner-manager’s assertion that he makes time for employees if they want to talk 
(see code 32 in Table 1).  Despite the abovementioned problems, there is 
agreement amongst the pharmacists that his management style encourages them to 
provide pharmaceutical care (see code 29 in Table 1 and (v) in 6.4.1).  This suggests 
that whilst the owner-manager’s management style may be perceived as being 
effective in promoting the delivery of a core pharmaceutical function, there may be 
weaknesses in how he manages people, which could perhaps potentially undermine 
employee morale and satisfaction.   
 
However, although there is agreement that the owner-manager’s management style 
promotes the provision of pharmaceutical care, some practices of his undermine this.  
For example, the pharmacist’s assistant highlights that when he takes medication out 
for her so that she can process a prescription on computer, he sometimes takes out 
original branded products and not generics.  There are two important problems here:  
(i) The roles seem to have been reversed, as the pharmacist’s assistant should 
be the one who performs the technical function of taking medication off 
shelves, whilst the pharmacist should be the one who evaluates the patient’s 
pharmacotherapy and history on computer, and processes the prescription.  A 
situation like this could lead to the pharmacist’s assistant practising outside 
her scope of practice, which has already been highlighted as a problem (see 
6.1), as well as the owner-manager not utilising the pharmacist’s assistant 
optimally in performing a technical function, so that he can have more time to 
provide pharmaceutical care; and 
(ii) The owner-manager is not offering patients the option of generic medication, 
which infringes s2.7.3.11 of the GPP standards outlined by the SAPC (South 
Africa. SAPC, 2010a).  This could contribute to the results of the patient 
questionnaire, in which only 34.50% of respondents state that they are always 
offered generics (see Figure 14). 
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As mentioned in 6.4.2.5 and 6.4.2.7, the owner-manager expects pharmacists to 
follow his working style and has “phased out” employees who do not.  Although there 
is a higher frequency count supporting the category that pharmacists do not feel as 
though they have to follow the working style of the owner-manager (see 6.4.2.5), 
perhaps they have expressed this perception because their natural working style is 
already similar to his, as alluded to by the owner-manager (see 6.4.2.7).  A potential 
disadvantage of this approach is that the benefits of innovative approaches to 
pharmacy practice may not reach the pharmacy (see 6.4.2.7).  Furthermore, 
practices of the owner-manager such as placing original branded products out for the 
pharmacist’s assistant could potentially send a signal to other pharmacists that this is 
the working style expected of them if they are not to be “phased out”.  This problem, 
anticipated in the author’s analysis in the first two chapters, could undermine 
compliance with s2.7.3.11 of the GPP standards (South Africa. SAPC, 2010a). 
 
The owner-manager, as the managing pharmacist, is also responsible for the public 
being able to identify the various categories of pharmacy employees.  There is a 
higher frequency count for the category stating that dispensary employees do not 
always wear a name tag (see code 46 in Table 1), with the pharmacist’s assistant 
claiming that some designations on the name tags are incorrect and misleading (see 
(xli) in 5.2).  There are two issues that are relevant here: 
(i) As mentioned in (xli) in 5.2, the author could not verify the validity of the 
pharmacist’s assistant’s claim, but if there is substance to this, then the 
deliberate misidentification of pharmacy employees could pose a significant 
legal and professional risk to the pharmacy and the owner-manager; and 
(ii) The owner-manager should be ensuring that dispensary employees wear their 
name tags at all times, so that members of the public are able to identify 
them, as per s1.2.1(e) and s1.6.1(g) of the GPP standards outlined by the 
SAPC (South Africa. SAPC, 2010a). 
 
The role of the owner-manager in shaping organisational culture was highlighted in 
3.6.8.1.  As mentioned in 6.4.1 and reflected in code 31 in Table 1, the consensus 
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amongst interviewees seems to be that the culture in the pharmacy is a positive, 
enjoyable one; there are two frequency counts for the category stating that there is a 
“family” culture.  However, the highest number of frequency counts (i.e. three) for the 
various categories in code 31 in Table 1 occurs for the category stating that 
problems are not addressed.  An example is provided of a dispensary employee 
complaining to the owner-manager about problems she was experiencing with 
colleagues and him apparently doing nothing about this.   
 
There are also two frequency counts for the category stating that an interviewee gets 
“sly comments” when spending time talking to patients.  An example of a “sly 
comment” was, “You should be charging consultation fees”.  Such comments could 
potentially have an adverse effect on the willingness of dispensary employees to 
spend time talking to patients, which is essential in obtaining necessary information 
so that the appropriateness of pharmacotherapy can be assessed, or that adequate 
patient counselling can be provided.  Spending time talking to patients also promotes 
the development of relationships with patients (see code 33 in Table 1).  This 
example also highlights the need to have an SOP for dispensing a prescription, so 
that pharmacists can obtain and exchange necessary information efficiently in their 
encounters with patients.  If the owner-manager felt that the particular dispensary 
employee mentioned above was taking too long speaking to patients, or perhaps 
was speaking of personal matters that were irrelevant to the provision of 
pharmaceutical care, then these issues should have been addressed. 
 
Another aspect of the organisational culture that may be problematic is the category 
stating that there is inadequate recognition of employees’ performance (see code 31 
in Table 1).  Although there is only one frequency count for this, suggesting that this 
view is held by a minority, it should nevertheless be raised, as it could reflect a 
deeper problem or perhaps an issue that other interviewees did not feel comfortable 
raising.  The interviewee commented, “You go in there [the pharmacy], do your thing 
and leave.  There is no ‘thank you’, nothing.”  This could perhaps reflect inadequate 
non-financial rewards (see 6.4.2.9).  The interviewee also mentioned that she 
developed depression after she started working at the pharmacy, as she struggled to 
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become accustomed to the organisational culture (see (xxviii) in 5.2).  This highlights 
the possible adverse effects of the organisational culture on employee wellbeing, 
which may impact on employee morale, motivation and retention. 
 
A final point about the owner-manager’s role is that not knowing if his dispensary 
employees have professional indemnity (see code 40 in Table 1) poses a risk to the 
pharmacy.  As it is, two dispensary employees, including a pharmacist, do not have 
professional indemnity, which is a requirement in s3.5 of the GPP standards outlined 
by the SAPC (South Africa. SAPC, 2010a).  One of these interviewees claims that 
the owner-manager did nothing when she told him of her need to acquire 
professional indemnity (see (xxxv) in 5.2).  It does not state in the GPP standards 
that a pharmacy has to cover professional indemnity fees for its dispensary 
employees, so the interviewee should perhaps not have been under this impression.  
However, the owner-manager should have told the interviewee that he is not 
covering her fee but that he requires her to have such indemnity, so that the 
interviewee could make alternative arrangements to ensure that she is covered.  
 
6.4.2.11 Quality management system 
 
A Quality Improvement Plan is required in s4.2.2.1 of the GPP standards (South 
Africa. SAPC, 2010a).  There is a higher frequency count (of two) for the category 
stating that there is no Quality Improvement Plan in XXX Pharmacy, and one 
frequency count indicating that the interviewee does not know if there is such a plan 
(see code 48 in Table 1).  One of those who states that there is no plan is the owner-
manager, who says that quality is “difficult to assess”, perhaps indicating inadequate 
skills and knowledge in quality management and GPP requirements on the part of 
the owner-manager.  It is thus difficult to understand what Quality Improvement Plan 
the pharmacist who claims that there is such a plan is referring to, since the owner-
manager states that there is no such plan.  This illustrates possible confusion and 
misunderstanding between the owner-manager and the pharmacist.  The latter says 
that he has limited involvement in the development of this plan, and that one of the 
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aspects of this plan is attempting to expand the clinic services to more often than just 
once a week (see code 48 in Table 1).  This is not raised by the owner-manager. 
 
The owner-manager says that there are basic quality control measures and 
standards (see code 48 in Table 1), for example relating to the labelling and storage 
of medication, cleaning of utensils and counters, refilling of packaging, temperature 
control and general hygiene.  These are important, and could possibly be what the 
pharmacist mentioned above might have been thinking of when he said that there is 
a Quality Improvement Plan.  Section 4.2.2.1(a) of the GPP standards (South Africa. 
SAPC, 2010a), however, which describes the contents of a Quality Improvement 
Plan, goes beyond these basic quality control measures and includes requirements 
such as quality standards for the services that the pharmacy provides; processes in 
the pharmacy, including the resources allocated to these; how customer feedback is 
to be elicited regarding the services provided; and training opportunities to allow 
employees to perform their quality management responsibilities.   
 
As stated in s4.2.2.1, the Quality Improvement Plan should be reviewed regularly 
and includes SOPs, which employees should be trained in and which should be used 
and assessed on a regular basis.  Furthermore, there should be necessary 
documentation related to standards; employees should be involved in the 
development and implementation of this plan, and obtain feedback on a regular 
basis on quality improvement outcomes; risk assessment; and employee training in 
the use of the quality improvement cycle (South Africa. SAPC, 2010a). 
 
From the above GPP requirements, it is evident that the pharmacy has several gaps 
in its Quality Management System.  There seem to be some components of such a 
system in place, evidenced in the presence of SOPs and basic quality control 
measures regarding several processes.  However, several key components are 
absent, such as a Quality Improvement Plan, a T&D programme to ensure that 
employees are competent in quality management and improvement, and a system to 
obtain patient feedback regarding the quality of pharmaceutical services provided by 
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the pharmacy and to address such feedback.  Moreover, there is a higher frequency 
count for the category stating that dispensary employees have not been told by the 
owner-manager to be compliant with the SOPs that are in place (see code 14 in 
Table 1).  The absence of these key components of a Quality Management System 
has the potential to undermine the provision of pharmaceutical care.   
 
The UKCPA (2009) suggests that clearly defining the processes involved in 
providing pharmaceutical care as a component of a Quality Management System 
can lead to the allocation of roles and responsibilities and enhance standards 
relating to patient outcomes (see 3.6.8.2).  This indicates that quality management 
interacts with other components of a PMS and is not a stand-alone component. 
 
6.5 Summary 
 
In this chapter, the findings related to each research objective were analysed.  At 
least 50% of patients and dispensary employees indicate that two out of ten 
pharmaceutical care services, which relate to the provision of patient counselling, are 
always provided.  The remaining services that appear not to always be provided 
relate primarily to the evaluation of pharmacotherapy and generic substitution.  The 
difficulties associated with assessing compliance with GPP standards were 
highlighted.  Although the effects of race and gender on patients’ responses could 
not be determined conclusively, the racial group rating the pharmacy’s services most 
favourably is Africans, and the gender that is most favourable is males.  There is 
broad consistency amongst the results obtained across racial groups and genders.  
All pharmacists view the provision of pharmaceutical care as a key performance 
area.  This was among ten factors identified as promoting the provision of 
pharmaceutical care.  Factors that could potentially undermine the provision of 
pharmaceutical care were explored and ten key weaknesses highlighted, such as in 
the vision and mission statement, outlining of responsibilities, performance appraisal, 
T&D, rewards and quality management system.     
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CHAPTER SEVEN:  CONCLUSIONS AND RECOMMENDATIONS 
 
7.1 Summary of research findings 
 
The research statement, as formulated in 1.3, is, “The current PMS for pharmacists 
and the pharmacist’s assistant undermines compliance with GPP standards for the 
provision of pharmaceutical care to patients”. 
 
Ten key weaknesses in various components of an integrated PMS have emerged 
from interviews with pharmacists and the pharmacist’s assistant.  These weaknesses 
could potentially have widespread effects; problems in how the owner-manager 
manages the pharmacy and shapes the organisational culture, for example, could 
impact adversely on employee morale and might thus affect all areas of employee 
performance.  Likewise, problems in remuneration could impact negatively on 
employee satisfaction, possibly leading to retention problems.   
 
Each of the ten identified weaknesses in the PMS, as highlighted below, can also 
potentially undermine the provision of pharmaceutical care to patients: 
(i) Although there is a philosophical commitment to the provision of 
pharmaceutical care by the owner-manager and other pharmacists, and 
pharmaceutical care is viewed as a key performance area, there is poor 
awareness of GPP standards.  The organisational vision and mission 
statement of the pharmacy do not explicitly commit to pharmaceutical care, 
and there is poor communication of these to dispensary employees.  This 
inadequacy in overall vision cascades down to other components of the PMS, 
contributing to pharmacists having a poor understanding of their roles and 
responsibilities in providing pharmaceutical care practically, on an everyday 
basis, in accordance with GPP standards; 
(ii) The abovementioned poor understanding of roles and responsibilities is made 
worse by the absence of current job descriptions for pharmacists and the 
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pharmacist’s assistant, which could have contributed to the pharmacist’s 
assistant not always practising within her scope of practice, and pharmacists 
not always performing all the tasks outlined in their scope of practice.  The 
provision of patient counselling is regarded as more of a responsibility than 
the evaluation of the appropriateness of a patient’s pharmacotherapy.  
Furthermore, the patient counselling provided tends to focus more on how 
patients should take their medication correctly, and less information and 
advice is provided about other aspects of pharmacotherapy; 
(iii) An inadequate induction and orientation programme makes it more difficult for 
new dispensary employees to familiarise themselves with current practices; 
basic information about the pharmacy and operational matters; and the 
organisational vision, values, strategies and plans.  This could undermine the 
ability of the new dispensary employee to provide pharmaceutical care or 
aspects of this, in the case of the pharmacist’s assistant; 
(iv) Having an insufficient number of dispensary employees, in particular 
pharmacists, directly affects the ability of the pharmacy to provide 
pharmaceutical care to all patients at all times; 
(v) There are no performance appraisals for pharmacists and the pharmacist’s 
assistant, and there is confusion regarding performance objectives.  There is, 
furthermore, predominant emphasis afforded to a particular performance 
target, namely to serve customers as quickly and efficiently as possible, which 
could contribute to a finding that emerged strongly from the interviews, 
namely that the time pressures and/ or other practicalities in the pharmacy 
make it difficult to provide pharmaceutical care; 
(vi) There is no formal, structured T&D programme, with the owner-manager not 
identifying and addressing the T&D needs of pharmacists and the 
pharmacist’s assistant in terms of the pharmaceutical and non-pharmaceutical 
skills necessary to provide optimal pharmaceutical care; 
(vii) There is management control by direct supervision, in which employees who 
do not fit in with the working style of the owner-manager are “phased out”.  
This could, in particular, act as a deterrent to pharmacists always offering 
patients the option of generic medication, as it is claimed that the owner-
manager does not always do so; 
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(viii) There is disagreement over whether remuneration and rewards adequately 
reflect the full ambit of responsibilities in providing pharmaceutical care; 
(ix) There are inadequacies in how the owner-manager manages the pharmacy 
and shapes the organisational culture.  In particular, there is the suggestion 
that the owner-manager does not treat all employees in the same manner, 
that problems are not addressed effectively and that the owner-manager does 
not make optimal and appropriate use of the pharmacist’s assistant in 
performing primarily technical tasks so that he can have more time for the 
provision of pharmaceutical care.  There are also problems that dispensary 
employees have with the performance of front-shop assistants; and 
(x) Weaknesses in the Quality Management System, notably the absence of a 
Quality Improvement Plan and compliance with SOPs, which are closely 
aligned to the GPP standards, not regarded as a key performance area. 
 
The abovementioned weaknesses in the pharmacy’s PMS could have contributed to 
the pharmacy appearing to not always comply with the following GPP standards for 
the provision of pharmaceutical care, as outlined by the SAPC (South Africa. SAPC, 
2010a), from the perspective of patients: 
(i) Sections 2.7.1.1(b)(i), 2.7.1.1(b)(ii) and 2.7.1.3.2(a), which together outline the 
comprehensive evaluation of the appropriateness of a patient’s 
pharmacotherapy, in terms of drug interactions, drug-disease interactions, 
adverse effects, efficacy and patient compliance.  These results are supported 
by data obtained from interviews with dispensary employees; 
(ii) Section 2.7.3.11, namely always offering patients the option of generic 
substitution, unless not permitted to do so in certain circumstances.  This 
finding is also consistent with interview results; and 
(iii) Section 2.7.1.1(c), namely contacting the prescriber if there is a problem with 
a prescription.  This finding differs from the interview results. 
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There is broad agreement between interview results and at least 50% of 
questionnaire respondents that only two out of the first ten pharmaceutical care 
services probed in the questionnaire are always provided by pharmacists, namely:  
(i) The pharmacist or pharmacist’s assistant explaining to a patient how to take 
his/ her medication correctly; and 
(ii) The pharmacist or pharmacist’s assistant providing the patient with advice or 
information regarding his/ her medication. 
 
Furthermore, when combining favourable responses, at least 50% of patients agree 
that another service, which does not have to be provided at each patient encounter if 
it has already been performed, is also provided.  This involves the pharmacist asking 
a patient about allergies to medication. 
 
The limitations of only considering the selected GPP standards, and the difficulties in 
assessing compliance with GPP standards and determining the degree of 
compliance with these standards that would be regarded as acceptable, were also 
highlighted.  The racial group responding most favourably to whether the pharmacy 
provides various pharmaceutical care services is African, and the gender responding 
most favourably is males, but it is not possible to determine if the differences 
amongst racial groups and genders are statistically significant.  There is broad 
consistency amongst the results obtained per racial group and gender.  Finally, 
statistical analysis reveals that a significantly higher proportion of respondents want 
to receive the pharmaceutical care services probed in the questionnaire.   
 
7.2 Commendations 
 
There are several aspects of the PMS that appear to be working well, which promote 
compliance with GPP standards for the provision of pharmaceutical care and for 
which XXX Pharmacy should be commended: 
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(i) The provision of pharmaceutical care is viewed as a key performance area by 
all pharmacists; 
(ii) A higher proportion of dispensary employees claim to be fully compliant with 
the pharmacy’s SOPs, which are closely aligned to GPP standards, even 
though there is a high frequency count indicating that the owner-manager has 
not told dispensary employees to be compliant with these SOPs; 
(iii) The provision of patient counselling is recognised as a performance objective; 
(iv) There is agreement that the number of pharmacists is sufficient to supervise 
the pharmacist’s assistant; 
(v) The owner-manager’s management style is viewed as encouraging 
pharmacists to provide pharmaceutical care; 
(vi) Dispensary employees state that they have good working relationships; 
(vii) Dispensary employees also claim to have been able to develop good 
relationships with patients; 
(viii) There seems to be a high level of intrinsic motivation and commitment to 
patient health amongst pharmacists and the pharmacist’s assistant; 
(ix) Although this is contested by patients’ responses to the questionnaire, a 
higher proportion of dispensary employees state that they regularly liaise with 
other health-care professionals and that the owner-manager encourages this; 
and 
(x) Performance in delivering pharmaceutical care is believed to be enhanced by 
the new layout of the pharmacy. 
 
7.3 General conclusions 
 
From the findings mentioned in 7.1 and 7.2, it can be concluded that the research 
statement may need to be rephrased and made more specific, as it is not possible to 
conclusively state that the current PMS undermines compliance with GPP standards 
for pharmaceutical care.  This is because the PMS has numerous components, and 
some of these, namely the ten aspects commended in 7.2, promote the provision of 
pharmaceutical care.  Furthermore, it is difficult to conclusively assess compliance 
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with GPP standards and the degree of compliance with these standards that would 
be considered acceptable. 
 
The research statement should thus be rephrased to state that there are several 
fundamental weaknesses in the PMS of XXX Pharmacy, which may undermine 
compliance with certain GPP standards for the provision of pharmaceutical care to 
patients.  In particular, compliance with GPP standards relating to the 
comprehensive evaluation of the appropriateness of pharmacotherapy and the 
provision of generic medication may be undermined. 
 
7.4 Recommendations 
 
7.4.1 Addressing identified weaknesses in the PMS 
 
Four recommendations that can assist the owner-manager in addressing the 
identified weaknesses in the pharmacy’s PMS that could potentially undermine 
compliance with GPP standards for the provision of pharmaceutical care are 
presented in Table 3 on the next page.  This table includes a user-friendly 
implementation plan in which, for each recommendation, the desired outcomes, key 
practical activities to ensure that the recommendation is achieved, responsible 
stakeholder(s) and expected costs and time periods, are outlined. 
 
These recommendations include a number of basic activities, to be completed within 
a time period of less than eleven weeks, which will serve as a foundation for the 
optimal operation of the PMS.  In addition to these fundamental activities, there are 
also recommendations involving activities that should be performed on an ongoing, 
longer-term basis at specified time periods.  A fifth recommendation, relating to the 
shortage of HR, is subsequently presented in 7.4.2.   
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Table 3: Recommendations with an implementation plan to address identified weaknesses in the PMS of XXX 
Pharmacy so that compliance with GPP standards for pharmaceutical care can be enhanced 
 
 Recommendation Desired 
outcome(s) 
Key activities Stakeholder(s) 
responsible  
Time period Expected costs 
1 Training and 
brainstorming 
session for all 
pharmacists and the 
pharmacist’s 
assistant 
• All dispensary 
employees 
having 
knowledge of the 
GPP standards 
outlined by the 
SAPC (South 
Africa. SAPC, 
2010a) and the 
pharmacy’s 
SOPs; 
• All dispensary 
employees 
having 
knowledge of the 
pharmacy’s 
vision and other 
key information, 
1.1 All pharmacists and the pharmacist’s 
assistant should prepare for this by reading 
the GPP standards and the pharmacy’s 
SOPs. 
All dispensary 
employees 
One week • Costs to print 
out GPP 
standards 
(available 
online from the 
SAPC’s 
website) for 
those who do 
not have a 
personal copy; 
• No other 
expected costs 
to the 
pharmacy as 
employees 
would read the 
documents 
whilst off-shift. 
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such as roles 
and 
responsibilities 
and performance 
objectives; 
• Enhanced team-
work. 
   1.2 Advertising to patients that the pharmacy 
will be closed for the day of training.  The 
pharmacy could offer to deliver medication 
(a service that is normally provided) to the 
homes of patients who would have come to 
the pharmacy on the day of the training to 
collect their chronic medication. 
Owner-manager Two weeks 
(including the one 
week in activity 
1.1) 
• Cost of 
advertising to 
patients that 
the pharmacy 
will be closed 
for this day; 
• Cost of 
delivering 
medication to 
patients. 
   1.3 Training and brainstorming session is 
conducted, at which dispensary employees 
openly discuss/ brainstorm the following: 
1.3.1 The pharmacy’s vision, strategies, 
mission statement and values; 
1.3.2 The philosophy of pharmaceutical care; 
GPP standards and the pharmacy’s 
SOPs, and how to comply with these so 
Owner-manager One day, perhaps 
a Sunday, when 
the trading hours 
are fewer 
• Opportunity 
cost of time, as 
the pharmacy 
would be 
closed for one 
day; 
• Loss of 
revenue for one 
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that pharmaceutical care is provided in 
everyday practice; 
1.3.3 Potential revisions to the current SOPs 
(for example to make them more user-
friendly) and the need for new SOPs, 
such as how to dispense a prescription 
and provide OTC medication, how to 
provide patient counselling, monitor 
patient outcomes and how to interact 
with difficult/ offensive patients.  The 
content of the new SOPs can also be 
brainstormed; 
1.3.4 Challenges experienced in the 
dispensary and pharmacy, as well as 
possible solutions; 
1.3.5 All employees’ roles and responsibilities; 
1.3.6 The need for an induction and 
orientation programme for new 
dispensary employees, and the duration 
and content of this programme.  This 
could include Fowler’s (1996) induction 
checklist cited in Cameron (2006b: 84), 
detailing the information to be provided 
on individual, task, functional and 
organisational levels; 
1.3.7 Performance objectives and targets for 
day; 
• Cost of 
overtime pay 
for those 
employees who 
would not 
normally be 
working on that 
Sunday; 
• Catering costs, 
which could be 
decreased if 
dispensary 
employees 
bring their own 
meals; 
• No venue cost 
as the training 
session can be 
held at the 
pharmacy. 
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employees, the dispensary and 
pharmacy; 
1.3.8 Introduction of a performance appraisal 
system; 
1.3.9 A skills needs analysis can be 
performed at an individual, task and 
organisational level, as described by 
McGehee and Thayer (1961) cited in 
Cameron (2006b: 93), in which the 
owner-manager and other dispensary 
employees identify their T&D needs and 
that of the dispensary and overall 
pharmacy in ensuring that optimal 
pharmaceutical care is provided; 
1.3.10 Rewards (financial and non-financial); 
1.3.11 A Quality Management System, 
including a Quality Improvement Plan; 
1.3.12 A Patient’s Charter, outlining the rights 
of patients and how patients should be 
treated; 
1.3.13 A Wellness Policy and Plan. 
   1.4 Team-building and communication can be 
enhanced by using the Johari window as an 
exercise, as described by Luft and Ingham 
(no date) cited in Shenton (2007: 488). 
 
All dispensary 
employees 
The one day in 
which the training 
session is 
conducted 
None 
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2 Development of key 
documentation and 
the introduction of 
these as performance 
management tools 
Development of 
certain pieces of 
written 
documentation that 
are currently absent 
or inadequately 
developed 
2.1 Based on the input and feedback received in 
the training and brainstorming session (see 
activity 1.3), the owner-manager drafts the 
following key documentation: 
2.1.1 A written vision and mission statement 
for the pharmacy, also outlining 
organisational values and committing to 
pharmaceutical care; 
2.1.2 Job descriptions for all pharmacists and 
the pharmacist’s assistant, outlining key 
performance areas, roles and 
responsibilities, performance objectives 
and targets, how often performance 
appraisals will be conducted and how 
performance will be appraised.  These 
job descriptions should be in alignment 
with all relevant GPP standards, for 
example standards relating to generic 
substitution and to the scope of practice 
of various categories of pharmacy 
employees.  The job descriptions would 
also make it compulsory to wear name 
tags with correct designations.  By being 
aligned with GPP standards, the roles 
and responsibilities in these job 
descriptions will thus reflect 
Owner-manager Three weeks None 
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pharmacists’ expertise as knowledge 
workers, and promote skill variety as 
described by Hackman and Oldham 
(1975) cited in Giannetti (2004: 217) 
(see 6.4.2.3).  The responsible party 
who will pay professional indemnity for 
dispensary employees will also be 
clarified in the job descriptions; 
2.1.3 Existing SOPs may need to be revised 
and new SOPs may need to be 
developed, such as SOPs relating to 
how to dispense a prescription 
(including, for example, the steps 
involved in analysing a prescription; the 
kinds of questions to ask patients; and 
how pharmacists and front-shop 
assistants should interact to allow 
pharmacists adequate control and task 
identity, as described by Hackman and 
Oldham (1975) cited in Giannetti (2004: 
217) (see 3.6.3), over patients receiving 
the correct medication), provide patient 
counselling and OTC medication, how to 
interact with difficult/ offensive patients 
as well as any other SOPs identified in 
the training and brainstorming session.  
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There should be an SOP on how to 
monitor patient outcomes, which could 
include, for example, standard questions 
being asked to patients presenting for 
repeats of their chronic medication.  The 
SOP relating to providing OTC 
medication should make provision for 
one pharmacist to be permanently 
stationed in the OTC section, to 
maintain adequate control over OTC 
sales and ensure that GPP standards 
relating to this are always complied with.  
Perhaps pharmacists could be rotated to 
the OTC section on a monthly or 
fortnightly basis.  This would require at 
least two pharmacists being on duty at 
all times in pharmacy (i.e. one for the 
OTC section and at least one in the 
dispensary).  The problem of a shortage 
of pharmacists, which would be an 
obstacle to implementing this activity, is 
addressed in 7.4.2; 
2.1.4 An induction and orientation programme 
for all new dispensary employees; 
2.1.5 A T&D Policy and Plan for the 
dispensary and individual dispensary 
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employees, which details how skills and 
knowledge gaps will be identified and 
addressed.  This will include 
pharmaceutical and non-pharmaceutical 
T&D gaps.  An example of the latter is 
diversity management skills; 
2.1.6 A document outlining the criteria for 
financial rewards, such as performance-
related and other types of bonuses, and 
to which categories of employees these 
apply.  It will also stipulate the monthly 
date on which employees will be paid 
their salaries, and a written commitment 
by the owner-manager that salaries will 
be paid on that date; 
2.1.7 A Quality Improvement Plan; 
2.1.8 A Patient’s Charter, expressing the 
standards governing how patients will 
be treated at all times, and patients’ 
rights.  This should be in alignment with 
the SAPC’s Code of Conduct and 
“Ethical Rules” (see 6.4.2.8); 
2.1.9 A Wellness Policy and Plan for 
employees.  Although the pharmacy has 
limited resources to necessarily be able 
to provide comprehensive assistance to 
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employees, other support could be 
considered, such as referral to medical 
specialists, negotiated time off work, 
perhaps subsidised counselling 
sessions with a psychologist and access 
to the services of the pharmacy’s nurse; 
2.1.10 A disciplinary policy and code, in which 
the disciplinary measures that can be 
instituted against an employee who 
does not comply with the roles and 
responsibilities outlined in his/ her job 
description are outlined and the 
disciplinary process explained. 
   2.2 Owner-manager gives the draft 
documentation to dispensary employees for 
their feedback.  This participation of 
employees in co-crafting key documentation 
is likely to promote employee “ownership” 
over these documents and thus compliance. 
Owner-manager 
and other 
dispensary 
employees 
One week for 
employees to 
provide feedback 
to owner-manager 
None 
   2.3 Owner-manager has individual meetings 
with the two other pharmacists and the 
pharmacist’s assistant, at which employees 
can provide feedback regarding the draft 
documentation and discuss possible issues 
of concern. 
Owner-manager Three days Opportunity cost of 
employee time, as 
the owner-manager 
and employee will 
not be working in 
the dispensary 
during these 
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meetings. 
   2.4 Based on the feedback from the meetings in 
activity 2.3, the owner-manager finalises the 
key documentation in activity 2.1. 
Owner-manager One week None 
   2.5 Copies of the above documentation are 
provided to all pharmacists and the 
pharmacist’s assistant, and these 
employees are informed that the pharmacy 
commits to compliance with these 
documents.   
Owner-manager Two days Printing costs, 
which could be 
decreased by 
emailing the 
documents to 
employees with an 
email address. 
   2.6 After reading the documentation in activity 
2.5, dispensary employees sign a form 
indicating that they have read the relevant 
documents, are aware of the contents and 
commit to complying with these.  
Owner-manager 
and other 
dispensary 
employees 
One week Cost to print out 
such a form 
3 Introduction and 
implementation of a 
formal performance 
appraisal process and 
the linking of this to 
the T&D programme 
and rewards system 
• A formal, well-
functioning 
performance 
appraisal 
process that is 
regularly 
implemented; 
• The T&D needs 
of individual 
3.1 The job descriptions designed and agreed 
upon in Recommendation 2 should be used 
as yardsticks against which performance is 
evaluated.  Performance appraisal meetings 
should be conducted between individual 
dispensary employees and the owner-
manager, at which 360-degree feedback on 
the employee’s performance is considered.  
This includes feedback from the owner-
• Owner-
manager and 
all dispensary 
employees; 
• Feedback from 
other 
stakeholders 
(e.g. patients, 
patients’ 
• Performance 
appraisal 
meetings held 
on a quarterly 
basis; 
• Critical 
incident diary 
should be 
used on an 
• Opportunity 
cost of 
employee time 
for the duration 
of the 
meetings; 
• Stationery 
costs to equip 
each 
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dispensary 
employees and 
the dispensary 
being identified 
and addressed; 
• The owner-
manager 
receiving 
feedback on his 
management 
style and 
performance; 
• Rewards 
adequately 
reflecting the 
successful 
execution of 
responsibilities 
inherent in 
providing 
pharmaceutical 
care. 
manager, the individual’s colleagues, those 
below the employee in the organogram (see 
Figure 2 in 2.2.8) and from other 
stakeholders, such as patients and other 
health-care professionals.  Employees 
should be encouraged to keep a critical 
incident diary, in which notable events or 
interventions with patients can be recorded, 
interested patients can record their feedback 
and in which the contact details of health-
care professionals who agree to be 
contacted as part of the performance 
appraisal process can be recorded. 
families, other 
health-care 
professionals). 
ongoing 
basis. 
dispensary 
employee with 
a little book to 
serve as a 
critical incident 
diary. 
   3.2 Based on the above meetings in activity 3.1, 
any identified T&D needs or gaps (both 
pharmaceutical and non-pharmaceutical) on 
Owner-manager 
and other 
dispensary 
In order to 
prevent 
dispensary 
• Costs of T&D 
activities; 
• Opportunity 
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the part of dispensary employees (both self-
identified skills and knowledge gaps, as well 
as gaps that the owner-manager has 
identified) can be addressed through 
appropriate T&D initiatives and activities, 
such as attending CPD courses or 
workshops.  Any wellness problems or 
concerns can also be raised at these 
meetings and possible ways of addressing 
these discussed (see activity 2.1.9). 
employees employees from 
being absent from 
the pharmacy at 
the same time, 
due to attending 
T&D activities, it 
is recommended 
that T&D activities 
be staggered 
throughout the 
year, so that 
employees are 
absent from the 
dispensary at 
different times, 
thus minimising 
disruptions to the 
operational 
functioning of the 
dispensary. 
cost of 
employee time 
whilst attending 
T&D activities; 
• Cost of 
possibly 
employing 
additional 
dispensary 
employees, 
such as a 
locum 
pharmacist, or 
the costs of 
dispensary 
employees 
working longer 
shifts, in order 
to address the 
shortage 
caused by an 
employee 
being absent. 
   3.3 The employee’s progress in closing the T&D 
gap can be assessed at performance 
appraisal meetings (see activity 3.1). 
Owner-manager 
and individual 
dispensary 
Quarterly basis None 
Dr Layla Cassim  Research Report MBA 5932 
262 
 
employee 
   3.4 Dispensary employees provide the owner-
manager with feedback on his performance 
and management style by completing an 
anonymous one-page evaluation form that 
they can drop into a sealed box in the 
dispensary, which is only opened at the end 
of the evaluation period, in order to protect 
the anonymity of the feedback.  The owner-
manager can design this evaluation form, 
and it would include questions assessing his 
performance in various roles and 
responsibilities of a managing pharmacist, 
according to GPP standards.  Employees 
should also be asked if they have any 
problems with his management style. 
Owner-manager 
and other 
dispensary 
employees 
Quarterly basis.  
The owner-
manager can print 
out the evaluation 
forms and give 
dispensary 
employees one 
week to complete 
these and place 
them in the box.  
The owner-
manager opens 
the box only after 
this one week.  
Cost of printing out 
the evaluation 
forms 
   3.5 The owner-manager could perhaps consider 
attending a management development 
course, provided on a part-time basis by 
many institutions of higher learning. 
Owner-manager In the owner-
manager’s own 
time, according to 
his needs and the 
requirements of 
the institution. 
Costs of the course 
   3.6 The satisfaction of dispensary employees 
with their financial and non-financial rewards 
is discussed at the performance appraisal 
meetings with the owner-manager.  
Owner-manager 
and other 
dispensary 
employees 
Quarterly basis Costs of additional 
financial rewards, if 
the owner-manager 
decides to provide 
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Depending on the feedback received and 
the financial performance and resources of 
the pharmacy, the owner-manager may 
decide to revise current financial rewards to 
dispensary employees.  These would have 
to be consistently and uniformly applied to 
all employees, in accordance with the 
criteria for rewards (see activity 2.1.6), to 
avoid the perception amongst employees of 
rewards being unfairly given. 
these 
   3.7 Excellent performance is routinely 
recognised by the owner-manager at 
dispensary and pharmacy meetings (see 
activities 4.4 and 4.5 respectively). 
Owner-manager Monthly basis None 
   3.8 Critical evaluation and reassessment of all 
aspects of the PMS, including the 
appropriateness of existing components of 
the PMS, problems being experienced and 
possible solutions to these, by the owner-
manager and all dispensary employees at a 
group meeting.  This promotes the “double-
loop model” of learning, as described by 
Argyris (1976: 363) (see 3.1.2.2). 
Owner-manager 
other dispensary 
employees 
Annual basis Meeting held after-
hours, thus not 
affecting trading 
hours, but overtime 
pay for dispensary 
employees would 
be necessary. 
4 Developing a culture 
of open 
communication, 
• Public 
commitment by 
4.1 Pharmacists should re-commit to the 
Pharmacist’s Oath at an in-house ceremony, 
to which patients and their families, other 
An organising 
committee could be 
set up, consisting of 
• Two weeks to 
prepare for 
• Costs of 
advertising the 
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active problem-
solving, collaboration, 
teamwork and 
commitment to 
enacting the values of 
pharmaceutical care 
the pharmacy to 
the philosophy, 
vision and 
practice of 
pharmaceutical 
care and 
educating the 
public about this; 
• Promoting the 
knowledge 
exchange, 
relationships and 
personal 
commitment 
characteristic of 
a “shared-access 
system” 
described by 
Ehin (2008: 343) 
(see 3.1.2.1); 
• Addressing the 
identified 
problems in 
organisational 
culture; 
health-care professionals and the wider 
public are invited to attend, in addition to all 
pharmacy employees (for whom the 
ceremony would be compulsory).  This Oath 
expresses the ethics governing pharmacy 
practice (see 6.4.2.8).  At this ceremony, the 
pharmacy’s Patient Charter (see activity 
2.1.8) can also be unveiled, and placed on 
permanent, prominent public display in the 
pharmacy.  The pharmacy’s vision, mission 
statement and values (see activity 2.1.1) 
could also be unveiled and placed on public 
display in the pharmacy. 
interested 
pharmacy 
employees and at 
least one 
pharmacist, and 
which reports on its 
progress to the 
owner-manager. 
the ceremony 
(after activity 
2.6 has been 
completed); 
• This 
ceremony 
should 
thereafter be 
held on an 
annual basis. 
ceremony; 
• Catering costs 
for the 
ceremony; 
• The pharmacy 
may have to 
close early or 
open later on 
the day of the 
ceremony, so 
there are the 
costs of lost 
revenue.  The 
ceremony 
could perhaps 
occur on a 
Sunday (fewer 
trading hours); 
• Overtime pay 
for pharmacy 
employees, if 
they are not 
scheduled to 
work on the 
day of the 
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• Greater 
communication 
and alignment 
between the 
dispensary and 
front shop. 
ceremony. 
   4.2 Holding an open-forum discussion with 
patients and other interested members of 
the public, at which attendees can be 
educated about pharmaceutical care and 
can provide feedback to the pharmacy on 
the pharmacy’s performance in this regard, 
as well as problems that patients are 
experiencing and possible solutions to 
these.  Such feedback from patients could 
potentially stimulate improvements in the 
quality of services provided by the 
pharmacy.  Patients would also be informed 
of the pharmacy’s SOPs and the benefits of 
various pharmaceutical care services, such 
as contacting prescribers if there is a 
problem with a prescription, monitoring 
patient outcomes, assessing patient 
compliance and the other services listed in 
section 2 of the questionnaire used in this 
research.  These discussions could also 
The organising 
committee in 
activity 4.1 
Quarterly basis • Advertising 
costs, which 
may decrease 
as the public 
becomes more 
familiar with the 
discussions; 
• Catering costs; 
• Cost of lost 
trading time; 
• Overtime pay 
for dispensary 
employees who 
would not have 
been working 
at that time.  
Overtime pay 
will not be paid 
to front-shop 
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assist in pharmacists being increasingly 
recognised by patients as knowledge 
workers. 
assistants, 
whose 
attendance is 
voluntary. 
   4.3 Introduction of a “green area” or participative 
management, as described by Horwitz and 
Townshend (1993: 926).  This would involve 
all pharmacy employees meeting for 15 
minutes at the start of each working day to 
discuss the day’s work activities and 
schedule, potential problems and possible 
solutions.  Teamwork and communication 
amongst employees and between front-shop 
and dispensary employees would be 
promoted, as well as the development of a 
“shared-access system”, as described by 
Ehin (2008: 343) (see 3.1.2.1). 
Owner-manager 15 minutes daily, 
on an ongoing 
basis 
15 minutes of 
trading time 
   4.4 Dispensary meetings, involving all 
dispensary employees, at which specifically 
dispensary-related issues, challenges and 
possible solutions are discussed, as well as 
changes in the pharmacy field and other 
pharmaceutical developments.  These 
meetings could also possibly be used as an 
opportunity to revise and learn 
pharmacological details related to specific 
Owner-manager Monthly basis Meetings could be 
held after-hours, 
thus not affecting 
trading hours.  
Overtime pay would 
be necessary for 
dispensary 
employees. 
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drugs and medical conditions, and could 
promote the development of the “shared-
access system” described by Ehin (2008: 
343) (see activity 4.3). 
   4.5 Pharmacy meetings, involving all dispensary 
employees and front-shop assistants, at 
which issues relating to the pharmacy are 
discussed, communication and information-
sharing between these two units is promoted 
and joint problem-solving of common 
challenges encouraged.  This contributes to 
developing a “shared-access system” 
described by Ehin (2008: 343) (see activity 
4.3).  Front-shop assistants should be 
educated about the approach to pharmacy 
practice and service delivery espoused by 
the dispensary, so that their performance is 
in alignment with this.  They should be made 
aware of the new SOPs related to the 
provision of OTC medication and how they 
should interact with pharmacists (see activity 
2.1.3), and instructed not to perform acts 
only in the scope of practice of dispensary 
employees.  They should also be informed 
as to what these acts are. 
Owner-manager Monthly basis Meetings could be 
held after-hours, 
thus not affecting 
trading hours.  
Overtime pay would 
be necessary for 
dispensary 
employees and 
front-shop 
assistants. 
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7.4.2 Recommendation 5: Addressing the problem of a shortage of 
dispensary employees by employing pharmacist interns 
 
The current shortage of pharmacists and pharmacist’s assistants has the potential to 
undermine the provision of pharmaceutical care to patients and the long-term 
sustainability of the pharmacy.  The owner-manager thus needs to address this 
underlying HR problem and the shortage of skills that the pharmacy faces. 
 
It is recommended that the owner-manager consider employing one pharmacist 
intern in each of the next two years.  The internship year is a compulsory period of 
practical experience for pharmacy graduates, before the one year of pharmaceutical 
community service (see 4.2.2.1.4).  The owner-manager could approach the nearby 
pharmacy schools and interview applicants from the final-year pharmacy class.  One 
of the selection criteria he could use is his perceived fit with the applicant.   
 
The chosen individuals would then perform their internship under his supervision and 
mentorship.  The internship is normally for a period of one year, but if the graduate 
would like to perform an internship at an academic institution or manufacturing 
pharmacy, the practical experience component is decreased to 400 hours, according 
to s10 of the Regulations Relating to Pharmacy Education and Training (South 
Africa. Department of Health, 2000).  The owner-manager can decide whether he 
would be willing to take an intern on for a period of 400 hours, or whether he would 
prefer an intern completing one year of practical training.  Once the chosen 
individuals have been selected, the owner-manager can train them during the period 
of their internship, and the interns will be able to share some of the workload in the 
dispensary.  According to s1.4(b) of Annexure A of the GPP standards (South Africa. 
SAPC, 2010a), a pharmacist intern can perform all the acts in the scope of practice 
of a pharmacist, but these must be performed under the direct personal supervision 
of a pharmacist.  Section 2.28.1 of the GPP standards requires that a pharmacist be 
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a registered tutor in order to supervise a pharmacist intern, so the owner-manager 
would have to obtain such registration, which he currently does not possess. 
 
In order not to lose the investment made in the pharmacist intern when the intern 
completes the internship, the owner-manager could include a clause in the 
employment contract with the intern stating that the intern has to work for the 
pharmacy full-time for a period of one year after the completion of his/ her 
community service, and provide dates by when this should occur.  If the individual 
would like to remain with the pharmacy beyond this obligatory one year period, this 
could also be considered by the owner-manager. 
 
If the owner-manager thus employs one intern in Year 1 (for example, 2012) and one 
intern in Year 2 (i.e. 2013), in 2013 the intern from Year 1 will have left the pharmacy 
to complete his/ her community service.  The owner-manager, however, will have the 
services of the new intern starting in January 2013.  When the intern from Year 2 
then leaves to complete his/ her community service in 2014, the intern from Year 1 
would return to the pharmacy, having successfully completed his/ her community 
service and thus now being registered as a pharmacist in South Africa.  The 
pharmacy would have, in 2014, thus gained one full-time pharmacist who is already 
familiar with the systems and practices in the pharmacy, as the owner-manager has 
already trained him/ her during the internship year.  Likewise, in 2015 the intern from 
Year 2, who has now also completed his/ her community service and is a registered 
pharmacist, would also join the pharmacy.  If the intern from Year 1 then decides to 
leave the pharmacy, having worked back the obligatory one year post-community 
service, the pharmacy is still left with one additional full-time pharmacist in 2015.   
 
This could develop into a four-year cycle, if the new pharmacists wish to leave the 
pharmacy after their one-year work obligation.  The prospects of career 
advancement within the pharmacy are limited, given the one level separating 
pharmacists and the owner-manager (see 2.2.8), so it might be expected that the 
new pharmacists may wish to explore other career opportunities after their obligatory 
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one-year period at the pharmacy.  In 2016, the owner-manager can, if needed, then 
repeat the abovementioned process by employing another pharmacist intern, and 
another in 2017, as described above, so that he always has a supply of at least one 
new full-time pharmacist assured.   
 
The advantage of such a strategic approach to recruitment and retention, besides it 
being potentially easier to train and mould the working style of a new pharmacist 
intern instead of a pharmacist who has been practising for a while and who might 
already have developed his/ her idiosyncratic ways of working, is that it is less costly 
to pay the salary of a pharmacist intern compared to a pharmacist.  The owner-
manager would, according to the suggested timeframes on the previous page, only 
have to pay the salary of an additional pharmacist in 2014, rather than in 2012.  That 
gives him some time to save up for this additional overhead. 
 
In the employment contract with the pharmacist intern, the owner-manager could 
state that the contract is conditional upon the owner-manager having sufficient 
financial resources to employ the newly-registered pharmacist for one year.  Such a 
clause would protect the owner-manager in the event of financial constraints. 
 
7.5 Possible barriers to implementation and ways to address these 
 
7.5.1 Resistance to change 
 
The recommendations in Table 3 involve a number of changes to the PMS and 
practices within the pharmacy.  There could be resistance to these changes from the 
owner-manager, as well as other dispensary employees and front-shop assistants.  
Such resistance could significantly undermine the effectiveness and sustainability of 
these changes.  The owner-manager, for example, has a crucial role to play in 
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espousing changes to the PMS and driving the change process, as suggested by 
Norhayati and Siti-Nabiha (2009) (see 3.6.8.1).   
 
Resistance to change may occur for many reasons.  Hendry and Hope (1994) cited 
in Cameron (2007b: 72) identify the following possible causes of such resistance: 
(i) Resilience of the current culture:  The owner-manager and employees may 
not be willing to change, and/ or may not realise why change is necessary or 
agree with the reasons for this.  As mentioned in 3.1.2.2, Greenwood and 
Hinings (1996: 1025) argue that the tendency towards stability entrenches 
“templates” or paradigms of management even further in organisations, which 
could contribute to resistance to culture change; 
(ii) Complexity of culture change envisaged:  A paradigm shift may be required in 
changing from a PMS with informal controls, to a more structured and formal 
system in which compliance with key documentation is required.  Likewise, 
there may a paradigm shift in changing from an appreciation of 
pharmaceutical care on an abstract, philosophical level to having to practise 
this with every patient on a practical level every day; 
(iii) Differences between individual and organisational values or, by extension, 
individual values and the values expressed in the new PMS:  Dispensary 
employees may not value, for example, the increased customer contact and 
feedback proposed in initiatives such as open-forum discussions and 360-
degree feedback (see Table 3).  Or there may be differences between 
individual desires to increase profits and the PMS’s insistence that GPP 
standards for generic substitution be complied with; and 
(iv) Contradictions that may be present with the desired changes:  It could be 
perceived, for example, that the requirement to spend time asking patients 
questions necessary to evaluate the appropriateness of their 
pharmacotherapy may lead to longer queues developing, due to the shortage 
of dispensary employees.  Furthermore, stationing one pharmacist in the OTC 
section of the pharmacy on a permanent basis (see activity 2.1.3 in Table 3) 
effectively removes one pharmacist from the dispensary, thus adding to the 
workload of those present in the dispensary. 
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Whipp (2003) cited in Boojihawon (2006) also identifies other reasons for resistance 
to change on an individual level, such as feelings of uncertainty, fear and inadequate 
knowledge about the change.  There may also be personal feelings of inadequacy 
regarding the individual’s competence in adjusting to new roles and responsibilities.  
With the exception of (iv) on the previous page, which is addressed in 7.4.2 and 
7.5.2, the other reasons for resistance to change mentioned in 7.5.1 could potentially 
be addressed by having a culture change workshop with all employees and the 
owner-manager prior to introducing the recommendations in Table 3.  This workshop 
should be facilitated by a change management specialist, discussed further below.  
Possible feelings of inadequacy regarding competence can also be addressed by the 
strong focus of the recommendations, in particular Recommendation 3, on T&D. 
 
There may be a budgetary constraint in acquiring the services of a change 
management specialist, which could perhaps be overcome by the owner-manager 
placing an advertisement for such services in the pharmacy.  Perhaps a patient or a 
patient’s family member may be a change management specialist and might agree 
to offer the service at a discounted fee.  If the change management specialist is a 
patient of the pharmacy, an additional benefit is that he/ she can assist the owner-
manager and pharmacy employees in understanding the potential benefits of the 
new pharmaceutical care-based PMS from a patient’s perspective. 
 
7.5.2 Insufficient resources 
 
The problem of inadequate HR, in particular dispensary employees, was addressed 
in the fifth recommendation (see 7.4.2), in which it was recommended that two 
pharmacist interns be employed over two years.  This shortage of knowledge 
workers should thus not be viewed as a barrier to implementing the 
recommendations in Table 3, but rather as a “knowledge management trigger”, as 
described by Dence (2008: 35), or a stimulus to address a knowledge management 
problem, namely the shortage of dispensary employees. 
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Critics might argue that some of the recommendations suggested in Table 3, such as 
the 15 minutes of daily trade lost due to “green area” gatherings or quarterly open-
forum discussions with patients (see activities 4.3 and 4.2 respectively), may be 
costly for the pharmacy.  However, the financial costs of these should be considered 
against the potential long-term value and gains associated with these initiatives.  The 
“green area” gatherings, for example, as described by Horwitz and Townshend 
(1993: 926), could enhance employee performance, whilst the open-forum 
discussions could build relationships with customers, which might make customers 
progress up Christopher, Payne & Ballantyne’s (1991) “loyalty ladder” cited in 
Stapleton (2004: 11), leading to enhanced customer retention.   
 
Furthermore, in assessing the financial implications of employing two pharmacist 
interns over a period of two years (see 7.4.2), the costs associated with not doing so 
should also be considered.  This would include the potential costs of not complying 
fully with GPP standards for the provision of pharmaceutical care, its associated 
legal costs and costs to the reputation of the pharmacy and to future revenue if the 
pharmacy is subjected to disciplinary action by the SAPC.  Developing a business 
case for a pharmaceutical care-based PMS thus aligns the proposed 
recommendations and the implementation plan for these to a strategic priority of the 
pharmacy, namely financial sustainability.  Dence (2008) believes that such 
connection with the strategic imperatives of an organisation is a key success factor 
in promoting the sustainability of knowledge management initiatives.  
 
7.5.3 The perception that patients do not want pharmaceutical care 
 
This potential quality gap between patients’ expectations of a pharmaceutical service 
and the owner-manager’s and other dispensary employees’ perceptions of these has 
been highlighted in 2.3.1 and 6.1.  This gap could be addressed by sharing some of 
the results found in this research, notably Figures 22 and 20, which show that there 
is a strong customer demand for all eleven pharmaceutical care services probed in 
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the questionnaire, with the owner-manager and other dispensary employees.  Once 
these individuals are aware that a large proportion of their customers thus want to 
receive these services, they may be encouraged to provide pharmaceutical care. 
 
7.6 Suggestions for future research 
 
The current research lends itself to a number of future studies that could be 
undertaken, as described below. 
 
This research could be extended to pharmacies in sectors other than the retail 
sector, such as the hospital and institutional sectors.  This could also, importantly, 
include pharmacies in the public sector, which are faced with additional imperatives, 
such as compliance with the principles of Batho Pele.  These principles, which aim to 
enhance service delivery and put “People First”, are expressed in the White Paper 
on Transforming Public Service Delivery (South Africa. Department of Public Service 
and Administration, 1997: 1) and are resonant with many of the values expressed in 
the GPP standards outlined by the SAPC (South Africa. SAPC, 2010a), such as 
accountability and excellence in service delivery.  Enhancing compliance with GPP 
standards for pharmaceutical care could thus also promote the enactment of the 
principles of Batho Pele in these organisations. 
 
The research methodology in this dissertation could also potentially be applied to 
larger pharmacies, such as pharmacy chain stores or retail stores that also include 
pharmacies in their outlets, to investigate the impact of the PMS on the compliance 
of these pharmacies with GPP standards for pharmaceutical care. 
 
Further research could also determine conclusively, using inferential statistical 
analysis, whether there is a relationship between demographic variables and 
patients’ perceptions and expectations of pharmaceutical services.  Furthermore, a 
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wider range of demographic variables can be explored, rather than solely focusing 
on race and gender.  Examples of such additional demographic variables could 
include the educational level, socioeconomic status and age of patients, as well as 
perhaps patients with different chronic medical conditions. 
 
The current sample size of 200 patients could also be increased and the research 
conducted at multiple pharmacies across all the provinces in South Africa instead of 
being restricted to Gauteng.  This would also allow differences in patients’ responses 
and compliance with GPP standards between provinces to be ascertained. 
 
A future study could assess compliance with a wider range of GPP standards for the 
provision of pharmaceutical care than the ten probed in the current questionnaire. 
 
Pharmacoeconomic analyses could also be performed to determine the current cost 
of DRP in South Africa, and the costs of not implementing pharmaceutical care.  
Ernst and Grizzle’s (2001) study was restricted to the USA and was reported a 
decade ago (see 3.3). 
 
The effects of collaborative initiatives among a variety of different health-care 
professionals, such as doctors, pharmacists and nurses, in enhancing patient 
outcomes and providing pharmaceutical care could also be investigated. 
 
Finally, the implications of the current research on recruitment and retention 
strategies for pharmacies and organisations or institutions with pharmacies can also 
be investigated, as can the implications for customer or patient relations and 
stakeholder management. 
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Glossary of pharmaceutical terms and phrases used in this report 
 
Adverse drug reaction:  See adverse effect 
 
Adverse effect:  An unwanted, negative physiological effect 
 of pharmacotherapy in a patient. 
 
Ambulatory patient: See outpatient 
 
Compliance with pharmacotherapy: A patient takes his/ her medication exactly 
as prescribed (i.e. the correct amount of 
medication, in the correct manner, at the 
correct dosing interval, for the correct 
number of days). 
 
Compounding medication: The combination of different ingredients, for 
example by mixing 
 
Counselling: In the context of pharmaceutical care, 
patient counselling refers to providing 
patients with information and advice 
regarding their pharmacotherapy and/ or 
medical condition(s). 
 
Dispensary: The part of the pharmacy in which Schedule 
2 to Schedule 6 medication is kept.  A 
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pharmacist has to be present at all times in 
the dispensary. 
 
Dosage form:    The physical formulation in which a drug is  
      administered, for example a tablet, capsule, 
      syrup, solution or suppository. 
 
DRP: These are defined by the PCNE Foundation 
(2010: 2) as “an event or circumstance 
involving drug therapy that actually or 
potentially interferes with desired health 
outcomes”.   
 
Drug interaction: An interaction between two drugs can either 
be potentially negative, resulting in adverse 
effects, or potentially positive, resulting in 
beneficial effects to the patient.  An 
example of a drug interaction that has a 
negative effect is a patient taking two drugs 
that have the same adverse effect, as the 
potential for toxicity is enhanced.  An 
example of a beneficial drug interaction is 
when a patient takes one drug that 
decreases the toxicity of another drug. 
 
Generic medication: Generic medication, also referred to as 
“interchangeable multi-source medication” 
in the Medicines and Related Substances 
Act 101 of 1965 (South Africa. National 
Parliament, 1965: 1), is defined in s1(1) of 
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this Act as containing the same active 
pharmaceutical ingredient(s) at the same 
concentration or strength, given through the 
same route of administration and in the 
same dosage form as another medicine 
(usually an original branded product), and is 
therapeutically equivalent to the other 
medicine.  A generic is often cheaper than 
the original branded product.  Generic 
medication usually comes to market after 
the patent on the branded product has 
expired and is often, but not always, 
manufactured by a different company. 
 
Health-care professionals: Includes doctors, physiotherapists, dentists, 
psychologists, optometrists, occupational 
therapists and other health-related 
professions represented within the Health 
Professions Council of South Africa 
(HPCSA) (HPCSA, no date).  Pharmacists 
and nurses are also health-care 
professionals, but are registered with 
separate professional bodies, namely the 
SAPC and the South African Nursing 
Council, respectively. 
 
Inpatient: A patient who stays overnight at a health-
care facility, such as a hospital, for 
treatment (American Heritage® Dictionary 
of the English Language, 2009 cited in 
TheFreeDictionary, 2011a). 
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Front-shop assistants: These employees of XXX Pharmacy are not 
pharmacists or pharmacist’s assistants.  
Most are students, who work in the 
pharmacy on a part-time basis.  These 
assistants do not work in the dispensary, 
but rather in the front shop, which sells 
food, beverages, toiletries, vitamins and 
herbal products.  Front-shop assistants are 
also stationed in the OTC part of the 
pharmacy. 
 
Locum pharmacist: A non-full-time pharmacist, who usually 
works shifts when one or both of the other 
pharmacists is not at work.  Locum 
pharmacists are also termed “relief 
pharmacists” (South Africa. SAPC, 2010a: 
199). 
 
OTC medication: Schedule 0, 1 and 2 medication, which does 
not require a doctor’s prescription in order 
to be dispensed.  Schedule 1 and 2 
medication can only be sold by a 
pharmacist, a pharmacist intern or a 
pharmacist’s assistant being supervised 
directly by a pharmacist, according to 
s22A(4)(a)(i) and s22A(5)(a) respectively of 
the Medicines and Related Substances Act 
101 of 1965 (South Africa. National 
Parliament, 1965), whereas Schedule 0 
medication can also be sold in an open 
shop, according to s22A(3) of the above 
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Act.  An example of an open shop is a 
grocery store. 
 
Outpatient: A patient who does not stay overnight at a 
health-care facility, such as a hospital, for 
treatment (The American Heritage® 
Dictionary of the English Language, 2009 
cited in TheFreeDictionary, 2011b). 
 
Patient morbidity: Patient disease or illness (MedTerms 
Dictionary, 1998) 
 
Patient outcomes: This refers to what happens to a patient 
after a treatment intervention such as a 
course of medication.  Outcomes could 
include, for example, impaired or improved 
quality of life, the occurrence of adverse 
effects or control of a chronic medical 
condition. 
 
Pharmaceutical care: This is a patient-centred approach to 
providing high quality, safe and efficacious 
pharmaceutical services to patients.  The 
SAPC (South Africa. SAPC, 2010a: 3) 
describes pharmaceutical care as “taking 
responsibility for the patient’s medicine-
related needs and being accountable for 
meeting these needs”. 
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Pharmacist-initiated therapy: This is when a pharmacist determines that a 
patient requires OTC medication, and 
provides the appropriate OTC medication, 
according to s2.12 of the GPP standards 
(South Africa. SAPC, 2010a).  A doctor’s 
prescription is not necessary. 
 
Pharmacoeconomics: “The scientific discipline that evaluates the 
clinical, economic and humanistic aspects 
of pharmaceutical products, services, and 
programs, as well as other health care 
interventions to provide health care decision 
makers, providers and patients with 
valuable information for optimal outcomes 
and the allocation of health care resources” 
(International Society for 
Pharmacoeconomics and Outcomes 
Research, 2011) 
 
Pharmacotherapy:    Drug therapy 
 
Responsible pharmacist: The pharmacist legally in charge of the 
pharmacy.  Each pharmacy must have a 
responsible pharmacist (South Africa. 
SAPC, 2010a). 
 
Scheduled medication: According to the Medicines and Related 
Substances Act 101 of 1965 (South Africa. 
National Parliament, 1965), medication is 
classified into a Schedule, between 0 and 7.  
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Schedule 3 and above requires a doctor’s 
prescription in order to be dispensed, whilst 
Schedule 2 and below are regarded as OTC 
medication.  Only up to Schedule 6 
medication can be kept in a pharmacy. 
 
Side-effect: See adverse effect   
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Appendix B: Written permission from three doctors and one dentist in the 
same medical complex as the pharmacy 
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Appendix C: Patient consent form 
 
I, ..................................................................., hereby give my informed consent to 
participate in the current study conducted by Dr Layla Cassim as part of her MBA 
research.  I also give her my informed consent to ask me my gender and race in her 
questionnaire, for the purposes of her research. 
 
Dr Cassim has explained her research project to me, and has assured me that my 
participation and responses to her questionnaire will be kept private, anonymous and 
confidential.  She has also given me a written statement containing details of her 
research project. 
 
I am aware that this research is conducted according to UNISA’s Policy on Research 
Ethics. 
 
 
 
 
Signature         Date 
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Appendix D: Written information provided to patients regarding the research 
project 
 
Dear Respondent 
 
As part of my MBA research, I am conducting a research project at XXX Pharmacy.  I am 
investigating the effect of the performance management system on the provision of pharmaceutical 
care to patients.  As part of this research, I am administering questionnaires to patients, to determine 
if pharmaceutical care is provided.  I am also interviewing the pharmacists and the pharmacist’s 
assistant, to learn more about the performance management system in the pharmacy and how this 
may affect the provision of pharmaceutical care. 
 
I am administering questionnaires to patients over a period of approximately two weeks, from 16-28 
February 2011.  Patients will be approached whilst in the pharmacy, as well as in the nearby doctors’ 
rooms in the medical centre.  I have the necessary permission of the owner of the pharmacy and the 
relevant doctors to approach patients in this manner.  The questionnaire will cover various services 
that form part of pharmaceutical care, and I will also be asking respondents whether they would like to 
receive these services.  There are no anticipated risks to you from participating in the study.  A 
possible benefit could be an improvement in the pharmaceutical services provided to you.   
 
I am the only researcher involved in this research.  I work at the Division of Clinical Pharmacology at 
the University of Cape Town, and my cellular telephone number is 074 999 5847.  XXX Pharmacy has 
been chosen as the site of this research, mainly due to the willingness of the owner of the pharmacy 
to have this research conducted at his pharmacy.  He is fully supportive of this study. 
 
I assure you that your participation and responses are completely private, anonymous and 
confidential.  You have the right not to participate in this study, and also the right not to complete the 
whole questionnaire once you have started, if you do not wish to do so.  Your name is not asked for 
on the questionnaire, and I will not disclose your responses to anyone.  I will be providing the owner 
of the pharmacy with a broad overview of the general research findings at the end of the project, but I 
will not be disclosing what individual participants’ responses are. 
 
I will be using the data obtained from questionnaires and from my interviews to write up my MBA 
thesis, and thereafter I hope to publish a paper in an academic journal on the study.  Once again, 
your privacy, anonymity and confidentiality will be completely protected.  This research is conducted 
in accordance with UNISA’s Policy on Research Ethics, and a copy of this can be made available to 
you, upon request. 
 
Thank you very much for your interest and participation, 
Dr Layla Cassim 
B.Pharm. (with distinction), PhD (Pharmacology) (Rhodes)    
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Appendix E: Semi-structured interview questions for pharmacists other than 
the owner-manager  
 
Dear X, 
 
Thank you so much for agreeing to be interviewed as part of my MBA research.  I 
am investigating the effect of the current performance management system at XXX 
Pharmacy on the provision of pharmaceutical care to patients.  It is hoped that the 
findings of my research project can contribute to improving the pharmaceutical 
services offered by the pharmacy.  I also have the permission of the owner of the 
pharmacy to conduct this research.  I have several questions that I would like to ask 
you.  I assure you that your responses are completely confidential and anonymous.  I 
will give a general summary of the broad research findings to the owner of the 
pharmacy, but I will not disclose to him what specific interviewees have said.  I am 
also not going to be recording the interview, but I will be taking notes.  I am happy to 
send you a typed copy of my notes tomorrow, or at your convenience, so that you 
could verify that the responses that I have typed for you are accurate.  This research 
is conducted in accordance with UNISA’s Policy on Research Ethics; I can give a 
copy of this to you, if you like.  You have the right not to participate in this interview, 
and also not to complete the interview, if you do not wish to do so.  Do you have any 
questions regarding the project before we begin? 
 
1 How long have you been practising as a pharmacist? 
2 How long have you worked at XXX Pharmacy? 
3 What do you understand by “pharmaceutical care”?  You don’t have to 
provide a technical definition, just the kinds of practices you believe are 
involved in pharmaceutical care. 
4 Do you believe that providing pharmaceutical care is a key responsibility for 
you?  Why or why not? 
5 Are you aware of the GPP standards for the provision of pharmaceutical 
care?  Please give a few examples of these standards. 
Dr Layla Cassim  Research Report MBA 5932 
311 
 
6 What is the vision of the pharmacy?  Is there a mission statement?  If so, what 
is the pharmacy’s mission statement? 
7 How is your performance managed at XXX Pharmacy? 
8 Do you have a written and signed job description? 
9 Are you aware of your roles and responsibilities in the pharmacy?  What are 
these? 
10 Are you aware of the SOPs that came into effect in August 2009?  Are you 
fully compliant with these SOPs?  Why or why not?  Do you think that these 
SOPs assist you to provide pharmaceutical care?  Please motivate your 
response. 
11 Have you been told by the managing pharmacist to follow these SOPs? 
12 When you started working at XXX Pharmacy, were you given training, 
orientation/ induction and information regarding the pharmacy and your role?  
Do you think that this has impacted on your ability to provide pharmaceutical 
care?  Why or why not? 
13 Are there regular performance appraisals?  Do you think that these help or 
hinder you from providing pharmaceutical care?  Why? 
14 If there are performance appraisals, do you give input in appraising your own 
performance?   
15 What performance objectives do you have?  In other words, what does the 
managing pharmacist expect you to do?  Do you have any targets?  Please 
elaborate; what kind of targets are these?   
16 Do you have any input in developing these performance targets or objectives?  
Do you think that these performance targets or objectives help or hinder you 
in providing pharmaceutical care?  Why? 
17 What are your working hours?  Do you feel that these working hours are too 
long or too short?  Do you think that your quantity of working hours helps or 
hinders you in providing pharmaceutical care?  Why or why not? 
18 Do you think that the number of pharmacists and pharmacist’s assistants 
employed by the pharmacy is sufficient to allow for pharmaceutical care to be 
provided to patients?  Why or why not? 
19 How many pharmacists are on duty at any point in time?  Do you think that 
this is a sufficient number to provide pharmaceutical care?  Why or why not?  
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Is it a sufficient number to adequately supervise the pharmacist’s assistant?  
Why or why not? 
20 Has the managing pharmacist ever identified that you needed additional 
training or development?  Or have you ever identified that you have training or 
development needs, and communicated these to the managing pharmacist? 
21 What was done about this (e.g. were you sent on any courses or workshops)?  
Did the additional training help you to provide better pharmaceutical care?  
Why or why not?  Could you please provide an example? 
22 Do you have a self-development/ individual development plan?  If you do, 
please tell me about this.  Does this help you to provide pharmaceutical care?  
How? 
23 Was there ever a time that the managing pharmacist told you that there was a 
problem with your performance?  Please tell me more about this.  What 
happened? 
24 How often are staff meetings?  What gets discussed at these meetings?  Do 
you think that these meetings help or hinder you and other pharmacists from 
providing pharmaceutical care?  Why? 
25 Do you have meetings that address dispensary-related problems and 
challenges?  Do you think that this helps or hinders you from providing 
pharmaceutical care?  Why? 
26 How would you describe the way in which the managing pharmacist manages 
the pharmacy?  Do you think that this encourages you to provide 
pharmaceutical care?  Why or why not? 
27 Do you often work shifts with the managing pharmacist? 
28 Do you feel that you have to follow the working style, practices or preferences 
of the managing pharmacist?  Could you please provide an example of how 
this has helped or hindered you from providing pharmaceutical care?  
29 How would you describe the culture in the dispensary and pharmacy?  Culture 
refers to “the way things are done around here”. 
30 Do you have good working relationships with your colleagues and the 
managing pharmacist?  What factors promote or hinder good working 
relationships with these individuals?  Do you think that these working 
relationships assist or prevent you from providing pharmaceutical care to 
patients?  Please motivate your response. 
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31 Are you able to develop good relationships with patients?  What factors 
promote or prevent this from occurring?  Do you think that your relationships 
with patients make it easier or more difficult to provide pharmaceutical care?  
Why? 
32 I won’t ask you what your remuneration is, but are you satisfied with your 
remuneration?  Do you think that it adequately reflects the extra 
responsibilities and duties in providing pharmaceutical care? 
33 How are you paid (e.g. monthly, hourly rate)? 
34 Do you get paid on time? 
35 Are there any other financial rewards that you get (e.g. performance-related 
bonus)?  Does this incentivise or motivate you to want to provide 
pharmaceutical care?  Why or why not? 
36 Do you receive any non-financial rewards (e.g. recognition at staff meetings)?  
Does this incentivise or motivate you to want to provide pharmaceutical care?  
Why or why not? 
37 If you were to provide pharmaceutical care, would you expect your financial 
rewards to increase?  Why or why not? 
38 At XXX Pharmacy, are you encouraged to participate in activities of the 
Pharmaceutical Society of South Africa?  Does this help or hinder you in 
providing pharmaceutical care?  Why? 
39 Are you involved in continuing professional development (CPD) activities?  
Does this help you in providing pharmaceutical care?  If so, how? 
40 Have you had any meetings to discuss the fact that CPD is being made 
compulsory from 2011 by the South African Pharmacy Council?  Please 
elaborate.  If you have had a meeting, what was decided upon?  Is there a 
plan to ensure that all pharmacists and the pharmacist’s assistant are 
compliant with CPD requirements? 
41 Do you have professional indemnity? 
42 Do you always offer patients generic medication, except when one cannot in 
terms of the Medicines and Related Substances Act?  Why or why not? 
43 Do you routinely analyse the appropriateness of a patient’s prescribed 
medication (e.g. in terms of dosage, allergies, the presence of drug-drug and 
drug-disease interactions)?  Why or why not?  What makes this feasible or 
difficult? 
Dr Layla Cassim  Research Report MBA 5932 
314 
 
44 Do you routinely: 
• Counsel patients about how to take their medication properly; 
• Provide advice and information on their pharmacotherapy; 
• Assess whether their medication is controlling or improving their 
medical conditions; and  
• Check for compliance with their pharmacotherapy?   
Why or why not?  What makes these tasks feasible or difficult? 
45 Have you ever performed a medication review for a patient?  This includes 
assessing the appropriateness of a patient’s drug therapy, developing a care 
plan and performing a follow-up evaluation to see if the patient is improving?  
If so, please tell me more about it.  How did the patient feel about the whole 
process?   
46 How often do you liaise with other health-care professionals, such as 
prescribers?  Does the managing pharmacist encourage you to do so?  Could 
you please give an example of how this has helped or hindered you in 
providing pharmaceutical care? 
47 Does the pharmacist’s assistant always work under the direct personal 
supervision of a pharmacist – either you or another pharmacist? 
48 How often do you check the pharmacist’s assistant’s work?  Please describe 
how exactly she is supervised? 
49 Do all dispensary employees wear a name tag indicating their name and 
designation?  Do you think that patients can identify who the pharmacists are 
and who the pharmacist’s assistant is? 
 
We are almost over; we just have ten questions left.  Thanks so much for your 
participation thus far. 
 
50 What control do you have over OTC sales?   
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51 Is OTC medication always selected for patients by a pharmacist or the 
pharmacist’s assistant, or do front-shop assistants also select OTC 
medication for patients? 
52 In providing OTC medication to patients, please describe the kinds of 
questions, if any, you ask patients?  What kind of patient counselling, if any, 
do you provide?  What makes it easy or difficult to ask patients questions or 
provide counselling regarding OTC medication? 
53 Is there a quality improvement plan for the pharmacy?  If so, please tell me 
more about it.  How involved are you in developing and assessing it?  Does 
this plan, or the lack of it, affect your ability to provide pharmaceutical care?  
How? 
54 Does the layout or design of the pharmacy help or hinder you in providing 
pharmaceutical care?  Why? 
55 In your opinion, do you comply fully with the GPP standards for 
pharmaceutical care? 
56 Do you think that there is anything that prevents you from fully complying with 
these GPP standards?  Please tell me more about this. 
57 Is there any aspect of the way in which your performance is managed that 
could be improved so that you could find it easier to comply fully with GPP 
standards for pharmaceutical care?  Please elaborate. 
58 Are there any specific or general problems you have with the performance 
management system in the pharmacy?  Please elaborate. 
59 Is there anything else you would like to mention? 
 
Thank you so much for your time and feedback.  It is much appreciated.  I assure 
you once again that your responses are completely anonymous and confidential.  
Would you like me to send you a typed copy of the interview, so that you could check 
the accuracy of the responses I have ascribed to you?   
 
 
  
Dr Layla Cassim  Research Report MBA 5932 
316 
 
Appendix F: Semi-structured interview questions for the owner-manager of the 
pharmacy 
 
Dear X, 
 
Thank you so much for agreeing to be part of my MBA research, and for allowing me 
to conduct my research at your pharmacy.  I am investigating the effect of the current 
performance management system in your pharmacy on the provision of 
pharmaceutical care to patients.  I have several questions that I would like to ask 
you.  I assure you that your responses are completely confidential and anonymous, 
and that the name of your pharmacy will not be disclosed in my thesis.  I will also not 
disclose any of your responses to the other pharmacists or the pharmacist’s 
assistant.  I am not going to be recording the interview, but I will be taking notes.  I 
am happy to send you a typed copy of my notes tomorrow, or at your convenience, 
so that you could verify the responses that I have typed for you as being accurate.  
This research is conducted in accordance with UNISA’s Policy on Research Ethics; I 
can give a copy of this to you, if you like.  You have the right not to participate in this 
interview, and also not to complete the interview, if you do not wish to do so.  Do you 
have any questions regarding the project before we begin? 
 
1 How long have you been practising as a pharmacist? 
2 How long have you worked at XXX Pharmacy? 
3 What do you understand by the term “pharmaceutical care”?  You don’t have 
to provide a technical definition, just the kinds of practices you believe are 
involved in pharmaceutical care. 
4 Do you believe that providing pharmaceutical care is a key responsibility for 
you and your pharmacy?  Why or why not? 
5 Are you aware of the GPP standards for the provision of pharmaceutical 
care?  Please give a few examples of these standards. 
6 What is your vision for the pharmacy?  Do you have a mission statement?  If 
so, what is your mission statement? 
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7 How do you manage the performance of your pharmacists and the 
pharmacist’s assistant? 
8 Do you have written and signed job descriptions for the dispensary staff? 
9 Are the dispensary staff aware of their roles and responsibilities?  If so, how 
did you tell them?  And what are these roles and responsibilities? 
10 Are the dispensary staff aware of the SOPs that came into effect in August 
2009? 
11 Have you told them to follow these SOPs?  Are you, your pharmacists and 
pharmacist’s assistant fully compliant with these SOPs?  Why or why not?  Do 
you think that these SOPs assist you and your pharmacists in providing 
pharmaceutical care?  Please motivate your response. 
12 When your pharmacists and pharmacist’s assistant started working here, 
were they given training, orientation/ induction and information regarding the 
pharmacy and their role?  Do you think that this has impacted on the 
pharmacists’ ability to provide pharmaceutical care, or the pharmacist’s 
assistant’s ability to provide patient counselling?  Why or why not? 
13 Are there regular performance appraisals?  Do you think that these help or 
hinder your pharmacists from providing pharmaceutical care, or the 
pharmacist’s assistant from providing patient counselling?  Why? 
14 If there are performance appraisals, do the pharmacists and pharmacist’s 
assistant give input in appraising their own performance? 
15 Do you ask them for feedback on your performance and the way in which you 
manage?  If so, kindly share what some of this feedback has been? 
16 What performance objectives do you have for the pharmacists and 
pharmacist’s assistant?  In other words, what do you expect them to do?  
17 Do you have any targets for them?  Please elaborate; what kind of targets are 
these?  How and how often do you set them?  How often do you revise your 
objectives?  Do the pharmacists and pharmacist’s assistant have any input in 
developing these performance targets or objectives?  Do you think that these 
performance targets or objectives help or hinder your pharmacists in providing 
pharmaceutical care, or your pharmacist’s assistant in providing patient 
counselling?  Why? 
18 What are your working hours and the working hours of your pharmacists?  Do 
you feel that these working hours are too long or too short?  Do you think that 
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the quantity of working hours helps or hinders you and your pharmacists in 
providing pharmaceutical care, or your pharmacist’s assistant in providing 
patient counselling?  Why or why not? 
19 Do you think that the number of pharmacists and pharmacist’s assistants 
employed by the pharmacy is sufficient to allow for pharmaceutical care to be 
provided to patients?  Why or why not? 
20 How many pharmacists are on duty at any point in time?  Do you think that 
this is a sufficient number to provide pharmaceutical care?  Why or why not?  
Is it a sufficient number to adequately supervise the pharmacist’s assistant?  
Why or why not? 
21 Have you ever identified that any pharmacist or pharmacist’s assistant needs 
additional training or development?  Or has any pharmacist or pharmacist’s 
assistant told you that he/ she has a specific training or development need? 
22 What was done about this (e.g. did you send them on any courses or 
workshops)?  Did the additional training help your pharmacists to provide 
better pharmaceutical care, or help your pharmacist’s assistant to better 
perform her job?  Why or why not?  Could you please provide an example? 
23 Do you have a self-development/ individual development plan?  If you do, 
please tell me about this.  Do your pharmacists and pharmacist’s assistant 
also have such a plan?  Does this help you and your pharmacists to provide 
pharmaceutical care?  How? 
24 Was there ever a time that you told a pharmacist or pharmacist’s assistant 
that you were not satisfied with his/ her performance?  Please tell me about 
this.  What happened?  What did you do? 
25 How often are staff meetings?  What gets discussed at these meetings?  Do 
you think that these meetings help or hinder you and your pharmacists from 
providing pharmaceutical care?  Why? 
26 Do you have meetings that address dispensary-related problems and 
challenges?  Do you think that this helps or hinders you and your pharmacists 
from providing pharmaceutical care?  Why? 
27 How would you describe the way in which you manage the pharmacy?  Do 
you think that it encourages your pharmacists to provide pharmaceutical 
care?  Why or why not? 
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28 Do you feel that you expect the other pharmacists to have to follow your 
working style, practices or preferences?  Could you please provide an 
example of how this has helped or hindered your pharmacists in providing 
pharmaceutical care?  
29 How would you describe the culture in the dispensary and pharmacy?  Culture 
refers to “the way things are done around here”. 
30 Do you have good working relationships with your dispensary employees?  
What factors promote or prevent good working relationships with these 
individuals?  Do you think that these working relationships assist or prevent 
you and your pharmacists from providing pharmaceutical care to patients, and 
the pharmacist’s assistant in providing patient counselling?  Please motivate 
your response. 
31 Are you and your dispensary employees able to develop good relationships 
with patients?  What factors promote or prevent this from occurring?  Do you 
think that the current relationships with patients make it easier or more difficult 
to provide pharmaceutical care?  Why? 
32 I won’t ask you what remuneration you offer, but do you think that your 
pharmacists and pharmacist’s assistant are satisfied with their remuneration?  
Do you think that the pharmacists’ remuneration adequately reflects the extra 
responsibilities and duties in providing pharmaceutical care? 
33 Are there any other financial rewards that you give to your pharmacists and 
pharmacist’s assistant (e.g. performance-related bonus)?  Do you think that 
this incentivises or motivates your pharmacists to want to provide 
pharmaceutical care, or your pharmacist’s assistant to provide patient 
counselling?  Why or why not? 
34 Do you give them any non-financial rewards (e.g. recognition at staff 
meetings)?  Do you think that this incentivises or motivates your pharmacists 
to want to provide pharmaceutical care, or your pharmacist’s assistant to 
provide patient counselling?  Why or why not? 
35 Do you think that if your pharmacists had to provide pharmaceutical care, and 
if the pharmacist’s assistant provided patient counselling, that they would 
expect their financial rewards to increase?  Why or why not? 
36 Do you encourage your pharmacists and pharmacist’s assistant to participate 
in activities of the Pharmaceutical Society of South Africa?  Do you participate 
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in such activities?  Does this help or hinder you and your pharmacists in 
providing pharmaceutical care?  Why? 
37 Are you involved in continuing professional development (CPD) activities?  Do 
you encourage your pharmacists and pharmacist’s assistant to be involved in 
these activities?  Does this help you and your pharmacists in providing 
pharmaceutical care, or your pharmacist’s assistant in performing her job?  If 
so, how? 
38 Have you had any meetings to discuss the fact that CPD is being made 
compulsory from 2011 by the South African Pharmacy Council?  Please 
elaborate.  If you have had a meeting, what was decided upon?  Is there a 
plan to ensure that all pharmacists and the pharmacist’s assistant are 
compliant with CPD requirements? 
39 Do you and your dispensary staff all have professional indemnity? 
40 Do you always offer patients generic medication, except when one cannot in 
terms of the Medicines and Related Substances Act?  Why or why not? 
41 Do you routinely analyse the appropriateness of a patient’s prescribed 
medication (e.g. in terms of dosage, allergies, the presence of drug-drug and 
drug-disease interactions)?  Why or why not?  What makes this feasible or 
difficult?  Do you encourage your pharmacists to perform such analysis?  Why 
or why not? 
42 Do you routinely: 
• Counsel patients about how to take their medication properly; 
• Provide advice and information on their pharmacotherapy; 
• Assess whether their medication is controlling or improving their 
medical conditions; and  
• Check for compliance with their pharmacotherapy?   
Why or why not?  What makes these tasks feasible or difficult? 
43 Have you ever performed a medication review for a patient?  This includes 
assessing the appropriateness of a patient’s drug therapy, developing a care 
plan and performing a follow-up evaluation to see if the patient is improving?  
If so, please tell me more about it.  How did the patient feel about the whole 
process?   
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44 How often do you liaise with other health-care professionals, such as 
prescribers?  Do you encourage your pharmacists and pharmacist’s assistant 
to liaise with other health-care professionals?  Could you please give an 
example of how this has helped or hindered you or your pharmacy in 
providing pharmaceutical care? 
45 Does the pharmacist’s assistant always work under the direct personal 
supervision of a pharmacist – either you or another pharmacist? 
46 Are you a registered tutor with the South African Pharmacy Council? 
47 How often do you check the pharmacist’s assistant’s work?  Please describe 
how exactly she is supervised? 
48 Do all dispensary employees wear a name tag indicating their name and 
designation?  Do you think that patients can identify who the pharmacists are 
and who the pharmacist’s assistant is? 
49 What control do you and the other pharmacists have over OTC sales?   
 
We are almost over; we just have ten questions left.  Thanks so much for your 
participation thus far. 
 
50 Is OTC medication always selected for patients by a pharmacist or the 
pharmacist’s assistant, or do front-shop assistants also sometimes select 
OTC medication for patients? 
51 In providing OTC medication to patients, please describe the kinds of 
questions, if any, you and your dispensary staff ask patients?  What kind of 
patient counselling, if any, do you provide?  What makes it easy or difficult to 
ask patients questions or provide counselling regarding OTC medication? 
52 How do you manage and ensure quality in the pharmacy? 
53 Do you have a quality improvement plan for the pharmacy?  If so, please tell 
me more about it.  How often do you assess it?  Are the other pharmacists 
also involved in assessing it?  Does this plan, or the lack of it, affect your 
pharmacy’s ability to provide pharmaceutical care?  How? 
54 Does the layout or design of the pharmacy help or hinder you in providing 
pharmaceutical care?  Why? 
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55 In your opinion, do you and your pharmacists comply fully with the GPP 
standards for pharmaceutical care? 
56 Do you think that there is anything that prevents you and your pharmacists 
from fully complying with these GPP standards?  Please tell me more about 
this. 
57 Is there any aspect of the way in which you manage performance that could 
be improved so that your pharmacy complies fully with GPP standards for 
pharmaceutical care?  Please elaborate. 
58 Are there any specific or general problems you have with the performance 
management system in the pharmacy?  Please elaborate. 
59 Is there anything else you would like to mention? 
 
Thank you so much for your time and feedback.  It is much appreciated.  I assure 
you once again that your responses are completely anonymous and confidential.  
Would you like me to send you a typed copy of the interview, so that you could check 
the accuracy of the responses I have ascribed to you?   
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Appendix G: Semi-structured interview questions for the pharmacist’s 
assistant 
 
Dear X, 
 
Thank you so much for agreeing to be part of my MBA research.  I am investigating 
the effect of the current performance management system at XXX Pharmacy on the 
provision of pharmaceutical care to patients.  It is hoped that the findings of my 
research project can contribute to improving the pharmaceutical services offered by 
the pharmacy.  I also have the permission of the owner of the pharmacy to conduct 
this research.  I have several questions that I would like to ask you.  I assure you that 
your responses are completely confidential and anonymous.  I will give a general 
summary of the broad research findings to the owner of the pharmacy, but I will not 
disclose to him what specific interviewees have said.  I am also not going to be 
recording the interview, but I will be taking notes.  I am happy to send you a typed 
copy of my notes tomorrow, or at your convenience, so that you could verify that the 
responses that I have typed for you are accurate.  This research is conducted in 
accordance with UNISA’s Policy on Research Ethics; I can give a copy of this to you, 
if you like.  You have the right not to participate in this interview, and also not to 
complete the interview, if you do not wish to do so.  Do you have any questions 
regarding the project before we begin? 
 
1 How long have you been practising as a pharmacist’s assistant? 
2 How long have you worked at XXX Pharmacy? 
3 What category of pharmacist’s assistant are you (i.e. basic or post-basic)? 
4 What do you understand by the term “pharmaceutical care”?  You don’t have 
to provide a technical definition, just the kinds of practices you believe are 
involved in pharmaceutical care. 
5 Do you believe that providing pharmaceutical care is a key responsibility for 
this pharmacy?  Why or why not? 
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6 Do you believe that providing patient counselling is a key responsibility for 
you?  Why or why not? 
7 What is the vision of the pharmacy?  Is there a mission statement?  If so, what 
is the pharmacy’s mission statement? 
8 How is your performance managed at XXX Pharmacy? 
9 Do you have a written and signed job description? 
10 Are you aware of your roles and responsibilities in the pharmacy?  What are 
these? 
11 Are you aware of the SOPs that came into effect in August 2009?  Are you 
fully compliant with these SOPs?  Why or why not?  Do you think that these 
SOPs assist you to perform your job better?  Please motivate your response. 
12 Have you been told by the managing pharmacist to follow these SOPs? 
13 When you started working at XXX Pharmacy, were you given training, 
orientation/ induction and information regarding the pharmacy and your role? 
14 Are there regular performance appraisals? 
15 If so, do you give input in appraising your own performance? 
16 What performance objectives do you have?  In other words, what does the 
managing pharmacist expect you to do?   
17 Do you have any targets?  Please elaborate; what kind of targets are these?  
Do you have any input in developing these performance targets or objectives? 
18 What are your working hours?  Do you feel that these working hours are too 
long or too short?  Do you think that your quantity of working hours helps or 
hinders you in providing patient counselling?  Why or why not? 
19 Do you think that the number of pharmacists and pharmacist’s assistants 
employed by the pharmacy is sufficient to allow for pharmaceutical care to be 
provided to patients?  Why or why not? 
20 How many pharmacists are on duty at any point in time?  Do you think that 
this is a sufficient number to adequately supervise you as a pharmacist’s 
assistant?  Why or why not? 
21 Has the managing pharmacist ever identified that you needed additional 
training or development?  Or have you ever identified that you have training or 
development needs, and communicated these to the managing pharmacist? 
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22 What was done about this (e.g. were you sent on any courses or workshops)?  
Did the additional training help you to do your job better?  Why or why not?  
Could you please provide an example? 
23 Do you have a self-development/ individual development plan?  If you do, 
please tell me about this. 
24 Was there ever a time that the managing pharmacist told you that there was a 
problem with your performance?  Please tell me more about this.  What 
happened? 
25 How often are staff meetings?  What gets discussed at these meetings? 
26 Do you have meetings that address dispensary-related problems and 
challenges?   
27 How would you describe the way in which the managing pharmacist manages 
the pharmacy? 
28 Do you often work shifts with the managing pharmacist? 
29 How would you describe the culture in the dispensary and pharmacy?  Culture 
refers to “the way things are done around here”. 
30 Do you have good working relationships with your colleagues and the 
managing pharmacist?  What factors promote or hinder good working 
relationships with these individuals?  Do you think that these working 
relationships promote or prevent you from providing counselling to patients?  
Please motivate your response. 
31 Are you able to develop good relationships with patients?  What factors 
promote or prevent this from occurring?  Do you think that your relationships 
with patients make it easier or more difficult to provide patient counselling?  
Why? 
32 Do you always work under the direct personal supervision of a pharmacist? 
33 How exactly does a pharmacist supervise your work? 
34 I won’t ask you what your remuneration is, but are you satisfied with your 
remuneration? 
35 How are you paid (e.g. monthly, hourly rate)? 
36 Do you get paid on time? 
37 Are there any other financial rewards that you get (e.g. performance-related 
bonus)?  Does this incentivise or motivate you to want to provide patient 
counselling?  Why or why not? 
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38 Do you receive any non-financial rewards (e.g. recognition at staff meetings)?  
Does this incentivise or motivate you to want to provide patient counselling?  
Why or why not? 
39 If you were to provide more patient counselling, would you expect your 
financial rewards to increase?  Why or why not? 
40 At XXX Pharmacy, are you encouraged to participate in activities of the 
Pharmaceutical Society of South Africa?  Does this help or hinder you in 
doing your job better?  Why? 
41 Are you involved in continuing professional development (CPD) activities?  
Does this help you in performing your job better?  If so, how? 
42 Have you had any meetings to discuss the fact that CPD is being made 
compulsory from 2011 by the South African Pharmacy Council?  Please 
elaborate.  If you have had a meeting, what was decided upon?  Is there a 
plan to ensure that all pharmacists and the pharmacist’s assistant are 
compliant with CPD requirements? 
43 Do you have professional indemnity? 
44 Do you always offer patients generic medication, except when one cannot in 
terms of the Medicines and Related Substances Act?  Why or why not? 
45 Do you routinely counsel patients about how to take their medication properly 
and provide advice and information on their pharmacotherapy?  Why or why 
not?  What makes this feasible or difficult? 
46 Do all dispensary employees wear a name tag indicating their name and 
designation?  Do you think that patients can identify who the pharmacists are 
and who the pharmacist’s assistant is? 
 
We are almost over; we just have ten questions left.  Thanks so much for your 
participation thus far. 
 
47 How often do you liaise with other health-care professionals, such as 
prescribers?  Does the managing pharmacist encourage you to do so?  Could 
you please give an example of how this has helped or hindered you in 
providing patient counselling, or in assisting the pharmacists? 
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48 Is OTC medication always selected for patients by a pharmacist or the 
pharmacist’s assistant, or do front-shop assistants also select OTC 
medication for patients? 
49 In providing OTC medication to patients, please describe the kinds of 
questions, if any, you ask patients?  What kind of patient counselling, if any, 
do you provide?  What makes it easy or difficult to ask patients questions or 
provide counselling regarding OTC medication? 
50 Is there a quality improvement plan for the pharmacy?  If so, please tell me 
more about it.  How involved are you in developing and assessing it?  Does 
this plan, or the lack of it, affect your ability to do your job?  How? 
51 Does the layout or design of the pharmacy help or hinder you in providing 
patient counselling?  Why? 
52 Are you aware of the GPP standards, which outline your scope of practice as 
a pharmacist’s assistant?  
53 In your opinion, do you always practice within your scope of practice or are 
you sometimes expected to perform other functions that a pharmacist’s 
assistant is not supposed to do?  If yes to the latter, why is this?  Could you 
please provide me with an example? 
54 Is there any aspect of the way in which your performance is managed that 
could be improved so that you could find it easier to comply fully with GPP 
standards for your scope of practice?  Please tell me more about this. 
55 Are there any specific or general problems you have with the performance 
management system in the pharmacy?  Please elaborate. 
56 Is there anything else you would like to mention? 
 
Thank you so much for your time and feedback.  It is much appreciated.  I assure 
you once again that your responses are completely anonymous and confidential.  
Would you like me to send you a typed copy of the interview, so that you could check 
the accuracy of the responses I have ascribed to you?   
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Appendix H: Mind-map showing the unravelling of the research problem and 
emerging themes 
 
 
 
 
 
 
 
 
 
 
 
 
  
Effect of PMS on 
pharmaceutical care
Is pharmacy compliant 
with GPP standards for 
pharmaceutical care?
Emphasis on 
serving patients 
efficiently and 
quickly - is there 
sufficient time to 
provide 
comprehensive 
pharmaceutical 
care to each 
patient?How is 
performance 
managed and 
measured?  
KPIs?
Are rewards reflective 
of responsibilities in 
providing 
pharmaceutical care?
From whose 
perspective?  
Patients, 
pharmacists, 
SAPC? 
Consequences 
of possible non-
compliance?  
Professional, 
legal risks to 
pharmacy; DRP 
in patients. 
What about the management-
related GPP standards that are 
supposed to promote 
pharmaceutical care, e.g. job 
descriptions, performance 
appraisals?  None of these 
present in pharmacy. 
Time required to ask 
patients questions (e.g. 
allergies, side-effects, co-
morbidities), analyse 
prescriptions, provide 
patient counselling.  Is there 
time to do all this, e.g. if 
pharmacy busy, or given the 
shortage of pharmacists? 
Quantitative KPIs used, 
e.g. number of 
prescriptions dispensed, 
time per prescription.  
Pharmacists are not 
expected to spend more 
than a few minutes on 
each prescription. 
What about qualitative 
KPIs, e.g. to assess 
customer satisfaction?  
Any KPIs for 
pharmaceutical care? 
E.g. 
generics? 
Do pharmacists view the provision of 
pharmaceutical care as a key 
performance area?  Do they actually 
want to provide this, see this as a 
professional responsibility? 
Focus on operational 
efficiency because high 
patient load, shortage of 
dispensary employees. 
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Appendix I: Use of an Ishikawa diagram, adapted from Gwiazda (2005) cited in 
Gwiazda (2006: 440) to illustrate several main themes of the research and 
important aspects shaping how the research was conducted  
 
 
 
 
Effects of PMS on 
provision of 
pharmaceutical 
care to patients? 
People 
Shortage of dispensary employees to 
provide pharmaceutical care? 
How to determine whether the pharmacy complies 
with GPP standards?  Would pharmacists be 
completely honest in their responses?  How about 
asking patients if they perceive certain GPP 
standards as being adhered to? 
Does culture promote pharmaceutical care?  Do 
pharmacists see it as a key performance area? 
Hold interviews with all dispensary employees, and 
administer questionnaires to patients (sample size 
of at least 150?). 
Equipment 
Author has GraphPad Prism software for 
statistical analysis of questionnaire results. 
Do patients want pharmaceutical care? 
Cost of conducting telephonic interviews 
may be high. 
Do patient demographics influence patient 
responses? 
Material 
Material required in project:  latest GPP 
standards document, printed copies of 
questionnaire (might be costly to print). 
Method 
Benefits of using a triangulation 
approach. 
Quantitative research method:  administration of 
survey questionnaires to patients, to determine if 
pharmacy complies with GPP standards for 
pharmaceutical care.  Get patients to complete 
questionnaire then and there, to increase response 
rate.  Only have 2 weeks away from work to do this 
data collection. 
Qualitative research method:  conducting semi-structured one-on-one 
interviews with all dispensary employees, to find out the effects of specific 
components of the PMS on the provision of pharmaceutical care.  Will have 
to conduct interviews telephonically, because:  (i) will not be able to take 
time off work to make another trip to Johannesburg for this; (ii) will not 
have time during 2 weeks in which patient questionnaires are administered, 
as questionnaire sample size is large and the author is the only researcher 
involved; (iii) not sure how willing patients are going to be to complete the 
questionnaire, so it may well take the full 2 weeks; and (iv) 2 weeks has to 
include pilot test of questionnaire. 
Management 
Owner-manager is fully supportive of 
the research project, proposed 
methodology. 
Measurement 
How is performance measured in 
the dispensary and pharmacy?  
KPIs?  Performance appraisals? 
How do we measure compliance 
with GPP standards for 
pharmaceutical care?  Surely the 
SAPC/ patients would expect “full” 
compliance?  How do we quantify 
this?  What percentage of patients 
would have to indicate a service is 
provided for one to conclude that 
the pharmacy complies with the 
GPP standard? 
Environment 
Regulatory pressures to comply 
with GPP standards?  SAPC? 
Must pilot test both questionnaire and interview questions. 
